8808605	cell selection
8808605	x-chromosome
8808605	hemizygous males
8808605	blood-cell phenotype
8808605	g6pd-normal
8808605	g6pd bari
8808605	glucose-6-phosphate dehydrogenase mutations
8808605	major determinant
8808605	somatic-cell mosaicism creates
8808605	severe enzyme deficiency
8808605	blood cell types
8808605	red-blood-cell glucose-6-phosphate dehydrogenase
8808605	g6pd portici
8808605	significant concordance
8808605	chronic nonspherocytic hemolytic anemia
8808605	g6pd
8808605	blood cells
8808605	small subset
8808605	enzyme-deficient phenotype
8808605	deficiency affects
8808605	pluripotent blood stem cells
8808605	significant excess
8808605	different blood-cell lineages
8808605	phenotypic characteristic
8808605	selective mechanism
8808605	heterozygous females
8808605	lymphoid cell lineages
8808605	somatic-cell
8808605	random process
9050866	exposure
9050866	genome damage
9050866	cell cycle regulation
9050866	microsomal fractions
9050866	premature protein termination
9050866	nuclear protein
9050866	high-molecular weight protein
9050866	atm
9050866	protein levels
9050866	peripheral blood lymphocytes
9050866	p53 levels
9050866	ataxia-telangiectasia patients homozygous
9050866	time interval
9050866	normal human cells
9050866	human fibroblasts
9050866	amino acid sequence
9050866	cell cycle
9050866	ataxia-telangiectasia gene
9050866	dna
9050866	radiomimetic drug neocarzinostatin
9050866	human lymphoblast cells
9050866	truncated atm
9050866	ataxia-telangiectasia gene product
9012409	missense mutation
9012409	enzyme thermal stability
9012409	lymphoblast cell lines
9012409	n314d/n314d
9012409	% reduction
9012409	neutral polymorphism
9012409	n314d-containing
9012409	d/d galt
9012409	wild type
9012409	galactose-1-phosphate uridyltransferase
9012409	characteristic isoform
9012409	enzyme activity
9012409	la
9012409	thermal lability
9012409	identical initial enzyme activity
9012409	n314d
9012409	molecular
9012409	l218l
9012409	la/n
9012409	n/n
9012409	base-pair transition 1721c
9012409	amino acid
9012409	biochemical phenotype
9012409	pedigree analyses
9012409	enzyme variant
9012409	different biochemical phenotypes
9012409	d/d
9012409	molecular genotype
9012409	la/d
9012409	human orythrocytes
9012409	protein abundance
9012409	translation rates
9012409	variant galactosemia
9012409	la/g
9012409	los angeles
9012409	n/n galt
9012409	duarte
9012409	favorable codon bias
9012409	comparable genotypes
9012409	biochemical phenotypes
9012409	degrees c
9012409	galt
8755645	missense mutation
8755645	lecithin cholesterol acyltransferase
8755645	lariat branchpoint sequence
8755645	sequencing
8755645	point mutation
8755645	human disorder
8755645	applicable strategy
8755645	nuclear precursors
8755645	vitro expression
8755645	fed
8755645	null allele
8755645	intronic defects
8755645	lcat
8755645	pcr
8755645	distinct intronic nucleotide sequence
8755645	central role
8755645	complete intron retention
8755645	fish-eye disease
8755645	ivs4 t-22c
8755645	compound heterozygosity
8755645	lariat branchpoint consensus sequence causes
8755645	reverse transcriptase
8755645	underlie differential gene expression
8755645	lariat structure
8755645	gene defect
8755645	normal human mrna processing
8755645	intronic mutation
8755645	branchpoint region
8755645	mrna results
8751855	mutation analyses
8751855	genetic
8751855	common hereditary forms
8751855	north american hereditary breast cancers
8751855	north american population
8751855	susceptibility gene
8751855	mutation
8751855	hereditary breast cancer
8751855	hereditary cancer
8751855	brca1
8751855	confer hereditary breast
8751855	ovarian cancer risk
8751855	twenty-three
8751855	chromosomes 17q
8751855	additional susceptibility genes
8751855	breast cancer
8751855	high-risk breast cancer research programs
8751855	ovarian cancer cases
8751855	brca2
8751855	additional genes
8674108	+/- mice
8674108	mutant blastocyst growth
8674108	tumor suppressor gene
8674108	ovarian cancers
8674108	mutant mice
8674108	buttressing
8674108	cell proliferation
8674108	lack tumors
8674108	vivo observations
8674108	extraembryonic region
8674108	cyclin-dependent kinase inhibitor p21
8674108	brca1
8674108	mesoderm formation
8674108	mutations
8674108	homozygous brca1
8674108	embryonic cellular proliferation
8674108	wild-type tetraploid embryos
8674108	mutant
8674108	mutant embryos
8674108	p53 activity
8674108	different germ layers
9223312	pax3-fkhr
9223312	alveolar rhabdomyosarcoma
9223312	furthermore
9223312	variant t
9223312	wild-type loci
9223312	copy number-independent process
9223312	solid tumors result
9223312	gene-specific mechanisms
9223312	chimeric proteins
9223312	tumorigenic potential
9223312	pax3
9223312	fusion gene amplification
9223312	pax7-fkhr
9223312	overexpression mechanisms ensure
9223312	overexpression occurs
9223312	solid tumor alveolar rhabdomyosarcoma
9223312	consistent t
9223312	alternative chromosomal translocations
9223312	chromosomal
9223312	transcription
9223312	distinct mechanisms
9223312	fusion
9223312	overexpression results
9223312	gene product
9223312	translocation generates
9223312	fusion proteins
9223312	fusion product overexpression
9223312	functional alterations
9223312	critical level
8917548	mature sperm
8917548	discrete molecular species
8917548	generate mice
8917548	spontaneous apoptosis
8917548	cell maturation
8917548	high level
8917548	mouse model
8917548	furthermore
8917548	protein exists
8917548	severe defects
8917548	atm-deficient
8917548	atm
8917548	ataxia-telangiectasia patients
8917548	ataxia-telangiectasia protein-deficient mice
8917548	pleiotropic
8825599	r =
8825599	molecular analysis
8825599	different variants
8825599	seattle-like
8825599	a-variants
8825599	blood samples
8825599	enzyme defect
8825599	fit line
8825599	muscle
8825599	dna
8825599	mediterranean
8825599	quadriceps muscle
8825599	g6pd
8825599	glucose-6-phosphate dehydrogenase deficiency
8825599	p =
8825599	genetic variant
8825599	390x +
8825599	male subjects
8825599	significant relationship
9072974	protein tyrosine phosphatase domain
9072974	breast cancer cell lines
9072974	homozygous deletions
9072974	mapping
9072974	candidate tumor suppressor gene
9072974	prostate cancer
9072974	suppress tumor cell growth
9072974	considerable frequency
9072974	pten
9072974	human cancers
9072974	prostate cancer cell lines
9072974	primary glioblastomas
9072974	preliminary screens
9072974	focal adhesions
9072974	human brain
9072974	actin filaments
9072974	putative protein tyrosine phosphatase gene
9072974	human chromosome
9072974	tumor cell invasion
9072974	extensive homology
9072974	protein tyrosine kinases
9072974	glioblastoma cell lines
8898652	pancreatic cancers
8898652	amino acid substitutions
8898652	primary colorectal cancer specimens
8898652	chromosome region
8898652	single-strand conformation polymorphism
8898652	methods mutation
8898652	such frequent allelic loss
8898652	somatic
8898652	conclusions
8898652	tumor-suppressor gene
8898652	aims
8898652	dpc4
8898652	minority show
8898652	allelic loss
8898652	somatic 12-base pair deletion
8898652	results
8898652	missense mutations
8898652	background
8898652	polymerase chain reaction
8898652	human colorectal cancers
8898652	dna
8898652	colorectal cancers
8898652	present study
8938427	low incidence
8938427	centromere-1fp 35-vat1-rho7-brca1-1a1-3b-telomer
8938427	somatic mutations suggests
8938427	sporadic tumors occurs
8938427	gtp
8938427	intragenic microsatellite markers
8938427	chromosomal instability
8938427	ribosomal protein pseudogene
8938427	d17s855
8938427	potential transcriptional regulatory elements
8938427	d17s1323
8938427	genomic region
8938427	ifp
8938427	cholinergic synaptic vesicles
8938427	rho7
8938427	tumor suppressive function
8938427	high density
8938427	brca1
8938427	breast-ovarian cancer susceptibility gene
8938427	loss
8938427	human chromosome
8938427	repetitive sequences
8938427	abundant membrane protein
8938427	rho family
8938427	b-box
8938427	protein pseudogene
8938427	complete
8938427	possible features
8938427	alu
8938427	81-kb region
8938427	genomic sequence
8938427	specific library
8938427	interstitial chromosomal deletion
8938427	alternative mechanisms
8938427	l21
8938427	vat1
8938427	dna
8938427	wild-type allele
8938427	d17s1322
8938427	leucine zipper protein
8938427	complete genes
8938427	contig contains
8938427	partial
8938427	intron lengths range
8621452	immunofluorescence studies
8621452	g1930
8621452	a11
8621452	drw1
8621452	amino acid substitutions
8621452	phe
8621452	different missense mutations
8621452	gly444
8621452	bfs
8621452	b5
8621452	null allele
8621452	type ii c2q0
8621452	molecular basis
8621452	complement protein
8621452	type ii
8621452	ser189
8621452	drw4
8621452	type ii c2
8621452	type
8621452	c4a3b1
8621452	l-cells
8621452	subsequent molecular biology
8621452	a2
8621452	b35
8621452	c4a0b1
8621452	mhc
8621452	arg
8621452	secretory pathway
8621452	c2q0
8621452	c2
8621452	gene product
8621452	major histocompatibility haplotypes
8621452	selective block
8621452	c566
8621452	allele-specific
8621452	human complement
8843194	initial
8843194	growth retardation
8843194	diverse group
8843194	thymic lymphoma
8843194	knockout animals
8843194	human disease ataxia-telangiectasia
8843194	normal growth
8843194	zygotene/pachytene stage
8843194	t-cell-dependent
8843194	histologic examination
8843194	tumor suppression
8843194	mutant mice
8843194	cellular processes
8843194	thymic lymphomas
8843194	mice results
8843194	chromosomal fragmentation
8843194	gene product plays
8843194	immune development
8843194	abnormal chromosomal synapsis
8843194	atm
8843194	meiosis
8843194	b220
8843194	gene recreates
8843194	physiological roles
8843194	somatic tissues
8843194	cell-cycle checkpoint control
8843194	immune defects
8843194	immune
8843194	subsequent chromosome fragmentation
8843194	immune responses
8843194	gross behavioral abnormalities
8843194	homologous recombination
8843194	dna
8843194	targeted
8843194	atm-/-
8843194	meiotic failure
8843194	homozygous mutant
8843194	pre-b cells
8843194	essential role
8843194	cd43-
8843194	functional impairment
8700509	pseudo-brca1 exon 1a
8700509	sporadic breast/ovarian tumorigenesis
8700509	acidic ribosomal phosphoprotein
8700509	adjacent 1a1-3b gene
8700509	genomic region
8700509	critical step
8700509	intron-exon structure
8700509	tandem duplication
8700509	reveals maintenance
8700509	brca1
8700509	evolutionary terms
8700509	human chromosome
8700509	breast/ovarian cancer susceptibility gene
8700509	arpp1
8700509	nucleotide sequence identity
8700509	high degree
8700509	recent event
8700509	p1
8700509	genome contains
8700509	sequence
8700509	dna
8700509	base pair intergenic region
8700509	mutation analysis
8700509	abnormal regulation
9241281	diseases ataxia-telangiectasia
9241281	complete resistance
9241281	additional loss
9241281	significant manner
9241281	acute radiation toxicity
9241281	damage response
9241281	mice heterozygous
9241281	null alleles
9241281	human tumours
9241281	dramatic acceleration
9241281	t-cell
9241281	genotypic combinations
9241281	similar roles
9241281	li-fraumeni
9241281	radiation sensitivity
9241281	organismal level
9241281	p53 apoptotic pathways
9241281	mutations
9241281	tumour formation
9241281	genes collaborate
9241281	atm-null
9241281	cellular proliferation
9241281	thymocyte development
9241281	mice
9241281	dna
9241281	finally-and
9241281	null mice
9241281	separate atm effector pathway
9241281	cell-cycle checkpoints
9218625	haplotype studies
9218625	c6
9218625	c7
9218625	splice defect
9218625	irish family
9218625	deficiency mutation
9218625	israeli
9218625	southern blots
9218625	molecular basis
9218625	different defects
9218625	israeli c7-deficient
9218625	molecular
9218625	irish families
9218625	exon pcr
9218625	moroccan sephardic
9218625	splice acceptor site
9218625	intergenic recombination
9218625	jewish origin
9218625	mis-sense mutation
9218625	gene region
9218625	appreciable antiquity
9218625	marker
8931701	mutation hotspots
8931701	mutation data
8931701	cumulative
8931701	cumulative data
8931701	wasp
8931701	extensive clinical heterogeneity
8931701	mild forms
8931701	x-linked
8931701	phenotype concordance
8931701	disparate phenotypes
8931701	severe disease
8931701	phenotypic outcome
8931701	genotype-phenotype disparities
8931701	identification
8931701	gene defects
8931701	n-terminal
8931701	missense mutations
8931701	was
8931701	substantial portion
8931701	wiskott-aldrich
8931701	immunodeficiency disease
8931701	mild cases
8931701	gene lesions
8931701	disease severity
8931701	similarly
8661102	region homologous
8661102	variable levels
8661102	mouse homolog
8661102	% overall identity
8661102	amino acids
8661102	mouse chromosome
8661102	band 9c
8661102	a-t
8661102	open reading frame
8661102	ataxia-telangiectasia gene
8661102	% similarity
8661102	situ hybridization
8661102	linkage analysis
8661102	human chromosome 11q22-q23
8661102	identification
8661102	different tissues
8661102	atm
8661102	fluorescence
8661102	chromosomal localization
8782829	missense mutation
8782829	endometrial cancer
8782829	microsatellite instability
8782829	extra nucleotides
8782829	length alterations
8782829	mutation
8782829	introducing
8782829	mismatch repair genes
8782829	mutant cell line
8782829	detectable mutations
8782829	functional role
8782829	human tumours
8782829	hhua
8782829	fen1
8782829	hnpcc
8782829	endometrial carcinomas
8782829	extracts
8782829	endometrial carcinoma
8782829	together
8782829	sporadic tumours exhibit instability
8782829	gene encodes
8782829	subsequent search
8782829	human homolog
8782829	heteroduplex repair
8782829	cell line
8782829	certain substrates
8782829	frameshift mutation
8782829	endometrial carcinoma cell line
8782829	msh3
8782829	gene mutation
8782829	rth
8782829	mismatch repair
8782829	dna
8782829	genomic instability
8782829	repetitive sequence elements
8782829	pre-mutational intermediates
8782829	msh6
8782829	hereditary nonpolyposis colorectal cancer
9066888	joint mobility
9066888	original patient
9066888	w. kniest
9066888	molecular defect
9066888	molecular findings
9066888	active life
9066888	col2a1
9066888	short stature
9066888	dna
9066888	gt
9066888	splice site
9066888	defective formation
9066888	molecular
9066888	severe chondrodysplasia
9066888	small inframe deletions
9066888	kniest
9066888	splice site mutations
9066888	ii
8841191	rare non-jewish patients
8841191	hereditary breast cancer
8841191	familial breast cancer
8841191	jewish population frequencies
8841191	comparable percentage
8841191	jewish samples
8841191	brca2
8841191	jewish population
8841191	study confirms
8841191	carrier frequency
8841191	5382insc mutation
8841191	large-scale population study
8841191	frequent mutation
8841191	different haplotype
8841191	brca
8841191	protein truncation
8841191	brca1
8841191	ashkenazi
8841191	breast cancer
8841191	ashkenazim
8841191	% lifetime risk
8841191	frequent mutation alleles
8841191	common mutations
8841191	mutations
8841191	breast cancer cases
8841191	jewish women
8841191	carrier females
8841191	jewish individuals
8841191	male breast cancer patients
8841191	6174delt mutation constitute
8841191	whereas mutations
8841191	185delag mutation
8841191	breast/ovarian cancer
8841191	6174delt mutation
8678979	corresponding equivalent chromosome locus
8678979	chr
8678979	chromosome
8678979	mapping
8678979	evolutionary pathway
8678979	fish
8678979	human descent
8678979	dna
8678979	rb1
8678979	phylogenetic marker
8678979	unique sequence human
9182899	kidney allografts
9182899	patients complement
9182899	agarose gels
9182899	haemolytic assays
9182899	deficiency genes
9182899	c6
9182899	c9
9182899	c7
9182899	alternative pathway activity
9182899	complete deficiency
9182899	complement function
9182899	elisa
9182899	c9-deficient
9182899	serological
9182899	low normal classical pathway
9182899	trace concentrations
9182899	western blot analysis
9182899	surprisingly
9182899	difficulties
9182899	compound heterozygote
9182899	caucasians
9182899	dna
9020847	genomic sequences
9020847	different human
9020847	molecular mechanisms
9020847	45-kb genomic segment
9020847	clinical severity
9020847	moderate
9020847	cag
9020847	tissues shows length mosaicism
9020847	ctgs
9020847	somatic repeat instability
9020847	transgenic mice
9020847	n repeat
9020847	different cell lineages
9020847	utr
9020847	ctg
9020847	55-ctg repeat
9020847	dmpk
9020847	triplet instability
9020847	mouse models
9020847	protein kinase gene
9020847	individuals whereas
9020847	myotonic
9020847	mitotic instability analysis
9020847	n trinucleotide repeat
9020847	somatic instability
9020847	dm
9174057	agg
9174057	gene encodes
9174057	mutations
9174057	cytogenetic level
9174057	different tumor types
9174057	arginine-rich protein gene
9174057	arp
9174057	specific mutation
9174057	pancreatic tumors
9174057	pcr
9174057	pancreatic cancer
9174057	chromosomal band
9174057	shridhar
9174057	different solid tumors
9174057	atg50
9174057	arginine-rich protein
9174057	present study
9083764	short stature
9083764	type 1a
9083764	identify distinct subgroups
9083764	kniest
9083764	type 1b
9083764	heterogeneity
9083764	genotype-phenotype correlations
9083764	bone dysplasia
9083764	original descriptions
9083764	schwartz
9083764	genetic linkage
9083764	primary bone dysplasia
9083764	bone changes
9083764	different mutations
9083764	aberfeld
9083764	mild skeletal changes
9083764	secondary consequences
9083764	schwartz-jampel
9083764	chromosome 1p36-34
9083764	genetic
9083764	chondrodystrophic myotonia
9083764	chromosomal region 1q36-34
9083764	own patients
9083764	pyle
9083764	sjs
9083764	mck
9083764	conclusions sjs
9083764	tentative clinico-radiological classification
9083764	clinical course
9083764	different types
9083764	moderate bone dysplasia
9083764	jampel
8636252	cerebral form
8636252	addison
8636252	ald
8636252	peripheral nerves
8636252	adrenomyeloneuropathy
8636252	primary idiopathic adrenocortical insufficiency
8636252	chain fatty acids
8636252	adrenocortical antibodies
8636252	's disease
8636252	x-linked
8636252	peroxisomal transporter protein
8636252	adrenal insufficiency
8636252	plasma concentrations
8636252	biochemical analysis
8636252	body fluids
8636252	data support
8636252	spinal cord
8636252	young adult male patients
8636252	xq28
8636252	electrophysiological tests
8636252	amn
8636252	common phenotype
8636252	male patients
8636252	young adults
8636252	central nervous system
8636252	adrenal
8636252	addisons
8636252	genetic disease
8636252	cerebral involvement
8636252	magnetic resonance
8636252	unknown function
8636252	clinical expression
8640236	mutant allele
8640236	mutant alleles
8640236	low
8640236	ovarian cancers
8640236	sporadic breast cancers
8640236	brca2
8640236	tumour types
8640236	tumour suppressor gene
8640236	brca1
8640236	ovarian cancer
8640236	inherited
8640236	breast cancer
8640236	familial breast cancer gene
8640236	probable germline mutation
8640236	familial breast
8640236	sporadic breast
8640236	familial tumour suppressor genes predispose individuals
8640236	undergoes mutation
8640236	somatic mutations
8640236	sporadic cancers
8640236	principal targets
8640236	heterozygous deletion
8640236	cell lines
8640236	pancreatic tumour cell line suggests
8640236	particular types
8640236	surprisingly
8640236	somatic mutation
8640236	breast carcinoma
8640236	individuals
8640236	tumour suppressor genes
8640236	significant fraction
8640236	pancreatic cancer
8640236	wild-type allele
8640236	familial forms
9050868	embryonic stem cells
9050868	major component
9050868	early adult life
9050868	mutant mice
9050868	iv ehlers-danlos
9050868	internal organs
9050868	shorter life span
9050868	normal collagen
9050868	early embryos
9050868	col3a1
9050868	mutations
9050868	mouse germ line
9050868	ultrastructural
9050868	heterozygous intercrosses
9050868	cardiovascular system
9050868	iii
9050868	aortic rupture
9050868	type iii
9050868	homologous recombination
9050868	homozygous mutant animals
9050868	extracellular matrix
9050868	normal cardiovascular development
9050868	major blood vessels
9050868	wild-type mice
9138149	sscp
9138149	donor site
9138149	aniridia patients
9138149	simple aniridia
9138149	pax6
9138149	sporadic patients
9138149	intron/exon boundaries
9138149	protein truncation test
9138149	specific enhancer
9138149	pcr
9138149	ten
9138149	acceptor sites
9138149	useful detection method
9138149	nonsense mutations
9138149	mutations
9138149	genomic products exons
9138149	ptt
9138149	mutation detection
9138149	functional outcome
9138149	family history
9138149	splice site mutations
9138149	genomic amplifications
9138149	familial cases
9138149	chemical cleavage
9138149	rt-pcr
9138149	mutation detection techniques
8931709	adenomatous polyposis coli
8931709	numerous adenomatous polyps
8931709	lymphoblastoid cell lines
8931709	mutations
8931709	germline
8931709	apc
8931709	adenomatous polyposis
8931709	colorectal cancer
8931709	mild form
8931709	western blot analysis
8931709	aapc
8931709	frameshift mutation
8931709	colorectal region
8931709	swiss family
8931709	familial
8931709	family members
8931709	stop codon
8931709	fap
8931709	dutch
8824873	genomic sequences
8824873	critical role
8824873	cag
8824873	hd
8824873	disease transcript
8824873	huntington
8824873	repeat instability
8824873	transgenic mice
8824873	cdna construct
8824873	months age
8824873	behavioral abnormalities
8824873	disease phenotype
8824873	utr
8824873	dna-protein
8824873	high levels
8824873	mrna expression
8824873	absence
8824873	frameshift mutation
8824873	morphometric analysis
8824873	vitro transfection studies
8824873	intergenerational stability
8824873	gene product
8824873	full length human
8824873	rna
8944024	nucleotide polymorphisms
8944024	reference
8944024	false positive mutations
8944024	two-colour fluorescence analysis
8944024	test samples
8944024	high density oligonucleotide arrays
8944024	valuable new technology
8944024	brca1
8944024	large gene
8944024	ovarian cancer gene
8944024	oligonucleotides 20-nucleotides
8944024	patient samples
8944024	detection
8944024	high-density arrays
8944024	high-throughput cost-efficient detection
8944024	possible heterozygous mutations
8944024	hybridization patterns
8944024	two-colour analysis
8944024	large numbers
8944024	hereditary breast
8944024	genetic alterations
8944024	dna
8944024	heterozygous mutations
8944024	wide range
8944024	control samples
8670333	long-term basis
8670333	various time points
8670333	metabolic factors
8670333	extensive peripheral tissue
8670333	considerable variation
8670333	furthermore
8670333	different patients
8670333	fmf
8670333	specific radioimmunoassay
8670333	breast milk
8670333	mediterranean
8670333	breast milk suggests
8670333	methods
8670333	individual breast milk composition
8670333	oral administration
8670333	clinical experience
8670333	objective
8670333	colchicine concentrations
8670333	parallel concentration time curves
8670333	results
8670333	colchicine
8670333	conclusion
8670333	colchicine milk concentration
9144525	family studies
9144525	first-degree relatives
9144525	membrane attack
9144525	genetic basis
9144525	c6
9144525	furthermore
9144525	c9
9144525	c7
9144525	complete deficiency
9144525	additional introns
9144525	deficiency
9144525	pcr
9144525	exon-intron junctions
9144525	single-chain serum protein
9144525	swiss family
9144525	tga
9144525	terminal complement components
9144525	marker studies
9144525	different point mutations
9144525	dna
9144525	cdna position
9144525	recurrent neisseria infections
9144525	gene structure
9144525	human complement
9144525	chromosome 5p
9222760	d-1
9222760	common missense mutation
9222760	rare mutations
9222760	dgge
9222760	common variant
9222760	k285n
9222760	q188r
9222760	duarte-2
9222760	gradient gel electrophoresis
9222760	intronic sequence changes
9222760	classical galactosemia
9222760	galactose-1-phosphate uridyltransferase
9222760	molecular genetics
9222760	classical
9222760	classical galactosemia alleles
9222760	n314d
9222760	molecular
9222760	novel candidate galactosemia mutations
9222760	duarte-1
9222760	common galactosemia mutation
9222760	duarte
9222760	d-2
9222760	mutation analysis
9222760	galt
9222760	neutral mutation
9056547	restriction site
9056547	exon 3b
9056547	plp
9056547	mild forms
9056547	mental retardation
9056547	x-linked
9056547	proteolipid protein gene
9056547	spg
9056547	personality disorders
9056547	plp-associated
9056547	nonsense mutation
9056547	spastic paraplegia
9056547	nonsense codon
9056547	pelizaeus-merzbacher
9056547	unusual form
9056547	connatal forms
9056547	dm20
9056547	alui
9056547	clinical picture
9056547	pmd
9056547	nonsense
8790412	likely transcription factor
8790412	helix protein
8790412	facilitate studies
8790412	transcriptional regulator
8790412	pax3-fkhr
8790412	expression
8790412	alveolar rhabdomyosarcoma
8790412	multiple layers
8790412	fusion protein
8790412	putative activator domain
8790412	pax3-fkhr-induced
8790412	pax3
8790412	fuses parts
8790412	chicken embryo fibroblasts
8790412	rcas
8790412	transcriptional activator
8790412	cellular transformation
8790412	pediatric
8790412	controls developmental programs
8790412	retroviral vector
8790412	fkhr
8790412	fusion product
8790412	chromosomal translocation
8790412	dna
8790412	alveolar rhabdomyosarcoma transforms fibroblasts
8790412	anchorage-independent growth
9090524	mutations
9090524	clinical phenotypes
9090524	wt
9090524	wilms
9090524	genetic basis
9090524	acute myeloid leukemia
9090524	juvenile granulosa cell tumour
9090524	childhood kidney cancer
9090524	wt1
9090524	clinical overview
9090524	small round cell tumour
9090524	gene mutations
9090524	constitutional intragenic
9090524	denys-drash
9090524	renal nephropathy
8843193	lipid kinase
8843193	defective responses
8843193	normal thymocytes
8843193	at
8843193	normal cell-cycle progression
8843193	+/- fibroblasts
8843193	cancer risk
8843193	dual
8843193	atm
8843193	cellular responses
8843193	mouse thymocytes
8843193	s-phase
8843193	growth defect
8843193	putative protein
8843193	cellular response
8843193	cell-cycle arrest
8843193	defective up-regulation
8843193	g1
8843193	poor checkpoint function
8843193	homologous recombination
8843193	cellular defects
8843193	constitutive level
8843193	cell growth control
8843193	atm-/-
8843193	serum stimulation
8843193	consistent
8659549	missense mutation
8659549	pcr-based
8659549	c152y
8659549	canavan
8659549	novel mutations
8659549	jewish mutations
8659549	deltaagaa mutation
8659549	introduce mutations
8659549	western european descent
8659549	a305e
8659549	wild-type cdna
8659549	non-jewish patients
8659549	vitro expression
8659549	mutant chromosomes
8659549	autosomal recessive trait
8659549	molecular basis
8659549	netherlands
8659549	y231x
8659549	non-jewish background
8659549	ashkenazi
8659549	e285a
8659549	mutations
8659549	england
8659549	ireland
8659549	d114e
8659549	enzymatic activity
8659549	4-bp deletions
8659549	single-base changes
8659549	identification
8659549	r168c
8659549	mutant chromosome
8659549	i16t
8659549	aspa
8659549	predominant mutations
8659549	deltat deletion
8659549	missense mutations
8659549	jewish background
8659549	independent patients
8659549	mutant cdna clones
8659549	african-american
8659549	current study
8659549	g123e
8659549	jewish patients
8659549	canada
8659549	g27r
8659549	germany
9145677	bilateral breast cancer
9145677	jewish ancestry
9145677	methods clinical
9145677	conclusions
9145677	coding-region mutations
9145677	referral clinic
9145677	high-risk families
9145677	brca1
9145677	ovarian cancer
9145677	ashkenazi
9145677	breast cancer
9145677	gel electrophoresis
9145677	individual families
9145677	probability tables
9145677	family history
9145677	conformation-sensitive
9145677	family histories
9145677	family members
9145677	background
9145677	dna
9145677	average age
9145677	genetic-linkage analysis
9145677	breast cancers
9145677	results brca1
9271438	vhl
9271438	recent
9271438	vegf
9271438	glutathione-s-transferase-vhl fusion protein
9271438	tumor suppressor gene
9271438	critical role
9271438	furthermore
9271438	promoter-luciferase constructs
9271438	deletion
9271438	vhl-responsive
9271438	tumor suppressor gene product interacts
9271438	direct inhibitory action
9271438	repress vascular endothelial growth factor promoter activity
9271438	144-bp region
9271438	clear-cell renal cell carcinoma
9271438	rcc
9271438	transcriptional repression
9271438	nuclear extracts
9271438	cell lines
9271438	observations support
9271438	rcc-
9271438	wt-vhl protein
9271438	hippel-lindau
9271438	mrna levels
9271438	gc
9271438	sp1-mediated
9271438	nuclear run-on studies
9271438	vascular endothelial growth factor
9271438	promoter activity
9271438	transcription factor
9271438	gene product
9271438	vhl-mediated
9271438	embryonic kidney
9271438	basal activity
9271438	sp1
9271438	new mechanism
9271438	rccs
9271438	dose-dependent manner
9271438	drosophila
9271438	transcriptional level
8605116	single-strand conformation polymorphism analysis
8605116	overall efficiency
8605116	new set
8605116	germline
8605116	new patients
8605116	biplex analysis
8605116	equal proportions
8605116	sporadic bilateral retinoblastoma
8605116	polymerase chain reaction
8605116	previous studies
8605116	pcr
8605116	promoter region
8605116	hereditary retinoblastoma
8605116	rb1
8605116	different exons
8605116	small insertions
8605116	single-pass regimen
8605116	identify mutation
8605116	point mutations
8605116	different sizes
8723064	snrpn
8723064	d15s11
8723064	fish
8723064	chromosome 15q
8723064	pws
8723064	situ hybridization
8723064	typical phenotype
8723064	critical region
8723064	cytogenetic deletion
8723064	cosmid probes
8723064	prader-willi
8723064	gabrb3
8723064	d15s10
8723064	deletion
8723064	small nuclear ribonucleoprotein polypeptide
8666397	m. musculus/m
8666397	trinucleotide repeat
8666397	sf tissue samples
8666397	wasp
8666397	lymphocytic infiltration
8666397	fatal lymphoreticular disease
8666397	tcfe3
8666397	mus
8666397	genomic structure
8666397	northern analysis
8666397	gata1
8666397	chromosomal
8666397	mouse gene
8666397	amino acid sequence
8666397	spretus backcross
8666397	non abnormalities
8666397	mouse homolog
8666397	gga
8666397	4-kb mrna
8666397	syndrome protein
8666397	wiskott-aldrich
8666397	musculus strains
8789439	murine homologue
8789439	molecular processes
8789439	olfactory bulb
8789439	early pathogenic events
8789439	outer plexiform layer disappears
8789439	mutant mice
8789439	retinal ganglion cell layer
8789439	x-linked
8789439	faithful model
8789439	old mice
8789439	situ hybridization
8789439	photoreceptor cell layer
8789439	hemizygous
8789439	human counterpart
8789439	recessive neurological disorder
8789439	mouse line
8789439	overall disorganization
8789439	nuclear layer
8789439	animal model
8789439	nd
8789439	amino acid sequence
8789439	norrie
8789439	outer segments
8789439	vitreous body
8789439	replacement mutation
8789439	retrolental structures
8789439	ocular findings
8789439	rna
8659522	apparent symptoms
8659522	it-15
8659522	cag
8659522	hd
8659522	repeat tract
8659522	subsequent findings
8659522	ccg
8659522	exceptional case
8659522	pcr
8659522	huntington
8659522	cambridge
8659522	healthy survival
8659522	phenotypic
8659522	disease size
8659522	normal elderly individuals
8659522	repeats suggests
8659522	95-year-old man
8659522	case histories
8659522	show cases
8659522	old age
8659522	trinucleotide lengths
8659522	large analyses
8659522	individuals
8659522	diagnostic setting
8659522	gene reveals
8659522	pathological size
8659522	abnormal cag
8659522	classical features
8659522	such individuals
8659522	hd-associated
8894695	inhibit adenine phosphoribosyltransferase
8894695	novel phenotype
8894695	d. w. melton
8894695	purine salvage pathways
8894695	insoluble derivative
8894695	self-mutilation behavior [
8894695	hprt-deficient
8894695	mouse embryonic stem cells exhibit
8894695	lesch-nyhan syndrome
8894695	aprt
8894695	nature genet
8894695	self-injurious behavior
8894695	behavioral abnormalities
8894695	humans results
8894695	hprt-aprt-deficient
8894695	behavioral symptoms
8894695	complete
8894695	aprt-hprt-deficient
8894695	additional abnormalities
8894695	hypoxanthine-guanine phosphoribosyl-transferase
8894695	hprt
8894695	lesch-nyhan
8894695	c. l. wu
8894695	hprt-deficiency
8894695	doubly-deficient mice excrete adenine
8894695	compulsive self-injurious behavior
8673132	autosomal dominant disorder
8673132	fibre degeneration
8673132	dmpk-/-mice
8673132	adult dmpk-/-mice
8673132	late onset progressive myopathy
8673132	young mice
8673132	myotonic dystrophy protein kinase
8673132	progressive skeletal myopathy
8673132	force generation
8673132	show ultrastructural changes
8673132	fibre size
8673132	dmpk
8673132	muscles
8673132	mature mice show variation
8673132	skeletal muscle structure
8673132	mice
8673132	myotonic
8673132	putative protein kinase
8673132	dmpk-/-
8673132	ctg
8673132	dm
8644703	multiple cases
8644703	analyze one-quarter
8644703	germ-line
8644703	breast/ovarian cancer families
8644703	ukcccr familial ovarian
8644703	brca1
8644703	multiplex heteroduplex analysis
8644703	substantial proportion
8644703	rapid
8644703	breast and/or ovarian cancer
8644703	early-onset breast and/or ovarian cancer
8644703	gene time
8644703	distinct mutations
8812423	proline-rich protein
8812423	recurrent chromosome aberrations
8812423	peripheral blood leukocytes
8812423	translocation partners
8812423	3-race analysis
8812423	amino-terminal region
8812423	hmgi-c/lpp
8812423	translocation partner gene
8812423	hmg
8812423	upon
8812423	polymerase chain reactions
8812423	novel member
8812423	somatic cell hybrids
8812423	hybrid transcripts
8812423	genomic region
8812423	ectopic genetic sequences
8812423	hmgic/lpp
8812423	lpp-encoded
8812423	primary lipomas
8812423	lpp
8812423	situ hybridization
8812423	fusion transcripts
8812423	cash
8812423	detectable involvement
8812423	fusion partner gene
8812423	fish
8812423	chromosome assignment
8812423	chromosome segment 3q27-q28
8812423	composite cdna
8812423	multiple
8812423	northern blot analysis
8812423	lipoma cell line
8812423	human tissues
8812423	previous studies
8812423	sequence analysis
8812423	lipoma cell lines
8812423	protein gene family
8812423	reverse transcriptase
8812423	lim
8812423	partial cdna
8812423	li-501/sv40
8812423	genetic organization
8812423	chromosome segment 12q13-q15
8812423	carboxy-terminal region
8812423	hmgic
8812423	high mobility group
8812423	open reading frame
8812423	nucleotide
8812423	partner gene
8812423	fusion proteins
8812423	leucine-zipper motif
8812423	protein gene
8812423	ectopic sequences
8812423	major cytogenetic subgroup
8833159	missense mutation
8833159	recently
8833159	genomic organization
8833159	different phenotypes benign familial neonatal convulsions
8833159	candidate region
8833159	chrna4
8833159	exon-intron
8833159	pcr
8833159	exon boundaries
8833159	transmembrane domain
8833159	idiopathic epilepsies
8833159	human neuronal nicotinic acetylcholine receptor alpha
8833159	sequence analysis
8833159	genomic regions adjacent
8833159	autosomal dominant nocturnal frontal lobe epilepsy
8833159	subunit gene
8833159	comprehensive mutation
8833159	dna
8833159	eeg
8833159	nucleotide sequence
8833159	primer pairs
8595416	genomic sequences
8595416	sequencing
8595416	n trinucleotide repeat expansion
8595416	comparison
8595416	transcription units
8595416	analysis shows
8595416	chromatin disruption
8595416	n repeat
8595416	protein levels
8595416	steady state levels
8595416	dmahp
8595416	characterisation
8595416	human tissues
8595416	patient tissues
8595416	dmpk
8595416	cpg
8595416	skeletal muscle
8595416	repeat expansion
8595416	myotonic
8595416	myotonic dystrophy
8595416	homeodomain protein
8595416	region shows
8595416	rt-pcr
8595416	ctg
8595416	dm
8595416	significant homology
9028321	receptor plays
9028321	immunological analysis
9028321	crucial role
9028321	common clinical
9028321	cell death
9028321	hla-dr
9028321	immune system
9028321	chronic lymphocyte activation
9028321	+ cells
9028321	fas
9028321	autoimmune lymphoproliferative syndrome
9028321	physiological process
9028321	programmed
9028321	distinct missense mutations
9028321	homeostatic maintenance
9028321	dn
9028321	novel family
9028321	alps
9028321	normal development
9028321	fas-induced
9028321	cd3
9028321	high levels
9028321	severe autoimmune manifestations
9028321	missense
9028321	soluble interleukin-2 receptor
9028321	serum activation markers
9028321	cd30
9028321	show lack
9028321	gene alleles
9028321	mrl-lpr/lpr
9028321	fas/apo-1
9028321	cd4-cd8-
9063749	breast cancer incidence
9063749	gln356leu871gly1038gly1613
9063749	general population
9063749	common haplotypes
9063749	ovarian cancer cases
9063749	brca2
9063749	strong linkage disequilibrium
9063749	glu1038gly
9063749	brca1
9063749	ovarian cancer
9063749	breast cancer
9063749	ser1613gly
9063749	penetrant mutations
9063749	breast cancer patients
9063749	control groups
9063749	gln356pro871glu1038ser1613
9063749	frequency >
9063749	common variants
9063749	ovarian cancer risk
9063749	gln356arg
9063749	large series
9063749	different genotype distribution
9063749	pro871leu
9063749	generate amino acid substitutions
9063749	arg356
9063749	multiple case families
9063749	modest individual risks
9063749	sites generate
9063749	significant contribution
9063749	young onset breast cancer
9063749	common polymorphisms
8758207	sscp
8758207	chromosome
8758207	strand conformation polymorphism
8758207	different parenchymal tumours
8758207	vhl
8758207	genetic changes
8758207	abnormal migration patterns
8758207	and/or heteroduplex
8758207	non-papillary renal cell carcinomas
8758207	sporadic renal cell carcinomas
8758207	mutation
8758207	chromophobe renal cell carcinomas
8758207	dna
8758207	renal oncocytomas
8758207	chromosome 3p sequences
8758207	non-papillary renal cell carcinoma
8758207	possible role
8758207	papillary renal cell tumours
8758207	hd
8758207	3p deletion
8786135	human chromosome 11q
8786135	d9mit99
8786135	ets1
8786135	at
8786135	d9mit6
8786135	rck
8786135	comparison
8786135	d9mit102
8786135	syrian
8786135	npat
8786135	rat chromosome
8786135	hamster chromosome
8786135	atm
8786135	fine genetic linkage
8786135	comparative
8786135	r-banding fish
8786135	human chromosome
8786135	linkage map
8786135	mmu9
8786135	hsa11
8786135	chromosomal rearrangement
8786135	acat1
8786135	chromosomal
8786135	new gene
8786135	cm distal
8786135	interspecific backcross mice
8786135	rodent species
8786135	additional comparative
8786135	chromosomal breakage
8786135	c-d
8786135	gria4
8786135	ataxia-telangiectasia region
8786135	mouse chromosome
8786135	cm proximal
8786135	dna
8786135	mitochondrial acetoacetyl-coa thiolase
8786135	atm-npat-acat1
8786135	proximal end
8637912	large international effort
8637912	molecular mechanisms
8637912	secretory epithelial cells
8637912	pac1
8637912	novel genetic locus
8637912	functional definition
8637912	important insights
8637912	furthermore
8637912	cell death
8637912	tumor suppression
8637912	cell death pathway
8637912	definition
8637912	microcell hybrids
8637912	human chromosome 10pter-q11
8637912	human prostate carcinoma
8637912	androgen deprivation
8637912	key pathways
8637912	prostatic adenocarcinoma
8637912	nude mice
8637912	vitro apoptosis
8637912	prostate
8637912	neoplastic transformation
8637912	nuclear localization
8637912	critical pathways
8637912	normal development
8637912	microcell fusion
8637912	trigger apoptosis
8637912	male cancer deaths
8637912	human chromosome
8637912	genetic events
8637912	prostate carcinomas
8637912	prostate adenocarcinoma
8637912	prostate adenocarcinoma cell line
8637912	tumor
8637912	prostatic adenocarcinoma cells
8637912	disease progression
8637912	microcell
8637912	androgen-dependent prostate carcinomas
8637912	region 10pter-q11
8637912	vivo tumor suppression
8637912	therapeutic manipulations
8637912	genetic locus
8931695	ao2/dtd
8931695	reduced
8931695	atelosteogenesis type
8931695	dtdst
8931695	c862t transition
8931695	single-strand conformation polymorphism analysis
8931695	premature termination
8931695	inorganic sulfate
8931695	acg1b
8931695	molecular basis
8931695	genotype-phenotype correlations
8931695	novel mutation
8931695	intermediate phenotype
8931695	sulfate transporter
8931695	r279w
8931695	achondrogenesis type 1b
8931695	dtdst r279w
8931695	phenotypic
8931695	genotypic overlap
8931695	diastrophic dysplasia
8931695	fibroblast cultures
8931695	ao-2
8931695	polymerase chain reaction amplification
8931695	mutations
8931695	fibroblast cdna
8931695	extracellular loop
8931695	compound heterozygotes
8931695	diastrophic dysplasia sulfate transporter gene
8931695	structural mutation
8931695	ao2
8931695	mrna levels
8931695	dtd
8931695	delta c418
8931695	delta c418 allele
8931695	new patients
8931695	residual activity
8931695	dna
8931695	finnish
8931695	previous observations
9069115	reverse transcription
9069115	whole murine cdna
9069115	overall identity
9069115	est
9069115	complete cdna-insert
9069115	corresponding gene hmga
9069115	amplify fragments
9069115	sequence tags
9069115	aku
9069115	cdna encodes
9069115	previous assignment
9069115	hgo
9069115	amino acid residues
9069115	cloning
9069115	fish
9069115	human alkaptonuria gene
9069115	amino acid
9069115	mouse liver cdna library
9069115	multiple sequence alignment
9069115	chromosomal region
9069115	homogeneous monomer
9069115	mouse liver cdna
9069115	different cdnas
9069115	codon sequence
9069115	mouse gene
9069115	mouse liver
9069115	amino acids
9069115	phase chromatography
9069115	polymerase chain reaction
9069115	rt-pcr
9069115	sequence
9069115	key enzyme
9069115	aspergillus
9069115	e. c.
9069115	various tissues
9069115	human chromosomal band
9069115	multipoint linkage analysis
9069115	homogentisate 1,2-dioxygenase gene
8673131	minor size changes
8673131	normal human
8673131	muscle cell lineages
8673131	mild myopathy
8673131	neck muscle fibres
8673131	crucial requirement
8673131	simple loss-
8673131	transgene expression
8673131	myotonic dystrophy protein kinase levels
8673131	nullizygous
8673131	dm-protein
8673131	dmpk
8673131	neonatal mortality
8673131	expression levels
8673131	hypertrophic cardiomyopathy
8673131	models lack
8673131	dependent atrophy
8673131	abnormal
8673131	myotonic
8673131	repeat expansions
8673131	ctg
8673131	dm
8871666	c56
8871666	small amount
8871666	c6
8871666	c7
8871666	subtotal deficiency
8871666	normal molecular weight
8871666	ser
8871666	molecular defect
8871666	low molecular weight
8871666	c6/c7
8871666	defective genes
8871666	molecular
8871666	isoelectric point
8871666	subtotal deficiencies
8871666	different consequences
8871666	splice donor site
8871666	combined
8871666	homozygous form
8871666	codon substitution
8871666	arg
8871666	profound deficit
8871666	c6-deficient
8871666	dna
8871666	molecular alteration
8871666	distinct haplotype
9245987	specific codon
9245987	cga
9245987	constitutively
9245987	constitutive presence
9245987	cpgs
9245987	particular region
9245987	point mutations
9245987	premature termination
9245987	mutations results
9245987	significant proportion
9245987	detect cytosine methylation
9245987	mutations
9245987	codon resides
9245987	hot spots
9245987	cpg
9245987	rb1
9245987	sodiumbisulfite conversion method
9245987	representative exons
9245987	recurrent premature termination mutations
9245987	genetic alterations
9245987	dna
9245987	large deletions
9245987	wide spectrum
9245987	present study
9245987	retinoblastoma gene
9245987	such recurrent
9245987	protein synthesis
9019400	metastatic tumors
9019400	primary human breast carcinomas
9019400	tumor susceptibility gene
9019400	breast cancer patients
9019400	intragenic deletions
9019400	cellular transformation
9019400	recent
9019400	nude mice
9019400	human homolog
9019400	human breast cance
9019400	dna
9019400	tsg101
9019400	tumor suppressor gene
9019400	sequence analysis
9019400	mouse gene
9019400	normal breast tissue
9019400	fibroblasts results
9019400	band p15
9019400	high frequency
9019400	human breast cancer
8776595	escherichia
8776595	emdm
8776595	% sucrose
8776595	soluble fractions
8776595	monoclonal antibodies
8776595	kda protein
8776595	edmd
8776595	muscle biopsy
8776595	emerin cdna
8776595	liver tissues
8776595	muscular dystrophy protein
8776595	lap2
8776595	pcr
8776595	inner nuclear membrane proteins
8776595	muscular dystrophy
8776595	biochemical
8776595	structural homologies
8776595	simple diagnostic antibody test
8776595	immunofluorescence
8776595	emery-dreifuss
8776595	large fragment
8776595	complete absence
8776595	nuclear membrane protein
8776595	recombinant protein
8776595	different epitopes
8776595	nuclear rim
8689689	pax6
8689689	wild-type background show
8689689	exhibit brain abnormalities
8689689	strikingly
8689689	iris hypoplasia
8689689	artificial chromosome transgenic mice
8689689	different eye phenotypes
8689689	aniridia
8689689	severe eye abnormalities
8689689	gene dosage
8689689	heterozygotes suffer
8689689	box gene
8689689	whereas
8689689	semidominant developmental disorders
8689689	eye background
8689689	transgene rescues
8689689	influence
8689689	transcriptional regulators
8689689	specific developmental abnormalities
8689689	nasal cavities
8689689	overexpression causes
8689689	developmental defects
8689689	small
8689689	homozygous mice lack eyes
8689689	multiple copies
8689689	mutant phenotype
8644702	missense mutation
8644702	sscp
8644702	cys61gly
8644702	intron region
8644702	clear linkage
8644702	intragenic polymorphism
8644702	present study confirms
8644702	breast-ovarian cancer families
8644702	ovarian cancers
8644702	d17s855
8644702	frameshift insertions
8644702	tgaga
8644702	wild-type chromosome
8644702	heteroduplex analysis
8644702	predominant ovarian cancer phenotype
8644702	brca1
8644702	ovarian cancer
8644702	nonsense mutation
8644702	malignant melanoma
8644702	hereditary breast cancer families
8644702	sweden
8644702	tumor types
8644702	swedish
8644702	mutation/haplotype carriers
8644702	different germ-line mutations
8644702	analysis
8644702	splice acceptor site mutation
8644702	protein-truncation test
8644702	hereditary breast
8644702	common origins
8644702	disease predisposition
8644702	lung cancer
8644702	premature translation termination
8644702	breast-ovarian cancer
8644702	eleven
8644702	founding brca1
8644702	ovarian cancer susceptibility gene
8929264	specific gene
8929264	chromosome 18q predicts
8929264	colorectal carcinomas
8929264	tumor cells
8929264	conclusions dcc
8929264	respective survival rates
8929264	colorectal cancer
8929264	background allelic
8929264	methods
8929264	tumor site
8929264	prognostic marker
8929264	ii
8929264	colorectal carcinoma
8929264	proportional-hazards model
8929264	therapeutic implications
8929264	cox
8929264	allelic loss
8929264	five-year survival rate
8929264	dcc
8929264	strong positive predictive factor
8929264	dcc-negative
8929264	adjuvant therapy
8929264	results
8929264	poor outcome
8929264	iii
8929264	survival rate
8929264	tumor differentiation
8828602	pku
8828602	somatic gene therapy
8828602	dna/protein
8828602	recombinant adenoviral vector
8828602	pah
8828602	adenoviral vectors
8828602	current dietary treatment
8828602	gene
8828602	classical
8828602	somatic gene
8828602	normal hepatic
8828602	different vector systems
8828602	limitations
8828602	hepatic phenylalanine hydroxylase
8828602	pah-deficient
8828602	normalizes serum phenylalanine levels
8828602	potential treatments
8828602	autosomal recessive disorder
8828602	vector systems
8828602	recombinant retrovirus
8828602	vectors
8828602	recombinant adenovirus
8828602	future development
8828602	low transduction efficiency
8944023	n-terminal ring
8944023	c-terminal
8944023	ring
8944023	tandem ankyrin repeats
8944023	breast cancer susceptibility
8944023	brca1-associated ring
8944023	brca1
8944023	ovarian cancer gene
8944023	bard1/brca1
8944023	brct
8944023	bard1
8944023	identification
8944023	novel protein
8944023	n-terminal
8944023	hereditary breast
8944023	missense mutations
8944023	gene product
8944023	regulatory proteins
8944023	tumour suppression
8944023	large polypeptide
8944023	c terminus
8944023	significant homology
8944023	protein contains
8682510	hot spot
8682510	mutation
8682510	wasp
8682510	single-strand conformation polymorphism
8682510	homology search
8682510	variable expression
8682510	x-linked
8682510	random distribution
8682510	turkish descent
8682510	strict genotype-phenotype correlations
8682510	nonsense mutations
8682510	large swiss family
8682510	actin-like filaments
8682510	distant relationship
8682510	missense mutations
8682510	gene product
8682510	was
8682510	syndrome protein
8682510	wiskott-aldrich
8682510	amino-terminal part
8682510	clinical picture
8682510	vasp
8682510	genotype-phenotype correlation
8954016	adult renal hamartomas
8954016	cystic kidney disease
8954016	chromosomal region 1q21-q32
8954016	tumor suppressor gene
8954016	hpt
8954016	locus telomeric
8954016	renal hamartomas
8954016	men
8954016	dominant primary hyperparathyroidism
8954016	multiple endocrine neoplasia
8954016	hpt-jt
8954016	hereditary
8954016	men1
8954016	d1s215
8954016	autosomal dominant disease
8954016	loss
8954016	jaw tumor syndrome
8954016	wild type allele
8954016	logarithm-of-odds scores
8954016	jaw tumor
8954016	autosomal
8954016	men2
8954016	omim
8954016	polycystic kidney disease
8954016	separate autosomal dominant gene
8954016	whereas linkage
8954016	hyperparathyroidism-jaw tumor syndrome
8954016	twenty
8954016	parathyroid tumor
8954016	microsatellite markers
8954016	sex-dependent penetrance
8954016	jt
8954016	hrpt2
8954016	new phenotypic variant
8954016	meiotic
8954016	renal lesions
8954016	1q21-q32 region
8692963	similar studies
8692963	substantial enzymatic activity
8692963	broad range
8692963	q188r
8692963	furthermore
8692963	holoenzyme structure-function relationships
8692963	heterodimer
8692963	subunit interactions
8692963	dimeric enzymes involves
8692963	particular interest
8692963	heterodimer pools
8692963	r333w
8692963	subunit assembly
8692963	patients raises
8692963	heterodimer activity
8692963	true molecular homozygotes
8692963	multiple subunits
8692963	mutant subunits
8692963	compound heterozygotes
8692963	null mutations
8692963	human enzyme galactose-1-phosphate uridylyltransferase
8692963	metabolic disorder galactosemia
8692963	allelic combination
8692963	allelic constitution
8692963	yeast system
8692963	human enzyme galactose-l-phosphate uridylyl-transferase
8692963	phenotypic severity
8692963	fundamental questions
8692963	galt
8968716	strong candidate
8968716	significant lesion
8968716	etiological role
8968716	subject group
8968716	moderate phenotype
8968716	ovarian cancers
8968716	ovarian cancer cases
8968716	novel missense
8968716	strong family history
8968716	high concordance
8968716	genotype-phenotype correlations
8968716	early onset
8968716	cancer incidence
8968716	recurrent mutations
8968716	brca1
8968716	r841w
8968716	ca
8968716	ovarian cancer
8968716	breast cancer
8968716	heritable cancer predisposition
8968716	different mutations
8968716	common mutations
8968716	significant number
8968716	family history
8968716	common mutation
8968716	cancer onset
8968716	additional instance
8968716	family members
8968716	genotype-environment interactions
8968716	brca1 r841w
8968716	% confidence interval
8968716	rare polymorphism
8968716	typical sporadic cases
8968716	orange
8968716	testing
8956035	human glucose 6-phosphate dehydrogenase gene
8956035	independent origin
8956035	deficient patients
8956035	vast majority
8956035	double mutant
8956035	new silent polymorphism
8956035	asn
8956035	enzyme deficiency
8956035	clinical favism
8956035	double mutations
8956035	point mutations
8956035	b gene
8956035	polymorphic variants
8956035	g6pd
8956035	g6pd malaga
8956035	g6pd santamaria
8956035	spain
8956035	haplotype analysis
8956035	val
8956035	iii
8956035	missense mutations
8956035	asp
8956035	nondeficient polymorphic variant
8956035	new polymorphic variant
8956035	enzymic properties
8825052	detectable deletion
8825052	bilateral sporadic aniridia
8825052	old female
8825052	fo2121
8825052	specific cosmids
8825052	sporadic aniridia
8825052	distal chromatin domain
8825052	familial aniridia patients
8825052	situ hybridisation
8825052	kb distal
8825052	position effect
8825052	reciprocal translocation
8825052	pax6
8825052	fish
8825052	chromosome abnormalities
8825052	band p13
8825052	fluorescence
8589723	common alleles
8589723	pcr-based
8589723	tandem repeat
8589723	variable penetrance
8589723	hras1
8589723	variable number
8589723	vntr
8589723	ovarian
8589723	susceptibility
8589723	brca1
8589723	cancer risk
8589723	ovarian cancer
8589723	certain types
8589723	breast cancer
8589723	relative risk
8589723	cancer syndrom
8589723	tandem repeats
8589723	possible genetic modifier
8589723	rare alleles
8589723	% risk
8589723	cancer penetrance
8589723	individuals
8589723	hereditary breast
8589723	hereditary ovarian cancer
8589723	alleles increases susceptibility
8589723	non-genetic factors
8589723	risk factors
8649785	report details
8649785	tetramerisation domain
8649785	extensive analysis
8649785	molecular studies
8649785	tumour suppressor gene
8649785	tp53
8649785	dna
8649785	key residue
8649785	profound implications
8649785	li-fraumeni
8649785	cell line
8649785	wild-type allele
8649785	codon
8649785	amino acid substitution
8649785	sporadic tumours
8649785	germline mutation
9241282	enhancer element
9241282	autosomal dominant multisystem disorder
9241282	trinucleotide repeat
9241282	hereditary adult neuromuscular disease
9241282	hypersensitive site
9241282	myotonic dystrophy locus reduces expression
9241282	trinucleotide
9241282	local chromatin environment
9241282	regulates transcription
9241282	previous
9241282	hypersensitive site contains
9241282	together
9241282	prevalent form
9241282	dystrophia myotonica
9241282	transcript levels
9241282	dmahp
9241282	steady-state transcript levels
9241282	fourfold reduction
9241282	pathogenic mechanisms
9241282	homeobox gene
9241282	l-hypersensitive site
9241282	dmpk
9241282	dnase
9241282	represses gene expression
9241282	analysis
9241282	repeat expansion
9241282	protein kinase gene
9241282	myotonic
9241282	local gene expression
9241282	allele-specific
9241282	wild-type allele
9241282	ctg
9241282	ctg-repeat
9241282	dm
9122265	ch
9122265	cl
9122265	no
9122265	channel pore
9122265	furthermore
9122265	positive potentials
9122265	muscle chloride channel
9122265	d3
9122265	autosomal dominant myotonia congenita affects pore properties
9122265	normal ion conductance
9122265	gly
9122265	cation-to-anion permeability ratio
9122265	whereas
9122265	glutamic acid
9122265	mammalian cell line
9122265	br
9122265	cl-
9122265	distinct ion
9122265	g230e
9122265	cation selectivity
9122265	clcn1
9122265	dominant myotonia congenita
9122265	residue resides
9122265	pore properties
9122265	d4
9122265	autosomal
9122265	current-voltage relationship
9122265	so
9122265	skeletal muscle
9122265	substantial changes
9122265	inward rectification
9122265	channel gene
9122265	hclc-1 conduction pathway
9122265	voltage-dependent
9122265	recombinant human muscle
9122265	wild-type channel
9122265	mutation causes
9122265	> thiocyanate >
9122265	exhibits outward rectification
9122265	extracellular iodide
9122265	wild-type channels
9122265	thiocyanate >
9012404	male breast cancer patients
9012404	germ-line mutations
9012404	breast and/or ovarian cancer
9012404	first-degree relatives
9012404	male breast cancer population
9012404	mutation
9012404	male breast cancer cases
9012404	california
9012404	breast/ovarian cancer
9012404	brca1
9012404	breast/ovarian cancer genes
9012404	family history
9012404	ovarian cancer
9012404	male breast cancer
9012404	brca2
8733131	weeks gestation
8733131	vhl
8733131	expression
8733131	disease product
8733131	specific role
8733131	disease tumour suppressor gene
8733131	down-regulate transcription
8733131	quantitative distribution
8733131	renal cell carcinoma
8733131	spinal haemangioblastomas
8733131	transcriptional elongation
8733131	situ hybridization
8733131	inactivation
8733131	fetal tissues
8733131	sporadic renal cell carcinoma
8733131	gene expression
8733131	ii
8733131	kidney development
8733131	germline vhl
8733131	adult tissues
8733131	germ layers
8733131	hippel-lindau
8733131	situ hybridization studies
8733131	weeks post conception
8733131	central nervous system
8733131	gene product
8733131	transcript elongation
8733131	vhl-mediated
8733131	normal human development
8733131	gene mutations predispose
8733131	growth suppressor genes
8733131	human embryogenesis
8733131	renal tubules
8733131	regulation
8733131	strong expression
8733131	important control mechanism
9195227	breast carcinomas
9195227	breast and/or ovarian cancer
9195227	variant allele
9195227	screening
9195227	somatic
9195227	estrogen receptor gene
9195227	germline substitution
9195227	breast cancer
9195227	gly160cys
9195227	hormonal therapy resistance
9195227	base mutations
9195227	family history
9195227	esr
9195227	present data
9195227	hence
9195227	dna
9195227	important mechanism
9195227	possible clinical significance
9195227	present study
9195227	ovarian cancer patients
9195227	estrogen receptor-positive breast carcinomas
8675707	d442g
8675707	intron 14g
8675707	key participant
8675707	high density lipoprotein
8675707	i. e.
8675707	plasma
8675707	cetp
8675707	cholesterol transport
8675707	coronary heart disease
8675707	independent risk factor
8675707	japanese ancestry
8675707	japanese-american
8675707	reverse transport
8675707	mg/dl men
8675707	gene mutations
8675707	hdl
8675707	chol levels
8675707	general inverse relationship
8675707	cholesteryl esters
8675707	relative risk
8675707	additional adjustment
8675707	increased chd
8675707	increased
8675707	cholesteryl ester
8675707	overall prevalence
8675707	chol >
8675707	rr
8675707	chd
8675707	high prevalence
8675707	heart program
8675707	reverse cholesterol transport
8675707	protein gene
8675707	risk factors
8808606	segregation distortion
8808606	common segregation probability
8808606	meiotic drive
8808606	allele size
8808606	single-sperm segregation data
8808606	possible problem
8808606	disease state
8808606	individuals heterozygous
8808606	human population
8808606	meiotic segregation
8808606	pcr
8808606	meiotic
8808606	upper limit
8808606	myotonic dystrophy locus
8808606	analysis
8808606	% confidence interval
8808606	significant difference
8808606	myotonic dystrophy
8808606	meiotic segregation distortion
8808606	amplification rates
8808606	ctg
8808606	sperm ejaculation
8808606	statistical models
8808606	dm
9223307	important roles
9223307	radiation exposure
9223307	protein kinases
9223307	a-t
9223307	isolation
9223307	radio-sensitive phenotype
9223307	atm
9223307	describe herein
9223307	human genetic disorder ataxia-telangiectasia
9223307	multiple aspects
9223307	effector functions
9223307	cell cycle control
9223307	defective cell cycle checkpoints
9223307	full-length cdna
9223307	overexpression
9223307	chromosome aberrations
9223307	possible approaches
9223307	protein kinase
9223307	dna
9223307	gene therapy
9223307	radiation signal transduction
9223307	ataxia-telangiectasia cellular phenotype
8651278	sscp
8651278	% base substitutions
8651278	cga
8651278	spectrum comprises
8651278	germ-line mutations
8651278	heteroduplex analysis
8651278	3-terminal region
8651278	pcr
8651278	tumor foci
8651278	hereditary retinoblastoma
8651278	previous
8651278	nonocular tumors
8651278	nonsense mutations
8651278	fragment-length analysis
8651278	previous investigations
8651278	rare sequence variants
8651278	recurrent
8651278	southern blot hybridization
8651278	rb1
8651278	small length alterations
8651278	splice signals
8651278	premature termination codons
8651278	base substitutions
8651278	large deletions
8651278	region contains
8625410	control diverse biological processes
8625410	molecular mechanism
8625410	wasp
8625410	c-terminally
8625410	cdc42hs
8625410	sequence contains
8625410	negative forms
8625410	novel effector
8625410	cdc42hs-n17
8625410	novel link
8625410	family members
8625410	cell morphology
8625410	actin polymerization
8625410	novel domains
8625410	action organization
8625410	actin cytoskeleton
8625410	was
8625410	syndrome protein
8625410	wiskott-aldrich
8625410	rac
8625410	gtpases
8625410	gtpase cdc42hs
8625410	rho
8625410	cellular abnormalities
8625410	cellular
9272171	l618s
9272171	japanese patients
9272171	infantile form
9272171	v289
9272171	cos-1
9272171	compound heterozygous mutation
9272171	ao-gld
9272171	enzymatic activities
9272171	adult
9272171	krabbe
9272171	g270d
9272171	mutant mrna
9272171	low enzymatic activity
9272171	pcr
9272171	i66m
9272171	i289
9272171	if-gld
9272171	pcr-sscp
9272171	mutation sites
9272171	initial symptoms
9272171	normal activity
9272171	central domain
9272171	adult onset globoid cell leukodystrophy
9272171	unique mutation
9272171	restriction enzyme digestion
9272171	polymorphism causes conformational
9272171	c-terminus
9272171	gld
9272171	missense mutations
9272171	onset globoid cell leukodystrophy
9272171	progressive spastic paraplegia
9272171	g27od
9272171	n-terminus
9272171	galactosylceramidase cdna
9272171	galc
9272171	subsequent sequence determination
9272171	polymerase chain reaction/single-strand conformation polymorphism
8589722	sequence homology
8589722	germline
8589722	secretory vesicles
8589722	exhibits properties
8589722	granin protein family
8589722	granin consensus
8589722	brca1
8589722	secretory protein
8589722	ovarian cancer
8589722	granins localize
8589722	tumour suppressor gene products
8589722	190-kd protein
8589722	c terminus
8589722	brca2
8589722	interestingly
8589722	biochemical analogy
9144439	multiple polymorphisms
9144439	low incidence
9144439	japanese subjects
9144439	general population
9144439	insulin-dependent diabetes mellitus
9144439	insulin-dependent diabetes mellitus locus
9144439	allele frequencies >
9144439	caucasian
9144439	ins
9144439	large number
9144439	high frequencies
9144439	association study
9144439	alleles
9144439	significant association
9144439	gene region contributes
9144439	genetic susceptibility
9144439	iddm
9144439	insulin gene
9144439	iddm2
9144439	region contains
9144439	insulin
8929413	short variant
8929413	5-ht uptake
8929413	transcriptional efficiency
8929413	5-htt gene promoter
8929413	association studies
8929413	antianxiety drugs
8929413	5-htt polymorphism accounts
8929413	5-htt expression
8929413	upstream regulatory region
8929413	transporter-facilitated
8929413	serotonin transporter gene regulatory region
8929413	human 5-ht transporter
8929413	common polymorphism
8929413	independent samples
8929413	total variation
8929413	personality traits
8929413	animal models
8929413	gene transcription
8929413	polymorphism reduces
8845838	rapid amplification
8845838	fatty acid beta-oxidation
8845838	acd
8845838	human acyl-coa oxidase
8845838	hybrid cell lines
8845838	very-long-chain
8845838	pcr
8845838	chromosomal assignment
8845838	vlcad
8845838	initial step
8845838	alignment
8845838	cloning
8845838	different mutations
8845838	specific distribution
8845838	straight-chain acyl-coa dehydrogenase
8845838	ends
8845838	race
8845838	human chromosome
8845838	northern blot analysis
8845838	human tissues
8845838	mutations result
8845838	western blot analysis
8845838	skeletal muscle
8845838	extensive sequence homology
8845838	amino acid sequence
8845838	acyl-coa dehydrogenase
8845838	dna
8845838	muscle symptoms
8845838	southern blot analysis
8845838	patient fibroblasts
8845838	mitochondrial flavoproteins
8845838	human very-long-chain acyl-coa dehydrogenase cdna
8892662	conformation polymorphism analysis
8892662	novel polymorphism
8892662	c728x
8892662	c7
8892662	complement c7
8892662	genetic nature
8892662	tgt
8892662	complement components
8892662	c7d
8892662	stop codon
8892662	homozygous 2-bp deletion
8892662	family study
8892662	cys728
8892662	premature termination codon
8892662	japanese males
8892662	recurrent bacterial infections
8892662	pcr/single-strand
8892662	neisseria
8892662	homozygous mutations
8892662	genetic
8892662	molecular bases
8892662	target exons
8892662	human complement
8892662	tga
8622978	defective
8622978	cys2010
8622978	disulfide bond reduction
8622978	defective multimer formation
8622978	factor subunits
8622978	normal vwf sequence
8622978	corresponding codon
8622978	> c transition
8622978	insect
8622978	vwf subunits
8622978	vwf carboxyl-terminal domain
8622978	monomeric molecule
8622978	mutant fragment
8622978	carboxyl-terminal domains
8622978	cys-
8622978	willebrand
8622978	recombinant baculovirus
8622978	asymptomatic parents
8622978	normal dimerization
8622978	iid
8622978	arg
8622978	apparent molecular mass
8622978	dimeric molecule
8622978	apparent abnormality
8622978	heterozygous mutation
8622978	structural consequences
8968760	morocco
8968760	tunisian origin
8968760	various antibodies
8968760	ataxia-telangiectasia
8968760	mutation-specific assays
8968760	moroccan
8968760	various ethnic groups
8968760	a-t
8968760	rapid carrier detection assay
8968760	various regions
8968760	founder effect
8968760	cerebellar degeneration
8968760	atm
8968760	stop codon
8968760	tunisia
8968760	wide variety
8968760	patient cells
8968760	large jewish community
8968760	african
8968760	autosomal recessive disorder ataxia-telangiectasia
8968760	unique opportunity
8968760	african jews
8968760	cancer predisposition
8755918	cellular phenotype
8755918	missense mutations
8755918	mutations
8755918	splice-donor site
8755918	different mutation
8755918	a-t
8755918	pcr
8755918	interesting question
8755918	atm
8755918	point mutation
8755918	alternative product
8755918	severe phenotype
8755918	cerebellar ataxia
8755918	variant phenotypes
8755918	kingdom
8755918	severe clinical
8755918	compound heterozygotes
8755918	137-bp insertion
8755918	milder phenotype
8696339	cleavage
8696339	gene product
8696339	cleavage increases
8696339	cysteine proteases
8696339	huntington
8696339	apopain
8696339	nematode cysteine protease death-gene product
8696339	human counterpart
8696339	ced-3
8696339	key role
8696339	cell death
8696339	polyglutamine tract
8696339	proapoptotic cysteine protease
8696339	proteolytic events
8696339	cag
8696339	huntingtin polyglutamine tract
8696339	hd
8696339	inappropriate apoptosis
8696339	apoptosis
8696339	apoptotic extracts
10192393	recently
10192393	amino-terminal segment
10192393	ctnnb1
10192393	cancers harbour
10192393	hair matrix cells
10192393	human tumours
10192393	beta-catenin/tcf encodes c-myc
10192393	apc
10192393	adult mice
10192393	tumour cells
10192393	lef/tcf
10192393	small percentage
10192393	transgenic mice
10192393	wnt
10192393	target genes
10192393	skin tumours
10192393	common human skin tumour
10192393	novo hair-follicle morphogenesis
10192393	hair matrix cell tumorigenesis
10192393	exhibits signs
10192393	cell origin
10192393	constitutive activation
10192393	colon cancers
10192393	cytoplasmic beta-catenin
10192393	implicates beta-catenin/lef misregulation
10192393	developmental programs
10192393	human pilomatricomas
10192393	biochemical evidence
10192393	adenomatous polyposis coli
10192393	transcriptional activation
10192393	lef-1
10194428	milder form
10194428	carrier chromosomes
10194428	mutations analysis
10194428	missense mutations
10194428	hla
10194428	main mutation
10194428	common autosomal recessive genetic disorder
10194428	chromosomes suggests
10194428	hh
10194428	candidate gene
10194428	h63d
10194428	hemochromatosis probands
10194428	i-like
10194428	s65c
10194428	hereditary
10194428	hfe
10194428	large series
10194428	missense substitution
10194428	c282y
10194428	mild form
10196379	rare form
10196379	rare forms
10196379	ovarian cancer cases
10196379	caucasian
10196379	rnase
10196379	ovarian cancer study
10196379	brca1
10196379	breast cancer susceptibility gene
10196379	missense alterations
10196379	ovarian cancer
10196379	cancer cases
10196379	ovarian cancer population
10196379	germline brca1
10196379	germline alterations
10196379	ovarian cancer risk
10196379	family history
10196379	consecutive ovarian cancer cases
10196379	q356r
10196379	accurate frequency estimates
10196379	mismatch cleavage assay
10196379	allele-specific amplification
10196379	frequency distribution
10196379	comprehensive screen
10196379	common polymorphisms
10021369	mammalian apc2
10021369	colon carcinoma cells
10021369	transient transcriptional activation assays
10021369	-/- colon carcinoma cells
10021369	formation induces
10021369	comparable functions
10021369	apc
10021369	rapid degradation
10021369	wnt
10021369	genomic structure
10021369	active betacatenin-tcf complexes
10021369	adenomatous polyposis coli tumour suppressor
10021369	complex
10021369	samp
10021369	glycogen synthase kinase 3beta
10021369	tumour-suppressor protein
10021369	gsk-3beta
10021369	identification
10021369	] [
10021369	apc2
10021369	transcription factor
10021369	overall domain structure
10021369	tcf-4
10021369	adenomatous polyposis coli
100562	eight-year-old son
100562	recent episode
100562	meningococcal meningitis
100562	chemotactic activity
100562	immunochemical assays
100562	bactericidal activity
100562	c7
100562	old woman
100562	host defense
100562	recurrent bacteremic infections
100562	genetic linkage
100562	bacteremic neisseria infections
100562	fresh normal serum
100562	lack serum hemolytic complement activity
100562	opsonization
100562	clinical syndrome
100562	neisseria
100562	immunochemical assessment
100562	hemolytic activity
100562	fresh serum
100562	complete
100562	infectious complications
100562	family members
100562	gonococcal infection
100562	hla
100562	major histocompatibility loci
100562	familial
10078749	adult-onset oromandibular dystonia
10078749	gch1
10078749	dopa-responsive dystonia
10078749	dystonic symptoms
10078749	l-dopa
10078749	obvious family history
10085150	t.
10085150	g. a.
10085150	lebron
10085150	lee
10085150	bacon
10085150	f.
10085150	ruddy
10085150	genet
10085150	loeb
10085150	r. c.
10085150	mintier
10085150	cell surface
10085150	fe-nitrilotriacetic
10085150	starnes
10085150	proc
10085150	tf-positive
10085150	enns
10085150	l. m.
10085150	mcclelland
10085150	r.
10085150	cell line
10085150	prasss
10085150	ellis
10085150	f. a.
10085150	specific control
10085150	d. a.
10085150	r. r
10085150	wolff
10085150	l.
10085150	jones
10085150	lauer
10085150	quintana
10085150	feder
10085150	risch
10085150	kronmal
10085150	hela
10085150	sigal
10085150	n. j
10085150	j. n.
10085150	reduces 55fe uptake
10085150	moeller
10085150	k. j
10085150	c.
10085150	sci
10085150	hereditary hemochromatosis protein
10085150	s.
10085150	receptor 10-fold
10085150	cellular acquisition
10085150	d. t.
10085150	basava
10085150	w.
10085150	hinton
10085150	endocytic compartments
10085150	hfe
10085150	p.
10085150	a.
10085150	tf
10085150	internal compartments
10085150	kimmel
10085150	brunke
10085150	j. biol
10085150	dormishian
10085150	tf-mediated
10085150	n. c.
10085150	n.
10085150	chem
10085150	cell system
10085150	domingo
10085150	irrinki
10085150	schatzman
10085150	d. b.
10085150	protein product
10085150	penny
10085150	bjorkman
10085150	drayna
10085150	autosomal recessive disease hereditary hemochromatosis
10085150	watson
10085150	fullan
10085150	b. r
10085150	j. n
10085150	morikang
10085150	z.
10085150	exocytic rates
10085150	g. s.
10085150	mapa
10085150	d. m.
10085150	natl
10085150	tfr
10085150	thomas
10085150	m. c.
10085150	v. k.
10085150	meyer
10085150	c. n
10085150	n. l.
10085150	acad
10085150	p. j.
10085150	gross
10085150	r. j.
10085150	moore
10085150	c. e
10085150	tsuchihashi
10085150	b. e.
10085150	hereditary hemochromatotic individuals
10085150	gnirke
10085150	nat
10085150	e.
10085150	ferritin levels
10085150	transferrin receptor
10090880	carrier chromosomes
10090880	haplotype studies
10090880	mutation
10090880	haplotype data
10090880	k695r
10090880	fmf
10090880	e148q
10090880	jewish population
10090880	carrier frequency
10090880	ashkenazi jews
10090880	ancestral relationships
10090880	recessive inheritance
10090880	mediterranean
10090880	ashkenazi
10090880	arab
10090880	recent report
10090880	symptomatic mutation-positive individuals
10090880	familial mediterranean
10090880	geographic region
10090880	diverse panel
10090880	mefv
10090880	multiple microsatellite haplotypes
10090880	common mutation
10090880	unusual case
10090880	present data
10090880	heterozygote advantage
10090880	missense mutations
10090880	p369s
10090880	dna
10090880	high carrier frequency
10090880	jewish patients
10090880	new ancestral relationships
10090880	recessive disorder
10090880	consistent
10090885	similar defects
10090885	apt1
10090885	apo-1
10090885	apoptotic pathway
10090885	autoimmune
10090885	death domain
10090885	cotransfection experiments
10090885	lymphoproliferative syndrome
10090885	fas
10090885	anti-fas agonist monoclonal antibody
10090885	cd95
10090885	dominant inhibition
10090885	variant
10090885	mediates apoptosis
10090885	fas-negative
10090885	alps
10090885	mutations
10090885	lymphocyte homeostasis
10090885	heterozygous mutation
10090885	immunological tolerance
10090885	alps-associated fas
10090885	cell line
10090885	extracellular mutations
10090885	apoptotic defects
10090885	genotype influences penetrance
10090885	intracellular mutations
10090885	significant alps-related
10090885	signal-sequence cleavage site
10090885	african american alleles
10090885	intracellular portion
10090885	versus extracellular
10190819	phenotypic expressions
10190819	japanese patients
10190819	peripheral blood leukocytes
10190819	direct nucleotide sequence analysis
10190819	skin fibroblasts
10190819	ald
10190819	addison
10190819	novel mutations
10190819	adult-onset
10190819	white patients
10190819	subtle amino acid changes
10190819	objectives
10190819	vegetative state
10190819	rapid neurologic deterioration
10190819	conduct mutational analyses
10190819	homologous gene products
10190819	x-linked
10190819	large genomic rearrangements
10190819	reverse transcriptase-polymerase chain reaction products
10190819	eighteen
10190819	adrenal insufficiency
10190819	molecular basis
10190819	genotype-phenotype correlations
10190819	conclusions
10190819	pmp70
10190819	methods
10190819	protein truncation
10190819	ag
10190819	obvious correlations
10190819	adult-onset cerebral
10190819	environmental factors modify
10190819	dinucleotide deletion
10190819	common mutation
10190819	results
10190819	independent mutations
10190819	small nucleotide alterations
10190819	lymphoblastoid cells
10190819	missense mutations
10190819	background x-linked
10190819	childhood cerebral
10190819	amino acids
10190819	pxa1p
10190819	milder
10190819	classic form
10190819	southern blot analysis
10190819	mutational analyses
10190819	mutational
10190819	progressive neurologic dysfunction
10190819	diverse clinical presentations
10190819	causative gene
10190819	rna
10190819	genotype-phenotype correlation
6859721	40-year-old man
6859721	complete deficiency
6859721	complement system
6859721	patients family
6859721	heterozygous deficiency
6859721	evaluation
6859721	cutaneous vasculitis
6859721	absence
6859721	chronic meningococcemia
6859721	c7
6859721	neisserial infection
6859721	chronic
10071185	dpd
10071185	+ 1g >
10071185	dihydropyrimidine dehydrogenase deficiency
10071185	point mutation
10071185	autosomal recessive disease
10071185	phenotypic basis
10071185	dihydropyrimidine
10071185	various mutations
10071185	clear correlation
10071185	mental retardation
10071185	complete deficiency
10071185	85t > c
10071185	splice-site mutation [
10071185	2983g >
10071185	invariant splice donor site
10071185	703c >
10071185	different mutations
10071185	abundant manifestations
10071185	large phenotypic variability
10071185	homozygous deficient patients
10071185	genotype
10071185	thymine homeostasis
10071185	various clinical abnormalities
10071185	deletions [ 295-298deltcat
10071185	motor retardation
10071185	variable clinical phenotype
10071185	analysis
10071185	1897delc ]
10071185	missense mutations
10071185	convulsive disorders
10071185	2658g >
10071185	ivs14
1323345	selective amplification
1323345	glucose-6-phosphate dehydrogenase
1323345	frequent mutation
1323345	deficiency cases
1323345	method involves
1323345	molecular defects
1323345	dna
1323345	significant differences
1323345	molecular
1323345	g6pd
1323345	taiwan
1323345	chinese males
1323345	aside
1323345	restriction enzymes
1323345	different mutations
1323345	common mutation
1323345	simple method
1323345	specific oligonucleotide primers
1323345	ninety-four
1323345	restriction sites
2828430	disease distinct
2828430	molecular level
2828430	immunohistochemical techniques
2828430	hepatic apob mrna
2828430	different cdna probes
2828430	hbl
2828430	control samples
2828430	apob mrna instability
2828430	elisa
2828430	homozygous hypobetalipoproteinemia
2828430	slot blot analyses
2828430	abnormal apob protein
2828430	normal individuals
2828430	normal gene
2828430	dna
2828430	major insertions
2828430	normal size apob mrna
2828430	homozygous
2828430	southern blot analysis
2828430	apob
2828430	total liver mrna
2828430	apob gene
2828430	rna
2828430	intracellular hepatic apob protein
10471457	hepatic fibrosis
10471457	transferrin-saturation values
10471457	four-year period
10471457	homozygous subjects underwent liver biopsy
10471457	skin pigmentation
10471457	mild microvesicular steatosis
10471457	northern european ancestry
10471457	conclusions
10471457	blood samples
10471457	excessive alcohol consumption
10471457	clinical findings
10471457	serum ferritin levels
10471457	hereditary hemochromatosis
10471457	normal range
10471457	background and methods hereditary
10471457	white adults
10471457	homozygous patients
10471457	c282y
10471457	results sixteen
10471457	busselton
10471457	h63d
10471457	liver biopsy
10471457	homozygous subjects
10471457	eleven
10471457	serum transferrin saturation
10471457	australia
10471457	hfe
10471457	ferritin levels
10471457	hemochromatosis gene
10471457	clinical expression
7574457	% increase
7574457	gene encodes
7574457	female carrier
7574457	central nervous system
7574457	dm20
7574457	skin fibroblasts
7574457	central nervous system tissue
7574457	rna
7574457	overexpression
7574457	plp
7574457	pelizaeus-merzbacher
7574457	myelin proteolipid protein
7574457	exonic mutations
7574457	gene transcripts
7574457	examination
7574457	male control skin fibroblasts
7574457	threefold increase
7574457	detectable exonic mutation
10466420	particular value
10466420	transmembrane domain
10466420	diastrophic dysplasia
10466420	molecular analysis
10466420	sulfate transporter
10466420	variant forms
10466420	well-known chondrodysplasias
10466420	homozygosity
10466420	fibular overgrowth
10466420	such atypical cases
10466420	unusual radiographic
10466420	molecular
10466420	pose diagnostic problems
10466420	q454p
10466420	dtdst
10466420	atypical
10466420	'broad bone-platyspondylic
10466420	wide metaphyses
10466420	metatropic dysplasia
1676565	cytogenetic analysis
1676565	prenatal diagnosis
1676565	maternal grandfather
1676565	family contains
1676565	intragenic polymorphism
1676565	dna
1676565	plp
1676565	pelizaeus-merzbacher
1676565	carrier
1676565	x-linked pelizaeus-merzbacher
1676565	pmd
1676565	gene cdna
1676565	new mutation
1676565	proteolipid protein
1676565	report carrier identification
1776638	adenomatous polyposis coli
1776638	interstitial deletion
1776638	gs
1776638	high-resolution
1776638	fpc
1776638	gs/or
1776638	result consistent
1776638	long arm
1776638	15-year-old boy
1776638	gardner
1776638	craniofacial abnormalities
1776638	present case
1776638	familial polyposis coli
1776638	5q- patients
1776638	mental retardation
1776638	linkage studie
1577763	c4a4
1577763	base pair
1577763	haplotype occurs
1577763	protein translation
1577763	28-base pair genomic deletion
1577763	bfs
1577763	common type
1577763	c2-deficient
1577763	null allele
1577763	molecular basis
1577763	complement protein
1577763	drw2
1577763	human complement
1577763	common complotype/haplotype
1577763	major histocompatibility haplotype/complotype
1577763	homozygous type
1577763	premature termination codon
1577763	hla-a25
1577763	ii
1577763	type
1577763	molecular genetic defect
1577763	base pairs upstream
1577763	ii c2
1577763	gene deletion
1577763	genetic deficiency
1577763	c2d
1577763	c2q0
1577763	c2
1577763	hla
1577763	complete deletion
1577763	selective block
1577763	28-base pair
1577763	c4b2
1577763	28-base pair deletion
1577763	28-base pair gene deletion causes
1577763	b18
1577763	deficient complotype/haplotype
1577763	ii c2-deficient
1577763	rna
1577763	a25
10767339	mild phenotype
10767339	functional rescue
10767339	physical features
10767339	knockout mouse
10767339	yac
10767339	own phenotype
10767339	extensive amounts
10767339	mental retardation
10767339	knockout mice
10767339	transgenic lines
10767339	fmr1
10767339	knockout phenotype
10767339	fmrp
10767339	knockout mouse phenotype
10767339	transgenic mice
10767339	therapeutic approaches
10767339	behavioral abnormalities
10767339	artificial chromosome
10767339	tissue-specific manner
10767339	fmr1 yac
10767339	endogenous protein
10767339	fragile x
10767339	animal model
10767339	behavioral responses
10767339	significant implications
10767339	complex behavioral phenotype
10767339	additional abnormal behaviors
10767339	human protein
10767339	macro-orchidism
10767339	gene therapy
10767339	exploratory behavior
10767339	additional behavioral assays
10767339	knockout mice exhibit
10767339	rna
10767339	thorough evaluation
10208848	enzymatic defect
10208848	c223g
10208848	whereas enzymatic dosages
10208848	studies
10208848	molecular carrier detection
10208848	inborn error
10208848	hemizygous males
10208848	glycosphingolipid metabolism
10208848	c202w
10208848	x-linked
10208848	detection systems
10208848	q327k
10208848	enzymatic detection
10208848	fluorescent chemical cleavage
10208848	at-risk females
10208848	fabry
10208848	novel alpha-galactosidase
10208848	r301q
10208848	splice-site mutation [
10208848	mrna translational reading frame
10208848	renal failure
10208848	x-chromosomal
10208848	mrna level
10208848	female carriers
10208848	premature termination codon
10208848	angiokeratoma corporis diffusum
10208848	fd
10208848	exclude heterozygosity
10208848	> c ]
10208848	severe acroparesthesia
10208848	terminal alpha-galactosyl moieties
10208848	neutral glycosphingolipids
10208848	mutational spectrum
10208848	chemical cleavage
10208848	missense mutations
10208848	clinically
10208848	carrier status
10208848	molecular investigations
10208848	lysosomal alpha-galactosidase
10208848	gla
10208848	n224d
10208848	accurate genetic
10208848	alpha-galactosidase deficiency
10208848	consequent alteration
10208848	ivs3 g
10208848	systemic accumulation
8533768	precise location
8533768	bipolar affective disorder
8533768	molecular evidence
8533768	parent-of-origin effect
8533768	rup
8533768	recurrent unipolar
8533768	bipolar disorder
8533768	susceptibility gene
8533768	apparent unilineal transmission
8533768	fathers sibs
8533768	i. e e.
8533768	bpad
8533768	lod
8533768	nuclear families
8533768	phi =
8533768	d18s41
8533768	evidence
8533768	polymorphic markers
8533768	d18s37
8533768	affected-sibpair analyses
8533768	sib pairs
8533768	paternal pedigrees
8533768	score methods
8533768	excess allele
8531967	additional rare sequence variants
8531967	general population
8531967	genomic dna
8531967	single-strand conformation polymorphisms
8531967	high risk
8531967	conclusions
8531967	minimal estimate
8531967	comprehensive
8531967	methods
8531967	brca1
8531967	ovarian cancer
8531967	inherited
8531967	breast cancer
8531967	young women
8531967	unknown functional importance
8531967	rare sequence variants
8531967	germ-line brca1
8531967	allele-specific assays
8531967	family history
8531967	family histories
8531967	results
8531967	rare variants
8531967	background
8531967	early-onset breast cancer
8531967	dna
8531967	reference population
8531967	alterations
10915776	unique region
10915776	polyclonal antibody
10915776	retinoschisis protein
10915776	macular region
10915776	furthermore
10915776	inner retinal layers
10915776	x-linked
10915776	retinoschisin
10915776	discoidin domain
10915776	inner portions
10915776	situ hybridization
10915776	retinal samples
10915776	retinoblastoma cells
10915776	expression pattern
10915776	photoreceptor protein
10915776	amino acid protein
10915776	rs1
10915776	human tissues
10915776	photoreceptor layer
10915776	release retinoschisin
10915776	unknown function
10915776	microcystic-like changes
10915776	retinal dystrophy
10915776	photo-receptor protein
10915776	weri-rb1
10915776	visual deterioration
10915776	murine retinae
10915776	protein product
10915776	antibody detects
10915776	antibody reveals retinoschisin
10915776	antisense riboprobe
10915776	causative gene
10915776	similar size
1302003	progressive degeneration
1302003	finland
1302003	additional evidence
1302003	large family
1302003	pathogenetic role
1302003	x-linked
1302003	molecular
1302003	aberrant
1302003	chm
1302003	donor splice site
1302003	diagnostic tool
1302003	choroideremia
1302003	exon c
1302003	point mutations
1302003	msel
1302003	male patients
7811247	missense mutation
7811247	different phenotypes
7811247	novel mutation
7811247	guanine transversion
7811247	ald
7811247	addison
7811247	polymerase chain reaction
7811247	symptomatic mother
7811247	bidirectional
7811247	chain fatty acids
7811247	metabolic defect
7811247	fragments
7811247	x-linked
7811247	additional pathogenetic factors
2352258	vhl
2352258	sporadic
2352258	bilateral retinoblastoma
2352258	cerebellar haemangioblastoma
2352258	renal cell carcinoma
2352258	stage mutation process
2352258	age incidence curves
2352258	symptomatic renal cell carcinoma
2352258	recessive tumour suppressor gene
2352258	n =
2352258	sporadic renal cell carcinoma
2352258	knudson
2352258	mutation model
2352258	somatic mutations
2352258	stage mutation model
2352258	hereditary tumours
2352258	hippel-lindau
2352258	analysis
2352258	statistical
2352258	sporadic cerebellar haemangioblastoma
2352258	sporadic tumours
10364518	missense mutation
10364518	ocrl1
10364518	germline mosaicism
10364518	syndrome families
10364518	novel mutations
10364518	nervous system
10364518	mutations cluster
10364518	5-phosphatase domain
10364518	x-linked
10364518	premature termination
10364518	c-terminal
10364518	oculocerebrorenal syndrome
10364518	direct implications
10364518	p2
10364518	altogether
10364518	nonsense mutations
10364518	characterization
10364518	mutations
10364518	major abnormalities
10364518	new mutations
10364518	ptdins
10364518	frameshift mutation
10364518	ocrl
10364518	e558x
10364518	missense mutations
10364518	amino acids
10364518	lowe
10364518	recurrent in-frame deletion
10364518	r317x
10364518	new microsatellite markers
10364518	r483g
10364518	frameshift mutations
10449429	muscle cells
10449429	exposure
10449429	dystrophin protein
10449429	furthermore
10449429	codon mutations
10449429	cell membrane
10449429	muscular injury
10449429	dmd
10449429	muscular dystrophy
10449429	duchenne
10449429	mdx mouse
10449429	significant number
10449429	treatment regimen
10449429	novel treatment regimen
10449429	animal model
10449429	aminoglycoside
10449429	skeletal muscles
10449429	mdx myotubes
10449429	antibiotics restore dystrophin function
10449429	mdx mice
10449429	functional protection
10449429	aminoglycoside treatment
10449429	dystrophin gene
1939657	polyacrylamide gels
1939657	production rate
1939657	vldl
1939657	g/ml lipoprotein fraction
1939657	g/ml lipoproteins
1939657	metabolic basis
1939657	cuboidal particles
1939657	premature in-frame
1939657	ldl
1939657	apob variant
1939657	virtual absence
1939657	molecular
1939657	normal chylomicrons
1939657	homozygous hypobetalipoproteinemia
1939657	autologous
1939657	normal range
1939657	interval contains
1939657	apparent half-removal time
1939657	rare example
1939657	low density lipoproteins
1939657	apob codon
1939657	postabsorptive state
1939657	patients plasma lipoproteins
1939657	nucleotide substitution
1939657	exponential disappearance
1939657	complete absence
1939657	normotriglyceridemic abetalipoproteinemia
1939657	triglyceride-rich lipoproteins
1939657	molar ratio
1939657	electron
1939657	c-to-t
1939657	normal secretion
1939657	metabolic disorder normotriglyceridemic abetalipoproteinemia
1409710	missense mutation
1409710	antibiotic ristocetin
1409710	platelet glycoprotein
1409710	gly-561
1409710	point mutation
1409710	functional defect
1409710	primary defect
1409710	ristocetin cofactor activities
1409710	ser
1409710	patients plasma vwf
1409710	multimeric glycoprotein
1409710	willebrand
1409710	different mechanisms
1409710	ib
1409710	unique variant
1409710	human vwf
1409710	snake venom protein botrocetin
1409710	mutation causes von
1409710	disease type b
1409710	normal multimers
1409710	corresponding mutant recombinant protein
1409710	g561s
1409710	data show
1409710	normal allosteric regulation
8554067	ring
8554067	ovarian cancer susceptibility
8554067	positive evidence
8554067	germ-line mutations
8554067	clear examples
8554067	sequencing
8554067	dna
8554067	normal length
8554067	breast-ovarian syndrome
8554067	brca1
8554067	breast-ovarian cancer families
8554067	cdna analysis
8554067	male breast cancer
8554067	high incidence
8554067	finger domain
8244393	missense mutation
8244393	na+/glucose
8244393	transport activity
8244393	> qter
8244393	+/glucose cotransporter gene
8244393	asp28
8244393	asn
8244393	brush border
8244393	cotransporter gene
8244393	genetic diseases
8244393	situ hybridization
8244393	sglt1
8244393	primary carrier protein
8244393	oral rehydration therapy
8244393	assignment
8244393	75-kda glycoprotein
8244393	autosomal recessive disease glucose/galactose malabsorption
8244393	membrane spans
8244393	intestinal lumen
8244393	chromosome 22q13.1
8244393	dietary sugars glucose
8244393	intestinal epithelium
8244393	na
8244393	distal q arm
1384323	disease carriers
1384323	i. e.
1384323	disease mutation
1384323	c739-to-t
1384323	at-risk couples
1384323	large proportion
1384323	vitro biochemical tests
1384323	tay-sachs
1384323	arg247
1384323	pseudodeficient subject
1384323	hexa
1384323	trp
1384323	pseudodeficiency allele
1384323	hex
1384323	standard biochemical
1384323	healthy subjects
1384323	additional pseudodeficient subjects
1384323	dna
1384323	non-jewish carriers
1384323	disease allele
1384323	deficiency
1307230	single-base transition
1307230	insertion mutation
1307230	carrier status
1307230	tay-sachs
1307230	extensive pedigrees
1307230	disease mutations
1307230	pedigree
1307230	cajun
1307230	tsd
1307230	ancestral couple
1307230	eleven
1307230	alpha-subunit exon
1307230	hex
1307230	ashkenazi
1307230	donor splice site
1307230	louisiana
1307230	alpha-subunit intron
1307230	france
8088831	genomic sequences
8088831	missense mutation
8088831	recently
8088831	bovine aspa gene
8088831	canavan
8088831	cross-species hybridization
8088831	genomic organization
8088831	vi
8088831	sequences cross-hybridize
8088831	situ hybridization
8088831	spongy degeneration
8088831	human aspartoacylase
8088831	17p13-ter region
8088831	identify mutations
8088831	human chromosome
8088831	human/mouse somatic cell hybrid cell lines
8088831	gt/ag consensus sequence rule
8088831	exon/intron organization
8088831	aspa
8088831	500-base sequence upstream
8088831	iii
8088831	human gene
8088831	bovine gene
8088831	severe leukodystrophy
8088831	dna
8088831	atg
8088831	southern blot analysis
8088831	sequences suggests
8088831	exon/intron splice junction sites
6524872	very-long-chain fatty acids
6524872	prenatal diagnosis
6524872	arrest neurological progression
6524872	peroxisomal disorders
6524872	ald
6524872	clear benefit
6524872	adrenoleukodystrophy
6524872	adrenal cortical insufficiency
6524872	x-linked
6524872	% adrenomyeloneuropathy
6524872	wide phenotypic variation
6524872	autosomal recessive inheritance
6524872	cerebrohepatorenal syndrome
6524872	dietary origin
6524872	zellwegers
6524872	biochemical
6524872	xq28
6524872	marrow transplant
6524872	bone
6524872	neonatal ald
6524872	distinct entity
6524872	sixty
6524872	subcellular organelle
6524872	c26
6524872	central demyelination
10441343	segregation distortion
10441343	french
10441343	japanese patients
10441343	normal alleles
10441343	intragenic polymorphism
10441343	sperm data
10441343	mjd1
10441343	normal chromosome
10441343	patient population
10441343	mjd
10441343	trans effect
10441343	disease patients
10441343	disease alleles
10441343	g/c
10441343	segregation
10441343	machado-joseph
10441343	repeat number
10441343	japanese descent
10441343	french patients
10441343	trinucleotide repeat disorders
10441343	likelihood-based
10441343	polymorphic marker
10441343	disease chromosome
10441343	data shows
10441343	exhibit gametic segregation distortion
10441343	meiotic segregation distortion
10441343	d14s1050
10441343	previous report
10441343	spermseg
10441343	wild-type allele
10441343	disease allele stability
10441343	gamete level
10441343	c/c
3346018	gene product
3346018	dna
3346018	large deletion precludes
3346018	nebulin
3346018	dmd
3346018	muscle specimen
3346018	muscular dystrophy
3346018	duchenne
8188241	alkaptonuria
8188241	human gene
8188241	mckusick
8188241	homogentisic acid oxidase activity
8188241	homogentisic acid
8188241	ochronosis
8188241	large amounts
8188241	predominant clinical complication
8188241	dark urine
8188241	black ochronotic pigment
8188241	chromosome 3q
8188241	rare autosomal recessive disorder
8188241	ochronotic arthropathy
8188241	pigment changes
8188241	slovak
8188241	collagenous tissues
8188241	alkaptonuria pedigrees
8188241	patients
8188241	aku
1317264	missense mutation
1317264	genetic changes
1317264	human gastric cancer
1317264	intestinal metaplasia
1317264	5-base pair deletion
1317264	apc
1317264	rnase
1317264	common cancer
1317264	nonsense mutation
1317264	gastric cancer
1317264	polymerase chain reaction products
1317264	somatic mutations
1317264	protection analysis
1317264	dnas
1317264	adenomatous polyposis coli
1317264	gene product
1317264	familial adenomatous polyposis
1317264	polymerase chain reaction
1317264	gastric cancers
1317264	adenomatous polyps
1317264	based
1317264	important role
10083734	main islands
10083734	sscp
10083734	mutant alleles
10083734	c9
10083734	arg95stop
10083734	pcr
10083734	molecular
10083734	arg95
10083734	conformation polymorphism
10083734	heterozygote
10083734	tga
10083734	serological studie
10083734	pcr/single-strand
10083734	common complement deficiency
10083734	japan
10083734	genetic
10083734	twenty
10083734	deficiency heterozygotes
10083734	heterozygous carriers
10083734	dna
10083734	c-to-t
10083734	human complement
10083734	allele-specific polymerase chain reaction
10083734	deficiency
2760209	carrier studies
2760209	nonrandom inactivation
2760209	cell hybrids
2760209	novo gametic event
2760209	furthermore
2760209	comparison
2760209	x-linked
2760209	maternal gamete
2760209	somatic
2760209	] deficiency
2760209	gene regulation
2760209	molecular
2760209	normal paternal
2760209	phosphoglycerate kinase
2760209	together
2760209	separate maternal
2760209	glucose-6-phosphate dehydrogenase
2760209	normal chromosomes
2760209	hypoxanthine phosphoribosyltransferase [
2760209	inactive paternal
2760209	female patient
2760209	hprt
2760209	lesch-nyhan
2760209	active maternal
2760209	cytogenetic
2760209	dna
2760209	methylation patterns
10323252	mutant forms
10323252	proper structure/function
10323252	edmd
10323252	cardiac conduction defects
10323252	x-linked
10323252	achilles
10323252	elbow contractures
10323252	cardiac involvement
10323252	nuclear envelope
10323252	p183
10323252	muscular dystrophy
10323252	biochemical
10323252	proline residue
10323252	ankle contractures
10323252	wild-type emerin
10323252	34-kda serine-rich protein
10323252	x-linked emery-dreifuss
10323252	xq28
10323252	mutations
10323252	nuclear lamina components
10323252	wide variety
10323252	upper limb weakness
10323252	emery-dreifuss
10323252	expression levels
10323252	protein studies
10323252	protein-protein interactions
10323252	limb weakness
10323252	missense mutations
10323252	early contractures
10323252	progressive muscle
10323252	cardiac muscle
10323252	emerin gene
10323252	emerin protein expression
7795653	antisense oligonucleotides
7795653	sporadic breast cancer progression
7795653	mammary epithelial cells
7795653	mammary epithelial cell growth
7795653	experimental
7795653	negative regulator
7795653	ovarian cancer gene
7795653	brca1
7795653	decreased
7795653	proliferative rate
7795653	breast cancer
7795653	malignant mammary cells
7795653	direct mutation
7795653	invasive cancer
7795653	gene expression
7795653	mrna levels
7795653	non-mammary epithelial cells
7795653	antisense inhibition
7795653	familial breast
7795653	accelerates growth
10827108	cytogenetic analysis
10827108	separate integration
10827108	plp
10827108	additional copy
10827108	standard karyotype analysis
10827108	additional
10827108	extra copy
10827108	normal copy
10827108	pericentric inversion
10827108	proteolipid protein gene
10827108	xp11
10827108	xp22
10827108	chromosomal rearrangements
10827108	noncontiguous site suggests
10827108	fish
10827108	such duplications
10827108	ahaii
10827108	genetic disorders
10827108	mutations
10827108	new families
10827108	similar findings
10827108	separate families
10827108	pelizaeus-merzbacher
10827108	xq22
10827108	family members
10827108	xq26
10827108	pmd
10827108	short arm
1975560	peak lod score
1975560	localisation
1975560	somatic cell hybrids
1975560	close linkage
1975560	ckmm
1975560	cyp2a
1975560	individual places
1975560	gene cluster
1975560	genetic linkage
1975560	apoc1-dm
1975560	map proximal
1975560	zmax
1975560	apoc1
1975560	evidence
1975560	c1
1975560	apoc2/c1/e
1975560	lod score
1975560	cyp2a-dm
1975560	recombinant individuals
1975560	apoc2
1975560	myotonic dystrophy
1975560	p450
1975560	linkage
1975560	theta max =
1975560	dm
10737981	amino acid substitutions
10737981	specific genetic lesions
10737981	gm1-gangliosidosis
10737981	lysosomal enzyme
10737981	severe form
10737981	r482h
10737981	r201h
10737981	cardiac involvement
10737981	specific clinical manifestations
10737981	acid beta-galactosidase
10737981	molecular
10737981	new beta-galactosidase gene mutations
10737981	hbeta-gal-related
10737981	c.
10737981	y591c
10737981	interestingly
10737981	lysosomal storage disorder
10737981	compound heterozygous
10737981	ivs8
10737981	+ 2t >
10737981	y591n
10737981	g.
10737981	r59h
10737981	cdna region
10737981	beta-galactosidase gene mutations
10737981	ivs14-2a
10737981	g579d
10737981	dna
10737981	cardiac abnormalities
10737981	glb1
10737981	italian patients
10737981	ebp
10737981	rna
1679035	haplotype analysis
1679035	rflp
1679035	acute attacks
1679035	gene cluster
1679035	conventional linkage analysis
1679035	exclusion
1679035	mediterranean
1679035	saa
1679035	polymorphic dinucleotide repeat
1679035	human serum amyloid
1679035	conventional restriction fragment length polymorphism
1679035	prominent physiologic markers
1679035	minimum crossover frequency
1679035	fmf
1679035	serum amyloid
1679035	gene marker
1679035	israeli fmf
1679035	autosomal recessive trait familial
10802667	trinucleotide repeat
10802667	skeletal muscle dystrophy
10802667	expansion
10802667	apparent abnormalities
10802667	cardiac conduction defects
10802667	mutant mice
10802667	mild myopathy
10802667	myotonic dystrophy phenotype
10802667	repeat expansion decreases expression
10802667	mouse orthologue
10802667	causes myotonic dystrophy
10802667	deficiency contributes
10802667	multiple tissues
10802667	cataract phenotype
10802667	dm1
10802667	adjacent gene
10802667	homeodomain transcription factor
10802667	dm15
10802667	utr
10802667	multigenic disorder
10802667	lenticular opacities
10802667	dmpk
10802667	skeletal muscle function
10802667	reporter expression
10802667	six5-mutant
10802667	six5
10802667	cardiac conduction abnormalities
10802667	mice
10802667	myotonic dystrophy
10802667	targeted
10802667	homozygous
10802667	beta-galactosidase reporter
10802667	ctg
1338764	gpg
1338764	screening
1338764	new patients
1338764	germ-line mutations
1338764	apc
1338764	new familial adenomatous polyposis
1338764	familial adenomatous polyposis patients
1338764	polymerase chain reaction
1338764	information helpful
1338764	pcr
1338764	base substitutions
1338764	presymptomatic diagnosis
1338764	examination
1338764	adenomatous polyposis coli
1338764	extracolonic manifestations
1338764	significant defects
1338764	ribonuclease protection assay
1338764	fap
1338764	great majority
1999552	hypocomplementemia
1999552	discoid lupus erythematosus
1999552	undetectable classic pathway complement activity
1999552	29-year-old woman
1999552	hereditary
1999552	c5
1999552	selective deficiency
10818206	recently
10818206	genomic organization
10818206	considerable amino acid sequence homology
10818206	human pyrin
10818206	fmf
10818206	rat genes
10818206	chromosome
10818206	important domains
10818206	functional evolution
10818206	knockin mouse models
10818206	isolation
10818206	murine gene contains
10818206	rat protein
10818206	familial mediterranean fever
10818206	zinc finger domain
10818206	nuclear localization signal
10818206	white pulp
10818206	chr
10818206	rodent proteins
10818206	b-box
10818206	ancient frame-shift mutation
10818206	familial mediterranean
10818206	% identity
10818206	c-terminal b30
10818206	high levels
10818206	a3-b1
10818206	primary follicles
10818206	marginal zones
10818206	myeloid cells
10818206	fmf-associated
10818206	human gene
10818206	coiled-coil domain
10818206	rat homolog
10818206	% similarity
10818206	protein product
10818206	robbins-dingwall
10818206	peripheral blood granulocytes
10818206	rat homologs
10818206	mefv
10818206	recessive disorder
10818206	consistent
10818206	expression analysis
1684569	multipotent stem cell
1684569	complete report
1684569	vast majority
1684569	atypical lyonization
1684569	carrier female
1684569	hematopoietic cell lineages
1684569	hematopoietic differentiation pathway
1684569	x-chromosome
1684569	thrombocytopenic female
1684569	rflp
1684569	manifest nonrandom
1684569	m27
1684569	fragment length polymorphism
1684569	methylation analysis
1684569	gene occurs
1684569	analysis
1684569	restriction
1684569	was
1684569	wiskott-aldrich
1684569	thrombocytopenic carrier female
1684569	thrombopoietic cell lineage
1684569	presumptive expression
10724175	replication-block checkpoint
10724175	brca1-mutated
10724175	mutations
10724175	restore survival
10724175	phosphorylation
10724175	nuclear foci
10724175	biochemical function
10724175	kinase family
10724175	dna
10724175	tumour suppressor gene
10724175	brca1
10724175	damage response
10724175	ovarian cancers
10724175	breast cancer
10724175	cell line
10724175	hcc1937
10724175	cds1
10724175	damage repair
10724175	cell-cycle checkpoint
10724175	gamma irradiation
10556285	immunochemical experiments
10556285	normal glutamine repeat
10556285	ataxin-3
10556285	nucleus exposes
10556285	unique conformation
10556285	cag
10556285	nuclear protein
10556285	neuronal dysfunction
10556285	cag/polyglutamine
10556285	polyglutamine domain
10556285	full-length ataxin-3
10556285	full-length non-pathological protein
10556285	nuclear matrix
10556285	intranuclear expression
10556285	intranuclear ataxin-3
10556285	machado-joseph
10556285	glutamine domain
10556285	novel conformation
10556285	sca3/mjd
10556285	early event
10556285	pathological form
10556285	spinocerebellar
10556285	repeat disease family
10556285	disease gene product
10556285	monoclonal antibody
10556285	fractionation
10556285	ataxia type-3
10556285	disease protein
10556285	polyglutamine disease implicate
10556285	experimental
10077614	adult heterozygous
10077614	heterozygous embryonic stem cells
10077614	causal link
10077614	key role
10077614	urogenital development
10077614	c-terminal
10077614	rare childhood disease
10077614	genital defects
10077614	male
10077614	zinc finger
10077614	breast cancer
10077614	zf3
10077614	valuable insight
10077614	characteristic urogenital abnormalities
10077614	xy
10077614	chimeric mice
10077614	mutant allele exerts
10077614	wt1
10077614	tumor -suppressor gene
10077614	denys-drash
10077614	mesangial sclerosis
10077614	exonic point mutations
10077614	zinc finger truncation
10077614	wilms
10077614	wt
10077614	induces mesangial sclerosis characteristic
10077614	dds
10077614	zf
7106752	important heterogeneity
7106752	clinical manifestations
7106752	molecular characteristics
7106752	southern spanish origin
7106752	spanish population
7106752	spanish males
7106752	new data
7106752	heterogeneity
7106752	new mutants
7106752	world health organization
7106752	mediterranean
7106752	ec
7106752	deficient variants
7106752	g6pd
7106752	chronic nonspherocytic
7106752	multiple geographic regions
7106752	g6pd mediterranean
7106752	spain
7106752	different mutants
7106752	residual erythrocyte
7106752	subjects
7106752	g6pd athens-like
7106752	g6pd betica
7106752	glucose-6-phosphate dehydrogenase
7106752	present study constitutes
7106752	numerous variants
7106752	provisionally
7106752	hemolytic anemia
7106752	glucose-6-phosphate
7106752	g6pd menorca
7106752	high degree
7106752	important findings
7106752	frequent variant
7106752	deficient phenotype
7106752	favism
7106752	new variants
10480214	postcervical muscles
10480214	pcr-based
10480214	sudden cardiac death
10480214	membrane protein emerin
10480214	emerin gene deletion
10480214	emerin
10480214	edmd
10480214	amplification product
10480214	typical symptoms
10480214	achilles
10480214	muscle involvement
10480214	muscular dystrophy
10480214	molecular genetic diagnosis
10480214	x-linked emery-dreifuss
10480214	early
10480214	cardiac abnormality
10480214	rt-pcr
10480214	dna
10480214	emerin gene
10480214	changes characteristic
10480214	muscle
1682919	b-cell
1682919	noncentrocytic lymphomas
1682919	kiel
1682919	bcl1 dna
1682919	novel cyclin
1682919	parathyroid adenomas
1682919	report pulsed-field gel electrophoresis data
1682919	d11s287e
1682919	excellent candidate
1682919	key consequence
1682919	unusual cases
1682919	parathyroid hormone gene
1682919	immediate vicinity
1682919	squamous cell neoplasms
1682919	chromosomal breakpoint region
1682919	bcl1
1682919	nearby protooncogene
1682919	putative oncogene
1682919	prad1
1682919	rearrangement
1682919	centrocytic lymphomas
1682919	centrocytic lymphoma
1682919	cll
7202134	fatty acid
7202134	c25
7202134	c23
7202134	c20
7202134	ald
7202134	plasma content
7202134	c24
7202134	new method
7202134	carrier identification
7202134	fatty acids
7202134	chain fatty acids
7202134	sem
7202134	adrenoleukodystrophy
7202134	c22
7202134	c26
7202134	total fatty acids
6337374	selective advantage
6337374	malarious area
6337374	red blood cells
6337374	sardinia
6337374	female heterozygotes
6337374	dehydrogenase deficiency inhibits
6337374	beta 0-thalassemia trait
6337374	male hemizygotes
6337374	ec
6337374	female heterozygote
6337374	g6pd
6337374	data support
6337374	fatal hemolysis
6337374	thalassemia trait
6337374	parasite growth
6337374	support growth
6337374	malaria equals
6337374	glucose-6-phosphate
6337374	vitro growth
6337374	plasmodium
6337374	protective effect
6337374	particular advantage
6337374	parasite
6337374	sardinians
3718019	immune response genes
3718019	myasthenia gravis
3718019	c2
3718019	possible linkage
3718019	systemic lupus erythematosus
3718019	aetiological implications
3718019	heterozygous complement factor
3718019	heterozygous c2
3718019	autoimmune disorders
3718019	certain histocompatibility antigens suggests
2963536	severe pyogenic infections
2963536	renal biopsy specimen
2963536	immune-complex disease
2963536	immune complexes
2963536	10-year-old laotian boy
2963536	vitro addition
2963536	bactericidal activities
2963536	patient serum
2963536	hemolytic complement
2963536	recurrent infections
2963536	inherited c3
2963536	plasma infusion
2963536	significant levels
2963536	humoral immunity
2963536	opsonic activities
2963536	serum
2963536	normal levels
2963536	mesangiopathic glomerulonephritis
2963536	c3
2963536	polymorphonuclear leukocyte chemotaxis
2963536	homozygous deficiency
2963536	recurrent bacterial infections beginning
2963536	antibiotic therapy
2963536	igg
2963536	serum opsonic activity
2963536	cellular
7586656	hprt
7586656	whole
7586656	southern analysis
7586656	southern analysis reveals
7586656	large deletion
7586656	lesch-nyhan
7586656	carrier status
7586656	female family members
7586656	dna
7586656	hypoxanthine phosphoribosyltransferase locus
7586656	hprt gene
7586656	genomic hprt clones
7586656	sequence deletion
7586656	x-chromosome
7586656	enzyme deficiency causal
7586656	rflp
10426999	ectopic
10426999	methyl methanesulfonate
10426999	breast cancer cells
10426999	formation
10426999	tumor suppressor
10426999	dna
10426999	cellular responses
10426999	brca1
10426999	discrete foci
10426999	damage response
10426999	familial breast
10426999	upon
10426999	ovarian cancers
10426999	damage agent
10426999	homozygous mutation
10426999	hcc/1937
3678494	monoclonal
3678494	nebulin polypeptides
3678494	large deletion
3678494	titin expression
3678494	recent proposal
3678494	muscle biopsies
3678494	different epitopes
3678494	nebulin
3678494	gel
3678494	normal pattern
3678494	frozen sections
3678494	dmd
3678494	muscular dystrophy
3678494	duchenne
3678494	nebulin show
8281152	unstable [
8281152	serine/threonine protein kinase
8281152	recent
8281152	multiple protein isoforms
8281152	mtjs
8281152	furthermore
8281152	dm
8281152	congenital cases
8281152	strikingly
8281152	clinical manifestation
8281152	signal mediation
8281152	immunohistochemical
8281152	complex pathophysiology
8281152	gross changes
8281152	] n
8281152	dm-pk
8281152	various muscles
8281152	myotonic dystrophy protein kinase
8281152	trinucleotide motif forms part
8281152	ctg
8281152	protein assembly processes
8281152	cardiac muscle extracts
8281152	structural organisation
8281152	muscular tissues
8281152	immunoreactive dm-kinase
8281152	low levels
8281152	dystrophy kinase
8281152	peptide antigens
8281152	myotonic
8281152	neuromuscular junctions
8281152	myotonic dystrophy
8281152	dna
8281152	nmjs
8281152	synaptic sites
8281152	histochemical studies
8281152	myotendinous junctions
8281152	rodent skeletal muscles
8281152	normal controls
7316485	italian
7316485	new genetic variants
7316485	g6pd
7316485	enzyme deficiency
7316485	glucose 6-phosphate dehydrogenase
7316485	common types
7316485	new variants
7316485	human erythrocyte
7316485	italy
10677309	approximately
10677309	germline mutations
10677309	general population
10677309	bilateral breast cancer
10677309	specific characteristics
10677309	dutch
10677309	sporadic breast cancer
10677309	normal blood lymphocytes
10677309	a-t
10677309	atm-heterozygotes
10677309	breast cancer
10677309	atm
10677309	relative risk
10677309	early age
10677309	mutations
10677309	atm-heterozygous
10677309	ivs10-6t
10677309	high percentage
10677309	mim
10677309	frequent bilateral occurrence
10677309	germline mutation
10677309	autosomal recessive disorder ataxia-telangiectasia
10677309	high frequency
10677309	breast cancer-susceptibility
10677309	protein-truncation test
10677309	heterozygous carriers
10677309	genomic-sequence analysis
10677309	germline mutations contribute
10677309	splice-site mutation
10677309	> /=
10677309	long-term survival
10677309	age <
10677309	contralateral breast tumor
10709732	autosomal homozygous mutation
10709732	lymphoproliferative syndrome
10709732	detection
10709732	fas
10709732	recessive disease
10709732	20-nucleotide duplication
10709732	fas-null
10709732	fas-mediated
10709732	blood leukocytes
10709732	pcr
10709732	sequencing
10709732	real-time quantitative
10709732	human homologue
10709732	alps
10709732	heterozygous family members
10709732	autosomal recessive
10709732	autoimmune
10709732	severe transcriptional defect
10709732	consanguineous parents
8551426	prevalent mutation
8551426	total body oxidation
8551426	white patients
8551426	q188r
8551426	black patients
8551426	different tissues
8551426	q188r/q188r
8551426	galactose-1-phosphate uridyltransferase
8551426	conclusions
8551426	methods
8551426	s135l/s135l
8551426	black american origin
8551426	d-
8551426	patients homozygous
8551426	enzyme impairment
8551426	clinical outcome
8551426	objective
8551426	black american patients
8551426	serine-to-leucine substitution
8551426	good clinical outcome
8551426	normal whole body oxidation
8551426	% prevalence
8551426	results
8551426	s135l
8551426	screen populations
8551426	white control subjects
8551426	activity varies
8551426	various degrees
8551426	patient homozygous
8551426	normal/normal
8551426	galt
8551426	g/g
8551426	classic galactosemia
10699184	constitutive
10699184	c-terminally
10699184	mouse model
10699184	expression patterns
10699184	smooth muscle-specific
10699184	distinct properties
10699184	triplet repeat expansion
10699184	splice site
10699184	mrna reading frame
10699184	neuromuscular disease
10699184	information
10699184	peptide motif
10699184	myotonic dystrophy protein kinase
10699184	major myotonic dystrophy protein kinase
10699184	independent stochastic events
10699184	smooth muscle
10699184	genetic defect
10699184	full-length mouse cdnas
10699184	cell type
10699184	dmpk
10699184	vsggg
10699184	and/or use
10699184	skeletal muscle-
10699184	kda full-length
10699184	myotonic
10699184	endogenous mouse
10699184	protein isoform expression patterns
10699184	dmpk-overexpressor
10699184	ctg
10699184	identical cell type-dependent distribution frequencies
10699184	dm
10417286	susceptibility locus
10417286	syndrome suggests
10417286	brazilian
10417286	recurrence risk <
10417286	cleft lip/palate
10417286	vws
10417286	clinical signs
10417286	pits and/or sinuses
10417286	cleft palate
10417286	linkage analysis
10417286	cp
10417286	linkage
10417286	van der
10417286	major gene
10417286	bifid uvula
10417286	at-risk genes
10417286	cl/p
10417286	incomplete penetrance
10417286	woude
3393536	g6pd ilesha
3393536	clinical manifestations
3393536	people worldwide
3393536	point mutation
3393536	enzyme deficiency
3393536	diverse point mutations
3393536	common genetic abnormality
3393536	precise molecular basis
3393536	point mutations
3393536	indian boy
3393536	italy
3393536	diverse
3393536	clinical
3393536	novo mutation
3393536	nondeficient polymorphic
3393536	ec
3393536	g6pd a-
3393536	g6pd
3393536	hematological point
3393536	catalytic efficiency
3393536	g6pd mediterranean
3393536	biochemical analyses
3393536	neonatal jaundice
3393536	single
3393536	nigeria
3393536	phenotypic heterogeneity
3393536	african
3393536	matera
3393536	g6pd santiago
3393536	g6pd metaponto
3393536	glucose-6-phosphate
3393536	separate point mutations
3393536	severe chronic hemolytic anemia
3393536	cg
3393536	amino acid replacement
3393536	severe hemolytic anemia
3393536	g6pd chatham
3393536	human glucose-6-phosphate dehydrogenase gene
2215607	common cholesteryl-ester
2215607	premature atherosclerosis
2215607	different regions
2215607	moderate hypercholesterolemia
2215607	background and methods
2215607	family members homozygous
2215607	cetp
2215607	high-density lipoprotein levels
2215607	lipoprotein profile
2215607	total cholesterol level [ +/-
2215607	conclusions
2215607	founder effect
2215607	sd
2215607	life span
2215607	additional families
2215607	apolipoprotein b
2215607	high-density lipoprotein
2215607	n =
2215607	hdl
2215607	normal range
2215607	cholesteryl esters
2215607	low-density lipoprotein cholesterol
2215607	increased
2215607	japan
2215607	identical haplotype
2215607	plasma cholesteryl-ester
2215607	results
2215607	family members
2215607	cholesterol levels
2215607	different parts
2215607	analysis
2215607	protein gene mutation
2215607	gene mutation
2215607	restriction-fragment-length polymorphisms
2215607	dna
2215607	members heterozygous
2215607	a-i
7523157	protein polymorphism
7523157	autosomal co-dominant manner
7523157	complement
7523157	c7 m/n
7523157	deficiency genes
7523157	c7
7523157	irish family
7523157	complement component deficiency predisposes
7523157	uncommon meningococcal serogroup
7523157	hereditary
7523157	novel haemolytic
7523157	complement activity
7523157	terminal complement deficiency
7523157	normal levels
7523157	recurrent infection
7523157	identification
7523157	terminal
7523157	immunosorbent assay
7523157	recurrent meningococcal infection
7523157	enzyme-linked
7523157	meningococcal infection
7523157	complement deficient patients
7523157	sufficient brother
3162536	patient possesses
3162536	similar exon deletions
3162536	clinical phenotype
3162536	severe muscular dystrophy
3162536	dna
3162536	becker
3162536	candidate gene sequences
3162536	dxs206
3162536	severe phenotype
3162536	dmd
3162536	dxs164
3162536	hip25
3162536	duchenne
3162536	bmd
3162536	deletions
3162536	xj1
3162536	mild
3162536	muscular dystrophy
3162536	xp21
10631148	segregation distortion
10631148	segregation analysis
10631148	normal allele
10631148	meiotic drive
10631148	segregation rate
10631148	retinoblastoma pedigrees
10631148	significant heterogeneity
10631148	different epidemiological studies
10631148	mutant retinoblastoma alleles
10631148	various mechanisms
10631148	segregation parameters
10631148	analysis shows
10631148	hereditary retinoblastoma
10631148	segregation probability
10631148	fertilization advantage
10631148	rb1
10631148	single-sperm
10631148	experimental parameters
10631148	recombination fractions
10631148	sperm samples
10631148	significant segregation distortion
10631148	preferential paternal transmission
10631148	short tandem repeats
10631148	retinoblastoma gene
10631148	spermseg
10631148	meiotic
10861298	v480d
10861298	syndrome differ
10861298	anion transport
10861298	non-syndromic hearing loss
10861298	pendrin transports iodide
10861298	usa
10861298	iodide transport
10861298	l236p
10861298	wild-type pendrin
10861298	residual level
10861298	pds
10861298	t416p
10861298	i490l/g497s
10861298	phenotypic variation
10861298	transmembrane protein
10861298	dfnb4
10861298	v653a
10861298	gene encodes
10861298	mutations
10861298	colloid space
10861298	pendrin function
10861298	pendred
10861298	complete loss
10861298	gene product
10861298	syndrome allele variants
10861298	e384g
10861298	autosomal recessive non-syndromic hearing loss
10861298	apical membrane
10861298	functional
10861298	vestibular aqueducts
1353340	clinical data
1353340	arsa
1353340	metachromatic leukodystrophy
1353340	molecular pathology
1353340	new allele
1353340	arylsulfatase gene family
1353340	late-onset
1353340	different degrees
1353340	phenotypical variation
1353340	mld
1353340	allele arginine84
1353340	late-onset metachromatic leukodystrophy
1353340	glutamine substitution
10200300	cytoplasmic death domain
10200300	ia
10200300	fadd/mort1
10200300	human autoimmune lymphoproliferative syndrome
10200300	heterozygous
10200300	autoimmune lymphoproliferative syndrome
10200300	abnormal allele
10200300	fadd
10200300	cd95
10200300	death-domain interactions
10200300	alps cd95
10200300	defective cd95/apo-1/fas
10200300	global alterations
10200300	unknown mechanism
10200300	death-domain mutations result
10200300	caspase recruitment
10200300	complex formation
10200300	alps
10200300	apo-1/fas
10408771	d1
10408771	constitutional factors
10408771	k285n
10408771	q188r
10408771	disorder exhibits
10408771	different base changes
10408771	lymphoblastoid cells lines
10408771	additional effects
10408771	mutant chromosomes
10408771	enzyme galactose-1-phosphate uridyl transferase
10408771	base changes
10408771	vitro expression systems
10408771	different populations
10408771	classical
10408771	enzyme activity
10408771	specific molecular changes
10408771	n314d
10408771	ethnic groups
10408771	severe phenotype
10408771	considerable genetic heterogeneity
10408771	overall
10408771	d2
10408771	different activities
10408771	european descent
10408771	amino acid substitution
10408771	globally
10408771	vitro expression results
10408771	phenotypic heterogeneity
10408771	significant differences
10408771	phenotypic variability
10408771	galactose-1-phosphate uridyl transferase
10408771	complete loss
10408771	considerable allelic heterogeneity
10408771	common mutation
10408771	nonallelic variation
10408771	individual populations
10408771	individuals
10408771	los angeles
10408771	countries worldwide
10408771	s135l
10408771	relative frequency
10408771	duarte
10408771	linkage disequilibrium
10408771	european populations
10408771	galt
10636421	recently
10636421	japanese patients
10636421	new point mutations
10636421	methods ten
10636421	clinical manifestations
10636421	genetic abnormalities
10636421	point mutations
10636421	x-linked
10636421	deleterious gene mutations
10636421	available information
10636421	conclusions
10636421	study increases
10636421	causes visual loss
10636421	nonsense mutation
10636421	rare vitreoretinal dystrophy
10636421	disease phenotype
10636421	objective
10636421	full ophthalmologic examination
10636421	frameshift mutation
10636421	xlrs
10636421	results
10636421	clinical relevance identification
10636421	missense mutations
10636421	background x-linked
10636421	slitlamp biomicroscopy
10636421	polymerase chain reaction
10636421	formutational changes
10636421	xlrs1
10636421	genomic dna
10636421	young men
10429004	significant relationship
10429004	mhp
10429004	methodology pah
10429004	mutation-phenotype associations
10429004	pku
10429004	reproductive outcome
10429004	mild hyperphenylalaninemia [
10429004	cognitive performance
10429004	sample sizes
10429004	pah
10429004	phenylalanine hydroxylase
10429004	relationship
10429004	conclusions
10429004	intellectual resources
10429004	cognitive development
10429004	future treatment
10429004	maternal phenylketonuria
10429004	various combinations
10429004	different mutations
10429004	biochemical phenotype
10429004	prenatal metabolic control
10429004	objective
10429004	hyperphenylalaninemic females
10429004	previous knowledge
10429004	phenylalanine level
10429004	cognitive
10429004	pah-deficient
10429004	mpkucs
10429004	results
10429004	maternal phenylketonuria collaborative
10429004	postnatal environmental circumstances
10429004	mutation combinations
10429004	complete genotype
10429004	optimal strategy
10429004	abolishes enzyme activity
10429004	iq
10429004	plan pregnancy
10429004	females
10429004	maternal pku collaborative
10429004	mutation classifications
10429004	hemizygous patients
10429004	based
10429004	gene mutations
10429004	phenylalanine hydroxylase deficiency
10429004	present study
1380672	proteolipid
1380672	amino-acid substitution
1380672	full complement
1380672	plp
1380672	myelin assembly
1380672	glial cell death
1380672	normal longevity
1380672	mutant mice
1380672	plp-dependent
1380672	cellular function
1380672	proteolipid protein gene
1380672	vital function
1380672	mutations
1380672	clinical spectrum
1380672	major polytopic membrane protein
1380672	premature cell death
1380672	pelizaeus-merzbacher
1380672	rumpshaker mice
1380672	uncoupling
1380672	ile-to-thr
1380672	x-chromosome-linked plp
1380672	surprisingly
1380672	neurological
1380672	normal oligodendrocytes
1380672	hypomyelination
1380672	new mouse mutant rumpshaker
1380672	jimpy mouse
1380672	glial cell development
1380672	oligodendrocyte degeneration
1380672	human genetic disorders
1380672	model systems
10594001	alkaptonuria
10594001	function mutations
10594001	m368v
10594001	h371r
10594001	hgo
10594001	novel mutations
10594001	finnish aku
10594001	aku
10594001	finnish
10594001	different ethnic origin
10594001	prototypic inborn error
10594001	mutational
10594001	alkaptonuria patients
10594001	r330s
10594001	r58fs
10594001	polymorphism analysis
10594001	2-dioxygenase gene
8441467	milder form
8441467	very-long-chain fatty acids
8441467	genomic sequences
8441467	patients fibroblasts
8441467	atp-binding
8441467	ald
8441467	candidate gene
8441467	progressive course
8441467	adrenoleukodystrophy
8441467	x-linked
8441467	abc
8441467	severe form
8441467	neurological symptoms
8441467	clinical manifestation
8441467	peroxisomal membrane protein
8441467	vlcfa
8441467	unexpected homology
8441467	peroxisome biogenesis
8441467	childhood ald
8441467	candidate
8441467	protein sequence shows
8441467	death occurs
8441467	normal oxidation
8441467	exon connection
8441467	central nervous system demyelination progresses
8441467	amn
8441467	dnas
8441467	vlcfa-coa
8441467	principal biochemical abnormality
8441467	adrenoleukodystrophy gene shares
8441467	familial cases
8441467	independent patients
8441467	adrenal
8441467	putative x-linked
8441467	addisons
8441467	identical deletion
8441467	cdna libraries
8441467	computer analysis
8441467	different clinical
8441467	significant sequence identity
10618304	macropatch analysis
10618304	auxiliary beta
10618304	oocyte
10618304	positive potentials
10618304	voltage dependence
10618304	wild-type hh1
10618304	-subunit association
10618304	conclusions
10618304	channel dysfunction
10618304	current decay
10618304	ivf
10618304	idiopathic ventricular fibrillation
10618304	human beta
10618304	channel alpha-subunit
10618304	congenital long-qt syndrome
10618304	hh1 mutation
10618304	cardiac na
10618304	potential pathophysiological mechanism
10618304	cardiac isoform
10618304	brugada
10618304	lqt3
10618304	skeletal muscle
10618304	methods and results
10618304	channel inactivation
10618304	coexpression
10618304	background mutations
10618304	possible explanation
10618304	activation kinetics
10618304	steady-state inactivation
10618304	negative potentials
10618304	xenopus
10618304	persistent currents
10618304	excitable tissues
10618304	functional effect
10618304	t1620m
10618304	na
10618304	severe functional defect
10618304	mutant channels
10369876	autosomal dominant disorder
10369876	parents heterozygous
10369876	v2
10369876	leu
10369876	neurohypophyseal diabetes insipidus
10369876	post-natal development
10369876	novel mutation
10369876	c301-
10369876	autosomal recessive inheritance
10369876	weak agonist
10369876	pro7
10369876	leu-avp
10369876	palestinian
10369876	avp
10369876	measured
10369876	active vasopressin
10369876	neurophysin-ii carrier protein
10369876	signal peptide
10369876	young children
10369876	autosomal
10369876	8-year-old brother
10369876	unknown mechanisms
10369876	cousin parents
10369876	arginine vasopressin
10369876	recessive familial neurohypophyseal diabetes insipidus
10369876	neuronal damage
10369876	water deprivation
10369876	familial
2575483	aniridia locus
2575483	positive
2575483	theta =
2575483	dutch
2575483	cat
2575483	lod scores
2575483	d11s16
2575483	autosomal
2575483	d11s151
2575483	cat/an2/d11s151
2575483	dominant aniridia
2575483	autosomal dominant aniridia
2575483	linkage group
2575483	fshb
2575483	zeta =
2575483	large pedigree
2575483	an2
2575483	d2s1
2575483	acp1
2575483	markers catalase
10607954	midline scalp defect
10607954	ct
10607954	knobloch
10607954	vitreoretinal degeneration
10607954	patient illustrates
10607954	4-year-old boy
10607954	central nervous system pathology whenever midline scalp defects
10607954	frontal region
10607954	frontal bone
10607954	magnetic resonance
10607954	high myopia
10607954	anterior midline scalp
10602116	missense mutation
10602116	recently
10602116	normal result
10602116	thyroid goiter
10602116	l445w
10602116	scan exploration
10602116	perchlorate discharge test whenever
10602116	profound congenital deafness
10602116	positive perchlorate discharge test
10602116	pds
10602116	anion transporter
10602116	molecular
10602116	present results
10602116	syndrome comprises congenital sensorineural hearing loss
10602116	profound congenital hearing loss
10602116	ct
10602116	tunisia
10602116	perchlorate test
10602116	phenotypic variability
10602116	pendred
10602116	inner ear
10602116	molecular analysis
10602116	autosomal recessive disorder
10602116	inner ear morphological
10602116	vestibular aqueduct
10602116	large families
10470088	's 'two-hit
10470088	new facet
10470088	tumor suppressor gene
10470088	different germline-somatic
10470088	sporadic colorectal cancers
10470088	small region
10470088	apc
10470088	colorectal adenomas
10470088	somatic mutation cluster region
10470088	mutation cluster region
10470088	mild disease
10470088	prime example
10470088	allelic
10470088	knudson
10470088	somatic mutations
10470088	broader spectrum
10470088	allelic loss
10470088	truncating
10470088	classical tumor suppressor
10470088	mutation association exists
10470088	germline mutation
10470088	somatic mutation
10470088	simple loss
10470088	fap
10470088	somatic mutation rate
10470088	clues
10470088	familial adenomatous polyposis
10470088	protein function
10470088	new mechanism
10470088	show allelic loss
10470088	missense germline variants
10470088	disease severity
10470088	different selective advantages
7769092	mitochondrial beta-oxidation
7769092	skin fibroblasts
7769092	mitochondrial palmitoylcoenzyme
7769092	very-long-chain acyl-coenzyme
7769092	molecular masses
7769092	major part
7769092	cardiac disease
7769092	protein synthesis
7769092	trace levels
7769092	vlcad
7769092	human liver
7769092	mitochondrial long-chain fatty acid oxidation
7769092	human very-long-chain acyl-coenzyme
7769092	skin
7769092	skeletal muscle
7769092	hypertrophic cardiomyopathy
7769092	native enzyme
7769092	dehydrogenation activities
7769092	clinically
7769092	deficient fibroblast lines
7769092	overall palmitic acid oxidation
7769092	mitochondrial
7769092	heterogenous nature
7769092	purification
1282899	missense mutation
1282899	deficient patients
1282899	hypoxanthine guanine phosphoribosyltransferase
1282899	hprt tokyo
1282899	specific oligonucleotide hybridization analysis
1282899	complete deficiency
1282899	important sequence
1282899	gly
1282899	synonymous mutations
1282899	human germ line
1282899	amino acid substitution
1282899	amino acid position
1282899	identification
1282899	putative 5-phosphoribosyl-1-pyrophosphate
1282899	valuable information
1282899	missense
1282899	prpp
1282899	hprt
1282899	missense mutations
1282899	hypoxanthine-guanine phosphoribosyltransferase
1282899	heterogeneous group
1282899	lesch-nyhan
1282899	asp
1282899	germ line mutation
1282899	polymerase chain reaction
1282899	dna
1282899	mutant gene
1282899	maternal germ line
1282899	allele
1282899	disease tends
1282899	active region
1282899	important region
1282899	germ line mutations
1301201	ivs12nt1
1301201	pku
1301201	m1v
1301201	att
1301201	cos
1301201	pah
1301201	translation initiation codon
1301201	phenylalanine hydroxylase
1301201	r408w
1301201	nondetectable levels
1301201	i65t
1301201	french canadians
1301201	enzyme activity
1301201	s349p
1301201	classical phenylketonuria
1301201	codominant inheritance
1301201	act
1301201	immunoreactive protein
1301201	mutations
1301201	homozygosity
1301201	phenylalanine hydroxylase locus
1301201	% loss
1301201	expression analysis
1301201	vivo correlations
1301201	quebec
1301201	i65t/r408w
1301201	converts codon
10557317	alpha2 putative ligand
10557317	mice homozygous
10557317	primary defect
10557317	immune system
10557317	histocompatibility loci
10557317	comprehensive set
10557317	faithfully
10557317	various hypotheses
10557317	immune parameters
10557317	secondary lymphoid organs
10557317	gut mucosal
10557317	precise role
10557317	possible role
10557317	essential function
10557317	genetic hemochromatosis
10557317	immune status
10557317	mhc
10557317	hfe-deficient
10557317	human hemochromatosis
10557317	regulatory proteins
10557317	hfe
10557317	transferrin saturation
10557317	experimental
10557317	open question
144081	azerbaijan
144081	who
144081	mutant alleles
144081	okhut
144081	mutant forms
144081	shekii
144081	gd-
144081	common parental mutant
144081	kinetic study
144081	heterozygotic carriers
144081	district hospital
144081	regions frequencies
144081	g6pd
144081	alasani-aphtalan
144081	resemblance
144081	zakataly
144081	ii
144081	electrophoretic mobility
144081	okhut ii
144081	examination
144081	physico-chemical
144081	carriers
144081	genetic
144081	iii
144081	erythrocyte enzyme activity
144081	martinique-like
144081	bideiz
144081	shirin-bulakh
6453040	gd-
6453040	electrophoretic mobility
6453040	iii
6453040	natural selection
6453040	azerbaijan
6453040	who
6453040	glucose-6-phosphate dehydrogenase ]
6453040	mutant forms
6453040	bash-kungut
6453040	comparison
6453040	shekii
6453040	allele distribution patterns
6453040	kinetic properties
6453040	ii
6453040	g6pd
6453040	new variants
6453040	iv
6453040	gene drift
6453040	nukha
10878391	lymphocytes
10878391	carriers suggests
10878391	critical role
10878391	wasp
10878391	peripheral blood mononuclear cells
10878391	carrier diagnosis
10878391	lineage commitment
10878391	waspdim
10878391	flow cytometric analysis
10878391	x-chromosomal
10878391	present studies
10878391	syndrome protein expression
10878391	previous
10878391	hemopoietic stem cell level
10878391	monocytes
10878391	useful tool
10878391	fcm-wasp
10878391	inactivation pattern
10878391	waspbright
10878391	carrier peripheral blood cells
10878391	carrier status
10878391	was
10878391	wiskott-aldrich
10878391	determination
10878391	control individuals
2161209	maximal lod score
2161209	xq28
2161209	nonneonatal form
2161209	ald
2161209	allelic heterogeneity
2161209	ald/amn
2161209	dna
2161209	heterozygote detection
2161209	recombination fraction
2161209	presymptomatic diagnosis
2161209	x-linked
2161209	amn
2161209	linkage
2161209	identical haplotype
2161209	phenotypic differences
2161209	dxs52
2161209	different mutations
2161209	analysis
8326491	british ancestry
8326491	previous study
8326491	english
8326491	irish ancestry
8326491	tay-sachs
8326491	p <
8326491	gene intron
8326491	high frequency
8326491	tsd
8326491	disease patients
8326491	welsh origin
8326491	donor splice site mutation
8326491	hexa
8326491	such families
8326491	gene occurs
8326491	donor splice site
8326491	non-jewish patients
8326491	blind study
8326491	splice site mutation
7959767	interspecific backcross
7959767	recently
7959767	d4s43
7959767	d5h4s43
7959767	murine homologue
7959767	it15
7959767	human alpha-adducin
7959767	human chromosome 4p16.3
7959767	alpha-adducin gene
7959767	mouse homologue
7959767	hd
7959767	disease gene
7959767	novel gene
7959767	cytoskeletal protein gene
7959767	genes map
7959767	d4s62
7959767	huntington
7959767	mammalian species
7959767	d5h4s62
7959767	hdh
7959767	severe autosomal dominant neurodegenerative disorder
7959767	d4s115
7959767	add1
7959767	mouse chromosome
7959767	chromosomal segment
7959767	murine homologues
7959767	ancestral chromosomal rearrangements
7959767	mammalian evolution
7959767	d5h4s115
2562820	taqi
2562820	human apolipoprotein
2562820	french-canadian
2562820	rflps
2562820	avaii
2562820	rflp
2562820	common form
2562820	theta =
2562820	df =
2562820	lod =
2562820	constant phi =
2562820	muscular dystrophy
2562820	long arm
2562820	human chromosome
2562820	substantial increase
2562820	apoc2 rflps
2562820	ncoi
2562820	c2
2562820	bgli
2562820	lod scores
2562820	apoc2
2562820	significant inter-apoc2
2562820	myotonic dystrophy
2562820	linkage study
2562820	linkage
2562820	linkage disequilibrium
2562820	bani
2562820	reveals linkage disequilibrium
2562820	bamhi
2562820	dm
10094552	blood spot
10094552	c282y
10094552	scandinavia
10094552	anonymous pilot study
10094552	faeroe
10094552	high prevalence
10094552	greenland
10094552	candidate gene
10094552	dbs
10094552	iceland
10094552	denmark
10094552	% +/-1
10094552	scandinavian
10094552	long-term follow-up evaluation
10094552	hfe
10094552	h63d/c282y
10094552	compound heterozygotes
10094552	allele frequencies
10094552	% +/-2
10094552	preventive health care
10484981	autosomal dominant disorder
10484981	p15ink4b
10484981	ile
10484981	ala
10484981	gene alteration
10484981	tumor tissues
10484981	glu
10484981	novel mutation
10484981	lys
10484981	common mechanism
10484981	adult cases
10484981	p16ink4a
10484981	missense point mutation
10484981	tumor markers
10484981	li-fraumeni
10484981	turkish family
10484981	peripheral blood cells
10484981	p57kip2
10484981	tp53
10484981	peripheral blood
10484981	healthy cousins
10484981	hereditary mutations
10484981	ata
10484981	tumor
10484981	existence
10484981	gene alterations
10484981	various types
10484981	homo/hemizygous deletion
10484981	aaa
10484981	gcg
10484981	cell cycle
10484981	different human cancers
10484981	gag
10484981	tp57kip2
10484981	mutation pattern
10484981	p15ink4b/p16ink4a
10484981	syndrome family
10484981	hereditary tp53
2884570	amino-acid substitution
2884570	mutant allele
2884570	pku
2884570	mutant alleles
2884570	point mutation
2884570	pah
2884570	rflp
2884570	phenylalanine 4-monooxygenase
2884570	molecular basis
2884570	northern european population
2884570	hybridization analysis
2884570	ec
2884570	phenylketonuria
2884570	direct
2884570	trp
2884570	caucasian populations
2884570	specific oligonucleotide
2884570	molecular lesion
2884570	hepatic phenylalanine hydroxylase
2884570	amino-acid metabolism
2884570	arg
2884570	autosomal recessive human genetic disorder
2884570	dna
2884570	c-to-t
2884570	linkage disequilibrium
2884570	common inborn error
2884570	restriction fragment-length polymorphism
8258524	grass
8258524	purpose
8258524	control mice
8258524	ganzfeld ergs
8258524	subjects gene deletions
8258524	human subjects
8258524	species differences
8258524	retinal gene product
8258524	ma
8258524	mouse gene defect
8258524	quincy
8258524	new clinical entity
8258524	milder allelic forms
8258524	conclusions
8258524	methods
8258524	ergs
8258524	negative electroretinogram
8258524	dmd
8258524	muscular dystrophy
8258524	biochemical role
8258524	duchenne
8258524	mdx mouse
8258524	complete ophthalmic examination
8258524	detectable deletions
8258524	noninvasive diagnostic tool
8258524	southern blot hybridization
8258524	normal findings
8258524	animal model
8258524	dystrophin gene locus
8258524	results
8258524	dystrophin gene deletions
8258524	grass instrument
8258524	erg
8258524	mdx mice
8258524	dystrophin gene mutations
8258524	ophthalmic
8258524	large deletions
8258524	dystrophin gene
1324223	dgge
1324223	dutch fap
1324223	gradient gel electrophoresis
1324223	point mutations
1324223	practical approach
1324223	genotype-phenotype correlations
1324223	apc
1324223	entire length
1324223	rnase
1324223	colorectal cancer
1324223	presymptomatic diagnosis
1324223	sensitive technique
1324223	previous
1324223	heterogeneous spectrum
1324223	informative families
1324223	routine laboratory
1324223	adenomatous polyposis
1324223	protection assay
1324223	linkage analysis
1324223	responsible gene
1324223	rapid presymptomatic diagnostic procedure
1324223	fap
1324223	recent isolation
1324223	familial adenomatous polyposis
1324223	sufficient number
1324223	single-strand conformation polymorphisms procedure
1324223	novel germ line mutations
1324223	rapid procedure
1324223	common polymorphism
1324223	such intragenic polymorphisms
1324223	adenomatous polyposis coli
1324223	familial
1324223	germ line mutations
10533068	putative leader sequence
10533068	intragenic deletion
10533068	novel mutations
10533068	twenty-three
10533068	x-linked
10533068	l13p
10533068	intronic sequence substitution
10533068	c. 38t
10533068	discoidin domain
10533068	c223r
10533068	putative leader peptide sequence
10533068	carboxyl terminal
10533068	different mutations
10533068	nonsense mutations
10533068	mutations
10533068	genetic evidence
10533068	novel
10533068	critical functional significance
10533068	c. 667t
10533068	functional significance
10533068	juvenile retinoschisis
10533068	novel ones
10533068	missense mutations
10533068	recessive disease
10533068	splice site defect
10533068	retinoschisis consortium
10533068	hum mol genet
10533068	> c
10533068	xlrs1
6585184	healthy brothers
6585184	rflps
6585184	useful linkage analysis
6585184	rflp
6585184	clinical
6585184	l1
6585184	health fall
6585184	child
6585184	informative restriction fragment length polymorphism
6585184	potential linkage analysis
6585184	dmd
6585184	n =
6585184	muscular dystrophy
6585184	duchenne
6585184	illustrative case
6585184	linkage analysis
6585184	gene transmission
6585184	seventy
6585184	families
6585184	dna
6585184	rc8
6585184	new mutation
6585184	obligatory female heterozygote
8471773	leu
8471773	new base substitutions
8471773	phe
8471773	diverse point mutations
8471773	g6pd-deficient
8471773	chinese descent
8471773	nucleotide substitutions
8471773	direct polymerase chain reaction
8471773	gly
8471773	pcr
8471773	molecular
8471773	g6pd
8471773	glucose-6-phosphate dehydrogenase
8471773	phenotypic heterogeneity
8471773	new findings
8471773	val
8471773	peripheral blood
8471773	arg
8471773	asians
8471773	high prevalence
8471773	dna
8471773	different types
8314592	positional
8314592	human genomic
8314592	norrie
8314592	ndp
8314592	protein sequence comparison
8314592	genomic deletions
8314592	candidate gene
8314592	dna
8314592	pcr
8314592	gene spans
8314592	detailed
8314592	regulates neural cell differentiation
8314592	patients shows
8314592	cell proliferation
8314592	possible function
8314592	disease gene
8314592	early genes
8314592	x-linked
8314592	neurodevelopmental disorder
122435	prenatal diagnosis
122435	acid lipase
122435	amniotic-fluid cells
122435	prenatal
122435	wolman
122435	fetal-tissue extracts
122435	control levels
122435	cells
122435	electrophoresis
122435	prostaglandin termination
122435	amniotic-fluid
122435	fetal tissues
122435	artificial substrates
122435	assay
122435	normal levels
122435	cell extracts
122435	analysis
122435	acid lipase and/or electrophoresis
122435	fetal-skin fibroblasts
122435	electrophoretic pattern
122435	acid lipase activity
7795652	sporadic ovarian tumours
7795652	intragenic marker
7795652	autosomal dominant syndrome
7795652	somatic mutations
7795652	somatic
7795652	describe somatic mutations
7795652	normal fractions
7795652	loh
7795652	tumour suppressor mechanism
7795652	small number
7795652	dna
7795652	sporadic carcinogenesis
7795652	potential role
7795652	single-strand conformation polymorphism technique
7795652	brca1
7795652	ovarian cancer
7795652	ovarian cancers
7795652	data support
2180286	skewed x
2180286	taqi
2180286	j-bir
2180286	twin results
2180286	hindiii
2180286	muscle biopsy
2180286	methylation differences
2180286	physical
2180286	additional
2180286	normal size
2180286	novo mutation
2180286	dystrophin-positive fibers adjacent
2180286	direct result
2180286	novel junction fragments
2180286	psti
2180286	gene function
2180286	large gene deletion
2180286	uniparental disomy
2180286	dmd
2180286	immunoblot
2180286	muscular dystrophy
2180286	duchenne
2180286	pfge
2180286	probes p20
2180286	j-66
2180286	cdna probes
2180286	normal karyotypes
2180286	uneven lyonization
2180286	dystrophin-negative fibers
2180286	linkage analysis
2180286	gene deletion
2180286	mz
2180286	junction fragments
2180286	pulsed-field gel electrophoresis
2180286	immunofluorescent
2180286	cytogenetic
2180286	dna
2180286	chromosome inactivation
2180286	disease expression
2180286	sfii
2180286	fingerprint analysis
2180286	creatine phosphokinase levels
1316718	kaposi
1316718	neuraminidase/galactose oxidase
1316718	studies
1316718	thrombocytopenia consistent
1316718	furthermore
1316718	initial inguinal lymph node biopsy
1316718	human immunodeficiency virus
1316718	immune function
1316718	immunoglobulin levels
1316718	hiv
1316718	t-cell
1316718	congenital immunodeficiency syndrome
1316718	mild immunosuppression
1316718	allograft transplantation
1316718	clinical diagnosis
1316718	recurrent mild infections
1316718	epstein-barr
1316718	severe immunosuppression
1316718	polymerase chain reaction
1316718	anti-cd43 antibody
1316718	major factor
1316718	was
1316718	wiskott-aldrich
1316718	mediastinal mass
1316718	proliferative responses
1316718	severe thrombocytopenia
1316718	large cell lymphoma
1316718	coincident kaposi
7964884	chenodeoxycholic acid
7964884	cholestanol concentration
7964884	clinical manifestations
7964884	contrarily
7964884	hmg
7964884	dramatic effects
7964884	% reduction
7964884	cerebrotendinous xanthomatosis
7964884	serum lipoprotein metabolism
7964884	ldl
7964884	cdca
7964884	coa
7964884	total cholesterol
7964884	low-density lipoprotein
7964884	high-density lipoprotein
7964884	hdl
7964884	normal range
7964884	electrophysiological findings
7964884	good treatment
7964884	oral administration
7964884	plant sterol levels
7964884	serum
7964884	combined
7964884	treatments
7964884	reductase inhibitor
7964884	serum cholestanol
7964884	ctx
7964884	serum lathosterol level
7964884	cholesterol synthesis
7964884	overall cholesterol synthesis
102474	silent allele
102474	genetic unit
102474	combined
102474	primary transcript
102474	subjects family
102474	c6
102474	sub-total deficiency
102474	structural locus
102474	c7
102474	clinical disease
102474	small quantities
102474	genetic deficiency
102474	likely explanation
102474	genetic characteristic
102474	structural mutation
102474	low quantities
2651669	novo cases
2651669	lgs
2651669	reports suggests
2651669	langer-giedion
2651669	complex issu
2651669	distal part
2651669	recognisable syndrome
2651669	critical segment
2651669	deletion 8q
2651669	obvious stigmata
2651669	proximal part
2651669	partial
10930361	molecular mass
10930361	escherichia
10930361	available form
10930361	native myfh1p exists
10930361	iron-dependent
10930361	concentrations supports
10930361	yfh1p
10930361	stepwise mechanism
10930361	autosomal recessive cardiodegenerative
10930361	yeast frataxin homologue
10930361	free radicals
10930361	+/-2 nm
10930361	frda
10930361	myfh1p sequesters
10930361	cardiac tissue
10930361	mda
10930361	yeast mitochondria
10930361	molecular weight >
10930361	isolated
10930361	multimer assembly
10930361	higher-order species
10930361	recombinant myfh1p reflects
10930361	recombinant yeast frataxin
10930361	increased
10930361	friedreich
10930361	sequester >
10930361	agent results
10930361	functional mechanism
10930361	myfh1p results
10930361	titration
10930361	genetic
10930361	frataxin
10930361	aerobic
10930361	regular spherical multimers
10930361	physiological role
10930361	mature form
10930361	mitochondrial protein
10930361	da
10930361	oxidative stress
10930361	sequential
10930361	oxidative damage
10930361	fe
10930361	soluble monomer
10930361	significant tendency
10930361	neurodegenerative disease
10698963	residual enzyme activity
10698963	inherited g6pd
10698963	human mutants
10698963	evolutionary conservation
10698963	such replacements
10698963	episodic hemolytic anemia
10698963	full genome
10698963	x-linked
10698963	corresponding protein
10698963	key electron donor
10698963	different organisms
10698963	reductive biosynthetic reactions
10698963	glucose 6-phosphate dehydrogenase reflect
10698963	nadph
10698963	g6pd
10698963	6-phosphate dehydrogenase
10698963	fava beans
10698963	glucose 6-phosphate dehydrogenase
10698963	amino acid residues
10698963	amino acid
10698963	useful tool
10698963	sequence conservation
10698963	aa replacements
10698963	cytosolic enzyme
10698963	evolutionary analysis
10698963	null mutations
10698963	glucose
10698963	comparing
10698963	current explosive increase
10698963	main function
10698963	life-long hemolytic anemia
10698963	evolutionary history
10698963	human mutations
8162051	sscp
8162051	post-reproductive age
8162051	bp deletion
8162051	new mutation cases
8162051	eighteen
8162051	somatic
8162051	apparent conflict
8162051	apc
8162051	heteroduplex analysis
8162051	average phenotype
8162051	high mutation rate
8162051	severe phenotype
8162051	patients worldwide
8162051	strand conformational polymorphism
8162051	early age
8162051	new mutations
8162051	colorectal tumourigenesis
8162051	fresh mutation
8162051	early event
8162051	syndrome adenomatous polyposis coli
8162051	family history
8162051	familial mutation
8162051	regionally
8162051	high frequency
8162051	familial cases
8162051	germline
8162051	frequent association
8162051	adenomatous polyposis coli
8162051	cancer development
8162051	5q21-22 results
10205262	hot spot
10205262	y62c
10205262	ggg
10205262	reexamination
10205262	herein
10205262	p230t
10205262	inv4
10205262	nucleotide substitutions
10205262	aku
10205262	hgo
10205262	w60g
10205262	+ 18a
10205262	inv11
10205262	inv1-1g
10205262	sequence motifs
10205262	+ 31a
10205262	loss-of-function mutations
10205262	significant proportion
10205262	novel single-nucleotide polymorphisms
10205262	remarkable allelic heterogeneity
10205262	d291e
10205262	important differences
10205262	polymorphisms reveals
10205262	dioxygenase gene
10205262	describe haplotype
10205262	cpg
10205262	ccc
10205262	analysis
10205262	sequence motif
10205262	nucleotide changes
10205262	a122d
10205262	specific short-sequence motifs
10205262	mutational analyses
7450778	markham
7450778	study demonstrates
7450778	salata
7450778	papua
7450778	th
7450778	g6pd
7450778	glucose-6-phosphate dehydrogenase deficiency
7450778	guinea
10353787	adult patients
10353787	oral mucosa
10353787	missense mutation
10353787	tuberous sclerosis
10353787	normal subjects
10353787	cys163ser
10353787	finnish agu
10353787	mental retardation
10353787	oral lesions
10353787	overgrowth
10353787	aga
10353787	p <
10353787	patients mucosal lesions
10353787	facial skin
10353787	immunohistochemical
10353787	biopsy
10353787	different mutations
10353787	mucosal overgrowth
10353787	lysosomal storage disorder
10353787	corresponding lesions
10353787	skin
10353787	oedemic
10353787	cytoplasmic
10353787	main symptom
10353787	epithelial hyperplasias
10353787	immunohistochemically
10353787	high frequency
10353787	facial lesions
10353787	gingival overgrowths
10353787	oral specimens
10353787	agu
10353787	buccal mucosa
10353787	lysosomal storage
10353787	finnish
10353787	oral mucosal lesions
10353787	aspartylglucosaminuria
10353787	facial angiofibromas
7550229	japanese patients
7550229	japanese suggests
7550229	novel mutations
7550229	q188r
7550229	cos
7550229	cell expression system
7550229	novel missense mutation
7550229	n314d galt
7550229	japanese families
7550229	caucasian
7550229	galactose-1-phosphate uridyltransferase
7550229	galactosemia mutations
7550229	cryptic splice acceptor site
7550229	n314d
7550229	molecular
7550229	g-to-a
7550229	r333w
7550229	mutant construct
7550229	caucasians
7550229	a-to-g
7550229	38th nucleotide
7550229	38-bp deletion
7550229	duarte
7550229	classic form
7550229	r231h
7550229	classic galactosemia mutations
7550229	galt
7550229	japanese persons
7550229	normal controls
1345170	powerful tool
1345170	simple sequence repeats
1345170	disease locus
1345170	delbrucks
1345170	bacterial cultures
1345170	diastrophic dysplasia
1345170	marker loci
1345170	finland
1345170	csf1r
1345170	mutation rate
1345170	allelic homogeneity
1345170	recombination fraction
1345170	fine structure localization
1345170	founder populations
1345170	disease genes
1345170	independent observations
1345170	dtd
1345170	luria
1345170	classical methods
1345170	predictions
1345170	linkage
1345170	linkage disequilibrium
1345170	mutation rates
10615125	heterozygous insertion mutations
10615125	expression
10615125	autosomal dominant bone disorder
10615125	d18s51
10615125	feo
10615125	familial expansile osteolysis
10615125	pdb
10615125	d18s64
10615125	early adulthood
10615125	large northern irish family
10615125	osteoclast activity
10615125	recombinant forms
10615125	mutations
10615125	signal peptide
10615125	mim
10615125	expression levels
10615125	osteoclast formation
10615125	nuclear factor-kappab
10615125	focal areas
10615125	nf-kappab
10615125	nuclear factor-kappa b
10615125	tnfrsf11a
10615125	osteolytic lesions
10615125	rank-mediated
10615125	paget
10615125	expansile osteolysis
10615125	long bones
10615125	normal cleavage
10615125	previous linkage studies
10615125	signal peptide region
10615125	familial
10615125	receptor activator
10615125	rank
10196381	atp-binding
10196381	efficient treatment
10196381	adrenoleukodystrophy protein deficiency
10196381	peroxisomal beta-oxidation defect
10196381	chain fatty acids
10196381	aldrp
10196381	x-linked
10196381	abc
10196381	pathognomonic accumulation
10196381	x-ald
10196381	pmp70
10196381	dietary treatment
10196381	adrenoleukodystrophy-related
10196381	lethal peroxisomal disorder
10196381	peroxisome proliferator fenofibrate
10196381	inherited
10196381	gene expression
10196381	biochemical defect
10196381	peroxisomal beta-oxidation
10196381	immunofluorescence
10196381	transporter adrenoleukodystrophy protein
10196381	stable overexpression
10196381	kda peroxisomal membrane protein
10196381	aldp-deficient
10196381	aldp
10196381	ectopic expression
10196381	human cdnas
10196381	functional replacement
10196381	pmp70-
8317477	similar onset ages
8317477	hd
8317477	influences age
8317477	normal parent
8317477	huntington
8317477	affected
8317477	variable ages
8317477	significant tendency
8317477	d4s10
8317477	transmission patterns
8317477	analysis
10545613	full mutation
10545613	fmr1
10545613	hypermethylation
10545613	histone hyperacetylation
10545613	suppresses transcription
10545613	5-azadc results
10545613	gene expression
10545613	full mutations
10545613	syndrome patients
10545613	lymphoblastoid cell lines
10545613	cgg
10545613	transcriptional reactivation
10545613	mrna levels
10545613	synergistic effect
10545613	important factor
10545613	5-fold increase
10545613	sodium butyrate
10545613	dna
10545613	rt-pcr
10545613	full mutation patients
10545613	histone acetylation
10545613	synergistic
1358807	dxs143
1358807	maximum lod score
1358807	dxs144e
1358807	peak lod score
1358807	significant evidence
1358807	dxs85
1358807	x-linked
1358807	dxs16
1358807	two-point
1358807	amelogenesis imperfecta
1358807	theta =
1358807	xp22
1358807	enamel protein amelogenin
1358807	recombination events
1358807	long arm
1358807	cm distal
1358807	abstract truncated at
1358807	locus heterogeneity
1358807	genetic
1358807	two-point linkage analysis
1358807	disease process
1358807	dental abnormality
1358807	lod score
1358807	words
1358807	cm proximal
1358807	dxs92
1358807	dna
1358807	amelx
1358807	f9
1358807	support interval
1358807	xai
1358807	multipoint linkage analysis
1358807	aih1
8304342	unambiguous identification
8304342	rflp-typed
8304342	mutant allele
8304342	hla-a
8304342	hla-f
8304342	hla-a11
8304342	critical region
8304342	linkage-disequilibrium analysis
8304342	kb proximal
8304342	hla-f. alternatively
8304342	disease gene
8304342	tight association
8304342	kb telomeric
8304342	brittany
8304342	generate haplotypes
8304342	i97 locus
8304342	overall
8304342	physical position
8304342	hla-a3
8304342	present report
8304342	data support
8304342	marker loci
8304342	strong peak
8304342	linkage-disequilibrium zone
8304342	normal chromosomes
8304342	anonymous
8304342	physical location
8304342	practical considerations
8304342	polymorphic markers
8304342	significant association
8304342	hemochromatosis haplotypes
8304342	hemochromatosis families
8304342	separate founder chromosome
8304342	centromeric boundary
8304342	hla
8304342	traditional linkage analysis
8304342	dna
8304342	phenotypic expression
8304342	400-kb expanse
8304342	kb distal
8304342	linkage disequilibrium
8304342	hemochromatosis chromosomes
8304342	hfe
8304342	major ancestral
8304342	hemochromatosis gene
8304342	additionally
8304342	crossover event
7617034	mathematical model
7617034	selective advantage
7617034	furthermore
7617034	geographical correlation
7617034	common enzymopathy
7617034	% reduction
7617034	enzyme deficiency
7617034	female heterozygotes
7617034	case-control studies
7617034	x-linked
7617034	male hemizygotes
7617034	g6pd a-
7617034	malaria suggests
7617034	g6pd
7617034	large case-control studies
7617034	selective disadvantage
7617034	natural selection
7617034	historical endemicity
7617034	african
7617034	glucose-6-phosphate
7617034	africa
7617034	hence
7617034	environmental conditions
7617034	benign disorder
7617034	malaria-endemic regions
7617034	severe malaria
6618488	pws
6618488	prader-willi
6618488	normal karyotype patients
6618488	15q11-12 deletion
6618488	clinical definition
6618488	clinical discussion
6618488	small supernumerary metacentric chromosomes
1301187	mutation results
1301187	specific restriction fragment-length polymorphism haplotypes
1301187	vitro expression analysis
1301187	pah
1301187	subsequent deamination
1301187	base deletions
1301187	various ethnic groups
1301187	different populations
1301187	molecular
1301187	different haplotypes
1301187	molecular methodologies
1301187	codon deletions
1301187	nonsense mutations
1301187	amino acid in-frame insertion
1301187	disease phenotype
1301187	mutations
1301187	new mutations
1301187	recurrent
1301187	cpg
1301187	high degree
1301187	missense mutations
1301187	single-base substitutions
1301187	significant correlation
1301187	human phenylalanine hydroxylase gene
1301187	large deletions
1483696	restriction site
1483696	french-canadian
1483696	infantile form
1483696	mutant alleles
1483696	tsd
1483696	disease mutation
1483696	saguenay-lac-st-jean
1483696	base adjacent
1483696	french canada
1483696	charlevoix
1483696	tay-sachs
1483696	french canadians
1483696	mutation occurs
1483696	hexa
1483696	donor splice site transition
1483696	ashkenazi
1483696	unambiguous
1483696	france
1483696	deletion mutation
1483696	allele-specific oligonucleotide hybridization
1483696	mutations
1483696	different geographic centre
1483696	g805a
1483696	ancestral homeland
1483696	obligate
1483696	donor splice site
1483696	human fibroblasts
1483696	compound heterozygote
1483696	recent ancestors
1483696	cultured
1483696	obligate carriers
1483696	quebec
1483696	ecorii
10465113	med
10465113	comp
10465113	ear pinna
10465113	healthy parents heterozygous
10465113	non-finnish patients
10465113	phenotypic spectrum
10465113	epiphyseal dysplasia
10465113	dtdst
10465113	recessive disorders achondrogenesis 1b
10465113	mckusick
10465113	cleft
10465113	multiple epiphyseal dysplasia
10465113	r279w
10465113	skeletal
10465113	changes consistent
10465113	edm1
10465113	autosomal recessive
10465113	different mutations
10465113	recessively
10465113	diastrophic dysplasia
10465113	multiple
10465113	hip dysplasia
10465113	counselling
10465113	club foot
10465113	diastrophic dysplasia sulphate transporter gene
10465113	edm2
10465113	common mutation
10465113	normal stature
10465113	edm4
10465113	sulphate incorporation defect
10465113	dna
10465113	observation confirms
10465113	tall-normal stature
10465113	dominant mutations
10465113	col9a2
10465113	hitch hiker thumb
10465113	recessive disorder
8098180	intergenerational variation
8098180	intergenerational enlargement
8098180	sex-dependent dynamics
8098180	meiotic instability
8098180	segregation analysis supports
8098180	progressive neuromuscular disorder
8098180	male meioses
8098180	positive correlation
8098180	exclusive maternal inheritance
8098180	n repeat
8098180	repeat meiotic instability
8098180	sex-dependent meiotic instability
8098180	analysis reveals
8098180	significant excess
8098180	clinical status
8098180	somatic mosaicism
8098180	repeat number
8098180	congenital form
8098180	5-kb fragments
8098180	familial predisposition
8098180	genetic study
8098180	myotonic
8098180	ctg
8098180	female meioses
8098180	dm
1517503	fatal case
1517503	systemic diseases
1517503	deficiencies
1517503	fatal
1517503	immunologic abnormalities
1517503	complement level
1517503	pyoderma gangrenosum
1517503	pg
1517503	c7
1517503	congenital complement deficiencies
1517503	neutrophil chemotaxis
1517503	aggressive nature
8589715	muscle cells
8589715	emerin
8589715	edmd
8589715	subcellular localization
8589715	sta
8589715	synthetic peptide fragments
8589715	emerin cdna
8589715	muscular dystrophy
8589715	unknown protein
8589715	together
8589715	gene encodes
8589715	x-linked emery-dreifuss
8589715	xq28
8589715	mutations
8589715	smooth muscles
8589715	kd protein
8589715	specific deficiency
8589715	emery-dreifuss
8589715	nuclear membrane
8589715	neuromuscular diseases
8589715	positive nuclear membrane
8589715	cardiac muscle
8589715	normal controls
7652577	autologous cytolytic
7652577	inhibitor p16ink4a
7652577	cell-cycle regulation
7652577	tumor-specific antigen
7652577	ctls
7652577	human melanoma
7652577	melanoma cells
7652577	tumor suppressor p16ink4a
7652577	cdk4
7652577	additional melanoma
7652577	metastasis tissue
7652577	hla-a2
7652577	patients lymphocytes
7652577	arginine-to-cysteine exchange
7652577	cyclin-dependent kinase
10487710	missense mutation
10487710	powerful tool
10487710	autosomal dominant trait
10487710	g1757
10487710	studies
10487710	neurohypophyseal diabetes insipidus
10487710	avp-neurophysin ii
10487710	universitario gregorio maranon
10487710	molecular defect
10487710	pcr
10487710	molecular
10487710	patients
10487710	hormone arginine vasopressin
10487710	avp
10487710	spain
10487710	replaces glycine
10487710	npii
10487710	identification
10487710	restriction endonuclease analysis
10487710	asymptomatic relatives
10487710	family members
10487710	familial neurohypophyseal diabetes insipidus
10487710	early asymptomatic diagnosis
10487710	avp-npii
10487710	asymptomatic carrier
10487710	early diagnosis
10487710	fndi
10487710	madrid
10487710	familial
10487710	additionally
10487710	present study
3572301	cd4
3572301	cd8
3572301	cell activation
3572301	mab stimulates
3572301	[ 3h ] thymidine incorporation
3572301	hla-dr
3572301	x-linked
3572301	bone marrow cells
3572301	lymphocyte proliferation
3572301	+ lymphocytes
3572301	anti-cd3 mab
3572301	stimulation
3572301	effective
3572301	sialophorin functions
3572301	surface sialoglycoprotein
3572301	dual-parameter facs
3572301	peripheral blood
3572301	l10
3572301	peripheral blood b lymphocytes
3572301	fc
3572301	il-2-r
3572301	sialophorin
3572301	time course
3572301	wiskott-aldrich
3572301	functional
3572301	surface molecule
10732811	rat spinocerebellar ataxia type
10732811	certain brain areas
10732811	mjd1
10732811	distinct autosomal dominant spinocerebellar ataxia type
10732811	cag
10732811	human brain sections
10732811	novel gene
10732811	mjd
10732811	c-terminal
10732811	mjd1/sca3
10732811	rat tissues
10732811	progressive cerebellar ataxia
10732811	mrna level
10732811	human sequence
10732811	expression pattern
10732811	additional molecules and/or regulatory events
10732811	putative protein differs
10732811	long polyglutamine
10732811	characterization
10732811	various rat
10732811	heterogeneous neurodegenerative disorders
10732811	rat testis
10732811	ataxin-3 protein
10732811	machado-joseph
10732811	human tissues
10732811	rat homologue
10732811	rat cdna
10732811	exclusive degeneration
10732811	analyzing
10732811	overall sequence identity
10732811	expression level
10732811	mature transcript
10732811	caucasians
10732811	normal function
10732811	transcription
10732811	n block
10732811	repeat expansions
10732811	human ataxin-3 genes
10732811	northern blot analyses
10732811	n trinucleotide repeat
10732811	unknown function
10732811	sca3
7630639	alveolar rhabdomyosarcoma
7630639	fusion gene
7630639	hybrid protein
7630639	transcriptional characteristics
7630639	fusion protein
7630639	solid tumors
7630639	strong carboxyl terminal activation domain
7630639	tumor cells
7630639	chimeric
7630639	functional role
7630639	pax3
7630639	aberrant expression
7630639	pax3/fkhr
7630639	gene fusions
7630639	identical transactivation activities
7630639	chromosomal translocations
7630639	pax
7630639	recognition sequences
7630639	transcriptional activator
7630639	artificial reporter genes suggests
7630639	transcription factors
7630639	forkhead family
7630639	primitive myogenic precursors
7630639	fkhr
7630639	transcriptional programs
7630639	specific manner
7630639	pax3 dna
7630639	dna
7581380	chromosome 17q
7581380	dominant non-dystrophic myotonias
7581380	ile-290-met clcn1
7581380	recessive myotonia
7581380	clcn1 gln-552-arg
7581380	bp deletion
7581380	point mutations
7581380	chloride channel disorder
7581380	trp-118-gly
7581380	adult skeletal muscle sodium channel
7581380	myogenic muscle stiffness
7581380	thomsens
7581380	myotonia congenita
7581380	thomsen
7581380	muscle hypertrophy
7581380	myotonia
7581380	dominant
7581380	clcn1
7581380	dominant myotonias
7581380	milder symptoms
7581380	similar forms
7581380	molecular genetic data
7581380	major muscle chloride channel
7581380	dominant inheritance
7581380	alpha subunit
7581380	low clinical expressivity
7581380	scn4a
7581380	myotonia levior
8282802	high density lipoprotein
8282802	premature atherosclerosis
8282802	lecithin cholesterol acyltransferase
8282802	stable isotope
8282802	cholesterol acyltransferase deficiency
8282802	plasma
8282802	a-ii
8282802	metabolic basis
8282802	plasma residence time
8282802	apoa-ii
8282802	genetic syndromes
8282802	lcat
8282802	plasma levels
8282802	plasma concentrations
8282802	lpa-i a-ii
8282802	classic lecithin
8282802	potential explanation
8282802	hdl
8282802	fish-eye disease
8282802	classic
8282802	markedly
8282802	low levels
8282802	selective effect
8282802	preferential hypercatabolism
8282802	residence time
8282802	fish-eye
8282802	atherosclerotic cardiovascular disease
8282802	lpa-i
8282802	high density lipoproteins
8282802	deficiency result
8282802	exogenous radiotracer
10598803	rna
10598803	germline mutation strengthens
10598803	high risk
10598803	furthermore
10598803	splice-acceptor region
10598803	splice-site acceptor mutation
10598803	gene predispose carriers
10598803	apc
10598803	founder effect
10598803	colorectal cancer
10598803	aapc
10598803	severe disease
10598803	inherited
10598803	colorectal polyps
10598803	mutations
10598803	geographic area demonstrates
10598803	germline mutation
10598803	polyposis phenotype
10598803	newfoundland
10598803	canada
10598803	adenomatous polyposis coli
10598803	multiple adenomatous polyps
1973404	blood group antigens
1973404	mns
1973404	recombination units distal
1973404	heterozygous family members
1973404	region 4q21-qter
1973404	map [
1973404	structural gene
1973404	map position
1973404	adh3
1973404	aga
1973404	z =
1973404	order cen-adh-egf-fg-mns-agu
1973404	multipoint
1973404	long arm
1973404	-mns ] suggests
1973404	marker loci
1973404	egf
1973404	order cen-adh-egf-agu-fg-mns
1973404	deficient activity
1973404	enzyme aspartylglucosaminidase
1973404	beta loci
1973404	loose
1973404	adh-
1973404	fragment length polymorphism alleles
1973404	agu
1973404	restriction
1973404	adh2
1973404	linkage
1973404	linkage analyses
1973404	aspartylglucosaminuria
1973404	multipoint analyses
1973404	finnish agu
1973404	fg
1671851	lod
1671851	prenatal diagnosis
1671851	dxs304
1671851	carrier status
1671851	ald
1671851	particular family
1671851	tight linkage
1671851	dna
1671851	linkage analysis
1671851	major structural rearrangement
1671851	xqter
1671851	vision blindness genes
1671851	linkage
1671851	f8c
1671851	dxs52
1671851	multipoint
1671851	viii
1671851	x-linked
1671851	large families
10090890	clinical significance
10090890	gh
10090890	european ancestry
10090890	infectious diseases
10090890	selection pressure
10090890	allele frequencies >
10090890	sri lanka
10090890	< /=
10090890	mb
10090890	mediterranean
10090890	mutation occurs
10090890	genetic disorders
10090890	indian subcontinent
10090890	europe
10090890	compound heterozygotes
10090890	genetic
10090890	c282y
10090890	selection pressures
10090890	environmental conditions
10090890	h63d
10090890	multicentric
10090890	new haplotypes
10090890	new haplotype
10090890	hfe
10090890	mutations differ
10090890	hemochromatosis gene
3563511	southern analysis
3563511	rna
3563511	pattern changes
3563511	rnas
3563511	base pair changes
3563511	cleavage patterns
3563511	cleavage procedure
3563511	general method
3563511	mutational lesions
3563511	mutation detection
3563511	low abundance messenger
3563511	point mutation detection
3563511	identification
3563511	human disease
3563511	alternative assays
3563511	hprt
3563511	lesch-nyhan
3563511	dna
3563511	hypoxanthine phosphoribosyltransferase
3563511	distinctive
3563511	polyuridylic acid-paper affinity procedure
3563511	polyuridylic acid-paper affinity chromatography step
10364520	family studies
10364520	therapeutic decisions
10364520	fmf-including
10364520	unfavorable renal prognosis
10364520	armenian patients
10364520	armenian ancestry
10364520	renal amyloidosis
10364520	pseudodominant transmission
10364520	fmf
10364520	particular modes
10364520	molecular evidence
10364520	incomplete penetrance
10364520	severe complication
10364520	mefv-gene
10364520	serosal inflammation
10364520	disease phenotype
10364520	new ways
10364520	therapeutic implications
10364520	familial mediterranean
10364520	prognostic value
10364520	unnecessary surgery
10364520	nonspecific clinical signs
10364520	m694v
10364520	homozygous genotype-genetic
10364520	r408q
10364520	diagnostic value
10364520	genetic-linkage analysis
10364520	mefv
10364520	renal
10364520	homozygous genotype
7568002	subcellular
7568002	it15
7568002	trinucleotide repeat
7568002	348-kda protein
7568002	identify native huntingtin
7568002	immunocytochemistry
7568002	hd
7568002	anti-fusion protein antibodies
7568002	soluble fraction
7568002	patch-like distribution
7568002	somatodendritic regions
7568002	huntington
7568002	monoclonal anti-fusion protein antibodies
7568002	monkey brain tissues
7568002	levels evident
7568002	synaptic vesicles
7568002	lymphoblastoid cell lines
7568002	cytosolic protein
7568002	western blots
7568002	mutant huntingtin
7568002	mutation impairs
7568002	juvenile-onset heterozygote
7568002	human lymphoblastoid cell lines
7568002	identification
7568002	mutant protein
7568002	huntingtin
7568002	lymphoblastoid cells
7568002	repeat expansion
7568002	molecular weight
7568002	human striatum
7568002	control cases
1319838	substantial number
1319838	correlation
1319838	colorectal polyps
1319838	recently
1319838	biological function
1319838	gene product
1319838	germ-line mutations
1319838	apc
1319838	familial adenomatous polyposis
1319838	clinical types
1319838	whereas mutations
1319838	profuse polyps
1319838	profuse types
1319838	nonsense mutation
1319838	adenomatous polyposis coli
1319838	result suggests
1319838	familial adenomatous polyposis patients
1319838	fap
1319838	sparse types
10480348	dystrophin mutations
10480348	show position-specific
10480348	dp260
10480348	mutation position
10480348	key role
10480348	muscle disease severity
10480348	retinal electrophysiology
10480348	human genotype-phenotype correlations
10480348	retinal signal transmission
10480348	duchenne/becker
10480348	transcript initiation site
10480348	central region
10480348	normal retinal electrophysiology
10480348	dmd/bmd
10480348	implicit times
10480348	c-terminal
10480348	defects correlate
10480348	carboxyl terminal dystrophin isoform
10480348	clinical examination
10480348	ergs
10480348	dmd
10480348	normal b-wave amplitude
10480348	muscular dystrophy
10480348	duchenne
10480348	becker
10480348	important determinant
10480348	distal mutations
10480348	genotype-phenotype
10480348	mouse studies
10480348	forty-six
10480348	phenotype mice
10480348	b-wave amplitude
10480348	individuals
10480348	oscillatory potentials
10480348	mouse models
10480348	dystrophin isoforms
10480348	erg
10480348	b-wave phenotype
10480348	systematic evaluation
1610789	galactosemia mutations result
1610789	l74p
1610789	polymorphism occurs
1610789	f171s
1610789	s135l
1610789	putative active-site nucleophile
1610789	useful tools
1610789	galactosemia mutations
1610789	normal activity
1610789	molecular characterization
1610789	molecular
1610789	enzymatic function
1610789	galt
1610789	human galactose-1-phosphate uridyltransferase
1610789	different functional domains
1610789	enzymatic activity
1610789	molecular heterogeneity
1610789	structure-function analysis
10777718	aj n370s
10777718	gba
10777718	n370s
10777718	european non-jewish
10777718	haplotype diversity
10777718	delta values
10777718	genetic history
10777718	significant bottleneck
10777718	ashkenazi
10777718	84gg insertion
10777718	str
10777718	short tandem repeat
10777718	gd
10777718	ashkenazim
10777718	3-cm region
10777718	type
10777718	d1s2721
10777718	84gg mutations
10777718	europe
10777718	84gg acid beta-glucosidase mutations
10777718	deficient activity
10777718	ld
10777718	d1s2777
10777718	aj
10777718	84gg chromosomes
10777718	acid beta-glucosidase
10777718	coalescence
10777718	different divergent haplotypes
10777718	gaucher
10777718	pklr
10777718	linkage disequilibrium
10777718	european population
10777718	d1s1595
10777718	non-neuronopathic lysosomal storage disorder
10777718	similar coalescence times
8209890	febrile convulsions
8209890	assess temperature regulation characteristics
8209890	wc
8209890	thermoregulatory characteristics
8209890	pws
8209890	nd
8209890	f.
8209890	reflect syndrome-specific hypothalamic abnormalities
8209890	survey instrument
8209890	prader-willi
8209890	sib
8209890	control groups sibs
8209890	significant
7298854	ldl-cholesterol
7298854	ctx hdl
7298854	normal value
7298854	low-normal concentrations
7298854	low concentration
7298854	hdl-cholesterol
7298854	lipoprotein distribution profile
7298854	cerebrotendinous xanthomatosis
7298854	free cholesterol
7298854	ldl
7298854	normal functions
7298854	minor form
7298854	total cholesterol
7298854	hdl
7298854	abnormal lipid composition
7298854	excessive deposits
7298854	relative
7298854	cholesteryl esters
7298854	low density lipoproteins
7298854	abnormalities
7298854	tissue sterols
7298854	genetic defect
7298854	electron micrographs
7298854	bile acid synthesis
7298854	plasma cholesterol
7298854	excess cholesterol
7298854	plasma lipoprotein profiles
7298854	metabolic defects
7298854	ctx
7298854	peripheral tissues
7298854	abnormal
7298854	particle size
7298854	high density lipoproteins
7298854	genetic disease cerebrotendinous xanthomatosis
10330348	missense mutation
10330348	splice-donor site
10330348	% ]
10330348	at
10330348	splice-acceptor site
10330348	fewer
10330348	genomic mutations
10330348	protein-truncation assay
10330348	consensus splice sites
10330348	new series
10330348	splicing
10330348	cryptic splice sites
10330348	ag
10330348	atm
10330348	significant proportion
10330348	new splice sites
10330348	intron retention
10330348	nonsense mutations
10330348	mutations
10330348	splice-donor sites
10330348	sequence analysis
10330348	exon deletions
10330348	lesser degree
10330348	cell line
10330348	silent mutations
10330348	ataxia-telangiectasia gene
10330348	dna
10330348	gt
10330348	normal controls
10593994	premature loss
10593994	ests
10593994	palmoplantar hyperkeratosis
10593994	pls
10593994	onset periodontitis
10593994	bp deletion
10593994	periodontal disease susceptibilit
10593994	epithelial regions
10593994	secondary dentitions
10593994	cathepsin c mutations
10593994	immune cells
10593994	nucleotide deletion
10593994	nonsense mutation
10593994	different mutations
10593994	amino acid
10593994	cathepsin c
10593994	stop codon
10593994	cm interval
10593994	ctsc
10593994	premature termination codon
10593994	turkish families
10593994	mutations
10593994	cathepsin c gene
10593994	complete understanding
10593994	high levels
10593994	sibs heterozygous
10593994	onset periodontitis characteristic
10593994	major gene locus
10593994	common ancestor
10593994	genetic maps
10593994	polymorphonuclear leucocytes
10593994	significant implications
10593994	papillon-lefevre
10593994	autosomal recessive disorder
10593994	rt-pcr
10593994	sequence
10593994	functional physiology
10593994	abnormal skin development
10593994	correlation
10593994	lysosomal protease cathepsin c gene
2910902	mutant proteins
2910902	protein concentrations
2910902	mutant forms
2910902	inclusion
2910902	cathodal migration
2910902	page
2910902	bulky arginine side chain
2910902	facilitates structure-function analysis
2910902	cloning
2910902	previous
2910902	hprtyale
2910902	amino acid position
2910902	disrupts protein
2910902	mutational mechanisms
2910902	chou-fasman
2910902	complete
2910902	transversion predicts substitution
2910902	nucleotide substitution
2910902	hypoxanthine-guanine phosphoribosyltransferase gene
2910902	identification
2910902	specific mutations
2910902	residual catalytic activity
2910902	beta-turn formation
2910902	nucleotide position
2910902	hprt
2910902	hypoxanthine-guanine phosphoribosyltransferase
2910902	lesch-nyhan
2910902	normal mrna
2910902	secondary structure analysis predicts
2910902	mutant form
2910902	nucleotide sequence
2927388	retinoblastoma patients
2927388	hpaii
2927388	restriction map
2927388	nature
2927388	t. p. dryja
2927388	j. med
2927388	j. m. rapaport
2927388	r. a. weinberg
2927388	n. engl
2927388	s. h. friend
2927388	chromosomal rearrangements
2927388	presymptomatic diagnosis
2927388	molecular
2927388	complicate molecular
2927388	chromosomal translocations
2927388	restriction enzymes
2927388	wiggs
2927388	kilobases [ kb ]
2927388	d. m. albert
2927388	putative retinoblastoma susceptibility locus
2927388	eagi
2927388	restriction fragment
2927388	fige
2927388	r. bernards
2927388	retinoblastoma susceptibility
2927388	rb1
2927388	candidate sequence
2927388	tiny fragment island
2927388	analysis
2927388	translocation cell line
2927388	large size
2927388	carrier detection
2927388	s. rogelj
2927388	dna
2927388	london
2927388	translocation breakpoints
2927388	field inversion gel electrophoresis
1338906	missense mutation
1338906	arg >
1338906	constitutional deletion
1338906	chromosome region
1338906	base pair insertion
1338906	end stage renal failure
1338906	genito-urinary system
1338906	constitutional
1338906	typical nephropathy
1338906	asp > asn
1338906	tumor gene
1338906	constitutional cells
1338906	genomic sequence
1338906	wt1
1338906	nucleotide position
1338906	denys-drash
1338906	missense mutations
1338906	obvious correlation
1338906	additional mutation
1338906	genital abnormalities
1338906	wilms
1338906	dna
1338906	arg > trp amino acid
1338906	resultant protein
1338906	phenotypic expression
1338906	heterozygous mutations
8198124	e453
8198124	3-bp deletion
8198124	sscp
8198124	skin ulcers
8198124	mutant genomic
8198124	mental retardation
8198124	severe form
8198124	pepd
8198124	mckusick
8198124	pcr
8198124	prolidase deficiency
8198124	rare autosomal recessive disorder
8198124	g448r
8198124	recurrent infections
8198124	direct
8198124	> c substitution
8198124	mutations
8198124	cdna fragments
8198124	splice acceptor mutations
8198124	conventional pcr
8198124	intronic
8198124	rt-pcr
8198124	dna
8198124	phenotypic expression
8198124	e452
8198124	pcr-amplified
8198124	mutant cdnas
2817003	[ t
2817003	translocation
2817003	an2
2817003	reciprocal translocation
2817003	clinical characteristics
10382909	missense mutation
10382909	age
10382909	pro183thr
10382909	milder phenotype
10382909	diagnostic implications
10382909	muscular dystrophy
10382909	ankle contractures
10382909	emerin protein
10382909	direct
10382909	x-linked emery-dreifuss
10382909	emd
10382909	genotype-phenotype
10382909	emerin mutations
10382909	significant differences
10382909	emery-dreifuss
10382909	mutant protein
10382909	x-linked emd
10382909	emerin mutations result
10382909	in-frame deletions
10382909	emerin gene
10382909	typical null mutations
10382909	muscle weakness
10382909	important regions
10947987	mouse colon epithelial cells
10947987	guanine nucleotide exchange factor
10947987	tumor suppressor
10947987	armadillo repeat domain
10947987	g-protein
10947987	adenomatous polyposis coli gene
10947987	furthermore
10947987	neuronal function
10947987	rac-specific
10947987	endogenous apc
10947987	apc-asef
10947987	apc
10947987	actin cytoskeletal network
10947987	asef-mediated
10947987	sporadic colorectal tumors
10947987	neuronal cells
10947987	cell morphology
10947987	gene product
10947987	familial adenomatous polyposis
10947987	gef
10947987	asef
10947987	mdck
10947987	lamellipodia formation
3600794	recent
3600794	phosphorylase b kinase locus
3600794	localization
3600794	gene homologous
3600794	duchenne/becker
3600794	x-chromosome
3600794	muscular dystrophy locus
3600794	mouse model
3600794	tabby
3600794	x-linked
3600794	region homologous
3600794	ta
3600794	g6pd
3600794	dmd
3600794	muscular dystrophy
3600794	becker
3600794	duchenne
3600794	phk
3600794	muscular dystrophies
3600794	distinct human myopathies
3600794	mild dystrophic syndrome
3600794	human disease
3600794	muscle development
3600794	sequences map
3600794	dxpas8
3600794	mouse mdx mutation affects muscle
3600794	st14-1
3600794	emery dreifuss
1301937	mutant alleles
1301937	biochemical assay
1301937	tsd
1301937	at
1301937	donor splice-site
1301937	berks
1301937	artificial substrate
1301937	carrier frequency
1301937	clinical
1301937	tay-sachs
1301937	enzyme activity
1301937	leaves valine
1301937	molecular
1301937	akli
1301937	pennsylvania dutch
1301937	triggs-raine
1301937	high frequency
1301937	kelly
1301937	following
1301937	polymorphism [
1301937	arg247trp
1301937	biochemical evidence
1301937	gt
3856322	mouse cells
3856322	prenatal diagnosis
3856322	pku
3856322	new opportunities
3856322	biochemical characterization
3856322	alternative genetic therapies
3856322	normal human liver products
3856322	pah
3856322	human phenylalanine hydroxylase
3856322	gene
3856322	gene contains
3856322	phenylketonuria
3856322	immunoreactive protein
3856322	nih3t3
3856322	enzymatic activity
3856322	necessary genetic information
3856322	genetic deficiency
3856322	enzyme phenylalanine hydroxylase
3856322	results support
3856322	dna
3856322	eukaryotic expression vector
3856322	mutant enzymes
3856322	rna
8302543	scotopic perimetry
8302543	photopic systems
8302543	scotopic sensitivities
8302543	human retinal degeneration
8302543	background recently
8302543	rod thresholds
8302543	affected
8302543	macular changes
8302543	retinal pigment epithelium
8302543	central visual loss
8302543	autosomal dominant retinitis pigmentosa
8302543	macular
8302543	central scotoma
8302543	cone
8302543	retinal degeneration
8302543	slow gene
8302543	individuals underwent ophthalmic examination
8302543	color-contrast sensitivity
8302543	asymptomatic children
8302543	rds gene
8302543	abnormal color-contrast sensitivity
8302543	methods affected
8302543	mutations
8302543	dark adaptometry
8302543	peripherally
8302543	peripheral rod function
8302543	primary cone dysfunction
8302543	results
8302543	cone electroretinograms
8302543	photoreceptor dysfunction
8302543	progressive macular dystrophy
8302543	normal implicit times
8302543	conclusion
8302543	central visual field
8302543	macular dystrophy
8302543	rod
23402	enzymatic defect
23402	italian
23402	biochemical characterization
23402	unique features
23402	maternal ingestion
23402	lamellar cataracts
23402	unexpected clinical
23402	male subjects
23402	young man
23402	cataract formation
23402	mutant enzyme whenever
23402	certain circumstances
23402	unusual clinical presentations
23402	mediterranean
23402	alexandra
23402	g6pd
23402	neonatal period
23402	unique combination
23402	camperdown
23402	gd
23402	neonatal jaundice
23402	new variant
23402	maltese
23402	vicia
23402	biochemical characteristics
23402	6-phosphate dehydrogenase variants
23402	laboratory results
23402	severe neonatal jaundice
23402	fresh broad beans
23402	glucose
23402	normal enzyme activity
23402	bilateral lamellar cataracts
2989709	leukocyte elastase
2989709	deficiency allele
2989709	pi z
2989709	aat
2989709	alpha 1-antitrypsin
2989709	pi
2989709	individuals homozygous
2989709	allele occurs
2989709	dna
2989709	alpha 1-protease inhibitor
2989709	bacterial proteases
2989709	restriction fragments
2989709	m alleles
2989709	extensive
2989709	genomic probes
2989709	polymorphic restriction sites
2989709	early adult onset emphysema
2989709	major plasma inhibitor
2989709	liver disease
2989709	linkage disequilibrium occurs
10976074	disease pathogenesis
10976074	adult humans
10976074	mice
10976074	myotonic
10976074	ctg
10976074	dmpk
10976074	transgenic mice
10976074	dm
10976074	cug
10976074	result supports
10976074	rna
10976074	whereas mice
10976074	muscular dystrophy
10976074	common form
10797418	snrpn
10797418	pws
10797418	critical region
10797418	cousins fathers
10797418	pws.
10797418	prader-willi
10797418	d15s63
10797418	fluorescence
10797418	paternal aunts
10797418	matrilineal line
10797418	situ hybridization
10797418	syndrome causes
10797418	analysis shows
10797418	fish
10797418	submicroscopic deletion
10797418	normal karyotypes
10797418	d15s11
10797418	methylation analysis
10797418	grandmatrilineal
10797418	gabrb3
10797418	d15s10
10797418	grandmatrilineal inheritance pattern
10797418	inheritance occurs
10797418	familial pws
10797418	submicroscopic
10797418	dna
10797418	female paternal
10797418	unique inheritance pattern
10915770	individuals exhibit neonatal hypotonia
10915770	orthologous mouse gene
10915770	pws
10915770	candidate gene
10915770	expression
10915770	affected
10915770	deletion region
10915770	prader-willi
10915770	terminal differentiation
10915770	mouse model
10915770	primary tissue
10915770	situ hybridization
10915770	control brain
10915770	ndnl1
10915770	fetal tissues
10915770	chromosome 15q11-q13
10915770	necdin expression
10915770	childhood-onset obesity
10915770	northern blot analysis
10915770	late developmental stages
10915770	necdin
10915770	% amino acid sequence similarity
10915770	monoallelic expression
10915770	brain development
10915770	mid-gestation mouse embryos
10915770	adult brain
10915770	neonatal presentation
10915770	pws-affected
10915770	central nervous system
10915770	ndn
10915770	homologous murine
10915770	rt-pcr
10915770	developmental delay
10915770	kb distal
10915770	magel2
10915770	strong expression
10915770	rna
1968617	metabolic disease
1968617	pku
1968617	recessive mutations
1968617	yemen
1968617	pah
1968617	different geographic areas
1968617	point mutations
1968617	molecular defect
1968617	different locations
1968617	defective gene
1968617	phenylketonuria
1968617	yemenite
1968617	genetic defect
1968617	ireland
1968617	jewish community
1968617	yemenite jews
1968617	hepatic enzyme phenylalanine hydroxylase
1968617	common ancestor
1968617	examination
1968617	family histories
1968617	high frequency
1968617	random sample
1968617	scotland
1968617	eighteenth century
1968617	sana
1968617	official documents
1968617	european population
7909252	unstable trinucleotide
7909252	kinase gene
7909252	myotonic dystrophy mutation
7909252	high resolution genetic analysis suggests
7909252	high resolution genetic analysis
7909252	founder effect
7909252	pcr
7909252	nature genet
7909252	physical distance
7909252	n repeat
7909252	dinucleotide marker
7909252	new mutations
7909252	ancestral mutations
7909252	alu
7909252	ctg
7909252	fragile x
7909252	genetic anticipation
7909252	particular haplotype
7909252	imbert
7909252	myotonic dystrophy
7909252	element polymorphism
7909252	low reproductive fitness
7909252	recent analysis
7909252	persistent complete allelic association
7909252	previous observations
7909252	complete linkage disequilibrium
7909252	dm
1322637	moroccan jews
1322637	tsd
1322637	gln
1322637	elsewhere
1322637	carrier frequencies
1322637	arg170-to-gln
1322637	jewish population
1322637	moroccan
1322637	ashkenazi jews
1322637	tay-sachs
1322637	additional mutations
1322637	ethnic groups
1322637	sephardic jews
1322637	hexa
1322637	g-to-a
1322637	stop codon
1322637	c-to-g
1322637	f304/305
1322637	nonradioactive assays
1322637	identification
1322637	rapid detection
1322637	cpg
1322637	mutations exists
1322637	complete absence
1322637	infantile tay-sachs
1322637	analysis
1322637	in-frame deletion
1322637	stop
1322637	adjacent phenylalanine codons
1322637	jewish families
1322637	obligate carriers
1322637	tyr180
1322637	arg170
7490097	interspecific backcross
7490097	somatic cell hybrid analysis
7490097	mouse homologues map
7490097	human chromosome
7490097	mapping
7490097	mouse chromosome
7490097	murine homologue
7490097	d8mit3
7490097	toxic milk mutation
7490097	possible location
7490097	atp4b
7490097	wd
7490097	wilson
7490097	mouse homologue
7490097	central region
7490097	atpase
7490097	atp7b
7490097	disease gene
7490097	analysis
7490097	assignment suggests
8116611	peripheral blood leukocytes
8116611	repeat contractions
8116611	kinase gene
8116611	anticipation
8116611	sixteen dm
8116611	clinical evidence
8116611	linear regression
8116611	intergenerational contractions
8116611	repeat contraction
8116611	such contractions
8116611	clinical data
8116611	sib population
8116611	< <
8116611	successive generations
8116611	parental repeat size
8116611	paternal transmissions
8116611	anticipation status
8116611	apparent anticipation
8116611	maternal transmissions
8116611	r2 =
8116611	characteristics
8116611	repeat contractio
8116611	intergenerational contraction
8116611	myotonic dystrophy
8116611	dna
8116611	paternal origin
8116611	ctg
8116611	dm
8116611	pbl
10571950	aberrant transcripts
10571950	deafness phenotype
10571950	sensorineural hearing loss
10571950	new splice-site mutation
10571950	disease gene
10571950	developmental abnormalities
10571950	intrafamilial variability
10571950	individual exons
10571950	spanish family
10571950	splice-site
10571950	chromosome 7q22-q31
10571950	pds
10571950	deafness presentation
10571950	chloride-iodide transport protein
10571950	hereditary deafness
10571950	pendred
10571950	moderate-severe deafness
10571950	donor splice site
10571950	nucleotide position
10571950	new donor splice site
10571950	diffuse thyroid enlargement
10571950	shows intrafamilial variability
10571950	mutation analysis
10571950	rna
10802668	autosomal dominant disorder
10802668	cardiac conduction disorders
10802668	+/k + -atpase alpha-1 subunit
10802668	repeat sequence
10802668	heterozygous
10802668	ocular cataracts
10802668	cardiac arrhythmia
10802668	mental retardation
10802668	cataract formation
10802668	dose-dependent loss
10802668	data support
10802668	previous
10802668	mice show
10802668	dm15
10802668	dmahp
10802668	genetic defect
10802668	six5-/-
10802668	dmpk
10802668	steady-state levels
10802668	skeletal muscle
10802668	ion homeostasis
10802668	mrna levels
10802668	six5
10802668	repeat expansion
10802668	partial loss
10802668	myotonic
10802668	dna
10802668	skeletal muscle force
10802668	na
10802668	contiguous gene syndrome
10802668	ctg
10802668	rna
10802668	dm
10484765	studies
10484765	furthermore
10484765	myogenic differentiation
10484765	inhibitory effect
10484765	myoblast fusion defect
10484765	ctgs
10484765	reporter transcripts
10484765	protein production
10484765	reporter gene
10484765	mutation acts
10484765	cell culture model
10484765	cug
10484765	loxp system
10484765	c2c12
10484765	deletion analysis
10484765	expansion and/or
10484765	characterization
10484765	nuclear foci
10484765	protein expression
10484765	cre-
10484765	dmpk
10484765	genetic
10484765	patient materials
10484765	cis
10484765	3-utr transcript
10484765	spontaneous deletion events
10484765	protein kinase gene
10484765	mouse myoblasts
10484765	myotonic dystrophy
10484765	3-utr mrna
10484765	cell culture model system
10484765	negative cis effect
10484765	inhibit myogenesis
10484765	data show
10484765	ctg
10484765	chimeric reporter constructs
10484765	dm
8071955	quotient profile
8071955	patient grou
8071955	specific deficits characteristic
8071955	sex differences
8071955	expansion difference
8071955	scaled
8071955	parent-child pairs
8071955	cognitive function
8071955	sd
8071955	intelligence quotient
8071955	intelligence
8071955	assess verbal
8071955	normal sibs
8071955	% risk
8071955	ctg
8071955	arithmetical cognitive performance
8071955	intergenerational deficit
8071955	wechsler adult intelligence scale revised
8071955	expansion size
8071955	sib pairs
8071955	iq
8071955	individual persons
8071955	reliable predictor
8071955	wais-r
8071955	myotonic dystrophy
8071955	parental sex
8071955	significant iq
8071955	disease severity
8071955	dm
1361318	sicca syndrome
1361318	endothelial cells
1361318	complement deficiencies
1361318	c2
1361318	cutaneous vasculitis
1361318	complement
1361318	connective tissue diseases
1361318	complement factor
1361318	dr2
1361318	serological family study
1361318	inherited
1361318	b18
1361318	family members
1361318	hla-a25
1361318	anticardiolipin antibodies
1361318	seropositive rheumatoid arthritis
1352883	taa
1352883	autosomal dominant trait
1352883	gaa
1352883	incomplete penetrance
1352883	point mutations
1352883	single-strand conformation polymorphism analysis
1352883	pcr
1352883	mild expression
1352883	oncogenic
1352883	certain families
1352883	mutations
1352883	single amino acid changes
1352883	cgg
1352883	modify protein structure/function
1352883	rb1
1352883	tgg
1352883	unusual low-penetrance phenotype
1352883	retinoblastoma phenotype
1352883	mild phenotypic expression
1352883	such families
1352883	potential cryptic splice acceptor site
1352883	retinoblastoma-predisposition gene
10502833	restriction site
10502833	arg1
10502833	nlaiii
10502833	madeira
10502833	cytosolic liver-type arginase enzyme
10502833	molecular basis
10502833	pcr
10502833	tga
10502833	exon/intron boundaries
10502833	sequence analysis
10502833	identification
10502833	l-arginine
10502833	portuguese patients
10502833	r21x
10502833	portugal
10502833	argininemia
10502833	dna
10502833	restriction
10502833	r21x cga
10502833	e. c.
10502833	rare autossomal recessive disorder
10502833	liver-type arginase gene
10930571	additional evidence
10930571	short stature
10930571	fgd1
10930571	multiple facial
10930571	rho/rac gef
10930571	gln
10930571	pleckstrin homology
10930571	arg-610
10930571	ph
10930571	x-linked
10930571	rho/rac
10930571	additional mutations
10930571	aas
10930571	insp
10930571	interestingly
10930571	aarskog-scott syndrome
10930571	faciogenital dysplasia
10930571	clinical diagnosis
10930571	human diseases
10930571	italian family
10930571	aarskog-scott
10930571	carrier females
10930571	guanine nucleotide exchange factors
10930571	tyrosine kinase
10930571	arg
10930571	brutons
10930571	original report
10930571	g2559
10930571	independent patients
10930571	genital abnormalities
10930571	btk
10930571	arg610gln
2055114	d1
2055114	enzyme deficient
2055114	localization
2055114	histidase regulatory locus
2055114	gamma interferon
2055114	histidine ammonia-lyase
2055114	phenylalanine hydroxylase
2055114	situ hybridization
2055114	robertsonian
2055114	citrate synthase
2055114	human chromosome region
2055114	hal
2055114	human chromosome
2055114	mouse somatic cell hybrid
2055114	human histidase cdna
2055114	mouse chromosome region
2055114	cell line
2055114	mouse homozygous
2055114	syntenic region
2055114	homologous locus
2055114	human gene
2055114	mouse chromosome
2055114	histidinemia mutation
2055114	dna
2055114	hsd
2055114	southern blot analysis
2055114	histidase structural gene locus
10364521	full mutation
10364521	repeat-amplification mechanism
10364521	expression
10364521	antibody test
10364521	dna-based
10364521	immunocytochemical technique
10364521	appreciable harm
10364521	simple envelope
10364521	blood smears
10364521	mentally
10364521	normal female
10364521	hair roots
10364521	hair root analysis
10364521	fmrp-specific
10364521	fmr1
10364521	pcr
10364521	patients cells
10364521	fmrp
10364521	uses monoclonal antibodies
10364521	diagnostic methods
10364521	hair follicles
10364521	blood cells
10364521	peripheral blood cells
10364521	female patients
10364521	southern blot hybridization
10364521	diagnostic center
10364521	identification
10364521	identify male patients
10364521	male fragile
10364521	new diagnostic test
10364521	noninvasive
10364521	gene product
10364521	hair root
10364521	dna
10364521	clear expression
10364521	control individuals
10364521	repeat size
10364521	novel test
10364521	fmrp-expressing
1384324	prenatal diagnosis
1384324	sscp
1384324	sequencing
1384324	plp
1384324	a-to-c
1384324	carrier mother
1384324	single-strand conformation polymorphism
1384324	proteolipid protein
1384324	rflp
1384324	proteolipid protein gene
1384324	obligate-carrier grandmother
1384324	amino acid
1384324	apparent history
1384324	t-to-c
1384324	leu-to-pro
1384324	pelizaeus-merzbacher
1384324	x-linked pelizaeus-merzbacher
1384324	genetic analysis
1384324	predicted-carrier mother
1384324	cvs
1384324	transmembrane segment
1384324	variant band pattern
1384324	carrier detection
1384324	pro
1384324	leu223
1384324	thr181
1384324	chorionic villus sample
1384324	thr-to-pro
2404853	muscular dystrophy
2404853	becker
2404853	prenatal diagnosis
2404853	dmd
10406661	28-bp deletion
10406661	midface hypoplasia
10406661	splice donor sites
10406661	severe type
10406661	mutant allele
10406661	short trunk
10406661	sequencing
10406661	exon 12-intron
10406661	18-bp deletion
10406661	furthermore
10406661	kniest
10406661	dysplasia results
10406661	heteroduplex analysis
10406661	dysplasia phenotype
10406661	severe myopia
10406661	predominant protein
10406661	identify sequence anomalies
10406661	ii
10406661	new dominant mutations
10406661	21-bp deletion
10406661	collagen triple helix
10406661	mutations
10406661	col2a1
10406661	splice donor site
10406661	4-bp deletions
10406661	shorter type
10406661	small deletions
10406661	encodes type
10406661	index patients genomic
10406661	in-frame deletions
10406661	kniest dysplasia
10406661	dna
10406661	splice site alterations
10406661	small
10406661	collagen monomers
10406661	hearing loss
8071957	adenomatous
8071957	previous patients
8071957	high risk
8071957	markers lie
8071957	recent cases suggests
8071957	apc
8071957	colorectal cancer
8071957	mcc
8071957	minor dysmorphic
8071957	long arm
8071957	laboratory findings
8071957	similar deletions
8071957	small insertion loop
8071957	adult patient
8071957	maternal intrachromosomal insertion
8071957	patients mother
8071957	interstitial deletion
8071957	molecular analysis
8071957	direct insertion
8071957	cytogenetic deletion
8071957	polyposis coli
8071957	dir ins
1338904	non-fap patients
1338904	loh
1338904	point mutations
1338904	small region
1338904	frameshift mutations
1338904	somatic
1338904	apc
1338904	mutation cluster region
1338904	1-bp deletion
1338904	combining
1338904	1-bp insertion
1338904	somatic mutations
1338904	colorectal tumors
1338904	twenty-one
1338904	fap
1338904	great majority
1338904	missense mutations
1338904	twenty-two
1338904	familial adenomatous polyposis
1338904	hence
1338904	mcr
1338904	adenomatous polyposis coli
3362213	ashkenazi tay-sachs
3362213	restriction site
3362213	jewish patient
3362213	mutant allele
3362213	infantile form
3362213	selective advantage
3362213	selective advantage hypothesis
3362213	lysosomal enzyme
3362213	multiple mutant alleles warrants
3362213	jewish population
3362213	single-base mutation
3362213	random genetic drift
3362213	tay-sachs
3362213	autosomal recessive genetic disorder
3362213	founder effect
3362213	splice site
3362213	hexa
3362213	ashkenazi
3362213	polymerase chain rection
3362213	different mutations
3362213	identification
3362213	high frequency
3362213	dna
3362213	ddei
3362213	rna
10484772	subsequently
10484772	missense mutation
10484772	norrie
10484772	unilateral variant
10484772	retinal angiogenesis
10484772	recent observations
10484772	classical form
10484772	unilateral retinal telangiectasis
10484772	so-called retinal telangiectasis
10484772	xp11
10484772	non-retinal tissue
10484772	protein product
10484772	abnormal retinal vascular development
10484772	coats
10484772	subretinal lipid accumulation
10484772	exudative retinal detachment
10484772	massive intraretinal
10484772	somatic mutation
10484772	normal retinal vasculogenesis
10484772	ndp
1357962	maternal age
1357962	human disorders
1357962	chromosome
1357962	disomic egg
1357962	pws
1357962	maternal
1357962	maternal disomy
1357962	important issues
1357962	instructive case
1357962	uniparental
1357962	normal sperm
1357962	molecular
1357962	prader-willi
1357962	uniparental disomy
1357962	typical features
1357962	genetic analysis
1357962	placental mosaicism
1357962	chorionic
1357962	trisomy
492335	b10
492335	active mouse
492335	mw
492335	c5
492335	somatic cell hybrids
492335	alpha chain
492335	sera
492335	d2/new
492335	chain precursor
492335	akr
492335	chicken erythroblasts
492335	tissue culture media
492335	d2/old
492335	mouse kidney
492335	levy
492335	possible molecular mechanisms
492335	culture synthesise
492335	different mouse strains
492335	direct data
492335	deficient mice lack
492335	genetic deficiency
492335	genetic
492335	beta chain
492335	swr
492335	dba/2j8 a/hej
492335	molecular weight
492335	addition deficient mice
492335	peritoneal cells
492335	similar methods
492335	radiolabelled
492335	serum glycoprotein
8528199	val75met
8528199	peripheral blood leukocytes
8528199	amino acid substitutions
8528199	novel mutations
8528199	compensatory splice site mutation
8528199	evident immune defect
8528199	wasp
8528199	x-linked
8528199	normal protein function
8528199	xp11
8528199	t-cell
8528199	leu27phe
8528199	detectable mrna
8528199	northern blots
8528199	cell line
8528199	valuable information
8528199	gene alterations
8528199	constitutional frameshift mutation
8528199	arg477lys
8528199	missense mutations
8528199	amino acids
8528199	congenital thrombocytopenia
8528199	dna
8528199	premature termination codons
8528199	was
8528199	thr48ile
8528199	wiskott-aldrich
8528199	frameshift mutations
8528199	gene mutations
1307253	human dystrophin gene
1307253	sscp
1307253	detection
1307253	strand conformation polymorphism
1307253	termination codon
1307253	pcr
1307253	dna
1307253	becker
1307253	co-amplification
1307253	severe phenotype
1307253	internal control
1307253	mutation introduces
1307253	nonsense mutation
1307253	premature translational termination
1307253	muscular dystrophy
1307253	duchenne
1307253	dmd/bmd
1307253	point mutations
1307253	dystrophin gene
8346255	common abnormality
8346255	endogenous sequences
8346255	point mutations
8346255	splice junctions
8346255	reading frameshift
8346255	perfect homology
8346255	true sporadic nature
8346255	single-strand conformation polymorphism technique
8346255	molecular
8346255	germ line
8346255	oncogenic mutations
8346255	stop codon
8346255	human retinoblastoma tumors
8346255	deletions
8346255	direct
8346255	mutations
8346255	rb1
8346255	arginine codon
8346255	independent mutations
8346255	dna
8346255	unilateral retinoblastoma
8346255	breakpoint junctions
8346255	small
8346255	loss-of-heterozygosity theory
7951315	congenital cataracts
7951315	specific neuronal progenitor cells
7951315	pst
7951315	critical role
7951315	human eye malformation aniridia results
7951315	partial activity
7951315	pax6
7951315	milder syndrome
7951315	c-terminal pst
7951315	late onset corneal dystrophy
7951315	dosage effect
7951315	nonsense mutations
7951315	domain activates transcription
7951315	severe craniofacial
7951315	compound heterozygote
7951315	n-terminal
7951315	dna-binding
7951315	central nervous system defects
7951315	mutant form
7951315	sey
7951315	gene dosage effect
409732	44-yr-old woman
409732	cm
409732	french-canadian
409732	studies
409732	c7
409732	close linkage
409732	immunochemical methods
409732	complement components
409732	basic coagulation studies
409732	simultaneous occurrence
409732	hereditary complement deficiencies
409732	b-27
409732	good health
409732	paternal aunt
409732	c2
409732	diagnosis
409732	hla
409732	patients family
409732	homozygous sisters
409732	hereditary c7
409732	opsonic activity
10598815	sensorineural hearing loss
10598815	d2s327
10598815	critical region
10598815	maximum two-point lod score
10598815	alms1
10598815	retinal degeneration
10598815	theta =
10598815	maximum lod
10598815	additional families
10598815	rare autosomal recessive disorder
10598815	acadian
10598815	d2s286
10598815	recombination events
10598815	human chromosome
10598815	meiotic
10598815	odds ratio
10598815	maximum cumulative multipoint lod score
10598815	pair-wise
10598815	african
10598815	d2s2110
10598815	1-cm interval
10598815	large linkage study
10598815	early-onset obesity
10598815	genetic heterogeneity
10598815	alstrom
10598815	fine resolution radiation hybrid map
10598815	non-insulin-dependent diabetes mellitus
2575071	prenatal diagnosis
2575071	dxys1
2575071	dxys5
2575071	tcd
2575071	data place
2575071	dxys12
2575071	haplotype data
2575071	rflps
2575071	northeastern finland
2575071	rflp
2575071	dxs72
2575071	theta =
2575071	pgk
2575071	non-tcd chromosomes
2575071	multipoint
2575071	marker loci
2575071	zmax
2575071	haplotype
2575071	linkage analysis
2575071	chromosomal restriction fragment length polymorphisms
2575071	choroideremia pedigrees
2575071	carrier females
2575071	dxys4
2575071	choroideremia families
2575071	linkage studies
2575071	finnish
2575071	multipoint linkage analysis
2575071	finnish tcd
2253938	g6pd montalbano
2253938	italy
2253938	g6pd ferrandina
2253938	moderate deficiency
2253938	eastern side
2253938	gene flow
2253938	g6pd a-
2253938	polymorphic variants
2253938	g6pd
2253938	italian peninsula
2253938	g6pd mediterranean
2253938	biochemical
2253938	gel electrophoresis
2253938	greek settlers
2253938	ii
2253938	overall rate
2253938	narrow geographic area
2253938	african
2253938	new polymorphic variants
2253938	sporadic variants
2253938	matera
2253938	g6pd tursi
2253938	g6pd metaponto
2253938	genetic
2253938	ionian
2253938	glucose-6-phosphate
2253938	iii
2253938	non-deficient electrophoretic variant
2253938	lucania
2253938	quantitative assay
2253938	lucanian apennines
2253938	glucose-6-phosphate dehydrogenase locus
2253938	genetic heterogeneity
2253938	geographic distribution
2253938	g6pd pisticci
2253938	gda-
2253938	g6pd cagliari
2253938	iv
10411929	cell activation
10411929	surface expression
10411929	ctla-4
10411929	abnormal vesicles
10411929	lymphoproliferative syndrome
10411929	cell surface
10411929	lymphocyte activation
10411929	secretory lysosomes
10411929	present similar characteristics
10411929	defective ctla-4
10411929	secretory lysosome pathway
10411929	cd152
10411929	possible mechanism
10411929	regulator gene
10411929	defective membrane
10411929	lyst
10411929	chediak-higashi
10411929	cytotoxic t
10411929	membrane expression
10411929	chs
10411929	defective surface expression
10411929	lymphoproliferative disease
10411929	major role
10411929	chs t
10411929	beige mice
10398436	genes chromosomes
10398436	beta-catenin gene
10398436	tumor suppressor
10398436	sequencing
10398436	beta-catenin expression
10398436	ctnnb1
10398436	hepatoblastoma tumorigenesis
10398436	tumor samples
10398436	rare malignant tumor
10398436	oncogenic potential
10398436	substitute biallelic
10398436	hepatoblastoma
10398436	epidemiologic
10398436	apc
10398436	tumor type
10398436	immunohistochemical study
10398436	sporadic cases
10398436	major function
10398436	beta-catenin levels
10398436	beta-catenin accumulation
10398436	molecular genetic studies
10398436	tumor types
10398436	beta-catenin
10398436	average age
10398436	adenomatous polyposis coli
10398436	epidemiologic data
1833974	sscp
1833974	polyacrylamide gels
1833974	tg
1833974	novel mutations
1833974	tctcc
1833974	ivs-9
1833974	g533
1833974	tay-sachs
1833974	disease patients
1833974	hexa
1833974	4-bp insertion
1833974	stop codon
1833974	amino acid substitution
1833974	g1496
1833974	splice-junction sequence
1833974	ivs-2
1833974	5-bp deletion
1833974	pcr-dependent
1833974	specify oligonucleotide primers
1833974	sequence
1833974	dna
1833974	rapid identification
1833974	2-bp deletion
1833974	g78
1833974	single-strand conformational polymorphisms
10742101	reduces obesity
10742101	mesenchymal cells
10742101	fat-cell proliferation
10742101	essential components
10742101	complete deficiency
10742101	hmgi
10742101	mesenchymal tumour cell types
10742101	hmgic-/-
10742101	disruption
10742101	obese mice
10742101	fat-cell tumours
10742101	studies implicate
10742101	adult tissues
10742101	gene-dose-dependent manner
10742101	lepob/lepob
10742101	hmgic
10742101	architectural factors
10742101	adipose-specific target
10742101	mice
10742101	vivo modulation
10742101	leptin deficiency
10742101	fat tissue
10742101	adipose tissue
10210128	+ weeks pregnant
10210128	prenatal diagnosis
10210128	amniotic fluid cell preparation
10210128	young boy
10210128	prenatal
10210128	plp
10210128	male fetus
10210128	pelizaeus-merzbacher
10210128	samples
10210128	mim
10210128	pelizaeus merzbacher
10210128	fish
10210128	lymphocyte preparations
10210128	boys maternal aunt
10210128	proteolipid protein
1056013	chronic lymphocytic leukemia
1056013	nonrandom involvement
1056013	lymphocyte clone
1056013	chromosomes
1056013	ataxia-telangiectasia
1056013	chromosome
1056013	somatic
1056013	14q translocation
1056013	anomalous clones
1056013	abnormal growth
1056013	immune deficiency
1056013	human lymphocytes
1056013	long arm
1056013	african-type burkitts
1056013	rare genetic disorder
1056013	patients whereas
1056013	lymphocyte clones
1056013	lymphoid neoplasms
1056013	initial chromosomal
1056013	structural rearrangement
1056013	lymphoid malignancies
1056013	chromosome instability
1056013	leukemic cells
1056013	lymphoid malignancy
1301200	hpa
1301200	pku
1301200	mutant alleles
1301200	mutant haplotype
1301200	pah
1301200	phenylalanine hydroxylase
1301200	enzyme activity
1301200	vivo hepatic activities
1301200	relative severities
1301200	genetic defects
1301200	different mutant
1301200	g-to-a
1301200	a322g
1301200	c-to-g
1301200	nuclear families
1301200	mild hyperphenylalaninemia
1301200	swedish pku/hpa
1301200	enzymes reflect
1301200	vitro activities
1301200	abstract truncated at
1301200	eukaryotic expression system
1301200	polymorphic restriction sites
1301200	enzyme activities
1301200	expression system
1301200	caucasians
1301200	mild mutation
1301200	words
1301200	missense mutations
1301200	r408q
1301200	sequence
1301200	dna
1301200	clinical severities
1301200	approximately
1301200	wide range
1301200	specific haplotypes
7959759	intronic sequences
7959759	sequences
7959759	ald
7959759	chain fatty acids beta-oxidation
7959759	adrenoleukodystrophy
7959759	color vision anomalies
7959759	frequent occurrence
7959759	genomic
7959759	abc
7959759	70-kda peroxisomal membrane protein
7959759	pmp70
7959759	severe neurodegenerative disease
7959759	secondary manifestation
7959759	new member
7959759	pulsed-field map
7959759	promoter region
7959759	l1cam
7959759	adrenoleukodystrophy gene
7959759	xq28
7959759	kb upstream
7959759	human genome
7959759	distal exons cross-hybridize
7959759	additional sequences
7959759	color pigment genes
7959759	frequent peroxisomal disorder
7959759	adult onset form
7959759	contiguous gene syndrome
7959759	gene structure
7959759	dxs15
7959759	significant homology
10220405	far
10220405	multiple processes
10220405	germ-line
10220405	histone deacetylase
10220405	brca1
10220405	human placenta cdna expression library
10220405	rbap46
10220405	ovarian cancer
10220405	tumor-suppressor gene
10220405	brct
10220405	histone deacetylases
10220405	hdac2
10220405	rb
10220405	purified brct
10220405	domain associates
10220405	genome integrity
10220405	carboxyl-terminal domain
10220405	western analysis
10220405	dna
10220405	rb-binding
10220405	hdac1
10220405	rbap48
10220405	isolate proteins
1279971	kit
1279971	chromosome segment
1279971	pdgfra
1279971	growth factor receptor alpha subunit
1279971	xy
1279971	dna
1279971	mast/stem cell growth factor
1279971	multiple congenital anomalies
1279971	southern blot hybridization analyses
1279971	deletion
1279971	mental retardation
1279971	human piebaldism results
1279971	piebald phenotype
3198117	enzyme deficiency
3198117	gd kaiping
3198117	china
3198117	blood samples
3198117	various regions
3198117	g6pd
3198117	gd huiyang
3198117	gd huazhou
3198117	dehydrogenase variants
3198117	guangdong province
3198117	glucose-6-phosphate dehydrogenase
3198117	gd guangzhou
3198117	gd boluo
3198117	glucose-6-phosphate
3198117	gd gaomin
3198117	gd haad yai-like
3198117	gd nanhai
3198117	guangdong
3198117	gd taiwan-hakka
3198117	gd qing-baijiang
3198117	genetic heterogeneity
3198117	gd gaozhou
3198117	new variants
3198117	gd haad yai
3198117	erythrocyte
10369860	breakpoints confer susceptibility
10369860	deletion end-points
10369860	interstitial duplication
10369860	vcfs/dgs
10369860	similar low copy repeats
10369860	malignant tumors
10369860	mb
10369860	common syndrome
10369860	rare patients
10369860	hamster-human somatic hybrid cell lines
10369860	chromosome rearrangements
10369860	cat-eye syndrome
10369860	large number
10369860	additional copies
10369860	haplotype analysis
10369860	velo-cardio-facial syndrome/digeorge syndrome
10369860	distal deletion breakpoint
10369860	common molecular basis
10369860	rearrangement disorders
10369860	different homologous recombination events
10369860	lcr22
10369860	particular regions
10369860	lcr22s
10369860	high prevalence
10369860	present models
10369860	unique deletions
1424237	marker chromosome
1424237	partial tetrasomy
1424237	genomic library
1424237	partial cat eye syndrome
1424237	supernumerary marker chromosome
1424237	fish
1424237	ces
1424237	typical cat eye syndrome
1313112	fapc
1313112	moderate degree
1313112	male patient
1313112	normal family members
1313112	deletion whereas loci
1313112	retinal pigment epithelium
1313112	mental handicap
1313112	apc
1313112	ef5
1313112	direct insertions
1313112	chrpes
1313112	maternal aunt
1313112	molecular
1313112	mcc
1313112	long arm
1313112	intrachromosomal insertion
1313112	familial adenomatous polyposis coli
1313112	recurrent microdeletion syndromes
1313112	molecular analyses
1313112	congenital hypertrophy
1313112	d5s98
1313112	interstitial deletion
1313112	report familial adenomatous polyposis coli
1313112	fluorescent hybridisation studies
1313112	d5s37
1313112	3q22q23 3q22q23
1313112	direct insertion
1313112	dir ins
1313112	epidermoid cysts
1313112	yn5
1313112	familial
1303170	pcr-based
1303170	stss
1303170	base pair
1303170	yac
1303170	artificial chromosomes
1303170	d4s10
1303170	hd
1303170	disease region
1303170	yacs
1303170	mb
1303170	huntington
1303170	complete characterization
1303170	ten
1303170	cloning
1303170	artificial chromosome
1303170	large number
1303170	d4s168
1303170	internal deletions
1303170	twenty-eight yac
1303170	chimeric inserts
1303170	dna
1303170	eventual isolation
1303170	continuous segment
1303170	likely contains
1303170	short arm
1303170	chromosomal location
8113388	position +
8113388	pros1
8113388	amino acids
8113388	transversion predicts
8113388	sequence abnormalities
8113388	protein s deficiency
8113388	novel mutations
8113388	hereditary protein s deficiency type
8113388	protein s deficiency type
8113388	protein s molecule
8113388	donor splice site consensus sequence
8113388	donor splice junction
8113388	normal protein s antigen levels
8113388	genetic analysis
8113388	rna
8113388	analysis
3029599	purine salvage enzyme hypoxanthine-guanosine phosphoribosyl transferase
3029599	clonal lines
3029599	mutant alleles
3029599	potential animal model
3029599	mouse embryonic stem cells
3029599	cells shows
3029599	purine metabolism lead
3029599	mutant mice
3029599	laboratory animals
3029599	total lack
3029599	male
3029599	different mutant
3029599	germ cells
3029599	biochemical defect
3029599	behavioural disorder
3029599	severe symptoms characteristic
3029599	animal model
3029599	hprt
3029599	lesch-nyhan
3029599	construct chimaeric mice
3029599	retroviral insertion
3029599	rare neurological
2316519	nondeletion cases
2316519	grandmaternal origin
2316519	duplication junction
2316519	intermediate cases
2316519	hindiii
2316519	muscular dystrophy locus
2316519	rflp
2316519	southern blot analyses
2316519	gene duplication
2316519	novel restriction fragment
2316519	dmd
2316519	muscular dystrophy
2316519	grandpaternal origin
2316519	becker
2316519	bmd
2316519	duchenne
2316519	nondeletion patients
2316519	fragment map
2316519	sister-chromatid exchange
2316519	southern blot hybridization
2316519	hybridization band intensity
2316519	gene deletion
2316519	translational reading frame
2316519	careful quantitative analysis
2316519	duplicational
2316519	reading frame
2316519	phenotypegenotype correlation
2316519	partial
2316519	unequal
6087154	selective advantage
6087154	hprt locus
6087154	principle predicts
6087154	partial hprt
6087154	x-linked
6087154	activity results
6087154	molecular
6087154	genetic lesions
6087154	gouty arthritis
6087154	constant introduction
6087154	haldanes
6087154	new mutations
6087154	ec2
6087154	hypoxanthine-guanine
6087154	hprt gene
6087154	initial survey
6087154	new mutation
6087154	family members
6087154	heterozygous state
6087154	l-n
6087154	hprt
6087154	unusual mutation
6087154	apparent difference
6087154	molecular analysis
6087154	heterogeneous collection
6087154	lesch-nyhan
6087154	metabolic salvage
6087154	dna
6087154	hprt mutations
3600793	sparse fur
3600793	mild pathological
3600793	candidate mouse genetic homologue
3600793	close genetic linkage
3600793	mouse homologue
3600793	x-linked
3600793	cdna clone
3600793	ornithine transcarbamylase
3600793	g6pd
3600793	recent discovery
3600793	otc
3600793	dmd
3600793	obvious mouse model
3600793	muscular dystrophy
3600793	therapeutic strategies
3600793	becker
3600793	duchenne
3600793	mdx mutation
3600793	mammalian species
3600793	x-linked duchenne
3600793	muscular dystrophy type
3600793	xq28-qter
3600793	chromosome sequences homologous
3600793	sequences map
3600793	hprt
3600793	molecular analysis
3600793	dna
3600793	muscular dystrophy gene
3600793	interspecific mouse domesticus/spretus cross
3600793	genetic disease
3600793	human locus
3600793	mild pathology
3600793	emery dreifuss
10094559	alkaptonuria
10094559	splice donor consensus sequence
10094559	wild-type product
10094559	mouse mutation
10094559	products shorter
10094559	hgd
10094559	rt-pcr
10094559	ethylnitrosourea mutagenesis
10094559	restriction
10094559	dna
10094559	alkaptonuria mouse model
10094559	identification
10094559	inborn error
10094559	mouse model
1347968	reciprocal
1347968	southern analyses
1347968	x-derived
1347968	novo rearrangements
1347968	chromosomal breakpoints
1347968	5-bp sequence
1347968	physical
1347968	somatic cell hybrids
1347968	translocation disrupts
1347968	rflp
1347968	18-kb intron
1347968	complex rearrangement event
1347968	sequence homology
1347968	ggaat
1347968	derivative chromosomes
1347968	opposite strand
1347968	causative mechanisms
1347968	dmd
1347968	muscular dystrophy
1347968	duchenne
1347968	corresponding normal regions
1347968	x/autosome
1347968	constitutional reciprocal translocation
1347968	xp21
1347968	normal chromosomes
1347968	human genome
1347968	common sequence motifs
1347968	gaatca
1347968	short
1347968	chromosome translocations
1347968	restriction
1347968	dna
1347968	chromosome contains
1347968	paternal origin
1347968	ggaatca
1347968	5-kb fragment
1347968	translocation breakpoints
1347968	rearrangement sites
1347968	novo translocation
10874302	germline mutations
10874302	endogenous pattern
10874302	similar pattern
10874302	germline mutagen test
10874302	ancient pattern
10874302	genetic variation
10874302	mammalian genome
10874302	genetic predisposition
10874302	ethnic groups
10874302	previous
10874302	n =
10874302	u. s. caucasians
10874302	ix
10874302	mendelian
10874302	endogenous processes predominate
10874302	hemophilia b patients
10874302	major source
10874302	germline mutation
10874302	diverse populations
10874302	mainland china
10874302	germline
10874302	human factor
10874302	multifactorial diseases
10874302	f9
10874302	additional data compatible
10874302	disease severity
10874302	hispanics
3591825	very-long-chain fatty acids
3591825	ald
3591825	adrenocortical insufficiency
3591825	neurologic disease
3591825	acth
3591825	compensatory high
3591825	normal relatives
3591825	phenotype
3591825	biochemical defect
10721669	abnormal protein
10721669	japanese patients
10721669	late onset
10721669	mutations 2871delc
10721669	a874v
10721669	r778l
10721669	wd
10721669	wilson
10721669	atp7b
10721669	early onset
10721669	effective genetic diagnosis
10721669	population-specific manner
10721669	large number
10721669	copper toxication
10721669	novel
10721669	asian countries
10721669	responsible gene
10721669	frame 1-amino acid deletion
10721669	missense mutations
10721669	hepato-neurologic type
10721669	autosomal recessive disorder
10721669	reading frame
10721669	copper accumulation
7759106	murine homologue
7759106	% nucleotide identity
7759106	disease gen
7759106	940-bp sequence
7759106	different-size introns
7759106	ccaat
7759106	hd
7759106	identical exon boundaries
7759106	structural
7759106	comparison
7759106	genomic region
7759106	tata
7759106	trinucleotide polymorphisms
7759106	high sequence identity
7759106	huntington
7759106	ca
7759106	trinucleotide intronic polymorphism
7759106	numerous potential
7759106	human chromosome
7759106	hdh
7759106	ct
7759106	putative translation
7759106	disease genes reveals conservation
7759106	ap2
7759106	putative promoter region
7759106	mouse chromosome
7759106	sp1
7759106	putative promoter
7759106	site reveals
6103091	homozygous deficiency
6103091	normal complement
6103091	membranoproliferative glomerulonephritis
6103091	c3-deficient
6103091	complement
6103091	deficiency predisposes
6103091	null gene
6103091	renal disease
6103091	proteinuria and/or microscopical haematuria
6103091	c3
6103091	family study
1222588	obligate heterozygotes
1222588	skin fibroblasts
1222588	skin
1222588	cytogenetic
1222588	chromosome damage
1222588	increased
1222588	chromosomal
1222588	14q +
1222588	israeli-moroccan
1222588	apparent abnormal clone
1222588	chromosome breakage
1222588	normal family members
1222588	large acrocentric marker chromosome
1222588	normal controls
1222588	peripheral blood lymphocytes
7991123	ald
7991123	adrenomyeloneuropathy phenotype
7991123	adrenal cortex
7991123	peripheral demyelination
7991123	dutch x-ald/amn
7991123	x-linked
7991123	dutch
7991123	frequent phenotype
7991123	netherlands
7991123	x-ald
7991123	predominance
7991123	percentages differ
7991123	peroxisomal beta-oxidation
7991123	adolcald
7991123	amn
7991123	main variants
7991123	male patients
7991123	childhood cerebral
7991123	long-chain fatty acids
7991123	ccald
7991123	phenotypic expression
7991123	adolescent cerebral
7991123	previous reports
7550230	pst
7550230	various ethnic groups
7550230	mutations
7550230	iris hypoplasia
7550230	autosomal dominant congenital disorder
7550230	glycine-rich region
7550230	new aniridia cases
7550230	aniridia
7550230	novel aniridia mutations
7550230	aniridia patient
7550230	splice mutation
7550230	pax6
7550230	different mutations
7550230	aniridia family
7550230	human aniridia
7550230	results support
7550230	familial cases
3354603	ocular fundus lesions
3354603	hepatoblastoma
3354603	possible presence
3354603	colon [
3354603	gardner
3354603	hereditary adenomatous polyposis
3354603	jaw lesions
3354603	kingston
3354603	jaw lesions and/or
3354603	clinical markers
3354603	rare neoplasm
3354603	osteomatous jaw lesions
3354603	colonic polyps
3354603	child survives
3354603	gs
7981671	causative
7981671	mutation
7981671	causative mutations
7981671	mapping
7981671	chm
7981671	complete open reading frame
7981671	interestingly
7981671	families deletions
7981671	different sizes
7981671	classical choroideremia
7981671	substantial part
7981671	polymerase chain reaction single-strand conformation polymorphism
7981671	pcr-sscp
7981671	sizeable deletions
7981671	mutation detection
7981671	southern blot hybridization
7981671	choroideremia patients
7981671	swedish
7981671	deletion endpoints
7981671	male patients
7981671	recent isolation
7981671	xq21
7981671	gene mutations
7981671	exon-intron boundaries
1562739	point mutations result
1562739	recently
1562739	ava ii
1562739	recognition sites
1562739	chinese infants
1562739	encodes human
1562739	leu
1562739	people worldwide
1562739	ethnic group
1562739	asn
1562739	taiwan
1562739	digestion method
1562739	diverse
1562739	biochemical criteria
1562739	ser
1562739	novel mutation
1562739	molecular basis
1562739	gly
1562739	dominant allele
1562739	chinese populations
1562739	pcr
1562739	ec
1562739	pcr/re
1562739	g6pd
1562739	interestingly
1562739	glucose-6-phosphate dehydrogenase
1562739	simultaneous detection
1562739	alu
1562739	pcr/restriction
1562739	direct proof
1562739	re
1562739	glucose-6-phosphate
1562739	nucleotide position
1562739	common human enzymopathy
1562739	arg
1562739	asp
1562739	polymerase chain reaction
1562739	dna
1562739	genetic heterogeneity
1562739	mutation causes
10875918	pathogenic mutations
10875918	fas-induced
10875918	specific region
10875918	human autoimmune lymphoproliferative syndrome
10875918	heterozygous
10875918	fas
10875918	extracellular domain
10875918	fluorescence resonance energy
10875918	death receptor
10875918	independent interaction
10875918	green fluorescent protein
10875918	receptor complexes
10875918	dominant inhibition
10875918	lymphocyte apoptosis
10875918	abnormal forms
10875918	preassociated fas
10875918	dominant interference
10875918	human disease
10875918	receptor oligomerization
8434621	prophylactic colchicine treatment
8434621	continuous colchicine treatment
8434621	natural history
8434621	amyloidotic kidney disease
8434621	considered
8434621	familial mediterranean
8434621	mediterranean
8434621	colchicine era
8434621	different stage
8434621	complete clinical
8434621	behavioral picture
8434621	fmf
1684088	residual enzyme activity
1684088	immuno-cross-reactive material
1684088	restriction site
1684088	point mutation
1684088	clones
1684088	available clinical
1684088	mp13
1684088	fragments
1684088	control expression
1684088	cdna sequence
1684088	late-onset forms
1684088	gene
1684088	pcr
1684088	appropriate size inserts
1684088	introduction
1684088	small residual activity
1684088	mld
1684088	g-to-a
1684088	enzyme-null mutations
1684088	new arylsulfatase
1684088	original patients family
1684088	individuals homozygous
1684088	splice-recognition sequence
1684088	normal levels
1684088	examination
1684088	intronic sequence
1684088	baby hamster kidney cells
1684088	arsa
1684088	dna
1684088	splice-site mutation
1684088	biochemical data
1684088	juvenile metachromatic leukodystrophy
1684088	transient expression
1684088	normal controls
1684088	juvenile-onset metachromatic leukodystrophy
1684088	additional individuals
10441329	toxic milk phenotype
10441329	morphological
10441329	homozygous mutant females
10441329	intracellular hepatic copper
10441329	wilson
10441329	atpase
10441329	neurological abnormalities
10441329	atp7b
10441329	disease gene
10441329	homozygous mutants
10441329	subsequent hepatic
10441329	intracellular copper accumulation
10441329	gene results
10441329	dramatic build-up
10441329	gene lead
10441329	homo-zygous mutants
10441329	progeny
10441329	hepatic copper
10441329	mammary glands
10441329	cirrhotic liver disease
10441329	mutations
10441329	copper deficient
10441329	gradual accumulation
10441329	mutant glands
10441329	copper deficiency
10441329	lesser extent
10441329	null
10441329	neuro-logical abnormalities
10441329	growth retardation characteristic
10441329	copper toxicity disorder
10441329	level 60-fold
10441329	null mice display
10441329	homologous recombination
10441329	copper concentration
10441329	late-onset hepatic nodular transformation
10441329	normal translation
10441329	newborn homozygous null mutants
218453	clinical variant
218453	function studies
218453	adrenal insufficiency
218453	pituitary-adrenal
218453	ald
218453	family members
218453	ald/amn
218453	acth
218453	clinical signs
218453	24-hour response
218453	pituitary-adrenal abnormality
218453	amn
218453	maximal exogenous
218453	morning plasma cortisol levels
218453	partial adrenal insufficiency
218453	adrenoleukodystrophy
218453	basal morning plasma adrenocorticotropic hormone
218453	subclinical partial adrenocrotical insufficiency
218453	endocrinologic dysfunction
8566952	defective
8566952	ald
8566952	vlcfas
8566952	peripheral nerves
8566952	chain fatty acids
8566952	adrenoleukodystrophy
8566952	x-linked
8566952	ald-gene
8566952	healthy persons
8566952	c22
8566952	745-amino-acid protein
8566952	nonsense mutations
8566952	peripheral nervous system
8566952	identification
8566952	leukoid areas
8566952	frequent inborn peroxisomal disease
8566952	central nervous system
8566952	ald/amn
8566952	dna
8566952	adrenal gland
8566952	eleven
8566952	metabolic disorder
8128954	n repeat variation
8128954	n repeat lengths
8128954	fathers sperm
8128954	broad range
8128954	differences
8128954	mitotic events
8128954	overall number
8128954	large allele expansions
8128954	ctgs
8128954	sperm
8128954	gonosomal mosaics
8128954	gonosomal
8128954	cell divisions
8128954	n repeat
8128954	i. e e.
8128954	embryonal origin
8128954	myotonic dystrophy patients
8128954	somatic tissues
8128954	tissue formation
8128954	similar extent
8128954	intergenerational length changes
8128954	congenital manifestation
8128954	early embryonic mitotic divisions
8128954	sex-dependent segregation phenomena
8128954	dnas
8128954	extreme expansion
8128954	offsprings blood
8128954	repeats
8128954	male patients
8128954	multiple cases
8128954	protein kinase gene
8128954	myotonic
8128954	abnormal expansion
8128954	germ-line tissue mosaics
8128954	repeat lengths
8128954	germ-line tissue formation
8128954	mitotic instability
8128954	ctg
8128954	length distributions
8128954	repeat length
8128954	dm
8128954	specific selection process
10712209	1q24-25 region
10712209	hpc1
10712209	putative hereditary prostate cancer loci
10712209	1-lod support interval
10712209	small proportion
10712209	america
10712209	previous linkage study
10712209	prostate
10712209	prominent role
10712209	overall
10712209	additional collections
10712209	male-to-male disease transmission
10712209	prostate cancer families
10712209	consortium
10712209	finland
10712209	peak parametric multipoint
10712209	lod
10712209	extensive heterogeneity
10712209	early age
10712209	hereditary prostate cancer families
10712209	combined
10712209	sweden
10712209	nonparametric approach
10712209	hereditary prostate cancer
10712209	icpcg
10712209	locus heterogeneity
10712209	family members
10712209	results support
10712209	subsequent reports
10712209	d1s212
10712209	hereditary prostate cancer linkage
10712209	norway
10712209	prostate cancer-susceptibility gene
10712209	prostate cancer-susceptibility locus
10712209	hlod
10712209	xq27-28
10712209	genetics
10712209	australia
10712209	significant effect
10712209	kingdom
10712209	parametric analysis
10712209	such families
10712209	alpha =
10712209	hlods
10712209	present study
8466512	very-long-chain acyl-coa dehydrogenases
8466512	dehydrogenase activity
8466512	palmitoyl-coa
8466512	skin fibroblasts
8466512	old boys
8466512	vlcad
8466512	mitochondrial very-long-chain acyl-coa dehydrogenase
8466512	palmitoyl-coa dehydrogenase activity
8466512	fatty acid oxidation
8466512	novel disease
1327525	constitutional mutations
1327525	tumor gene
1327525	inherited wt1
1327525	wilms
1327525	new cases
1327525	previous reports
1327525	familial studies
1327525	wt1
1327525	patients
1327525	genital anomalies
1327525	incomplete penetrance
1327525	denys-drash
2008213	missense mutation
2008213	-dependent absorption
2008213	na+/glucose
2008213	ggm
2008213	dietary glucose
2008213	selective failure
2008213	autosomal recessive disease
2008213	brush border
2008213	normal
2008213	-dependent glucose transport
2008213	+ electrochemical potential gradient
2008213	sglt1
2008213	glucose absorption
2008213	basolateral membrane
2008213	+/glucose cotransporter
2008213	normal human ileum
2008213	specific defect
2008213	intestinal
2008213	brush border membrane
2008213	complete loss
2008213	glucose carrier
2008213	severe diarrhoea
2008213	xenopus
2008213	glucose/galactose
2008213	polymerase chain reaction
2008213	sequence
2008213	dna
2008213	intestinal epithelium
2008213	na
2008213	distal q arm
2008213	rna
2008213	cellular
10639175	excessive genomic damage
10639175	apoptotic pathway
10639175	nervous system
10639175	ataxia-telangiectasia
10639175	mice shows
10639175	death effectors
10639175	large proportion
10639175	neurological lesion
10639175	cns
10639175	data implicate
10639175	genotoxic stress
10639175	death effector
10639175	hereditary multisystemic disease
10639175	atm
10639175	additional reduction
10639175	p53-dependent collateral pathway exists
10639175	bax-dependent
10639175	immune defects
10639175	bax-independent
10639175	ir
10639175	atm-dependent
10639175	atm-null
10639175	bax-/-
10639175	developmental origin
10639175	ataxia telangiectasia
10639175	bax
10639175	ir-induced
10639175	caspase-3 activation
10639175	neurodegenerative pathways
10639175	central nervous system
10639175	molecular details
10639175	atm-/-
10639175	mice nullizygous
10639175	atm-
1301190	restriction site
1301190	tsd
1301190	novel insertion
1301190	rough endoplasmic reticulum
1301190	cos
1301190	> c transition
1301190	e482k
1301190	strand conformational polymorphism analysis
1301190	china
1301190	insertion site
1301190	early termination codon
1301190	tay-sachs
1301190	oligonucleotide hybridization
1301190	pcr
1301190	fnu4hi
1301190	w485r
1301190	mutation occurs
1301190	chinese families
1301190	hexa
1301190	direct
1301190	nakano
1301190	single
1301190	cells hexosaminidase s activity
1301190	novel
1301190	mutation creates
1301190	corresponding amino acid substitution
1301190	disease mutations
1301190	cpg
1301190	defective intracellular transport
1301190	novel tay-sachs
1301190	golgi
1301190	alpha cdna
1301190	allele-specific
3348216	protective effect
3348216	hematologic malignancy
3348216	gdb
3348216	glucose
3348216	6-phosphate dehydrogenase deficiency
3348216	healthy heterozygotes
3348216	g6pd
3348216	sardinian
3348216	hematological malignancies
3348216	glucose 6-phosphate dehydrogenase
3348216	control group
3348216	hematologic neoplasms
3348216	negative association
3348216	clonal hematologic disease
3348216	heterozygous women
7951316	breast cancer patients
7951316	p1
7951316	cdna clones
7951316	hereditary breast
7951316	meiotic breakpoints
7951316	deleterious mutations
7951316	candidate genes
7951316	pcr
7951316	new reagents
7951316	ovarian cancer gene
7951316	cm region
7951316	chromosome 17q12-21
7951316	brca1
7951316	map comprises
7951316	partial sequences
7951316	artificial chromosomes
7951316	physical map
7951316	narrow region
10404839	syndrome patients
10404839	syndrome thyrocytes
10404839	mechanisms
10404839	sulfate
10404839	sensory-neural deafness
10404839	sulfate transporter
10404839	sufate transporters
10404839	thyroid goiter
10404839	abnormal sulfate transport
10404839	sulfate transport
10404839	pds
10404839	pendred
10404839	functional studies
10404839	dyshormonogenic goiter
10404839	novel protein
10404839	iodide organification
10404839	syndromic deafness
10404839	common form
10430841	chronic myelopathy
10430841	ctx
10430841	spinal xanthomatosis
10430841	dutch
10430841	post-mortem
10430841	extensive myelin loss
10430841	spinal
10430841	sole expression
10430841	white matter abnormalities
10430841	mri
10430841	separate entity
10430841	spinal cord
10430841	cerebrotendinous xanthomatosis
10430841	differential diagnosis
10430841	dorsal columns
10430841	spinal cord syndrome
10827109	northern british origin
10827109	recently
10827109	6-kb duplication
10827109	european ancestry
10827109	geographic diversity
10827109	polymerase chain
10827109	english-speaking
10827109	haplotyping
10827109	britain
10827109	additional families
10827109	brca1
10827109	duplication screening
10827109	s.
10827109	common ancestor
10827109	family history
10827109	diverse populations
10827109	portuguese family
10827109	founder mutation
10827109	historical links
10827109	brca1 exon
10827109	australia
10827109	belgium
10827109	canada
10827109	early-onset breast and/or ovarian cancer cases
7493024	analysis supports
7493024	germline mutations
7493024	germline
7493024	mutations
7493024	twenty-two
7493024	breast and/or ovarian cancer
7493024	ovarian cancer families
7493024	significant correlation
7493024	haplotype
7493024	recurrent mutations
7493024	mutation carriers
7493024	brca1
7493024	ovarian cancer incidence
7493024	ovarian cancer
7493024	breast cancer
7493024	common ancestors
7493024	different mutations
7493024	% lifetime risk
7493024	previous data
7493024	genotype-phenotype correlation
10767347	affected
10767347	expansion mutations
10767347	cell death
10767347	homozygous deletions
10767347	mouse model
10767347	milder phenotype
10767347	knockout models
10767347	pathological changes
10767347	residual frataxin expression
10767347	frda
10767347	inactivation
10767347	frataxin knockout mouse
10767347	yeast
10767347	early embryonic lethality
10767347	common autosomal recessive ataxia
10767347	human tissues
10767347	homozygous intronic expansions
10767347	friedreich
10767347	patient heart biopsies
10767347	surprisingly
10767347	mitochondrial protein
10767347	frataxin defect causes
10767347	embryonic resorption
10767347	gene product
10767347	ataxia mouse gene
10767347	embryonic lethality
10767347	biochemical data
10767347	early development
10767347	specific iron-sulfur protein deficiency
10767347	important role
1301189	positive control
1301189	cos-1
1301189	sequencing
1301189	tsd
1301189	disease mutation
1301189	cos
1301189	protein environment
1301189	mammalian expression vector
1301189	eco rv
1301189	ser
1301189	normal alpha-cdna
1301189	tay-sachs
1301189	pcr
1301189	gly269
1301189	mutation occurs
1301189	cdna construct
1301189	cotransfection
1301189	beta-cdna expression vector
1301189	cdna fragments
1301189	causes juvenile-onset
1301189	control values
1301189	mutant alpha-cdna
1301189	> aspartate substitution
1301189	mock transfection
1301189	abstract truncated at
1301189	mutation introduces
1301189	hex
1301189	cell activity
1301189	lebanese-maronite
1301189	lebanese-canadian
1301189	restriction enzyme
1301189	g250d
1301189	words
1301189	wild-type counterpart
1301189	residual activity
1301189	dna
1301189	20-fold increase
1301189	enzymatic activity
1301189	new recognition site
8252631	adenomatous polyposis coli patients
8252631	ocular fundus lesions
8252631	different allelic manifestations
8252631	chrpe
8252631	apc
8252631	specific subgroup
8252631	restriction
8252631	causes adenomatous polyposis coli
8252631	colorectal cancer
8252631	tumor suppressor gene
8252631	ocular
8252631	mutation occurs
8252631	phenotypic expression
8252631	retinal pigment epithelium
8252631	specific families
8252631	congenital hypertrophy
8252631	associates characteristic patches
7759076	hereditary breast
7759076	d17s776
7759076	fallopian tube
7759076	genetic recombinant
7759076	primary peritoneal cancer
7759076	chromosome 17q12-q21
7759076	canadian families
7759076	overall evidence
7759076	canadian breast
7759076	brca1-linked
7759076	breast-ovarian cancer families
7759076	linkage
7759076	brca1
7759076	ovarian cancer
7759076	breast cancer
7759076	malignant melanoma
7759076	breast-ovarian cancer family
7759076	cancer susceptibility gene
1248000	close relatives
1248000	heterozygous carrier
1248000	random sample
1248000	heterozygous
1248000	individual carriers
1248000	a-t
1248000	general population
1248000	clinical criterion
1248000	laboratory test
1248000	basal cell
1248000	malignant neoplasms
1248000	malignant neoplasm
1248000	cervical carcinomas
1248000	malignant
1248000	ataxia-telangiectasia
1248000	heterozygotes
1248000	autosomal recessive syndrome
1248000	biliary system carcinomas
2309142	mutant allele
2309142	pku
2309142	mutant haplotype
2309142	pcr-amplified dna
2309142	pah
2309142	normal haplotype
2309142	genetic disorder
2309142	rflp
2309142	transition causes
2309142	molecular
2309142	nonsense mutation
2309142	phenylketonuria
2309142	hungarian pku
2309142	europe
2309142	arg243
2309142	hepatic phenylalanine hydroxylase
2309142	specific mutations
2309142	new molecular lesion
2309142	asians
2309142	termination codon
2309142	mutational event
2309142	europeans
2309142	c-to-t
2309142	geographic distribution
2309142	phenylalanine hydroxylase gene
2309142	linkage disequilibrium
8575748	amino acid identity
8575748	nucleotide level
8575748	homologue cdna clones
8575748	f1
8575748	distal mouse chromosome
8575748	sequence variant
8575748	mouse homologue
8575748	northern analyses
8575748	ring
8575748	isolation
8575748	mus
8575748	brca1
8575748	large part
8575748	hereditary human breast
8575748	ovarian cancer
8575748	czech ii
8575748	human chromosome
8575748	sequence analysis
8575748	finger gene
8575748	mouse models
8575748	p1
8575748	mouse chromosome
8575748	m. musculus
8575748	dna
8575748	intersubspecific backcross
8575748	c57bl/ksj
6783144	complement hemolytic
6783144	meningococcal meningitis
6783144	serum
6783144	c6
6783144	hemostatic abnormalities
6783144	appropriate amounts
6783144	haemostasis abnormality
6783144	human deficiency
6783144	bactericidal activities
1346773	segregation analysis
1346773	additional marker
1346773	timp
1346773	dxs14
1346773	linkage data
1346773	dxs7
1346773	theta =
1346773	loci distal
1346773	hoatl1
1346773	dxs146
1346773	chromosomal region
1346773	oatl1
1346773	marker locus
1346773	loci proximal
1346773	xpter-dxs7-timp-
1346773	xp
1346773	locus maps
1346773	was
1346773	wiskott-aldrich
1346773	dxs255
1346773	loci order
1346773	short arm
318684	escherichia
318684	transitory elevation
318684	hemolytic activities
318684	anti-c3 activity
318684	properdin
318684	c4
318684	c5
318684	c9
318684	candida
318684	skin rash
318684	infectious agent
318684	total hemolytic complement activity
318684	hereditary
318684	complement components
318684	cobra venom factor
318684	fifty-second day
318684	clq
318684	c3b-ina
318684	normal rate
318684	protein
318684	34-month-old male
318684	autosomal codominance
318684	whole blood
318684	generate neutrophil chemotactic factors
318684	c1
318684	c3
318684	family members
318684	crp
318684	ml 1-hour-old
318684	normal whole blood
318684	normal immune adherence activity
318684	e.
318684	factor b
318684	whole blood transfusion
318684	undetectable levels
2544995	chromosome
2544995	sequences
2544995	chromosome translocation identifies
2544995	multiple species
2544995	chromosomal localization
2544995	wilms
2544995	genitourinary abnormalities
2544995	an2
2544995	cloning
2544995	sizable deletion
2544995	wagr
2544995	mental retardation
2544995	comparison
2544995	phage restriction maps exclude
2544995	familial aniridia
10923035	missense mutation
10923035	sscp
10923035	italian pedigrees
10923035	candidate gene
10923035	italian
10923035	infantile convulsions
10923035	candidate region
10923035	ivs5-10c
10923035	neurological abnormalities
10923035	benign
10923035	australian
10923035	gefs
10923035	benign familial
10923035	febrile seizures
10923035	ivs5
10923035	caucasian bfic
10923035	+ 30g >
10923035	patients
10923035	scn1b
10923035	europe
10923035	bfic
10923035	sodium channel beta1 subunit gene
10923035	subunit gene
10923035	infantile convulsions syndrome
10923035	+ phenotype
10923035	sodium channel beta
10923035	rare autosomal dominant epilepsy syndrome
10923035	exon variants
10923035	chromosome 19q
7696601	disease
7696601	expansion
7696601	mri
7696601	dm
7696601	early estimate
7696601	brain disease
7696601	molecular defect
7696601	molecular basis
7696601	cognitive test deficits
7696601	brain involvement
7696601	performance
7696601	white matter lesions
7696601	molecular findings
7696601	extensive cognitive
7696601	psychometric performance
7696601	quantification
7696601	cognitive dysfunction
7696601	strong correlation
7696601	molecular analysis
7696601	abnormal
7696601	amplification
7696601	myotonic dystrophy
7696601	cognitive tests
7696601	repeat size
7696601	cerebral atrophy
7696601	ctg
7696601	magnetic resonance
10528853	life insurance
10528853	us $
10528853	extensive multiplex
10528853	different polymorphic variants
10528853	current lack
10528853	inexpensive system
10528853	pcr
10528853	brca1
10528853	clinical setting
10528853	manual technique
10528853	quantitative data
10528853	dimensional electrophoresis
10528853	uncertain clinical value
10528853	positive test result
10528853	high frequency
10528853	hereditary breast
10528853	rapid accrual
10528853	high risk women
10528853	ovarian cancer syndrome
10528853	gene mutational
10528853	genotype-phenotype associations
10528853	widespread use
10528853	low cost test
10083733	sscp
10083733	reverse transcription-polymerase chain reaction
10083733	mutant allele
10083733	mutation detection rate
10083733	rna
10083733	nineteen
10083733	detect germline mutations
10083733	single-strand conformation polymorphism
10083733	protein truncation test
10083733	detectable mutations
10083733	apc
10083733	aberrant bands
10083733	ptt
10083733	korean
10083733	korean fap
10083733	fap
10083733	mutational spectrum
10083733	germline
10083733	familial adenomatous polyposis
10083733	germline adenomatous polyposis coli
10083733	rt-pcr
10083733	dna
10083733	gene mutations
10083733	familial adenomatous polyposis patients
10842298	euro j hum genet
10842298	syndrome region
10842298	lebanese
10842298	intriguingly
10842298	omax
10842298	d8s270
10842298	clinical entity
10842298	distinctive facial appearance
10842298	d8s267
10842298	mental retardation
10842298	coh1
10842298	hypotonia
10842298	novel genetic entity
10842298	maximum two-point
10842298	lod
10842298	zmax
10842298	fact encourages
10842298	homozygosity
10842298	d8s514
10842298	kolehmainen
10842298	clinical diagnosis
10842298	chorioretinal dystrophy
10842298	gene region overlaps
10842298	8-cm region
10842298	gene region
10842298	progressive postnatal growth deficiency
10842298	cohen
10842298	chromosome band
10842298	= 3..
2835825	hprt
2835825	mutant gene suggests
2835825	unusual patient
2835825	reversion event involves
2835825	lesch-nyhan
2835825	mild symptoms
2835825	spontaneous
2835825	original mutation
2835825	precise duplication
2835825	molecular
2835825	gene rearrangement
2835825	gene duplication
2835825	internal duplication
2835825	unequal crossing-over event
2835825	epstein-barr
2835825	selective medium
2835825	mutant gene
2835825	spontaneous somatic reversion
2835825	+ revertants
7422429	renal function
7422429	dialysis beginning
7422429	tf
7422429	renal failure
7422429	wiskott-aldrich
7422429	renal disease
7422429	nephropathy
7422429	progressive renal failure
7422429	additional patient
7422429	renal failure occurs
7795596	disease segregates
7795596	inappropriate chromatin environment
7795596	open reading frame
7795596	aniridia pedigrees
7795596	cytogenetic rearrangements
7795596	evidence suggests
7795596	chromosomal rearrangements
7795596	chromosomal breakpoint
7795596	normal expression
7795596	position effect
7795596	kb distal
7795596	mutant phenotype
7795596	pax6
7795596	current
7795596	yac
7795596	aniridia-associated
7962532	missense mutation
7962532	plasma cholesteryl ester
7962532	position +
7962532	d442g
7962532	general population
7962532	novel intron
7962532	dominant expression
7962532	splice donor site mutation
7962532	furthermore
7962532	cetp
7962532	hdl-c
7962532	heterozygote frequencies
7962532	major determinant
7962532	restriction map modification
7962532	null allele
7962532	strand conformational polymorphism analysis
7962532	japanese men
7962532	gly
7962532	protein deficiency
7962532	mutation acts
7962532	pcr
7962532	n =
7962532	hdl
7962532	int14
7962532	allele frequencies
7962532	subjects
7962532	int14 t
7962532	high density lipoprotein cholesterol
7962532	genetic compound heterozygote
7962532	japan
7962532	cholesteryl ester
7962532	genetic
7962532	null mutations
7962532	homozygous state
7962532	prevalent mutations
7962532	-to-a mutation
7962532	general sample
7962532	genetic deficiency state
7962532	significant fraction
7962532	dna
7962532	asp442
7962532	exon14/intron14 boundary
7962532	total variance
7962532	defective allele
3377761	kinetic
3377761	substrate analogues
3377761	x-linked
3377761	homozygous mutants
3377761	wild type
3377761	mus
3377761	hemizygous
3377761	isoelectric point
3377761	g6pd
3377761	nadp
3377761	relative utilization
3377761	x-linked g6pd
3377761	glucose-6-phosphate dehydrogenase
3377761	animal model
3377761	glucose-6-phosphate dehydrogenase deficiency
3377761	tissue extracts
3377761	km
3377761	wild types
3377761	thermal stability
3377761	electrophoretic migration
3377761	male mice
3377761	show differences
3377761	activity alteration
3377761	erythrocyte
10798358	transcription initiation site
10798358	donor site
10798358	human glycine decarboxylase gene
10798358	furthermore
10798358	translation initiation triplet
10798358	acceptor sites adhere
10798358	glycine decarboxylase gene
10798358	structural
10798358	large deletion
10798358	pcr
10798358	variant form
10798358	in-born error
10798358	human liver
10798358	control subjects
10798358	severe neurological disturbance
10798358	nonketotic hyperglycinemia
10798358	mutations
10798358	nkh
10798358	psigldc gene
10798358	gene spans
10798358	gt-ag
10798358	internal control
10798358	bp upstream
10798358	gc
10798358	gldc
10798358	exons
10798358	molecular analysis
10798358	polymerase chain reaction
10798358	% homology
10798358	gt
10798358	large homozygous deletion
10798358	rna
8589721	growth retardation
8589721	sporadic breast
8589721	retroviral vector
8589721	mutant brca1
8589721	nude mice
8589721	peritoneal treatment
8589721	breast cancer cells
8589721	tumour inhibition
8589721	mcf-7
8589721	inhibits tumour growth
8589721	ovarian cancer cell growth
8589721	brca1
8589721	ovarian cancer
8589721	inherited
8589721	ovarian cancer cell lines
8589721	lung cancer cells
8589721	gene inhibits growth
126380	striking
126380	hitherto
126380	genetic marker
126380	epidemiologic studies
126380	evaluation
126380	healthy subjects
126380	w27-negative
126380	indentification
126380	positive males
126380	27w-positive blood donors
126380	hl-a
126380	ankylosing
126380	postal questionnaires
126380	cent chance
126380	true prevalence
126380	susceptible persons
126380	pelvic radiography
126380	hl-a w27
7663517	hereditary breast
7663517	rapid
7663517	breast and/or ovarian cancer families
7663517	ptt
7663517	novel mutations
7663517	rt-pcr
7663517	combined
7663517	small deletions
7663517	brca1-linked
7663517	brca1
7663517	nonsense mutation
7663517	furthermore
7663517	valuable technique
7663517	nucleotide insertions
7663517	ovarian cancer gene
7663517	rna
7663517	protein truncation test
1376553	new variant
1376553	restriction endonuclease cleavage site
1376553	following segregation
1376553	plp
1376553	pelizaeus-merzbacher
1376553	sequence defect
1376553	haeiii
1376553	pmd
1376553	amino acid
1376553	one-hundred-ten
1376553	proteolipid protein
1376553	rare mutation
7390473	biochemical polymorphism
7390473	fayoum-like
7390473	corinth-like
7390473	bulgarian
7390473	bulgaria
7390473	petrich
7390473	mediterranean
7390473	panay
7390473	kilgore
7390473	ten
7390473	boston
7390473	g6pd
7390473	poznan
7390473	gotze delchev
7390473	new variants
7390473	erythrocyte glucose-6-phosphate dehydrogenase
7390473	variants
7390473	ohut ii
10381492	null allele
10381492	missense mutation
10381492	null mutation
10381492	c282y
10381492	mutation results
10381492	mutation deletes
10381492	homozygosity
10381492	murine hemochromatosis gene
10381492	mice
10381492	targeted
10381492	large portion
10381492	mutation accumulate
10381492	mutation introduces
10381492	hfe
10381492	hereditary hemochromatosis
10381492	normal controls
10381492	interestingly
2209091	corresponding cosmid
2209091	current maximal lod score
2209091	identify hybrid cell lines
2209091	ataxia locus
2209091	d9s15
2209091	physical
2209091	disease locus
2209091	theta =
2209091	frda
2209091	hybrid cell panels
2209091	situ location
2209091	human chromosome
2209091	mct112
2209091	mj1
2209091	linkage analysis
2209091	friedreich
2209091	recombination fraction
2209091	physical assignment
2209091	regional localisation
2209091	situ hybridisation
2209091	dr47
2209091	d9s5
2209091	variable heterochromatin region
10470286	missense mutation
10470286	functional domain
10470286	amino acid substitutions
10470286	gtt
10470286	leu
10470286	polymerase
10470286	phe
10470286	ala
10470286	human tumor cell lines
10470286	ttc
10470286	gln
10470286	gaa
10470286	human neurofibrosarcomas
10470286	solid tumors
10470286	little
10470286	mxi1
10470286	potential tumor suppressor gene
10470286	chain reaction-single-strand conformation polymorphism
10470286	glu
10470286	lys
10470286	gtg
10470286	gly
10470286	myc
10470286	distinct polymorphisms
10470286	soft tissue tumors
10470286	gca
10470286	pcr-sscp
10470286	neurofibrosarcoma patient
10470286	ctc
10470286	val
10470286	caa
10470286	missense
10470286	various types
10470286	aaa
10470286	missense mutations
10470286	gcg
10470286	esophageal cancers
10470286	intron-exon boundary upstream
10470286	hlh
10470286	gga
10470286	gta
10470286	gct
10470286	human gastric cancers
7833921	primary structure
7833921	high level
7833921	structural gene
7833921	additional conservative amino acid
7833921	enzyme catalyses
7833921	full-length cdna clones
7833921	alternative
7833921	molecular basis
7833921	val49iie
7833921	molecular
7833921	gly40arg
7833921	direct
7833921	sequence conservation
7833921	dietary fructose
7833921	mutations result
7833921	human ketohexokinase
7833921	benign condition
7833921	mutational analysis
7833921	hepatic fructokinase
7833921	compound heterozygotes
7833921	essential fructosuria
7833921	inborn errors
7833921	khk
7833921	essential
7833921	early recognition
7833921	mrna species
7833921	alternative polyadenylation
7833921	ala43thr
7833921	ala43th
7833921	e. c.
7833921	control individuals
10449794	loss
10449794	ionizing
10449794	therapeutic intervention
10449794	gene product
10449794	a-t
10449794	ros
10449794	mechanistic basis
10449794	ataxia-telangiectasia gene product causes oxidative damage
10449794	oxidative damage
10449794	purkinje
10449794	ataxia-telangiectasia
10449794	radiation oxidizes macromolecules
10449794	reactive oxygen species
10449794	animal model
10449794	pathologic changes
10449794	target organs
10449794	rational foundation
10449794	atm-deficient
10449794	atm
10449794	causes tissue damage
6604602	segregation analyses
6604602	phenotypic expressions
6604602	family studies
6604602	intestinal bacteria
6604602	hla b27
6604602	clinical sub-types
6604602	multifactorial etiology
6604602	clinical
6604602	's syndrome
6604602	inflammatory bowel disease
6604602	different genetic factors interact
6604602	psoriatic arthropathy
6604602	acute anterior uveitis
6604602	bechterew
6604602	environmental
6604602	radiographical examinations
6604602	degree relatives
6604602	hereditary multifocal relapsing inflammation
6604602	peripheral arthropathy
6604602	hemri
6604602	different genetic predispositions
6604602	disease susceptibility
6604602	iii
6604602	hla
6604602	ankylosing
6604602	genetics
6604602	radiographical
6604602	descriptive name
6604602	positive relatives
1315306	recent
1315306	pdeb
1315306	gene order
1315306	corresponding mouse
1315306	mouse homologue
1315306	retinal degeneration mouse
1315306	hd
1315306	human genes
1315306	disease region
1315306	chromosome
1315306	rod photoreceptor cgmp phosphodiesterase beta-subunit gene
1315306	tight linkage
1315306	chromosome locations
1315306	huntington
1315306	comparative map
1315306	rd mouse
1315306	nonsense mutation
1315306	human hereditary retinopathies
1315306	humans shows
1315306	cm distal
1315306	mgsa
1315306	animal model
1315306	pde
1315306	analysis
1315306	human gene
1315306	mouse chromosome
1315306	beta-subunit gene
1315306	possible sites
1315306	linkage
1315306	backcross analysis
1315306	certain forms
1315306	gene symbol
777027	biological properties
777027	escherichia
777027	siblings serum
777027	chemotactic activity
777027	study examines
777027	critical role
777027	bactericidal activity
777027	c5
777027	bakers yeast
777027	human serum
777027	staphylococcus
777027	c5-deficient
777027	candida
777027	normal serum concentrations
777027	saccharomyces
777027	normal chemotactic scores
777027	c5d
777027	sucrose hemolysia
777027	sera
777027	biological
777027	coli endotoxin
777027	normal neutrophils
777027	probands serum
777027	findings underscore
777027	hereditary
777027	human gamma-globulin
777027	ii
777027	serum dilutions
777027	normal human neutrophils
777027	s.
777027	normal levels
777027	generate chemotactic activity
777027	healthy half-sister
777027	normal phagocytosis
777027	family members
777027	paroxysmal nocturnal hemoglobinuria
777027	inactive systemic lupus erythematosus
777027	hereditary deficiency
777027	acid hemolysis tests
777027	salmonella
777027	minimal role
777027	cytolytic reactions
10807793	peripheral blood leukocytes
10807793	monocytic differentiation
10807793	myeloid-specific promoters
10807793	granulocytic lineage
10807793	myelocyte stage
10807793	rna
10807793	hl60
10807793	il
10807793	il-10
10807793	fmf
10807793	lineage commitment
10807793	tumor necrosis factor
10807793	tissue specificity
10807793	reverse transcriptase-polymerase chain reaction
10807793	situ hybridization
10807793	mediterranean
10807793	serosal inflammation
10807793	mature neutrophils
10807793	growth factor beta
10807793	early leukocyte development
10807793	inflammatory mediators
10807793	upstream regulatory regions
10807793	prepromyelocytic cell line
10807793	results refine understanding
10807793	ifn-alpha
10807793	familial mediterranean
10807793	previous studies
10807793	thp-1
10807793	u937
10807793	antiinflammatory cytokines interleukin
10807793	mefv
10807793	bone marrow leukocytes
10807793	normal function
10807793	cd34
10807793	inflammatory promoter elements
10807793	vitro stimulation
10807793	hematopoietic stem-cell cultures
10807793	ifn
10807793	such expression
10807793	induction
10807793	differential expression
10807793	ifn-gamma
10807793	monocytic cell lines
10807793	consistent
10807793	proinflammatory agents interferon
10807793	recessive disorder
10807793	myelomonocytic-specific proinflammatory pathway
10807793	inflammatory regulator
10556283	spectrum
10556283	atp-dependent
10556283	editing mutations
10556283	swi/snf
10556283	homozygous deletions
10556283	point mutations
10556283	human cancer
10556283	new tumor suppressor gene
10556283	aggressive cancers
10556283	genotype-phenotype correlations
10556283	hsnf5/ini1 gene
10556283	various origins
10556283	choroid plexus carcinomas
10556283	splice site
10556283	hsnf5/ini1 mutations
10556283	common pathogenetic origin
10556283	point alterations
10556283	hsnf5/ini1 point mutations
10556283	mutations
10556283	young children
10556283	malignant rhabdoid tumors
10556283	recurrent
10556283	common pathways
10556283	tumor types
10556283	homogeneous family
10556283	high-performance liquid chromatography
10556283	hsnf5/ini1 alteration
10556283	rhabdoid phenotyp
10556283	hsnf5/ini1 alterations
10556283	rhabdoid tumors
10556283	central primitive neuroectodermal tumors
10556283	wilms
10556283	hsnf5/ini1 somatic mutations
10556283	breast cancers
624546	autochtonous variants
624546	kabyle
624546	strikingly
624546	heterogeneity
624546	titteri
624546	mediterranean
624546	algiers
624546	g6pd
624546	multiple geographic regions
624546	gd
624546	deficient subjects
624546	blida
624546	thenia
624546	different variants
624546	alger
624546	berber-kabyle
624546	glucose-6-phosphate dehydrogenase deficiency
624546	glucose-6-phosphate
624546	male population
624546	urban area
624546	red blood cell
624546	algeria
624546	laghouat
624546	deficient males
624546	new variants
1302032	ccg
1302032	fmr1
1302032	typical clinical
1302032	trinucleotide repeat fragment
1302032	fragile x
1302032	x-inactivation
1302032	homogeneous disorder
1302032	cytogenetic expression
1302032	submicroscopic deletion
10589394	vws
10589394	accurate size estimation
10589394	high penetrance
10589394	confirmation
10589394	cm region
10589394	disease mutation
10589394	specific alleles
10589394	candidate region
10589394	score analyses
10589394	variable expression
10589394	disease gene
10589394	autosomal dominant craniofacial disorder
10589394	caucasian vws
10589394	lip pits
10589394	different locations
10589394	possible unique origin
10589394	str
10589394	short tandem repeat
10589394	unique origin
10589394	lod
10589394	short tandem repeat markers
10589394	cleft lip and/or cleft palate
10589394	candidate gene region
10589394	high penetrance autosomal dominant model
10589394	marker allele fragment sizes
10589394	multipoint limit
10589394	alleles suggests
10589394	locus heterogeneity
10589394	woude
10589394	assay method
10589394	van
10589394	date map
10589394	possible heterogeneity
10589394	available members
7550349	reference individuals
7550349	ethnic origin
7550349	mutation stats
7550349	such individuals confer
7550349	major gene
7550349	high risk
7550349	breast and/or ovarian cancer
7550349	jewish breast/ovarian families
7550349	carrier frequency
7550349	185delag frameshift mutation
7550349	reference samples
7550349	unique mutations
7550349	high-risk families
7550349	brca1
7550349	ashkenazi
7550349	ovarian cancer
7550349	breast cancer
7550349	female carriers
7550349	ashkenazim
7550349	% lifetime risk
7550349	% risk
7550349	jewish individuals
7550349	% confidence limit
7550349	following
7550349	185delag mutation
7550349	high-risk pedigrees
8460149	dramatic reduction
8460149	generate mice
8460149	human hypobetalipoproteinemia
8460149	plasma concentrations
8460149	mice
8460149	plasma triglyceride concentrations
8460149	high density lipoprotein cholesterol
8460149	apolipoprotein b gene results
8460149	targeted
8460149	coronary vascular disease
8460149	familial
8460149	apob
8460149	apob protein
8460149	mice manifest
8460149	autosomal codominant disorder
8460149	allele display
8460149	developmental abnormalities
10398279	germline mutations
10398279	jewish men
10398279	mutant allele
10398279	common germline mutations
10398279	hereditary breast cancer
10398279	4-5-fold increase
10398279	prostate cancer patients
10398279	ovarian cancers
10398279	jewish population
10398279	brca2
10398279	prostate cance
10398279	conclusions
10398279	prostate cancer
10398279	methods
10398279	brca1
10398279	ashkenazi
10398279	young age
10398279	jewish prostate cancer patients
10398279	common mutations
10398279	background families
10398279	early prostate cancer
10398279	results
10398279	high incidence
10398279	% confidence interval
10398279	predispose men
10398279	common germline mutation
10398279	male relatives
10398279	dna
3565372	medical observation
3565372	hereditary non-spherocytic hemolytic anemia
3565372	glucose-6-phosphate dehydrogenase
3565372	new deficient variants
3565372	g6pd huron
3565372	objective improvement
3565372	g6pd wayne
3565372	hereditary nonspherocytic hemolytic anemia
3565372	g6pd
3565372	sporadic variants
3565372	special racial predilection
3565372	underwent splenectomy
3565372	considerable period
3565372	new variants
3565372	patients
3565372	hnsha
3565372	northern european origin
6650504	jews
6650504	near
6650504	a. d.
6650504	tsd
6650504	incidence data
6650504	russian ancestry
6650504	diaspora
6650504	north american jewish populations
6650504	carrier frequencies
6650504	major migrations
6650504	disease gene
6650504	eastern origins
6650504	carrier frequency
6650504	tay-sachs
6650504	geographic variations
6650504	czechoslovakian
6650504	relative
6650504	ashkenazi jewry
6650504	polish
6650504	austrian
6650504	a. d
6650504	russia
6650504	jewish individuals
6650504	poland
6650504	such data
6650504	russian origins
6650504	twofold increase
6650504	hungarian
8533757	founder mutation 185delag
8533757	single-strand conformation analysis
8533757	novel nonsense mutations
8533757	male carrier
8533757	mutation
8533757	negative lod scores
8533757	665-nt segment
8533757	brca2
8533757	jewish descent
8533757	positive lod scores
8533757	brca1
8533757	overall
8533757	ashkenazi
8533757	ovarian cancer
8533757	breast cancer
8533757	thirty-seven
8533757	novel
8533757	multiple sporadic breast cancers
8533757	variable expressivity
8533757	genomic sequence
8533757	polymorphic markers
8533757	prostatic cancer
8533757	expressivity
8533757	different germ-line mutations
8533757	putative promoter region
8533757	coding-sequence mutations
8533757	early-onset breast cancer
8533757	lod scores
8533757	185delag mutation
8533757	jewish families
10767343	transgenic
10767343	dramatic expansions
10767343	high level
10767343	furthermore
10767343	large human genomic sequences
10767343	strong bias
10767343	repeat instability
10767343	large human
10767343	different factors
10767343	transgenic mice
10767343	different sizes
10767343	patients exhibit somatic mosaicism
10767343	successive generations
10767343	big jumps
10767343	dmpk
10767343	repeat expansion
10767343	large amplification
10767343	size-dependent characteristics
10767343	somatic instability
10767343	myotonic
10767343	protein kinase
10767343	repeat intergenerational
10767343	repeat mimic
10767343	congenital forms
10767343	ctg
10767343	dm ctg
10767343	dm
133535	blood groups
133535	major histocompatibility
133535	w24
133535	c2
133535	fu
133535	hodgkins
133535	w18
133535	bf
133535	clinical manifestations
133535	sd2
133535	close
133535	type 7a
133535	factor b polymorphism
133535	linkage
133535	electrophoretic variation
133535	ld
133535	family study
133535	hl-a
133535	c2-deficient
133535	mhc
10051007	subtle differences
10051007	normal repeat length
10051007	age
10051007	clinical information
10051007	apolipoprotein e
10051007	likely candidate
10051007	apoe
10051007	genotyping
10051007	huntington
10051007	specific effects
10051007	male patients
10051007	ao
10051007	cag
10051007	alzheimer
10051007	specific influence
10051007	epsilon2epsilon3 genotype
10051007	neurological diseases
10051007	hd
10051007	repeat length
10051007	sex difference
1978564	recombination
1978564	colorectal carcinomas
1978564	small region
1978564	apc
1978564	ef5
1978564	presymptomatic diagnosis
1978564	44-yn5 44-yn5
1978564	two-point linkage analysis support
1978564	chromosome 5q
1978564	present study suggests
1978564	62-apc-ef5 62-apc-ef5
1978564	linkage map
1978564	48-telomer e
1978564	linkage analysis
1978564	high-density map
1978564	genetic
1978564	ecb27-l5
1978564	fap
1978564	sporadic colorectal cancer
1978564	l5
1978564	familial adenomatous polyposis
1978564	crucial recombination events
1978564	dna
1978564	genetic heterogeneity
1978564	locus order
1978564	genetic linkage map
1978564	yn5
1978564	centromere-pi 227-c11p11-ecb27-l5
8370681	perturb cleavage
8370681	variable levels
8370681	diabetes insipidus
8370681	detection
8370681	molecular basis
8370681	signal peptide
8370681	dominant neurohypophyseal diabetes insipidus
8370681	arginine vasopressin
8370681	novel arginine vasopressin defect
8370681	autosomal
8370681	new method
8370681	familial form
8370681	dna
8370681	precursor protein
8370681	avp
8370681	novel defect
8370681	autosomal dominant neurohypophyseal diabetes insipidus
8259519	mutations
8259519	gene product
8259519	apc
8259519	e-cadherin-associated
8259519	tumor initiation
8259519	tumor suppressor protein
8259519	15-amino acid repeat
8259519	27-residue fragment
8259519	human colorectal cancer
8259519	proteins alpha-
8259519	cell adhesion
8259519	nucleotide sequence analysis
8259519	cellular proteins
8259519	important link
2703233	zmax
2703233	c2
2703233	netherlands
2703233	maximum lod score
2703233	tight
2703233	apoc2
2703233	myotonic
2703233	myotonic dystrophy
2703233	myotonic dystroph
2703233	creatine kinase muscle type
2703233	genetic linkage
2703233	canada
2703233	muscle-type creatine kinase
2703233	useful marker
2703233	recombination frequency
2703233	myotonic dystrophy families
2703233	dm
2703233	ckmm
7767095	genotype-phenotype correlations
7767095	repeat number analysis
7767095	discordant
7767095	observation strengthens
7767095	clinical outcome
7767095	clinical manifestations
7767095	myotonic dystrophy
7767095	childhood onset
7767095	myotonic dystrophy relatives
7767095	n >
7767095	ctg
7767095	early severe childhood
7767095	dm
10554035	med
10554035	recently
10554035	j. hum
10554035	germline mutations
10554035	vhl
10554035	w. m. linehan
10554035	k. kinzler
10554035	germline mosaicism
10554035	research group
10554035	genetic basis
10554035	genet.
10554035	j. med
10554035	retinal hemangioblastomas
10554035	harbor point mutations
10554035	constitutional deletions
10554035	chromosome 3p25-26
10554035	human cancer
10554035	endolymphatic sac tumors
10554035	pancreatic cysts
10554035	am
10554035	clinical
10554035	germline deletions
10554035	constitutional
10554035	situ hybridization
10554035	epididymal cystadenomas [
10554035	jr.
10554035	b. zbar
10554035	f. latif
10554035	fish
10554035	renal cell carcinomas
10554035	single-strand conformation
10554035	washington dc
10554035	reliable method
10554035	e. a. maher
10554035	gene deletions
10554035	c. stolle
10554035	tumor types
10554035	mcgraw-hill
10554035	japan
10554035	hum
10554035	j. m. whaley
10554035	b. vogelstein
10554035	hippel-lindau
10554035	medicine
10554035	cancer syndrome
10554035	surv.
10554035	e. r. maher
10554035	p1
10554035	central nervous system
10554035	w. g. kaelin
10554035	r. d. klausner
10554035	germline
10554035	gene abnormalit
10554035	assoc.
10554035	baltimore
10554035	mol
10554035	mutat.
10554035	f. chen
10554035	present study
7481765	ovarian cancer lines
7481765	nuclear phosphoprotein
7481765	gene product
7481765	malignant effusions
7481765	aberrant subcellular location
7481765	histological sections
7481765	breast cancer biopsies
7481765	absence
7481765	brca1
7481765	breast ductal epithelial cells
7481765	aberrant
7481765	breast cancer
7481765	subcellular localization
7481765	normal cells
7481765	breast cancers
7481765	tumor cell lines
7481765	variable extent
107868	ulcerative colitis
107868	inflammatory bowel disease
107868	first-degree relatives
107868	as
107868	b27
107868	peripheral psoriatic arthritis
107868	genetic heterogeneity
107868	positive males
107868	twenty-five
107868	hla b27
107868	sero-negative peripheral arthritis
107868	environmental event
107868	negative patients
107868	positive fathers
7858169	lysosomal enzyme
7858169	pd
7858169	late
7858169	infantile metachromatic leukodystrophy
7858169	autosomal recessive trait
7858169	metachromatic leukodystrophy
7858169	mld
7858169	different mutations
7858169	habbanite jews
7858169	small jewish isolate
7858169	knowledge
7858169	point mutation c >
7858169	splice donor site
7858169	different ethnic groups
7858169	aryl
7858169	high incidence
7858169	israel
7858169	arsa
7858169	molecular analysis
7858169	moslem arabs
7858169	clinical effect
7858169	habbanite
7858169	jerusalem
7858169	neurodegenerative disease
7858169	arabs
10982189	different germline
10982189	hereditary colorectal cancer syndrome familial adenomatous polyposis
10982189	genomic
10982189	single-nucleotide alterations
10982189	intragenic rearrangement
10982189	apc
10982189	genomic rearrangements
10982189	tumor-suppressor gene result
10982189	mutation detection methods
10982189	nonhomologous recombinations
10982189	tumor-suppressor gene
10982189	alu
10982189	small deletions
10982189	mutations suggests
10982189	partial deletion
10982189	fap
10982189	germline
10982189	familial adenomatous polyposis
10982189	dna
10982189	protein product
10982189	small insertions
10982189	mutation analysis
10982189	adenomatous polyposis coli
10982189	frequent germline
8075631	chromosome 17q
8075631	additional pedigrees
8075631	hereditary breast
8075631	early-onset breast cancer
8075631	lod score-16
8075631	familial
8075631	genetic basis
8075631	breast
8075631	strong evidence
8075631	brca1
8075631	ci
8075631	identification
8075631	ovarian cancer locus
8075631	male breast cancer
8528200	expansions intermediate
8528200	displays inter-generational instability
8528200	pyramidal signs
8528200	mjd1
8528200	pathologic expansion
8528200	cag
8528200	common founders
8528200	inter-generational instability
8528200	hd
8528200	novel observations
8528200	markers amongst
8528200	large repeats
8528200	caucasian
8528200	mjd
8528200	male meioses
8528200	[ e.g
8528200	p <
8528200	negative effect
8528200	huntington
8528200	share haplotypes
8528200	large cohort
8528200	fourth
8528200	normal range
8528200	disease phenotype
8528200	early age
8528200	clinical phenomenon
8528200	machado-joseph
8528200	evidence
8528200	r =
8528200	microsatellite markers
8528200	function effect
8528200	expansion fo
8528200	subject homozygous
8528200	n repeat array
3674116	diagnosis
3674116	normal chromosomes
3674116	physical findings
3674116	pws
3674116	chromosome studies
3674116	prader-willi
3674116	unusual familial occurrence
3674116	familial prader-willi
3674116	clinical findings
7759075	early onset breast and/or ovarian cancer
7759075	age
7759075	first-degree relatives
7759075	breast/ovarian cancer susceptibility locus
7759075	interim period
7759075	clinical management
7759075	breast-ovarian cancer families
7759075	logistical problems
7759075	familial breast cancer
7759075	breast and/or ovarian cancer
7759075	significant
7759075	dutch
7759075	founder effect
7759075	brca1
7759075	strong positive family history
7759075	ovarian cancer
7759075	low proportion
7759075	brca1 dna
7759075	intake cut-off
7759075	breast cancer families
7759075	linkage study
1999339	pvuii
1999339	population origin
1999339	biochemical characterization
1999339	g6pd castilla
1999339	nlaiii/foki/pvuii/psti
1999339	haplotype characteristic
1999339	g6pd a-
1999339	g6pd
1999339	mexican patients
1999339	spain
1999339	+ genotype
1999339	g6pd betica
1999339	ancient origin
1999339	distrito
1999339	europe
1999339	glucose-6-phosphate
1999339	g6pd tepic
1999339	africa
1999339	dna
1999339	mexican glucose-6-phosphate dehydrogenase variants
1999339	mexico
1999339	mexican males
10924409	common somatic mutation
10924409	germline mutations
10924409	early-onset colorectal cancer
10924409	general population
10924409	mutation
10924409	afap
10924409	genotype-phenotype correlation
10924409	benign colorectal tumors
10924409	apc
10924409	tumor-suppressor gene result
10924409	inactivation
10924409	mutations results
10924409	somatic inactivation
10924409	patients
10924409	somatic mutations
10924409	major tumor-suppressor function
10924409	typical patients
10924409	colorectal tumors
10924409	fap
10924409	germline
10924409	familial adenomatous polyposis
10924409	molecular genetic mechanism
10924409	adenomatous polyposis coli
10924409	functional
10924409	colorectal tumorigenesis
10924409	as9
10924409	germline mutant
1334370	strong candidate
1334370	aniridia patients
1334370	rare case
1334370	wagr
1334370	candidate aniridia gene
1334370	fluorescence
1334370	cosmid marker
1334370	mental retardation
1334370	horseshoe kidney
1334370	candidate marker
1334370	situ hybridization
1334370	cosmid probes
1334370	fish
1334370	strong potential
1334370	pax-6
1334370	cell lines
1334370	genitourinary abnormalities
1334370	clinical applications
1334370	reliable technique
1334370	wt1
1334370	an2
1334370	results support
1334370	aniridia candidate gene
1334370	molecular analysis
1334370	submicroscopic
1334370	wilms
1334370	novo aniridia cases
1334370	tumor predisposition gene
1334370	translocation breakpoints
8279472	normal haplotypes
8279472	important implications
8279472	d13s133
8279472	wnd
8279472	d13s314
8279472	show nonrandom distribution
8279472	haplotype
8279472	dna
8279472	dinucleotide repeat polymorphisms
8279472	d13s316
8279472	marker alleles
8279472	significant differences
8279472	mutation detection
8279472	ca
8279472	polymorphic markers
8279472	wilson
8279472	molecular diagnosis
8279472	disease gene
8279472	d13s315
8279472	northern european families
10541953	ventilatory output
10541953	stimulatory effect
10541953	central inspiratory drive
10541953	body composition
10541953	respiratory function
10541953	activity level
10541953	gh
10541953	pws
10541953	conclusion
10541953	growth hormone
10541953	growth hormone treatment increases
10541953	inspiratory drive
10541953	prader-willi
10541953	body mass index
10541953	ventilatory response
10541953	co
10541953	airway occlusion pressure
10541953	growth hormone therap
10541953	central respiratory structures
8522307	vhl
8522307	sporadic cystadenomas
8522307	thymine transition
8522307	tumor suppressor gene
8522307	intermediate molecular weight keratins
8522307	immunohistochemical studies
8522307	renal cell carcinoma
8522307	single-strand conformation polymorphism analysis
8522307	somatic
8522307	alpha 1-antitrypsin
8522307	papillary
8522307	positive immunohistochemical
8522307	amino acid
8522307	stop codon
8522307	metastatic renal cell carcinoma
8522307	direct
8522307	molecular genetic analyses
8522307	ema
8522307	hippel-lindau
8522307	cea
8522307	gene mutation
8522307	alpha 1-antichymotrypsin
8522307	authors describe
8522307	polymerase chain reaction
8522307	uncommon benign lesion
8522307	cam
8522307	ae1/ae3
8522307	clear cell papillary cystadenoma
8522307	gene mutations
7825586	susceptibility locus
7825586	% confidence interval
7825586	early-onset breast cancer
7825586	linkage consortium
7825586	genetic heterogeneity
7825586	chromosome region 17q12-q21
7825586	breast
7825586	linkage analysis
7825586	breast-ovarian cancer families
7825586	brca1
7825586	overall
7825586	ovarian cancer
7825586	breast-ovary cancer families
7825586	breast cancer
7825586	ovarian cancers
7825586	male breast cancer
7825586	dominant predisposition
7825586	large majority
4019732	vws
4019732	autosomal dominant mode
4019732	mutation
4019732	high penetrance
4019732	affected
4019732	general non-vws population
4019732	extreme phenotypes
4019732	lip pits
4019732	cleft
4019732	new pedigrees
4019732	extreme expression
4019732	lip
4019732	cleft lip
4019732	proband bias
4019732	year period
4019732	sex ratios
4019732	gene expression
4019732	oral cleft
4019732	relative risk
4019732	genetic background
4019732	literature show
4019732	gene carrier
4019732	different methods
4019732	clp
4019732	significant number
4019732	cleft palate
4019732	cp
4019732	genetic
4019732	differential fecundity
4019732	woude
4019732	target tissues
4019732	demarquay
4019732	van der
2491010	gmgx11
2491010	wapenaar
2491010	koenig
2491010	intermediate patients
2491010	endpoints
2491010	baumbach
2491010	present paper
2491010	intron/exon boundaries
2491010	intermediate patient
2491010	clinical
2491010	intermediate phenotype
2491010	molecular
2491010	severe phenotype
2491010	phenotypic analysis
2491010	dmd
2491010	eighty
2491010	becker
2491010	duchenne
2491010	bmd
2491010	muscular dystrophy
2491010	dxs239
2491010	major deletion-rich region
2491010	gene deletions
2491010	thirty-eight
2491010	genomic probes
2491010	deletion-rich region
2491010	recent findings
2491010	entire dystrophin cdna
2491010	independent patients
2491010	in-frame deletions
2491010	reading frame
2491010	malhotra
2491010	phenotypic severity
2491010	frameshift deletions
2491010	dxs269
10417279	dysmyelinating disease
10417279	male bias
10417279	k value
10417279	sharp contrast
10417279	investigating
10417279	three-generation families
10417279	plp
10417279	k =
10417279	proteolipoprotein
10417279	female germ cells
10417279	point mutations
10417279	x-linked
10417279	clinical
10417279	sporadic cases
10417279	significant male mutation imbalance
10417279	pelizaeus-merzbacher disease
10417279	plp-gene
10417279	gene analysis
10417279	equal mutation rate
10417279	network
10417279	chi2 =
10417279	male/female mutation frequency
10417279	maternal status
10417279	splice-site regions
10417279	carrier mothers
10417279	central nervous system
10417279	novo mutations
10417279	direct estimation
10417279	developmental defect
10417279	male germ cells
10417279	pmd
10417279	frequent abnormality
10417279	grandparental generations
2569949	exon sequences
2569949	northern european population
2569949	normal alleles
2569949	pku
2569949	haplotype distribution
2569949	turkish phenylketonuria families
2569949	haplotype
2569949	phenylalanine hydroxylase gene
2569949	polymorphic sites
2569949	different haplotypes
2569949	normal phenylalanine hydroxylase
2569949	pah
2569949	turkish phenylketonuria
7668252	control fibroblasts
7668252	human mitochondrial very-long-chain acyl-coenzyme
7668252	patients fibroblasts
7668252	rational design
7668252	quantitative
7668252	molecular characterization
7668252	cdna inserts
7668252	normal human
7668252	protein causes
7668252	cdna expression
7668252	pcr-amplified vlcad
7668252	40-amino acid leader peptide
7668252	important information
7668252	vlcad
7668252	cloning
7668252	normal control fibroblast activity
7668252	palmitic acid beta-oxidation flux
7668252	615-amino acid
7668252	cdna clones
7668252	vlcad-deficient
7668252	human very-long-chain acyl-coenzyme
7668252	105-bp deletion
7668252	entire protein
7668252	vaccinia viral system
7668252	amino acids
7668252	long-chain fatty acid beta-oxidation activity
7668252	patient fibroblasts
7668252	mature polypeptide
7668252	future somatic gene therapy
2601691	splice alterations
2601691	mutations
2601691	somatic mutations
2601691	precise errors
2601691	detect expression
2601691	mutant allele
2601691	gene product
2601691	polymerase chain reaction
2601691	rnase
2601691	protection assay
2601691	dna
2601691	rb
2601691	rb1
2601691	inactivation
2601691	nucleotide sequence
2601691	mutant transcripts
2601691	normal retinal development initiates
2601691	small deletion
2601691	point mutations
2601691	germ line mutations
1505982	pvuii
1505982	d11s323
1505982	original linkage results
1505982	maximum lod score
1505982	d2s71
1505982	haeiii
1505982	wagr
1505982	aniridia mutation
1505982	rflps
1505982	significant evidence
1505982	acp1
1505982	theta =
1505982	d2s1
1505982	aniridia family
1505982	autosomal dominant aniridia family
1505982	an1
1505982	aniridia phenotype
1505982	tests
1505982	distinct loci
1505982	d2s5
1505982	autosomal dominant aniridia
1505982	an2
1505982	acid phosphatase-1
1505982	lod score
1505982	resolution
1505982	chromosome 2p
1505982	markers
1505982	linkage
1505982	locus d11s325
1505982	contiguous gene syndrome
1505982	apob
1505982	chromosome 2p markers
3615198	pku
3615198	at
3615198	splice donor site mutation
3615198	pah
3615198	c-terminal
3615198	gene
3615198	molecular basis
3615198	protein instability
3615198	deletion abolishes
3615198	expression studies
3615198	classical phenylketonuria
3615198	human liver
3615198	cdna clones
3615198	splice donor site
3615198	hepatic phenylalanine hydroxylase
3615198	splice donor site causes
3615198	mutant chromosomal
3615198	human chromosomal
3615198	amino acids
3615198	autosomal recessive human genetic disorder
3615198	base pair deletion
3615198	deletion causes
3615198	gt
3615198	rna
10521293	interesting cases
10521293	molecular genetic analysis
10521293	novel mutations
10521293	clear-cut correlations
10521293	syndrome-carrier status
10521293	structural rearrangements
10521293	in-frame insertion
10521293	point mutations
10521293	clinical
10521293	syndrome kindreds
10521293	amino acid transmembrane protein
10521293	autosomal recessive neurodegenerative disorder
10521293	small sample size
10521293	progressive optic atrophy
10521293	nonsense mutations
10521293	direct dna
10521293	pathogenic mtdna mutations
10521293	genotype-phenotype relationships
10521293	obvious mutation
10521293	hot spots
10521293	compound heterozygotes
10521293	wolfram
10521293	diabetes mellitus
10521293	missense mutations
10521293	hence
10521293	in-frame deletions
10521293	wfs1
10521293	dna
10521293	mtdna deletions
10521293	juvenile-onset diabetes mellitus
10521293	wide spectrum
10521293	upstream exons
10521293	complete analysis
10521293	frameshift mutations
10521293	disease severity
10521293	psychiatric disorders
10521293	british kindreds
10521293	common founder mutation
10528860	mild developmental delay
10528860	jigsaw puzzles
10528860	maternal heterodisomy
10528860	normal appetite
10528860	pws
10528860	time precocious puberty
10528860	middle ear infections
10528860	prader-willi
10528860	high pain threshold
10528860	pws-like
10528860	robertsonian
10528860	uniparental disomy
10528860	motor development
10528860	xy
10528860	recurrent
10528860	sleep disturbance
10528860	chromosomal
10528860	great skill
10528860	normal karyotype
10528860	upd
10528860	behavioural problems
10528860	maternal
10528860	mild dysmorphic
10528860	dna
10528860	maternal uniparental disomy
10528860	intrauterine growth retardation
10528860	previous identification
7611277	sscp
7611277	potential difficulties
7611277	epidemiological evidence suggests
7611277	different families
7611277	male breast cancer
7611277	breast/ovarian cancer families
7611277	intra-abdominal carcinomatosis
7611277	prostate cancer
7611277	40-bp deletion
7611277	oligonucleotide hybridization
7611277	brca1
7611277	early onset familial breast cancer
7611277	ovarian cancer
7611277	breast cancer
7611277	sequence changes
7611277	detection
7611277	familial breast/ovarian cancer
7611277	direct detection
7611277	mutations
7611277	prophylactic oophorectomy
7611277	results suggests
7611277	genetic
7611277	frameshift mutation
7611277	male proband
7611277	missense mutations
7611277	dna
7611277	cancer susceptibility
7611277	wide array
7611277	control individuals
7611277	variant sscp
7611277	allele-specific
2729274	color
2729274	xq28
2729274	vision defects
2729274	observe contiguous gene defects
2729274	abnormal scores
2729274	visual pigment loci
2729274	test scores
2729274	amn
2729274	different alterations
2729274	abnormal color vision
2729274	farnsworth-munsell
2729274	hue
2729274	visual pigment genes
3169738	cdna probes
3169738	particular small group
3169738	patterns
3169738	cf56a
3169738	detect exons
3169738	becker
3169738	exon deletions
3169738	central part
3169738	dmd
3169738	muscular dystrophy
3169738	duchenne
3169738	bmd
3169738	deletions
3169738	cf23a
7951327	atp
7951327	deletion removes
7951327	lec
7951327	rat shows similarity
7951327	heavy metals
7951327	possible interaction
7951327	rat gene
7951327	gene homologous
7951327	animal model
7951327	wilson
7951327	atpase
7951327	copper transport
7951327	atp7b
7951327	partial deletion
7951327	disease gene
7951327	long-evans cinnamon
7951327	liver pathophysiology
8440142	xpter
8440142	dxs742-
8440142	novel sequence
8440142	dxs742
8440142	-dxs209-dxs148-dxs196- + + +
8440142	consensus genetic map
8440142	timp
8440142	dxs7
8440142	dxs77
8440142	dsx7
8440142	ndp
8440142	disease locus
8440142	maoa
8440142	xp11
8440142	> p11
8440142	combining
8440142	new submicroscopic
8440142	detection
8440142	differential alu pcr
8440142	new submicroscopic deletion interval
8440142	physical order
8440142	disease locu
8440142	maob-maoa-dxs7
8440142	disease deletion interval
8440142	dxs426
8440142	norrie
8440142	short arm
8440142	dna
8440142	physical map
8440142	xcen-dxs14-dxs255-
8440142	alu pcr
1731805	genetic
1731805	normotriglyceridemic abetalipoproteinemia
1731805	rare familial disorder
1731805	american case
1731805	apolipoprotein b gene
1731805	normotriglyceridemic
1731805	genetic markers
1731805	point substitution
1731805	genetic abnormalities
1731805	different apob gene alleles
1731805	normal apob-48
1731805	apob gene
10788334	sscp
10788334	germline mutations
10788334	peripheral blood leukocytes
10788334	ovarian cancers
10788334	brca2
10788334	breast-ovarian cancer syndrome
10788334	recurrent mutations
10788334	brca1
10788334	founder mutations
10788334	ovarian cancer
10788334	breast cancer
10788334	polish
10788334	mutations
10788334	c61g
10788334	distinct mutations
10788334	study group
10788334	breast-ovarian cancer
10788334	founder
10788334	genomic dna
10788334	age <
10788334	breast cancers
7762560	hinfi
7762560	modern humans
7762560	negroid
7762560	normal alleles
7762560	small number
7762560	insertion/deletion polymorphism
7762560	specific alleles
7762560	dm
7762560	canadians
7762560	allelic distribution
7762560	g/t
7762560	caucasoids
7762560	hinfi-2
7762560	myotonin protein kinase gene
7762560	new founder haplotypes
7762560	caucasoid
7762560	numerous
7762560	non-african peoples
7762560	alu
7762560	nearby polymorphisms
7762560	african
7762560	rare ancestral
7762560	myotonic dystrophy locus
7762560	dmk
7762560	repeat polymorphism
7762560	african negroid
7762560	africa
7762560	europeans
7762560	myotonic dystrophy
7762560	intron 9/hinfi polymorphism
7762560	mutation event
7762560	myotonic dystrophy kinase
7762560	african negroids
7762560	linkage disequilibrium
7762560	repeat lengths
7762560	ctg
7762560	hinfi-1
7573040	instability
7573040	adca
7573040	neurodegenerative disorders
7573040	cag
7573040	spinocerebellar ataxia 3/machado-joseph disease locus
7573040	marked
7573040	disease gene
7573040	dentatorubropallidoluysian atrophy
7573040	families shows
7573040	ataxochoreic form
7573040	mjd
7573040	neuropathological findings
7573040	gonadal mosaicism
7573040	clinical disease
7573040	spinocerebellar ataxia
7573040	autosomal dominant cerebellar ataxia
7573040	trinucleotide repeats
7573040	machado-joseph
7573040	phenotypic heterogeneity
7573040	share clinical
7573040	triplet repeat
7573040	strong negative correlation
7573040	evidence
7573040	analysis
7573040	heterogeneous group
7573040	french family
7573040	sca3
7573040	repeat sequence
2309698	milder form
2309698	regulatory genes
2309698	ald
2309698	% frequency
2309698	frequent phenotypic color vision anomalies
2309698	neural involvement
2309698	furthermore
2309698	recent data
2309698	blue cone monochromacy
2309698	color vision genes
2309698	visual pigment rearrangements
2309698	x-linked
2309698	red pigment gene
2309698	fragment size difference
2309698	color vision
2309698	red-green visual pigment gene region
2309698	xq28
2309698	specific very-long-chain fatty acyl-coa synthetase
2309698	small numbers
2309698	normal individuals
2309698	phenotypic color vision defects
2309698	cosmid walk
2309698	amn
2309698	green color pigment genes
2309698	color vision gene cluster
2309698	color vision arrays
2309698	previous findings
2309698	pulsed-field gel electrophoresis
2309698	pigment genes
2309698	green pigment genes
2309698	such rearrangements
2309698	red/green color vision gene
2309698	molecular analysis
2309698	abnormal
2309698	ald/amn
2309698	dna
2309698	previous report
2309698	phenotypic color vision anomalies
2309698	red/green color pigment
2309698	abnormal color vision
2309698	r/gcp
2309698	fortuitous coincidence
2309698	long deletion
10662807	recently
10662807	cathepsin c gene suggests
10662807	pls
10662807	cathepsin c mutation
10662807	report identification
10662807	simple autosomal recessive inheritance
10662807	mutation segregates
10662807	atrophic changes
10662807	radiographic deformity
10662807	autosomal recessive pattern
10662807	phenotypic influences
10662807	hms
10662807	premature periodontal destruction
10662807	parental
10662807	turkish family
10662807	amino acid
10662807	ctsc
10662807	cathepsin c
10662807	c.
10662807	additionally
10662807	severe periodontitis
10662807	india
10662807	cathepsin c gene
10662807	genetic defect
10662807	nuclear families
10662807	cathepsin c gene mutations
10662807	allelic variants
10662807	palmoplantar keratoderma
10662807	cathepsin c peptide
10662807	allelic mutations
10662807	common ancestor
10662807	genetic loci
10662807	haim-munk
10662807	papillon-lefevre
10662807	cochin
10662807	additional findings
10662807	religious isolate
10662807	autosomal recessive transmission
10662807	ppk
10662807	common haplotype
10377440	piga
10377440	high efficiency
10377440	glycosyl phosphatidylinositol
10377440	gpi
10377440	growth advantage
10377440	loxp sites flank part
10377440	equal numbers
10377440	salient exceptions
10377440	red blood cells
10377440	allele undergoes
10377440	female mice
10377440	eiia-cre
10377440	cre-mediated
10377440	gene knockout
10377440	gpi-linked
10377440	early embryonic development
10377440	blood cells
10377440	cre/loxp
10377440	clonal dominance
10377440	chimeric mice
10377440	gpi-anchor
10377440	somatic mutation
10377440	analysis
10377440	high embryonic lethality
10377440	paroxysmal nocturnal hemoglobinuria
10377440	piga-null
10377440	somatic cell selection rescue female mice
10377440	chromosome inactivation
10377440	mosaic mice
1301161	obligate disease region
1301161	yac
1301161	dxs7
1301161	mental retardation
1301161	disease gene
1301161	x-linked
1301161	ndp
1301161	yacs
1301161	l1
1301161	maoa
1301161	xp11
1301161	disease gene maps
1301161	marker centromeric
1301161	xp11.3
1301161	sensory neural deafness
1301161	submicroscopic deletion
1301161	congenital blindness
1301161	together
1301161	submicroscopic chromosomal deletion
1301161	n polymorphism
1301161	right arm
1301161	unknown etiology
1301161	maob
1301161	mao
1301161	5-3-3-5 configuration
1301161	dxs7-maoa-maob-ndp-dc12-ymao dxs7-maoa-maob-ndp-dc12-ymao
1301161	centromeric extent
1301161	analysis
1301161	recombination event
1301161	alur
1301161	norrie
1301161	marker telomeric
1301161	alu-pcr
1301161	apparent order
1301161	chromosomal segment
1301161	dna
1301161	mao yac
1301161	ymao
1301161	kb region
1301161	obligate region
1301161	gt
1301161	recessive disorder
2393028	rapid electrophoretic mobility
2393028	different mutation
2393028	mediterranean
2393028	molecular
2393028	g6pd
2393028	de
2393028	g6pd mediterranean
2393028	g6pd sassari
2393028	generic term
2393028	glucose-6-phosphate dehydrogenase
2393028	vulliamy
2393028	g6pd andalus1361a
2393028	arginine-to-histidine substitution
2393028	spanish origin
2393028	glucose-6-phosphate
2393028	g6pd andalus
2393028	common human enzymopathy
2393028	heterogeneous group
2393028	jewish origin
2393028	additional mutation
2393028	dna
2393028	e. c.
2393028	g6pd cagliari
2393028	different biochemical variants
1303277	snrpn
1303277	nuclear ribonucleoprotein polypeptide
1303277	brain suggests
1303277	human chromosome
1303277	smn
1303277	pws
1303277	chromosomal deletions
1303277	maternal disomy
1303277	critical region
1303277	chromosome region 6pter-p21
1303277	snrpnp1
1303277	prader-willi
1303277	furthermore
1303277	minimal deletion interval
1303277	small
1303277	paternal alleles
1303277	region 15q11-13
1303277	rna
10064668	register center
10064668	cohort underwent follow-up
10064668	first-degree relatives
10064668	population
10064668	basal cell carcinoma
10064668	study confirms
10064668	registry
10064668	countrywide epidemiologic surveys
10064668	conclusions
10064668	cancer incidence
10064668	significant excess risk
10064668	objective previous
10064668	defective immunity
10064668	twenty-two patients
10064668	incidence ratio
10064668	average cancer incidence
10064668	cartilage-hair hypoplasia
10064668	increased
10064668	results
10064668	chh
10064668	% confidence interval
10064668	study design
10064668	finnish
10064668	non-hodgkins lymphoma
6540752	g6pd corinth
6540752	g6pd nedelino
6540752	g6pd mediterranian
6540752	bulgarian
6540752	rudosem
6540752	hemizygous carriers
6540752	clinical manifestations
6540752	considerable genetic heterogeneity
6540752	g6pd mediterranean
6540752	g6pd
6540752	g6pd seattle
6540752	g6pd ohut ii
6540752	polymorphic variant
6540752	genetic
6540752	new variants
6540752	high frequency
1349199	molecular studies
1349199	vast majority
1349199	critical region
1349199	consistent deletions
1349199	maternal allele
1349199	physical
1349199	deletion
1349199	somatic cell hybrids places
1349199	chromosome
1349199	parent-of-origin
1349199	interstitial deletions
1349199	submicroscopic deletions
1349199	d22s75
1349199	d22s259
1349199	cardiac malformations
1349199	dgs
1349199	normal karyotypes
1349199	developmental field defect
1349199	paternal allele
1349199	pharyngeal pouches
1349199	studies support
1349199	parathyroid glands
1349199	d22s66
1349199	genetic etiology
1349199	molecular analysis
1349199	digeorge
1349199	cytogenetic
1349199	dna
1349199	present study
1349199	important role
1301146	southern analysis
1301146	xq28
1301146	characterisation
1301146	sensitive fragile site
1301146	molecular analysis
1301146	sequence characteristic
1301146	situ hybridization
1301146	dna
1301146	fraxe
1301146	typical folate
1301146	kb distal
1301146	new rare fragile site
1301146	fragile site
1301146	new fragile site
1301146	abnormal results
1301146	fraxa
1301146	cytogenetic detection
1301146	mental retardation
1301146	fragile sites
7939630	loss
7939630	sporadic breast
7939630	show allele loss
7939630	mutations
7939630	ovarian carcinomas
7939630	early-onset breast cancer
7939630	allelic loss
7939630	germline alterations
7939630	tumor suppressor
7939630	ovarian tumors
7939630	early-onset cancers
7939630	primary breast
7939630	brca1
7939630	familial tumors
7939630	mutant germline allele
7939630	ovarian cancers
7939630	confers susceptibility
7939630	heterozygosity data
8307570	positions
8307570	n-terminal
8307570	tata
8307570	ewing
8307570	cpg-rich
8307570	dna
8307570	gene spans
8307570	exons encode
8307570	ccaat
8307570	ewsr1
8307570	consensus sequences
8307570	chromosome translocation
8307570	nucleotide sequence
8307570	lacks canonical promoter elements
8307570	neuroectodermal tumors
8307570	genomic
8307570	rna
8307570	arginine-rich motifs
8307570	ews
8307570	exons
8364574	congenital malformation
8364574	iris hypoplasia
8364574	aniridia
8364574	aniridia patients
8364574	intragenic mutations
8364574	mouse mutant
8364574	subsequently pax6
8364574	smalleye
8364574	mutations suggests
8364574	animal model
8364574	human aniridia patients
8364574	pax6
8364574	mutations highlight regions
8364574	candidate aniridia gene
8364574	point mutations
8111379	cag-glutamine
8111379	sscp
8111379	mutations
8111379	splice donor site
8111379	aniridia families
8111379	pcr-sequencing
8111379	complete inactivation
8111379	hereditary aniridia
8111379	pax6
8111379	small
8111379	family-specific mutation
8111379	family band shifts
8111379	tag-stop
8111379	cgaarg
8111379	analysis
10735274	autosomal recessive ataxia
10735274	stm7/x25
10735274	disease locus
10735274	different forms
10735274	relevant portion
10735274	tendon reflexes
10735274	haplotype
10735274	locus homogeneity
10735274	frda2
10735274	friedreich
10735274	strong evidence
10735274	studying
10735274	frda
10735274	typical mutations
10735274	gaa
10735274	uncommon symptom
10735274	disease gene
10735274	locus
10735274	patient demonstrates
10735274	common form
10767326	forkhead transcription factor genes
10767326	anterior segment development
10767326	ocular drainage structures
10767326	ocular phenotypes
10767326	trabecular meshwork
10767326	glaucoma development
10767326	extracellular matrix synthesis
10767326	genetic backgrounds
10767326	foxc1
10767326	iop
10767326	similar abnormalities
10767326	iris hypoplasia
10767326	axenfeld-rieger
10767326	various families
10767326	collagen bundles
10767326	fkhl7
10767326	mfh1
10767326	genetic background
10767326	mf1
10767326	anterior segment abnormalities
10767326	mutations
10767326	schlemms
10767326	ara
10767326	useful models
10767326	human homolog
10767326	eccentric pupils
10767326	human patients
10767326	aberrant ocular development
10767326	obvious abnormalities varies
10767326	foxc2
10767326	transcription factors
10767326	normal diameter
10767326	elastic tissue
10767326	anterior
10767326	schwalbes
10767326	clinically
10767326	fkhl14
10767326	segment developmental disorders
10767326	haploinsufficiency
10767326	dominant anterior segment defects
10767326	intraocular pressure
10446987	morphological transformation
10446987	receptor kinase inhibitor
10446987	expression
10446987	growth rate
10446987	pdgf
10446987	fusion protein
10446987	chimeric gene
10446987	structural properties
10446987	control cells
10446987	ialpha1
10446987	ialpha1/platelet-derived
10446987	nude mice
10446987	b-chain
10446987	cgp57148b
10446987	ectopic production
10446987	colia1
10446987	colia1/pdgfb
10446987	dermatofibrosarcoma
10446987	pdgf-bb
10446987	nih3t3
10446987	pdgfb
10446987	colia1/pdgfb-expressing
10446987	end product
10446987	cell line
10446987	pharmacological treatment
10446987	coia1
10446987	collagen type
10446987	displays chromosomal rearrangements
10446987	tumor development
10446987	receptor kinase inhibitors
10446987	pulse-chase
10446987	autocrine loop
10446987	fusion gene generates
10446987	dfsp
10446987	s. c c. injection
10446987	giant cell fibroblastoma
10446987	growth factor
10446987	tumor growth
10446987	intron 7-pdgfb intron
10446987	e. g.
2006152	missense mutation
2006152	pku
2006152	tetrahydrobiopterin oxygen oxidoreductase
2006152	asia
2006152	population
2006152	] gene
2006152	pro413
2006152	predominant haplotype
2006152	pah
2006152	genetic studies
2006152	heterologous mammalian cells
2006152	caucasian
2006152	phenylalanine 4-monooxygenase
2006152	g-to-c
2006152	founder effect
2006152	ec
2006152	gene results
2006152	previous
2006152	prevalent phenylketonuria mutation
2006152	r413p
2006152	chinese patient
2006152	l-phenylalanine
2006152	restriction fragment length polymorphism haplotype
2006152	mongoloids
2006152	racial divergence
2006152	mutant protein
2006152	negligible enzymatic activity
2006152	protein polymorphism studies
2006152	classic phenylketonuria
2006152	caucasians
2006152	orient
2006152	japanese populations
2006152	founder
2006152	arg413
2006152	human phenylalanine hydroxylase [
2006152	oriental population
2006152	orientals
10528243	milder form
10528243	characterize demographic
10528243	low colchicine dose
10528243	commercial kit
10528243	molecular genetic characteristic
10528243	late onset
10528243	regular follow-up visit
10528243	fmf
10528243	late age defines
10528243	chronic arthritis
10528243	mediterranean
10528243	mild disease
10528243	distinct clinical
10528243	typical clinical
10528243	molecular genetic characteristics
10528243	late-onset
10528243	african
10528243	overall severity score
10528243	control group
10528243	m694v
10528243	abdominal attacks
10528243	mutational
8195156	tataa
8195156	na+/glucose
8195156	lambda phage clones
8195156	infectious origin
8195156	dietary glucose
8195156	structure
8195156	important gene
8195156	+/glucose cotransporter gene
8195156	six-membrane-span ancestral precursor
8195156	gene duplication event
8195156	brush border
8195156	cotransporter gene
8195156	data facilitate
8195156	genomic region
8195156	base pairs
8195156	-dependent cotransporter gene structure
8195156	sglt1
8195156	secondary structure
8195156	missense mutation underlies hereditary glucose/galactose malabsorption
8195156	fatal diarrhea
8195156	+/glucose cotransporter
8195156	new missense mutation
8195156	restriction enzymes
8195156	glucose/galactose malabsorption
8195156	entire 112-kilobase region
8195156	-dependent cotransporters
8195156	intestinal
8195156	normal transport
8195156	sequence considerations
8195156	new glucose/galactose
8195156	future evolutionary comparisons
8195156	transcription
8195156	possible evolutionary origin
8195156	sglt1 na
8195156	na
8195156	oral rehydration therapy exploits
8195156	entire human
10766245	p95/nbs1 construct
10766245	phenotypic similarities
10766245	breakage syndrome
10766245	chromosomal instability
10766245	at
10766245	radiomimetic drugs
10766245	activation
10766245	nijmegen
10766245	checkpoint pathway
10766245	normal cells
10766245	atm
10766245	radiation sensitivity
10766245	gene encodes
10766245	rare diseases ataxia-telangiectasia
10766245	functional interactions
10766245	observations link
10766245	s-phase
10766245	atm-dependent
10766245	nbs
10766245	functional deficiency
10766245	phenotypic abnormalities
10766245	whereas p95/nbs1
10766245	p95/nbs1 gene
10766245	protein kinase
10766245	dna
10766245	phosphorylation site
10766245	phosphorylates p95/nbs1
10766245	cell-cycle checkpoints
1671881	france
1671881	new point mutations
1671881	pku
1671881	classical
1671881	distinct mutations
1671881	autosomal recessive disease
1671881	belgium
1671881	large variety
1671881	hepatic phenylalanine hydroxylase
1671881	clinical heterogeneity
1671881	present study supports
1671881	pah
1671881	bamhi
1671881	mutant genotypes
1671881	rflp
10839544	carboxy-terminal phosphatidylinositol 3-kinase-like domain
10839544	repair proteins
10839544	mrel1
10839544	breakage syndrome
10839544	complexes
10839544	similar cellular phenotypes
10839544	ataxia-telangiectasia
10839544	genetic diseases
10839544	breakage syndrome gene products
10839544	ser
10839544	rad50
10839544	a-t
10839544	biochemical link
10839544	nijmegen
10839544	atm
10839544	together
10839544	nuclear foci
10839544	checkpoint activation
10839544	s-phase
10839544	cellular response
10839544	nbs
10839544	nbs1/mrel1/rad50
10839544	nbs1
10839544	dna
10839544	protein product
10839544	recessive genetic disorders
10839544	functional
10839544	cell-cycle checkpoints
8499920	putative serine-threonine protein kinase activity
8499920	genomic sequences
8499920	important step
8499920	cdna sequences
8499920	myotonic dystrophy
8499920	trinucleotide repeat
8499920	structure
8499920	kinase gene
8499920	pcr
8499920	novel polymorphisms
8499920	genomic sequence
8499920	ctg
8499920	complete sequence
8499920	translation initiation codon
8499920	dm
8499920	molecular biology
10712201	radiation-hybrid human transcript maps
10712201	pws
10712201	regional control
10712201	deletion region
10712201	prader-willi
10712201	deletion interval
10712201	exclusive paternal expression
10712201	angelman
10712201	sequence tags
10712201	additional genes
10712201	parent-of-origin-specific manner
10712201	5-mb domain
10712201	transcripts localize
10712201	physical maps
10712201	deletions
10712201	center suggests
10712201	syndrome deletion region
10712201	loss
10712201	signal acts
10712201	snrpn-associated
10712201	reverse transcriptase-pcr assay
10712201	developmental disorders
10712201	identification
10712201	strong regional control
10712201	transcript map
10712201	pws-as
10712201	new transcripts
10712201	as
10712201	human chromosome 15q11-q13
10712201	physical map
10441573	differences reflect
10441573	female relatives
10441573	whereas differences
10441573	ovarian cancers
10441573	true differences and/or methodological problems
10441573	breast and/or ovarian cancer
10441573	methodological problems
10441573	possible explanations
10441573	low penetrance
10441573	mutation carriers
10441573	brca1
10441573	founder mutations
10441573	ovarian cancer
10441573	ashkenazi
10441573	n =
10441573	breast cancer
10441573	altogether
10441573	preferential segregation
10441573	family cancer clinic
10441573	different ways
10441573	overall findings
10441573	penetrances
10441573	breast-ovarian cancer
10441573	norwegian
10441573	whether
10441573	index
10441573	consecutive ovarian cancers
10441573	breast cancers
10441573	present study
7535801	carboxy-terminal part
7535801	cdna fragments
7535801	splice donor site
7535801	puex expression system
7535801	detectable concentrations
7535801	carboxy-terminal end
7535801	c5b
7535801	% shorter
7535801	intron boundary
7535801	c6
7535801	molecular
7535801	pcr-amplified
7535801	fusion proteins
7535801	putative enzymatic region
7535801	subtotal complement
7535801	individuals
7535801	interestingly
10408776	sscp
10408776	germline mutations
10408776	vhl
10408776	specific pattern
10408776	somatic mutations vs
10408776	tumor suppressor gene
10408776	sporadic human renal cell carcinomas
10408776	risk factor
10408776	single-strand conformational polymorphism analysis
10408776	pcr
10408776	somatic von
10408776	% correspond
10408776	sporadic renal cell carcinoma
10408776	proteins versus
10408776	rcc
10408776	nonsense mutations
10408776	mutations
10408776	new mutations
10408776	pattern corresponds
10408776	hippel-lindau
10408776	specific missense mutations
10408776	missense mutations
10408776	nonpapillary renal cell carcinoma
10408776	polymerase chain reaction
10408776	significant difference
10408776	dna
10408776	mutational events
10911990	u2af
10911990	short regions
10911990	mrna isoforms
10911990	triplet repeats
10911990	novel isoform
10911990	auxiliary factor
10911990	polypyrimidine tract
10911990	new dominant effect
10911990	cug
10911990	mrna isoform ratios
10911990	utr
10911990	relative levels
10911990	dmpk
10911990	essential cis
10911990	gene causes myotonic dystrophy
10911990	n expansion
10911990	psf
10911990	myotonic
10911990	u2
10911990	hnrnp c
10911990	ptb
10911990	ctg
10911990	rna
10911990	dm
10077651	dmt1
10077651	positive control
10077651	excessive dietary
10077651	duodenal
10077651	murine model
10077651	transferrin receptor
10077651	mutations lead
10077651	hh
10077651	duodenal expression
10077651	hereditary
10077651	tfr
10077651	divalent metal transporter
10077651	data support
10077651	duodenal crypt cells
10077651	hereditary hemochromatosis
10077651	resultant stabilization
10077651	ire
10077651	responsive element
10077651	common autosomal recessive disorder
10077651	hepatic expression
10077651	hfe-/-
10077651	+/+ littermates
10077651	hfe
10077651	northern blot analyses
10077651	transferrin saturation
10077651	transferrin saturations
10077651	low crypt cell
10077651	mechanism
1325652	valuable resource
1325652	yac
1325652	putative interstitial deletions
1325652	artificial chromosomes
1325652	somatic cell hybrids
1325652	yacs
1325652	apc
1325652	megabase pairs
1325652	significant portion
1325652	functional studies
1325652	mcc
1325652	polyposis patient
1325652	colorectal carcinoma
1325652	yeast
1325652	chromosome 5-specific cosmid library
1325652	cell lines
1325652	familial polyposis
1325652	small heterozygous deletion
1325652	total distance
1325652	molecular analysis
1325652	gene region
1325652	dna
1325652	constitutional submicroscopic deletions
1325652	adenomatous polyposis coli
1325652	familial adenomatous polyposis patients
1269174	structural albumin locus
1269174	atopic dermatitis
1269174	12-year-old american indian girl
1269174	analbuminemia
1269174	normal chromosomal
1269174	serum albumin
1269174	gc-locus
1269174	mild bronchial asthma
1269174	clinical findings
1269174	gc-protein
1269174	subnormal levels
1269174	immunologic
1269174	american indian girl
1269174	trace amounts
1269174	normal serum albumin
1269174	autosomal recessive transmission
1269174	-like mutation
1269174	patients parents
1269174	corneal arcus
1269174	mild seizure disorder
1269174	chromosomal deletion
1269174	gc-types
1269174	heterozygotes
1269174	mg/100 ml
3524231	placebo treatment
3524231	serum enzymes
3524231	gh
3524231	motor ability tests
3524231	growth hormone inhibitor
3524231	height measurements
3524231	year-old monozygotic twins
3524231	growth hormone
3524231	double-blind therapeutic trial
3524231	drug mazindol
3524231	benign course
3524231	growth hormone inhibitors
3524231	dmd
3524231	muscular dystrophy
3524231	dystrophic process
3524231	duchenne
8528198	missense mutation
8528198	mutation
8528198	patients result
8528198	wasp
8528198	thrombocytopenia reveals allelic heterogeneity
8528198	x-linked wiskott-aldrich
8528198	extensive phenotypic variability
8528198	pcr-sscp
8528198	genetic defect
8528198	identification
8528198	gene defects
8528198	thrombocytopenia patients
8528198	primary immunodeficiency disease
8528198	gene alterations
8528198	gene mutation
8528198	congenital thrombocytopenia
8528198	premature translation termination
8528198	reading frame
8528198	was
8528198	wiskott-aldrich
8528198	valuable tool
8528198	mild cases
8528198	mild presentations
8178825	possible phenocopies
8178825	retrospective review
8178825	sample mix-up
8178825	rare occasions mutations
8178825	biological relevance
8178825	mutations
8178825	patients clinical
8178825	clinical phenotype
8178825	it15
8178825	family studies
8178825	hd
8178825	huntington
8178825	molecular mechanism
8178825	clerical error
8178825	cag
8178825	study shows
8178825	repeat length
8178825	disease range
8178825	novel gene
6101415	allelic exclusion occurs
6101415	syndrome carrier
6101415	obligate carrier
6101415	particular cell-type
6101415	glucose-6-phosphate dehydrogenase
6101415	b isoenzyme
6101415	b types
6101415	was
6101415	wiskott-aldrich
6101415	allelic
6101415	gene occurs
6101415	glucose-6-phosphate dehydrogenase isoenzyme
6101415	particular cell-types
6101415	x-linked
10487695	carrier state
10487695	expression
10487695	g395r
10487695	hutterite
10487695	sodium/iodide symporter
10487695	gly395
10487695	novel mutation
10487695	recessive form
10487695	aga
10487695	pcr
10487695	congenital hypothyroidism
10487695	sodium/iodide symporter gene
10487695	perchlorate-sensitive iodide uptake
10487695	peripheral blood cells
10487695	nis
10487695	severe defect
10487695	intermediate saliva/serum technetium ratio
10487695	transmembrane helix
10487695	extensive consanguinity
10487695	tsh
10487695	potential parents
10487695	iodide transport defect
10487695	cos-7
10487695	gene exon
10487695	gene diagnostics
10487695	arg
10487695	gene mutation
10487695	ix-24
10487695	original report
10487695	identify patients
10487695	gga
10487695	dna
10487695	previous report
10487695	early diagnosis
10487695	canada
10487695	additional children
10487695	present study
2071157	hprt
2071157	molecular level
2071157	identifies insertions
2071157	purine salvage enzyme
2071157	lesch-nyhan
2071157	cell lines
2071157	guanine phosphoribosyltransferase
2071157	rapid identification
2071157	determination
2071157	inosine monophosphate
2071157	previous
2071157	hypoxanthine
2071157	polymerase chain
2071157	point mutations
2071157	significant heterogeneity
2071157	guanosine monophosphate
7444053	corona radiata
7444053	contrast infusion
7444053	ct
7444053	ald
7444053	corpus callosum
7444053	numerous previous descriptions
7444053	fiber systems
7444053	non-contrast scans
7444053	phenotypic variant
7444053	type ii
7444053	internal capsules
7444053	various white-matter structures
7444053	posterior periventricular areas
7444053	type ii ald
7444053	cerebral peduncles
10706858	thrombophilic conditions
10706858	blood
10706858	phenotypic diagnosis
10706858	first-degree relatives
10706858	index patients
10706858	major structural defects
10706858	thrombotic risk
10706858	genetic level
10706858	relatives
10706858	thrombotic event
10706858	s. protein
10706858	risk factor
10706858	venous thrombosis
10706858	inconclusive results
10706858	pros1
10706858	low free protein s level
10706858	first-degree
10706858	patients relatives
10706858	twenty-eight
10706858	protein s deficiency
10706858	s deficiency
10706858	phenotypic variability
10706858	gene defects
10706858	genetic
10706858	free protein s levels
10706858	reliable way
10706858	% confidence interval
10706858	gene defect
10706858	missense mutations
10706858	reliable predictor
10706858	free protein s estimation
10706858	selection bias
10706858	thrombophilic defect
10382910	severe disease phenotype
10382910	interfamilial heterogeneity
10382910	x-linked emery-dreifuss
10382910	severe muscle
10382910	severe
10382910	genetic modification
10382910	clinical expression
10382910	clinical variability
10382910	rare benign neuromuscular disorder
10382910	emery-dreifuss
10382910	edmd
10382910	tctac
10382910	emerin gene
10382910	muscular dystrophy
10382910	milder phenotype
10382910	present study
7825578	french
7825578	chromosome 14q24.3-q32.2
7825578	d14s291
7825578	new markers
7825578	recombinant haplotype analyses localize
7825578	candidate region
7825578	afm343vf1
7825578	3-cm interval
7825578	d14s280
7825578	disease locus
7825578	29-cm region
7825578	diseases result
7825578	french population
7825578	machado-joseph
7825578	combined
7825578	linkage analysis
7825578	recombination fraction
7825578	two-point linkage analyses
7825578	maximal lod scores
7825578	french family
7825578	spinal cerebellar ataxia
7825578	chromosome 14q
7825578	d14s81
7825578	linkage disequilibrium
7825578	15-cm interval
7825578	new microsatellite markers
7825578	d14s256
7825578	d14s67
7825578	sca3
7825578	additional individuals
1831007	40-year-old man
1831007	adult onset
1831007	discovery
1831007	huntington
1831007	tourette
1831007	ts
1831007	hd
7761412	converts inositol
7761412	insect cells
7761412	encodes amino acids homologous
7761412	5-bisphosphate 5-phosphatase
7761412	5-phosphatase isoenzyme
7761412	relative ability
7761412	protein hydrolyzes
7761412	critical metabolite
7761412	oculocerebrorenal syndrome
7761412	control cellular levels
7761412	ii
7761412	protean manifestations
7761412	phosphatidylinositol-4,5-bisphosphate 5-phosphatase
7761412	sf9
7761412	phosphatidylinositol 4-phosphate
7761412	lipid phosphatase
7761412	human platelets
7761412	phospholipid substrate 10-
7761412	ocrl
7761412	protein deficient
7761412	lowe
7761412	inositol polyphosphate 5-phosphatase
7761412	platelet 5-phosphatase
7761412	recombinant protein
7761412	enzyme converts phosphatidylinositol
7761412	ocrl-expressing sf9
7761412	similar enzyme
7761412	cdna encodes aa
7761412	deficiency
10323740	autosomal dominant disorder
10323740	sander
10323740	vws
10323740	allele loss assay
10323740	microdeletions
10323740	d1s3753
10323740	allele loss
10323740	chromosome bands 1q32-q41
10323740	lip pits
10323740	proximal breakpoint
10323740	mb
10323740	cleft lip
10323740	new deletion
10323740	kb deletion
10323740	syndromic forms
10323740	cleft lip/palate
10323740	nonsyndromic cleft lip
10323740	cleft lip and/or cleft palate
10323740	popliteal pterygia syndrome
10323740	chromosome bands 1q32-q41 [
10323740	surprisingly
10323740	woude
10323740	polymorphic marker
10323740	van
10323740	hum mol genet
10323740	relatives exhibit developmental delays
10323740	cardinal signs
7607677	incomplete short direct repeats
7607677	repetitive elements
7607677	heteroallelic state
7607677	galns
7607677	mucopolysaccharidosis
7607677	n-acetylgalactosamine-6-sulfatase
7607677	alu-alu
7607677	autosomal recessive disorder
7607677	gene cluster
7607677	separate deletions
7607677	mps iva
7607677	common double deletion
7607677	alu
7607677	mucopolysaccharidosis iva
7607677	illegitimate recombinational events
7607677	0-kb deletion
7607677	deletion breakpoints
7607677	iva
2995231	informative meioses
2995231	theta =
2995231	physical order
2995231	dna
2995231	studies
2995231	recombination fraction
2995231	segregation
2995231	muscular dystrophy families
2995231	c7
2995231	xp21
2995231	dmd
2995231	xp21.2-xp21.3
2995231	dmd-754
2995231	duchenne
2995231	bmd
2995231	becker
2995231	centromere-754-dmd-bmd-c7-x telomere
2995231	bm
2995231	muscular dystrophy
2995231	z max = +
8281142	chromosome 17q
8281142	large breast/ovarian family
8281142	germline mutations
8281142	breast/ovarian cancer pedigree
8281142	bilateral breast cancer case
8281142	family show loss
8281142	new proximal boundary
8281142	candidate genes
8281142	minimal region
8281142	mb
8281142	tumour suppressor gene
8281142	edh17b1
8281142	breast tumour/blood pairs
8281142	brca1
8281142	combining
8281142	consistent inheritance
8281142	17q haplotypes shows
8281142	d17s857
8281142	genetic
8281142	beta-oestradiol dehydrogenase genes
8281142	analysis
8281142	recombination event
8281142	bov3
8281142	edh17b2
8281142	information suggests
10590055	platelet glycoprotein
10590055	immunochemical
10590055	polymerase
10590055	point mutation
10590055	hpa-5b
10590055	platelet
10590055	-positive platelets
10590055	acg
10590055	ia
10590055	aca
10590055	chain reaction-restriction fragment length polymorphism analysis
10590055	mae iii
10590055	glu
10590055	lys
10590055	stable chinese hamster ovary transfectants
10590055	polymorphic bases
10590055	gp
10590055	hpa-5a
10590055	severe case
10590055	aggregation responses
10590055	br
10590055	gpia
10590055	142-bp exon
10590055	met
10590055	alloantigenic determinants
10590055	gene adjacent
10590055	normal individuals
10590055	sequence analysis
10590055	allele-specific recombinant forms
10590055	gpia/iia
10590055	low frequency
10590055	sit
10590055	analysis
10590055	new platelet-specific alloantigen
10590055	neonatal alloimmune thrombocytopenia
10590055	restriction enzyme
10590055	german population
10590055	dna
10590055	mutation affects
10590055	whereas amino acid
10590055	nucleotide
10590055	new human platelet alloantigen
10590055	whereas anti-br
10590055	thr
3464560	familiar cases
3464560	x-chromosomal dna
3464560	carrier status
3464560	female mutation rates
3464560	dna
3464560	estimation
3464560	classical methods
3464560	female ratio
3464560	muscular dystrophy families
3464560	female relatives
3464560	mutation rates
3464560	dmd
3464560	novel procedure
3464560	maternal grandfathers
3464560	duchenne
3464560	x-specific
3464560	restriction fragment length polymorphisms
3464560	muscular dystrophy
3789016	major histocompatibility
3789016	genetic characteristics
3789016	genetically
3789016	brittany
3789016	null gene allelic
3789016	preliminary pedigree analysis suggests
3789016	allotype analysis
3789016	major histocompatibility locus
3789016	null gene
3789016	spaniel dogs
3789016	current study
3789016	shares biochemical
3789016	c3
3789016	human disorder
3789016	genetic
3789016	structural gene
3789016	clinical characteristics
3789016	spaniel dogs shares
10426139	novel frameshift mutation
10426139	amino acid position
10426139	single-base deletion causes
10426139	molecular analysis
10426139	novel mutation
10426139	xk
10426139	serum creatinine kinase
10426139	50-year-old man
10426139	mcleod
10426139	syndrome gene
10426139	kx
10426139	expression level
10426139	choreic movement
10426139	muscular atrophy
10426139	kell
10426139	nucleotide position
10330430	actc
10330430	maximal lod score
10330430	missense mutations
10330430	alpha-cardiac actin gene
10330430	lod scores
10330430	likely disease gene
10330430	novel disease gene
10330430	mutation
10330430	adult human heart
10330430	alpha-cardiac
10330430	linkage
10330430	linkage analyses
10330430	plausible candidate genes
10330430	idc
10330430	ala295ser
10330430	familial hypertrophic cardiomyopathy
10330430	possible disease loci
10330430	fhc
8084618	ewings
8084618	soft parts
8084618	solid tumors
8084618	atf
8084618	protein binds
8084618	ews
8084618	carboxy terminal
8084618	primitive neuroectodermal tumors
8084618	ews-b
8084618	rgg
8084618	transcriptional activators/repressors
8084618	chromosome translocation
8084618	chimeric protein
8084618	malignant melanoma
8084618	sarcoma cells
8084618	transcriptional activation properties
8084618	transcriptional activator
8084618	human chromosome
8084618	ewing
8084618	wide variety
8084618	small round cell tumors
8084618	ntd-ews
8084618	novel regulatory domains
8084618	band q12
8084618	ews-erg
8084618	amino acids
8084618	regulatory domain
8084618	sequence
8084618	fli-1
8084618	mutational
8084618	amino terminal domain
8084618	rna
1301938	reverse transcription
1301938	pcr-based
1301938	allele trace
1301938	lysosomal enzyme
1301938	tsd
1301938	nlaiii
1301938	carrier alleles
1301938	aberrant species
1301938	cryptic donor sites
1301938	ivs-9
1301938	common disease allele
1301938	tay-sachs
1301938	autosomal recessive genetic disorder
1301938	pcr
1301938	hexa
1301938	genomics
1301938	ashkenazi
1301938	akli
1301938	am j hum genet
1301938	diagnostic test
1301938	together
1301938	ireland
1301938	numerous
1301938	europe
1301938	hex
1301938	additional splice products
1301938	triggs-raine
1301938	caucasians
1301938	black
1301938	low levels
1301938	kingdom
1301938	rna
1302022	unstable [
1302022	characterization
1302022	species reveals
1302022	clinical
1302022	myotonic dystrophy region predicts
1302022	ctg-repeat
1302022	dmr-b15
1302022	dmr-n9
1302022	myotonic dystrophy
1302022	protein product
1302022	ctg
1302022	kinase gene
1302022	large open reading frame
1302022	protein kinase activity
1302022	heart transcripts
1302022	active gene
1302022	multiple protein
1302022	dm-kinase
1302022	rna
1302022	dm
2310692	patients erythrocytes
2310692	paroxysmal nocturnal haemoglobinuria
2310692	postoperative transfusion
2310692	mild haemolysis
2310692	critical role
2310692	c9
2310692	addition
2310692	nocturnal haemoglobinuria
2310692	daf
2310692	pnh
2310692	haemolytic attacks
2310692	functional assays
2310692	massive haemolytic attack
2310692	paroxysmal
2310692	normal human serum
2310692	47-year-old woman
2310692	massive spontaneous haemolysis
2310692	characteristic haemolysis
2310692	daf-negative
2310692	gross
2310692	pnh-iii
2310692	whole blood
2310692	surprisingly
2310692	ham
2310692	monoclonal antibody
2310692	complement component
2310692	sugar water test
2310692	laser
2310692	complement-sensitivity lysis tests
2310692	patients serum
10943845	swi/snf-related
10943845	germline
10943845	predominant form
10943845	conventional chromatographic techniques
10943845	brg1
10943845	tumor suppressor gene
10943845	brca1
10943845	human cells
10943845	predispose individuals
10943845	swi/snf
10943845	ovarian cancers
10943845	breast cancer
10943845	dominant-negative mutant
10943845	transcriptional control
10943845	direct function
10943845	chromatin structure
10943845	brca1-containing
10943845	mass
8375105	haplotype analysis
8375105	carrier status
8375105	germinal
8375105	three-generation family
8375105	muscle dystrophin
8375105	accurate genetic
8375105	germinal mosaicism
8375105	healthy maternal grandfather
8375105	immunohistochemical
8375105	immunohistochemical muscle dystrophin studies
8375105	dmd
8375105	probands mother
8375105	muscular dystrophy
8375105	duchenne
8375105	muscular dystrophy family
8375105	germinal mosaic
8375105	possible carriers
10198641	nuclear division
10198641	unequal chromosome segregation
10198641	centrosome duplication
10198641	ovarian cancers
10198641	mutant cells
10198641	functional centrosomes
10198641	molecular basis
10198641	mouse embryonic fibroblast cells
10198641	brca1
10198641	brca1-related
10198641	data uncover
10198641	extensive chromosomal abnormalities
10198641	genetic stability
10198641	g1-s
10198641	tumor suppressor gene predispose women
10198641	germline
10198641	isoform-deficient cells
10198641	mutant
10198641	g2-m
10198641	centrosome
10198641	essential role
10198641	genetic instability
10198641	cell cycle checkpoint
1769645	intron 10/exon
1769645	chromosomal haplotypes
1769645	normal
1769645	in-frame insertion
1769645	pah
1769645	gly-leu-gln
1769645	tight association
1769645	phenylalanine hydroxylase
1769645	italy
1769645	enzyme activity
1769645	catalytic activity
1769645	classical phenylketonuria
1769645	aberrant
1769645	cryptic splice site
1769645	conformational changes
1769645	additional amino acids
1769645	bulgaria
1769645	europe
1769645	homozygous patients
1769645	phenylalanine hydroxylase mrna
1769645	bp upstream
1769645	particular haplotypes
1769645	high frequency
1769645	normal sequences
1769645	frequent defects
1769645	causes aberrant
10814710	mature size
10814710	mild phenotype
10814710	gene family
10814710	structural analysis
10814710	transient expression analysis
10814710	mucopolysaccharidosis iva
10814710	salt bridge
10814710	different reasons
10814710	biochemical approaches
10814710	insoluble precursor forms
10814710	tertiary structural model
10814710	severe phenotype
10814710	biochemical
10814710	variable clinical phenotypes
10814710	iva
10814710	lysosomal storage disorder
10814710	mutants
10814710	c79s
10814710	x-ray
10814710	sulfatase family
10814710	n-acetylgalactosamine-6-sulfate
10814710	omim
10814710	-acetylgalactosamine-6-sulfate sulfatase
10814710	mild mutations
10814710	extensive sequence homology
10814710	entire conformation
10814710	missense mutations
10814710	galns
10814710	mutant
10814710	structural analyses
10814710	mps iva
10814710	active site mutations
10814710	c79t
10814710	active site
10814710	crystal structure
10814710	structure-function relationship
10814710	considerable residual activity
10814710	hydrophobic core
10814710	sulfatases
10814710	genotype-phenotype correlation
7437512	heterozygous mother
7437512	male siblings
7437512	skin fibroblasts
7437512	small number
7437512	heterozygous female
7437512	g-6-pd
7437512	x-chromosome
7437512	x-linked
7437512	appreciable small platelet subpopulation
7437512	progenitor cells
7437512	vitro culture
7437512	additionally
7437512	peripheral blood cell types
7437512	isolated
7437512	possible means
7437512	cis position
7437512	probable recombination
7437512	hemopoietic progenitor cells
7437512	histogram analysis
7437512	informative subjects
7437512	carrier detection
7437512	platelet size
7437512	was
7437512	wiskott-aldrich
7437512	linkage
7437512	hemopoietic system
7437512	cellular impairments
7437512	cellular abnormalities
7437512	small platelets
7437512	observation suggests
7437512	primitive progenitors
2792129	half-normal levels
2792129	diagnosis
2792129	familial
2792129	haemolytic
2792129	recurrent meningococcal infections
2792129	normal human serum
2792129	haemolytic titration
2792129	c7
2792129	recurrent meningitis
2792129	heterozygous state
2792129	complete absence
2792129	patients serum
2792129	11-year-old girl
10190331	inner ear abnormality
10190331	non-syndromic sensorineural hearing loss
10190331	particular genetic interest
10190331	syndrome locus
10190331	hearing loss
10190331	chromosomal region
10190331	recessive manner
10190331	pds
10190331	non-syndromic
10190331	pendred
10190331	enlarged
10190331	vestibular aqueduct
10190331	present results
10190331	present study
10190331	non-syndromic hearing loss
10190331	compound heterozygotes
10190331	eva
10190331	common form
3480530	chromosomal sequences
3480530	additional evidence
3480530	mutant allele
3480530	mutant alleles
3480530	mesenchymal tumors
3480530	previous evidence
3480530	cdna fragment
3480530	childhood tumor
3480530	retinoblastoma
3480530	germ line
3480530	apparent predisposition
3480530	frequent target
3480530	deletions
3480530	somatic mutations
3480530	normal functional role
3480530	recessive oncogene
3480530	rb1
3480530	germinal mutations
3480530	sequence
3480530	dna
3480530	band q14
3480530	retinoblastoma gene
2862466	active hepatitis
2862466	transferrin levels
2862466	impaired
2862466	activation fragment
2862466	genetically
2862466	c4b
2862466	c4a
2862466	structural genes
2862466	hepatic synthesis
2862466	null allotypes
2862466	albumin levels
2862466	c4
2862466	serum levels
2862466	c4d
2862466	c3d
2862466	c3
2862466	defective expression
2862466	autoimmune chronic
2862466	cah
3417303	allele-specific oligonucleotides
3417303	male theta = female theta
3417303	distinguish heterozygous carriers
3417303	theta =
3417303	maximum lod score
3417303	tight
3417303	novel approach
3417303	alleles epsilon
3417303	myotonic dystrophy
3417303	apoe
3417303	relevant segment
3417303	apoc2
3417303	hybridization assay
3417303	linkage relationship
3417303	useful marker
3417303	recombination frequency
3417303	cii
3417303	synthetic
3417303	dm
7894493	missense mutation
7894493	germline mutations
7894493	candidate gene
7894493	confirmation
7894493	basepair insertion
7894493	chain termination mutations
7894493	single-strand conformation polymorphism analysis
7894493	mutations lead
7894493	protein truncations
7894493	brca1
7894493	ovarian cancer
7894493	cryptic splice site
7894493	different mutations
7894493	breast cancer patients
7894493	brca1 dna
7894493	genetic evidence
7894493	intronic single basepair substitution destroys
7894493	n-terminal
7894493	acceptor site
7894493	chain termination
7894493	rna
7894493	ovarian cancer patients
7937795	pcr-based
7937795	r524p
7937795	ovarian tumor cell lines
7937795	mutant allele
7937795	different regions
7937795	patient
7937795	patients ovarian tumor
7937795	mismatch-repair gene
7937795	point mutation
7937795	genetic instability
7937795	human mismatch-repair gene
7937795	human ovarian cancers
7937795	high proportion
7937795	germ-line mutation
7937795	ovarian cancer
7937795	onset and/or progression
7937795	bulk tumor tissue
7937795	human ovarian cancer cell lines
7937795	cell lines
7937795	serous cystadenocarcinoma
7937795	ovarian tumors
7937795	ovarian tumor
7937795	cell line
7937795	genetic
7937795	high frequency
7937795	mercurial fashion
7937795	38-year-old heterozygote
7937795	dna
7937795	genomic instability
7937795	salmonella muts
7937795	msh2
7937795	wild-type allele
7937795	hereditary nonpolyposis colorectal cancer
7937795	wild-type alleles
7937795	normal tissue
3455778	pku
3455778	exhibit pterin-dependent phenylalanine hydroxylase activity
3455778	somatic gene therapy
3455778	pah
3455778	human phenylalanine hydroxylase
3455778	cdna sequence
3455778	whole animals
3455778	recombinant virus
3455778	recombinant viruses
3455778	retroviral-mediated
3455778	recombinant
3455778	phenylketonuria
3455778	mammalian cells
3455778	hepatic origin
3455778	cells express
3455778	stable incorporation
3455778	cellular extracts
3455778	hepatic enzyme phenylalanine hydroxylase
3455778	culture medium
3455778	hepatoma cells
3455778	retroviral vector
3455778	recombinant provirus
3455778	bacterial neo gene
3455778	entire hydroxylation system
3455778	mouse hepatoma cell line
3455778	retroviral capsid
3455778	infected
3455778	nih
3455778	full-length human
7599636	defective enamel biomineralisation
7599636	novel mutations
7599636	molecular defects
7599636	disease classification
7599636	x-linked
7599636	g-t
7599636	amelogenesis imperfecta
7599636	extensive allelic heterogeneity
7599636	xp22
7599636	single-strand conformational polymorphism analysis
7599636	family-specific mutations
7599636	heterogenous family
7599636	enamel organ
7599636	amelogenins
7599636	amelogenin gene
7599636	heterogenous group
7599636	characterisation
7599636	molecular pathology
7599636	amgx
7599636	enamel formation
7599636	clinical phenotype
7599636	disturbances
7599636	dna
7599636	c-t
7599636	cytosine deletion
7599636	objective system
7599636	tooth development
7599636	aih1
10192399	cell systems
10192399	sulfate-transporter signature sequence
10192399	detect evidence
10192399	syndrome gene encodes
10192399	putative transmembrane protein
10192399	sulfate transport proteins
10192399	congenital sensorineural hearing loss
10192399	common form
10192399	sulfate transporter
10192399	pds
10192399	sat-1
10192399	human diastrophic dysplasia sulfate transporter
10192399	transmembrane domain
10192399	rat sulfate-anion transporter
10192399	sf9
10192399	chloride-iodide transport protein
10192399	sulfate transport
10192399	pendred
10192399	syndromic deafness
10192399	pendrin
10192399	dra
10192399	dtd
10192399	xenopus
10192399	laevis oocytes
10192399	pds-recombinant
10192399	% amino acid sequence identity
10192399	pendrin functions
10192399	human sulfate transporter
10192399	thyroid physiology
161677	c2
161677	dw2
161677	hla
161677	distinct haplotypes
161677	hla-a
161677	ancestral recombinant event
161677	gene maps
161677	glo1
161677	c2o
161677	gl02
161677	hla-b
161677	linkage
161677	b18
161677	b homozygous
161677	family members
161677	immunogenetic
161677	c2-deficient
161677	hla-a25
161677	hla-d
1319059	recently
1319059	region show
1319059	entire large domain
1319059	c-terminal
1319059	skeletal muscle extracts
1319059	5-kb mrna
1319059	nonmuscle tissues
1319059	cloning
1319059	major product
1319059	dmd
1319059	427-kda proteins
1319059	cysteine-rich domains
1319059	duchenne
1319059	additional amino acids
1319059	muscular dystrophy
1319059	5-kb mrna encodes
1319059	vitro transcription
1319059	brain-type dystrophin isoforms
1319059	spectrin-like repeats
1319059	gene products
1319059	n-terminal
1319059	gene product
1319059	muscular dystrophy gene
1319059	71-kilodalton protein
1319059	8-kda protein
1146783	heterozygous carrier
1146783	classical type
1146783	biochemical observations
1146783	classical
1146783	blood histidine
1146783	atypical form
1146783	skin histidase activity
1146783	partial impairment
1146783	histidinemia
1937471	base substitution
1937471	hprtswan
1937471	hprtperth
1937471	genetic basis
1937471	partial deficiency
1937471	enzyme activity
1937471	hprttoowong
1937471	virtual absence
1937471	case predicts
1937471	patients genomic
1937471	gouty arthritis
1937471	partial deficiencies
1937471	amino acid substitution
1937471	hprturangan
1937471	hypoxanthine-guanine
1937471	phosphoribosyltransferase deficiency
1937471	novo events
1937471	human disease
1937471	hprt
1937471	hprtflint
1937471	hypoxanthine-guanine phosphoribosyltransferase
1937471	lesch-nyhan
1937471	dna
1937471	allele-specific amplification
3343337	hexadecanol content
3343337	impaired
3343337	fatty alcohol synthesis
3343337	skin fibroblasts
3343337	deficient fatty alcohol
3343337	[ 1-14c ] palmitate
3343337	primary defect
3343337	lipid
3343337	deficient utilization
3343337	fatty acid
3343337	nad
3343337	fatty alcohol
3343337	+ oxidoreductase
3343337	n =
3343337	cellular lipids
3343337	normal cells
3343337	radioactive hexadecanol
3343337	enzyme activities intermediate
3343337	total activity
3343337	sjogren-larsson
3343337	hexadecanol
3343337	intact sls
3343337	glycerol ether synthesis
3343337	fatty alcohol metabolism
3343337	[ 14c ] -hexadecanol
3343337	intracellular hexadecanol
3343337	whereas incorporation
3343337	nicotinamide adenine dinucleotide oxidoreductase activity
3343337	normal fibroblasts
3343337	fatty
3343337	coa-inhibitable activity
3343337	mean
3343337	fatty alcohol oxidation
3343337	fibroblasts
3343337	sls
10736265	glycerol
10736265	missense mutation
10736265	impaired
10736265	six-marker haplotype
10736265	french-canadian
10736265	severe hyperglycerolemia
10736265	founder effect-the
10736265	complex system
10736265	initial cohort
10736265	triglyceride metabolism
10736265	x-linked
10736265	aspartic acid
10736265	cardiovascular disease
10736265	common disease haplotype
10736265	primary entry
10736265	resequencing
10736265	xp21
10736265	lod
10736265	saguenay lac-st.
10736265	simple genetic trait
10736265	quebec-a
10736265	dxs8039
10736265	glucose tolerance
10736265	family members
10736265	diabetes mellitus
10736265	gk
10736265	n288d
10736265	microsatellite markers
10736265	-jean region
10736265	plasma glycerol levels
10736265	asparagine residue
10736265	linkage
10736265	igt
1505217	lysosomal storage disorder
1505217	agu
1505217	aga
1505217	xx
1505217	aspartylglucosaminidase gene
1505217	human enzyme
1505217	aspartylglucosaminuria
1505217	assignment
1505217	enzyme aspartylglucosaminidase
1505217	structural gene
10891444	base pair
10891444	fibrinogen aalpha gene account
10891444	fibrinogen alpha
10891444	ivs4
10891444	fgg
10891444	causative mutations
10891444	homozygous deletions
10891444	congenital afibrinogenemia
10891444	fibrinogen genes
10891444	distinct ancestral chromosomes
10891444	congenital
10891444	common mechanism
10891444	nonhomologous recombination
10891444	common recurrent mutation
10891444	fgb
10891444	swiss family
10891444	nonsense mutations
10891444	11-kb deletion
10891444	mutations
10891444	direct repeats
10891444	detectable fibrinogen
10891444	haplotype
10891444	donor splice site
10891444	complete absence
10891444	splice site mutation
10891444	afibrinogenemia alleles
10891444	fga
10891444	frameshift mutations
10891444	recessive disorder
523196	patients fibroblasts
523196	adenine nucleotides
523196	guanine nucleotides
523196	usual manner
523196	purine metabolism
523196	patients cells
523196	hypoxanthine guanine phosphoribosyl transferase
523196	nonmutilative patient
523196	famous patient
523196	normal cells
523196	hat
523196	hypoxanthine aminopterin thymidine
523196	b.
523196	dysarthric speech
523196	hprt
523196	central nervous system symptoms
523196	h. chr
523196	lesch-nyhan
523196	genetic heterogeneity
523196	utilization
523196	e. c.
523196	similarly
8023850	certain mutations
8023850	canavan
8023850	> ala mutant
8023850	nonsense tyr231
8023850	splice-acceptor site
8023850	autosomal recessive leukodystrophy
8023850	non-jewish patients
8023850	mutant chromosomes
8023850	point mutations
8023850	base changes
8023850	> ter
8023850	> c transversion
8023850	> glu mutations
8023850	jewish descent
8023850	ashkenazi
8023850	european descent
8023850	vitro expression studies
8023850	sixty-four
8023850	missense ala305
8023850	complete loss
8023850	predominant
8023850	mutant chromosome
8023850	aspa
8023850	jewish origin
8023850	> glu mutation
8023850	> c
8023850	founding-father effect
8023850	splice-site mutation
8023850	> ala mutation
8023850	non-jewish probands
8023850	wild-type enzyme
1678319	previous candidate gene
1678319	ribosomal signal recognition particle
1678319	apc
1678319	deletion mutations
1678319	candidate genes
1678319	familial adenomatous polyposis coli
1678319	dna
1678319	dp3
1678319	new genes
1678319	familial polyposis locus
1678319	srp19
1678319	mcc
1678319	identification
1678319	dp1
1678319	dp2
1678319	small
1678319	kd component
10830910	vhl
10830910	multi-centric hemangioblastoma
10830910	partial deletions
10830910	sensitive method
10830910	renal cell carcinoma
10830910	germline deletions
10830910	genotype-phenotype correlations
10830910	hereditary tumor syndrome
10830910	germline deletion
10830910	central nervous system hemangioblastoma
10830910	family-specific mutation
10830910	fish
10830910	data support
10830910	genotype-phenotype
10830910	hippel-lindau
10830910	partial deletion
10830910	gene exhibit
10830910	central nervous system
10830910	molecular analysis
10830910	von hippel-lindau
10830910	dna
10830910	low risk
10830910	southern blot analysis
10767313	protein translation
10767313	molecular mechanism
10767313	rough endoplasmic reticulum
10767313	understanding
10767313	mental retardation
10767313	common form
10767313	triplet repeats
10767313	molecular basis
10767313	rna-binding
10767313	fmr1
10767313	fmrp
10767313	massive expansion
10767313	mental retardation-1
10767313	cgg
10767313	recent progress
10767313	fragile x
10767313	general class
10767313	human diseases
10767313	trinucleotide repeat expansion
10767313	repeat expansion
10767313	subsequent mental retardation
10767313	human cognition
10767313	physiological function
7076260	dehydrogenase deficiency
7076260	various regions
7076260	deficient individuals
7076260	papua
7076260	glucose-6-phosphate
7076260	red cell glucose-6-phosphate dehydrogenase
7076260	g6pd
7076260	twenty-six g6pd
7076260	study illustrates
7076260	new variants
7076260	biochemical
7076260	extreme heterogeneity
7076260	guinea
3862128	pku
3862128	hybrid cells
3862128	cytogenetic characterization
3862128	pah
3862128	map position
3862128	phenylalanine 4-monooxygenase
3862128	cdna clone
3862128	disease locus
3862128	situ hybridization
3862128	reference point
3862128	ec
3862128	phenylketonuria locus
3862128	regional map position
3862128	various deletions
3862128	phenylketonuria
3862128	major human disease locus
3862128	human chromosome
3862128	human genome
3862128	linkage analysis
3862128	hepatic enzyme phenylalanine hydroxylase
3862128	human cdna
3862128	amino acid metabolism
3862128	autosomal recessive disorder
3862128	dna
3862128	human-hamster somatic cell hybrids
3862128	human lymphoblastoid cell line
3862128	southern blot analysis
3862128	phenylalanine hydroxylase gene
3862128	corresponding gene
2390095	plasma cholesteryl ester
2390095	human plasma
2390095	oligonucleotide primers
2390095	metabolic factors
2390095	furthermore
2390095	cetp
2390095	molecular basis
2390095	5-splice donor site
2390095	genetic defects
2390095	g-to-a
2390095	total deficiency
2390095	subjects homozygous
2390095	cholesteryl ester
2390095	compound heterozygotes
2390095	lipoprotein patterns
2390095	lipoprotein profiles
2390095	high density lipoprotein-cholesterol levels
2390095	polymerase chain reaction
2390095	dna
2390095	lack plasma
2390095	cetp-deficient
2390095	rna
3876122	platelet contents
3876122	bt
3876122	abnormal vwf
3876122	small amount
3876122	platelet
3876122	additional kindreds
3876122	low plasma concentrations
3876122	sds
3876122	1-deamino-8-d-arginine vasopressin
3876122	complete set
3876122	ristocetin cofactor
3876122	heterogeneity
3876122	normal concentrations
3876122	normal platelet levels
3876122	ricof
3876122	vwf multimers
3876122	ag
3876122	plasma vwf
3876122	abnormal von
3876122	willebrand
3876122	large multimers
3876122	ddavp
3876122	type
3876122	factor antigen
3876122	platelet discordant
3876122	sodium dodecyl sulfate
3876122	platelet vwf
3876122	-agarose gel electrophoresis
1303171	phage library
1303171	yac
1303171	dxs7
1303171	ndp
1303171	b genes
1303171	recombination analysis
1303171	disease locus
1303171	maoa
1303171	l1
1303171	deletion patient place
1303171	pfge
1303171	end point
1303171	characterization
1303171	dash ii
1303171	maob
1303171	mao
1303171	pulsed-field gel electrophoresis
1303171	yl1
1303171	norrie
1303171	monoamine oxidase genes
1303171	restriction
1303171	long range genomic map
1303171	proximal end
8477262	choroideremia gene
8477262	sscp
8477262	strand conformation polymorphism
8477262	gene product
8477262	danish families
8477262	polymerase chain reaction
8477262	pcr
8477262	dna
8477262	identification
8477262	chm
8477262	different mutations
8477262	employing
8477262	correct translation
8477262	danish choroideremia families
10543403	extragenic marker haplotypes
10543403	similar intragenic
10543403	mutant alleles
10543403	haplotype
10543403	trinucleotide repeat
10543403	friedreich
10543403	point mutation
10543403	g130v
10543403	frda
10543403	gaa
10543403	recombination events
10543403	mutation founder
10543403	common founder
10543403	point mutations
7605382	missense mutation
7605382	recently
7605382	japanese subjects
7605382	high density lipoprotein
7605382	general population
7605382	normal value
7605382	hdl-cholesterol
7605382	splice defect
7605382	cetp
7605382	corneal opacity
7605382	coronary heart disease
7605382	pcr
7605382	frequency
7605382	japanese hyperalphalipoproteinemic subjects
7605382	hdl
7605382	common mutations
7605382	relative allelic frequency
7605382	japanese hyperalphalipoproteinemic
7605382	japan
7605382	atherosclerotic symptoms
7605382	abstract truncated at
7605382	cholesteryl ester
7605382	b-containing
7605382	dominant effect
7605382	new mutation
7605382	words
7605382	polymerase chain reaction
7605382	specific activity
7605382	current study
7605382	homozygous subjects
7605382	s. d.
7605382	subject homozygous
7605382	transient expression experiment
7605382	protein gene
7605382	transfers cholesteryl ester
7605382	cholesteryl
7605382	allelic frequency
10071193	shows tissue-specific
10071193	normal mother
10071193	syndrome region
10071193	candidate gene
10071193	non-specific forms
10071193	q26 region
10071193	dxs294/dxs730
10071193	alternative transcription
10071193	male patient
10071193	fluorescence
10071193	mental retardation
10071193	duplication breakpoint interval
10071193	x-linked
10071193	fhf2
10071193	bfls
10071193	dxs155
10071193	400-kb interval
10071193	large gene
10071193	borjeson-forssman-lehmann
10071193	gene localisation
10071193	growth factor homologous factor
10071193	skeletal muscle
10071193	end exon
10071193	new exons
10071193	available genomic
10071193	database
10071193	xq26
10071193	familial cases
10071193	fibroblast
10071193	dna
10071193	bfls-like
10071193	northern blot hybridisation
10071193	situ hybridisation
10071193	artificial chromosome clones
10071193	tissue-specific expression pattern
10071193	gene structure
10071193	fibroblast growth factor homologous factor gene
10071193	duplication breakpoint
8098245	novel mutations
8098245	abnormal pattern
8098245	pah
8098245	cdna sequence
8098245	ivs10
8098245	phenylalanine hydroxylase
8098245	premature termination
8098245	e390g
8098245	illegitimate
8098245	l333f
8098245	present study supports
8098245	illegitimate transcription
8098245	molecular genetic studies
8098245	useful tool
8098245	easy access
8098245	splice acceptor site
8098245	hyperphenylalaninemic children
8098245	missense mutations
8098245	gene transcripts
8098245	phenylalanine hydroxylase gene
8098245	nucleotide sequence
8098245	rna
10958786	colorectal
10958786	chemical inhibitors
10958786	inhibitors block proteolytic processing
10958786	proteolytic activity
10958786	metalloproteases potentiate
10958786	axonal chemoattractant netrin-1 guides spinal commissural axons
10958786	functional extracellular axon guidance receptors
10958786	dcc
10958786	function
10958786	axonal chemoattractant
10958786	deleted
10958786	axon outgrowth
10958786	spinal cord explants
10958786	netrin activity
10958786	metalloprotease activity
10958786	protein levels
10958786	axon migration
10958786	metalloprotease-dependent ectodomain
2886237	segregation analysis
2886237	dxys1
2886237	tcd
2886237	dxys12
2886237	useful diagnostic tool
2886237	formal genealogical proof
2886237	historical-genealogical evidence
2886237	x-linked
2886237	previously
2886237	above haplotype
2886237	tcd/dxys1
2886237	recombination distance
2886237	choroideremia
2886237	common founder couple
2886237	historical-genealogical approach
2886237	finland
2886237	linkage analysis
2886237	carrier females
2886237	progressive tapeto-choroidal dystrophy
2886237	linkage
2886237	large kindreds
2886237	female meioses
2886237	restriction fragment length polymorphisms
10369870	inhibitory domain
10369870	finger transcription factor
10369870	functional consequences
10369870	charcot-marie-tooth
10369870	increases transcriptional activity
10369870	knockout mice
10369870	nab
10369870	zinc finger mutations
10369870	early growth response
10369870	zinc finger
10369870	cys2his2zinc
10369870	transcriptional analysis
10369870	mutations
10369870	krox20
10369870	egr2
10369870	peripheral neuropathies
10369870	transcriptional co-repressors
10369870	dejerine-sottas
10369870	r1
10369870	inheritance patterns
10369870	display hypomyelination
10369870	schwann
10369870	pns
10369870	dna-binding
10369870	possible disease mechanisms
10369870	dna
10369870	early stage
10369870	peripheral nervous system myelination
10369870	human myelinopathies
10369870	functional
10369870	disease severity
10369870	domain mutation prevents interaction
2786201	functional domain
2786201	expression
2786201	human von
2786201	vwd patients
2786201	vwf mrna
2786201	platelet von
2786201	peripheral blood platelets
2786201	recombinant vwf
2786201	important vwf
2786201	molecular
2786201	willebrand
2786201	cis defect
2786201	iia
2786201	characteristic structural abnormality
2786201	vwd plasma
2786201	factor mrna
2786201	vwf mrna transcription
2786201	vwf gene
2786201	large size
2786201	heterologous cells
2786201	polymerase chain reaction
2786201	qualitative defect
2786201	adhesive glycoprotein
2786201	adjacent missense mutations
2786201	silent vwf allele
10430930	pws
10430930	correct imprint
10430930	homologous association
10430930	situ hybridization analyses
10430930	phenotypic basis
10430930	prader-willi
10430930	gene order
10430930	angelman
10430930	epigenotype
10430930	female germ cells
10430930	pws/as-homologous
10430930	etiological genes
10430930	central part
10430930	therapeutic approaches
10430930	lmp2a
10430930	intact chromosome
10430930	replication asynchrony
10430930	angelman syndromes
10430930	mouse chromosome 7c
10430930	epstein-barr
10430930	mouse models
10430930	heritable chromosome deletion mouse model
10430930	mouse chromosome
10430930	human 15q11-q13
10430930	allelic expression
10430930	as
10430930	latent membrane protein
10430930	dna
10430930	complete deletion
10430930	human chromosome 15q11-q13
10430930	somatic cells
10430930	heritable-deletion mouse model
10430930	transgene insertion
10747931	central utility
10747931	transgenic
10747931	molecular mechanisms
10747931	hmg
10747931	ubiquitous expression
10747931	adipose tissue inflammation
10747931	c-terminal
10747931	fusion transcripts
10747931	transgenic mice
10747931	human benign tumors
10747931	perturb adipogenesis
10747931	chromosomal
10747931	animal model
10747931	fusion partner
10747931	common kind
10747931	high incidence
10747931	transcription factors
10747931	i-c dna-binding
10747931	high mobility group
10747931	high prevalence
10747931	dna-binding
10747931	selective abundance
10747931	potential role
10747931	i-c
10747931	hmg i-c
10747931	fat tissue
10747931	human lipomas
10051005	endometrial cancer
10051005	hereditary non-polyposis cancer syndrome
10051005	high risk
10051005	ovarian cancers
10051005	finnish hnpcc
10051005	intersex differences
10051005	colorectal cancer families
10051005	d2s288
10051005	us families
10051005	english
10051005	extensive analysis
10051005	p <
10051005	english hnpcc
10051005	founder effect
10051005	colorectal cancer
10051005	splice site
10051005	mutation carriers
10051005	nt943 +
10051005	n =
10051005	hnpcc
10051005	mlh1
10051005	premenopausal ovarian cancer
10051005	haplotype analysis
10051005	england
10051005	identify colorectal cancer susceptibility modifiers
10051005	recent common origin
10051005	splice site mutation
10051005	gene mutation
10051005	specific differences
10051005	microsatellite markers
10051005	colorectal cancer risks
10051005	newfoundland
10051005	phenotypic expression
10051005	t msh2
10051005	ca5
10051005	msh2
10051005	colorectal families
10051005	common haplotype
7814011	japanese families
7814011	japanese males
7814011	hearing impairment
7814011	norrie
7814011	mutant types
7814011	novel
7814011	gtg
7814011	amino terminus
7814011	typical ocular
7814011	atg
7814011	initiation codon
7814011	new mutation
7814011	disease gene
7814011	gene expression
7814011	nd
7814011	normal nucleotide sequences
7814011	mental retardation
8571953	likely instances
8571953	diverse breast
8571953	breast/ovarian cancer families
8571953	haplotype differences
8571953	mutation origin
8571953	ovarian cancer families
8571953	mutation-specific phenotypes
8571953	brca1
8571953	ovarian cancer
8571953	relative proportions
8571953	international study
8571953	tests
8571953	short-tandem-repeat markers
8571953	haplotype
8571953	polymorphic markers
8571953	haplotype conservation
8571953	high degree
8571953	individual mutations
8571953	family-specific differences
8571953	splice-site mutation
8571953	mutational events
8571953	phenotype analysis
7166314	g6pd nagano
7166314	substrate analogues
7166314	heat instability
7166314	enzyme activity
7166314	chronic nonspherocytic hemolytic anemia
7166314	normal utilization
7166314	g6pd
7166314	new glucose-6-phosphate dehydrogenase variant
7166314	chronic hemolytic anemia
7166314	km g6p
7166314	new variant
7166314	faster-than-normal electrophoretic mobility
7166314	infection-induced
7166314	new glucose-6-phosphate dehydrogenase
7166314	ki nadph
7166314	hemolytic anemia
7166314	thermal instability
7166314	upper respiratory infection
7166314	enzymatic characteristics
7166314	normal ph optimum curve
7166314	hemolytic crisis
7166314	km nadp
7166314	congenital hemolytic anemia
1468459	13-year follow-up
1468459	individual patients
1468459	milder pattern
1468459	hypotonia
1468459	extracranial
1468459	craniofrontonasal
1468459	supportive measures
1468459	developmental delay
1468459	prominent longitudinal grooves
1468459	previous reports
1468459	cfnd
1468459	brittle nails
1468459	frontonasal dysplasia
1468459	classical cases
1468459	craniofrontonasal dysplasia
1468459	coronal craniosynostosis
1468459	clinical expression
1468459	mild
1468459	x-linked
1707231	normal chromosomes
1707231	changes amino acid
1707231	plp
1707231	c-to-t
1707231	pelizaeus-merzbacher
1707231	obligate carriers
1707231	magnetic resonance
1707231	hphi
1707231	new mutation
1707231	proteolipid protein
1707231	german family
7579347	amino acid substitutions
7579347	small platelets
7579347	transient eczema
7579347	severe clinical phenotypes
7579347	point mutations
7579347	x-linked
7579347	xlt
7579347	minimal immune deficiency
7579347	unique mutations
7579347	direct evidence
7579347	patients
7579347	recurrent infections
7579347	direct
7579347	cell lines
7579347	sequence analysis
7579347	termination codons
7579347	complex mutations
7579347	missense mutations
7579347	early termination
7579347	congenital thrombocytopenia
7579347	dna
7579347	was
7579347	splice-site mutation
7579347	wiskott-aldrich
7579347	severe clinical symptoms
7579347	approximate location
7579347	recessive disorder
7579347	gene mutations
1709636	pah
1709636	residual enzyme activity
1709636	phenylalanine hydroxylase
1709636	variant forms
1709636	pku
1709636	portugal
1709636	kinetic variant
1709636	autosomal recessive disease
1709636	phenylalanine hydroxylase gene results
1709636	hepatic enzyme
1709636	3-base pair in-frame deletion
1709636	activity results
1709636	mutant phenotype
1709636	phenylketonuria
1709636	study suggests
1709636	mild variant
1709636	particular deletion
1709636	functional evidence
1709636	km
1709636	molecular event
10633128	currently
10633128	autosomal recessive neurodegenerative disease
10633128	excess production
10633128	rational therapeutic strategies
10633128	cellular damage
10633128	mutant alleles
10633128	natural course
10633128	free radicals
10633128	trinucleotide repeat
10633128	friedreich
10633128	frda
10633128	rapid advances
10633128	recent discovery
10633128	gaa
10633128	possible function
10737119	clinical classification
10737119	genetic criteria
10737119	autosomal dominant forms
10737119	sensorineural deafness
10737119	dopa-responsive dystonia
10737119	atp-binding
10737119	gtp
10737119	ddp
10737119	i. e.
10737119	primary dystonias
10737119	article reviews
10737119	mental retardation
10737119	major symptom
10737119	x-linked
10737119	date gene loci
10737119	clinical
10737119	primary
10737119	focal dystonia
10737119	gene
10737119	recessive form
10737119	dystonia parkinsonism syndrome
10737119	molecular genetics
10737119	paroxysmal dystonic choreoathetosis
10737119	pedigree analyses
10737119	mendelian
10737119	mutations
10737119	xq22
10737119	adult-onset idiopathic torsion dystonia
10737119	disease genes
10737119	dyt5
10737119	autosomal recessive variant
10737119	idiopathic torsion dystonia
10737119	recessive forms
10737119	movement disorders
10737119	distinct autosomal dominant
10737119	dyt1
10737119	unknown function
10737119	xq13
10533031	clinical
10533031	diabetes mellitus
10533031	genetic study
10533031	patients homozygous
10533031	australian
10533031	significant correlation
10533031	mutant alleles
10533031	autosomal recessive disorder
10533031	210-amino acid protein
10533031	foot deformity
10533031	trinucleotide repeat
10533031	friedreich
10533031	point mutation
10533031	bladder symptoms
10533031	frda
10533031	allele size
10533031	gaa
10533031	wheelchair use
10533031	vibration sense
492812	absent
492812	immunologic mechanisms
492812	c6-deficient
492812	immune competence
492812	meningococcal meningitis
492812	black girl
492812	recurrent
492812	normal chemotactic
492812	recurrent neisserial infections
492812	recurrent meningococcal meningitis
492812	c6
492812	bacteriolytic activity
492812	phagocyte bactericidal activity
492812	complement components
492812	specific antibody activity
492812	complement-dependent assay
492812	consistent defect
492812	alternative complement pathway
492812	normal serum
10519880	polymerase chain reaction-single strand conformation polymorphism
10519880	reverse transcription
10519880	blood leucocytes
10519880	mutation
10519880	objectives
10519880	sterol 27-hydroxylase gene
10519880	constructive abnormality
10519880	patients cdna fragment
10519880	cerebrotendinous xanthomatosis
10519880	pcr
10519880	methods
10519880	pcr-sscp
10519880	cyp27
10519880	splice donor site
10519880	samples
10519880	simple technique
10519880	sequence alteration
10519880	results
10519880	direct conjuction
10519880	ctx
10519880	conclusion
10519880	rapid technique
10519880	rt-pcr
10519880	italian patient
10519880	rna
8187068	therapeutic agents
8187068	transurethral resections
8187068	ala
8187068	polymerase chain
8187068	stimulatory effect
8187068	prostate cancer
8187068	frequent
8187068	act
8187068	direct
8187068	metastatic prostate cancer cell line
8187068	selective growth advantage
8187068	metastatic prostate cancer
8187068	androgen receptor
8187068	dnas
8187068	growth factor receptor oncogene
8187068	treatment refractory disease
8187068	lncap
8187068	hormonal therapy
8187068	prostate cancers
8187068	genetic alterations
8187068	prostatic
8187068	tissue specimens
8187068	mutation confers
8187068	ar
8187068	gct
8187068	thr
8187068	androgen receptor gene
10802669	nibrin-mre11-rad50 association
10802669	phosphorylation
10802669	cerebellar dysfunction
10802669	foci formation
10802669	breakage syndrome
10802669	chromosomal instability
10802669	biochemical pathway
10802669	radiation exposure
10802669	dsbs
10802669	rad50
10802669	a-t
10802669	phosphorylates nibrin
10802669	nijmegen
10802669	s343a
10802669	atm
10802669	strong parallels
10802669	genetic disorder ataxia-telangiectasia
10802669	mutations
10802669	nuclear foci
10802669	complex localizes
10802669	ir
10802669	atm-dependent
10802669	full-length mutant protein
10802669	biochemical explanation
10802669	nbs
10802669	dna-damage
10802669	sensors suggests
10802669	nbs1
10802669	biochemical pathways
10802669	cellular phenotypes
10802669	dna
10802669	mre11
10802669	cancer predisposition
10802669	cellular exposure
10802669	complement radiosensitivity
1346924	dominant condition segregates
1346924	fragment varies
1346924	ercc1
1346924	detection
1346924	myotonic
1346924	dna
1346924	myotonic dystrophy
1346924	progressive muscle weakness
1346924	clinical variability
1346924	disease show extreme variation
1346924	muscle contraction
1346924	genetic markers
1346924	critical region
1346924	unstable fragment
1346924	wide range
1346924	muscular dystrophy
1346924	normal siblings
1346924	dm
1346924	d19s51
1346924	common form
10987655	single-strand conformation analysis
10987655	different missense mutations
10987655	distinct disorders
10987655	point mutation
10987655	furthermore
10987655	recurrent muta tion
10987655	novel missense mutation
10987655	different chromosome
10987655	recurrent mutations
10987655	spinocerebellar ataxia
10987655	g5260a
10987655	cacna1a
10987655	amino acid substitution
10987655	ca2
10987655	family member
10987655	detection
10987655	mutations
10987655	+ channel alpha1 subunit gene
10987655	sca6
10987655	familial hemiplegic migraine
10987655	c2272t
10987655	p/q
10987655	protein product
10987655	ea-2
10987655	fhm
10987655	recurrent mutation
10987655	episodic ataxia type
10987655	mild clinical signs
10987655	additionally
10987655	present study
10213492	multiple colorectal adenomas
10213492	molecular explanation
10213492	mutations cluster
10213492	central region
10213492	severe polyposis
10213492	genotype-phenotype correlations
10213492	germ-line mutations
10213492	apc
10213492	apc1309
10213492	negative effect
10213492	mutation cluster region
10213492	subsequent carcinomas
10213492	colon epithelial cells
10213492	inactivation
10213492	colorectal tumor growth
10213492	patients
10213492	together
10213492	wild-type apc
10213492	loss
10213492	dominant
10213492	disease correlates
10213492	possible explanation
10213492	fap
10213492	experimental evidence
10213492	gene products
10213492	familial adenomatous polyposis
10213492	gene product initiates colorectal tumorigenesis
10213492	adenomatous polyposis coli
10213492	genotype-phenotype correlation
1717985	kit
1717985	gene mutation
1717985	mutation results
1717985	gly
1717985	mast/stem cell growth factor receptor
1717985	autosomal dominant genetic disorder
1717985	mutation
1717985	normal individuals
1717985	probands family
1717985	human homologue
1717985	cogenital patches
1717985	similar disorder
1717985	human piebaldism
1717985	c-kit protooncogene
1717985	piebaldism
1717985	arg
1717985	mast/stem cell growth factor
1717985	tyrosine kinase domain
1717985	classic autosomal dominant piebaldism
1717985	piebald phenotype
8104633	threonine residue
8104633	missense mutation
8104633	escherichia
8104633	lebanese
8104633	adjacent intron boundaries
8104633	metachromatic
8104633	single-strand conformation polymorphism analysis
8104633	t274m
8104633	discrete reactions
8104633	enzyme activity
8104633	pcr
8104633	ec
8104633	severe clinical presentatio
8104633	mld
8104633	amino acid
8104633	consanguineous marriages
8104633	autosomal recessive lysosomal storage disorder
8104633	analysis
8104633	arsa
8104633	additional homozygotes
8104633	resultant mutant protein
8104633	polymerase chain reaction
8104633	sequence alterations
8104633	amplified arsa
8104633	late-infantile metachromatic leukodystrophy
8104633	iv
7717396	3-bp deletion
7717396	recently
7717396	sscp
7717396	clinical expressions
7717396	atp-binding
7717396	missense mutation
7717396	ald
7717396	addison
7717396	female relatives
7717396	site mutation
7717396	i. e.
7717396	crucial role
7717396	prenatal diagnosi
7717396	current biochemical techniques
7717396	sufficient reliability
7717396	x-linked
7717396	x-ald
7717396	systematic mutation
7717396	pcr
7717396	cerebral childhood
7717396	aldp/pmp70
7717396	nonsense mutation
7717396	severe childhood
7717396	amino acid
7717396	mutations
7717396	ado
7717396	common peroxisomal disorder
7717396	different clinical phenotypes
7717396	amn
7717396	disruptive nature
7717396	frameshift mutation
7717396	analysis
7717396	different clinical expression
7717396	38-bp deletion
7717396	gene play
7717396	clinical phenotype
7717396	classical picture
7717396	carrier detection
7717396	dna
7717396	families lack
7717396	peroxisomal membrane transporter protein
8571951	recent observation
8571951	aoii
8571951	ao ii
8571951	biochemical pathway
8571951	dtdst
8571951	sulfate-transporter gene
8571951	inorganic sulfate
8571951	defective uptake
8571951	insufficient sulfation
8571951	atelosteogenesis
8571951	ii
8571951	together
8571951	severe diastrophic dysplasia
8571951	ib
8571951	lethal chondrodysplasia
8571951	severe chondrodysplasia
8571951	patient mesenchymal cells
8571951	dtd
8571951	similarity suggests
8571951	residual activity
8571951	histological characteristics resemble
8571951	diastrophic dysplasia sulfate-transporter gene
8571951	achondrogenesis type
8571951	phenotypic series
10732816	postcervical muscles
10732816	ultrathin cryosections
10732816	nuclear pore
10732816	muscle disorder
10732816	gold particles
10732816	high risk
10732816	emerin
10732816	edmd
10732816	rigorous contraction-relaxation movements
10732816	hydrophilic region
10732816	x-linked
10732816	achilles
10732816	hela
10732816	humero-peroneal muscles
10732816	severe stress
10732816	cytoplasmic surface
10732816	muscle tissues
10732816	human skeletal muscle
10732816	muscular dystrophy
10732816	membrane proteins
10732816	clinical triad
10732816	cardiac conduction block
10732816	solubilizes membrane lipids
10732816	inner nuclear membrane
10732816	smooth muscles
10732816	xq28
10732816	emerin anchors
10732816	calcium flux
10732816	emerin contributes
10732816	nucleoplasmic surface
10732816	emery-dreifuss
10732816	nuclear membrane
10732816	nuclear lamina
10732816	detergent treatment
10732816	nuclear functions
10732816	novel protein
10732816	sudden death
10732816	possible physiological role
10732816	ultrastructural localization
10732816	early contractures
10732816	non-muscle tissues
10732816	nuclear structure
10447258	syndrome phenotype
10447258	milder phenotypes
10447258	complementation group
10447258	furthermore
10447258	zellweger
10447258	molecular basis
10447258	pmp70
10447258	molecular
10447258	refsum
10447258	subsequent studies
10447258	syndrome patient
10447258	1-bp insertion
10447258	pmp70-deficient
10447258	pex1-deficient
10447258	pex1
10447258	syndrome patients
10447258	previous studies
10447258	high percentage
10447258	c. 2097inst
10447258	identification
10447258	functional peroxisomes
10447258	neonatal adrenoleukodystrophy
10447258	cell
10447258	cell biology studies
10447258	cg1
10447258	fusion complementation studies
10447258	protein function
10861282	gene increase susceptibility
10861282	recurrence risk ratio
10861282	parent-case trio families
10861282	poor metabolizer alleles
10861282	non-mhc gene
10861282	debrisoquine hydroxylase
10861282	association studies
10861282	polymorphisms
10861282	weak
10861282	significant
10861282	case-control studies
10861282	sporadic cases
10861282	susceptibility gene
10861282	genetic risk
10861282	familial rheumatic disorder
10861282	parent-case trios
10861282	previous
10861282	sibling-pair families
10861282	homozygosity
10861282	heterozygosity
10861282	cyp2d6*4
10861282	mhc
10861282	hla-b27
10861282	as
10861282	chromosome 22q13.1
10861282	phenotypic expression
10861282	twins >
10861282	p450
10861282	linkage study
10861282	ankylosing
10861282	cyp2d6
10861282	natural toxin
10861282	frequent poor metabolizer allele
10746568	gene promoter region
10746568	reporter gene assay
10746568	family studies
10746568	novel mutations
10746568	heterozygous relatives
10746568	novel hexanucleotide insertion/deletion polymorphism
10746568	polymorphism genotype
10746568	genotype-phenotype relationship
10746568	f10
10746568	autosomal recessive trait
10746568	basepair substitutions
10746568	factor x
10746568	sporadic cases
10746568	such relationship
10746568	autosomal dominant pattern
10746568	negative effect
10746568	molecular
10746568	laboratory phenotype
10746568	luciferase reporter gene assay
10746568	variation
10746568	rare haemorrhagic condition
10746568	antigen level
10746568	individual mutant
10746568	prime determinant
10746568	missense
10746568	variable clinical presentation correlates
10746568	promoter activity
10746568	laboratory phenotypes
10746568	splice sites
10746568	protein product
10746568	splice-site mutation
10746568	deletion allele
10888879	new stacks
10888879	stable generation
10888879	electrophysiological correction
10888879	photoreceptor function
10888879	photoreceptor ultrastructure
10888879	photoreceptor discs
10888879	complex ultrastructural cell defect
10888879	photoreceptor-specific membrane glycoprotein
10888879	aav
10888879	visual pigments
10888879	undetectable concentrations
10888879	autosomal dominant retinitis pigmentosa
10888879	null mutation
10888879	retinal degeneration
10888879	prph2rd2/rd2
10888879	apoptotic loss
10888879	prph2 rd2/rd2
10888879	photoreceptor cells
10888879	structural integrity
10888879	ergs
10888879	photoreceptor dystrophies
10888879	prph2
10888879	mutations
10888879	slow mice
10888879	complete failure
10888879	transgene results
10888879	vivo gene
10888879	photoreceptor layer
10888879	restoration
10888879	normal outer segments
10888879	subretinal
10888879	outer segment structures
10888879	outer segments
10888879	b-wave amplitudes
10888879	photoreceptor outer segment discs
10888879	gene therapy
10888879	macular dystrophy
2563633	pku
2563633	samoans
2563633	asia
2563633	common haplotypes
2563633	polynesian
2563633	pah
2563633	cook islanders
2563633	phenylalanine hydroxylase
2563633	severe phenylketonuria
2563633	evolutionary origins
2563633	precursor populations
2563633	tongans
2563633	gene locus
2563633	considerable genetic continuity
2563633	control group
2563633	major haplotypes
2563633	maori
2563633	caucasians
2563633	asians
2563633	phenylalanine
2563633	genetic homogeneity
2563633	polynesians
2563633	hydroxylase gene haplotypes
2563633	asian affinities
2563633	niueans
10557309	developmental transcription factor
10557309	myogenin
10557309	pax3-fkhr
10557309	alveolar
10557309	aggressive pediatric cancer
10557309	alveolar rhabdomyosarcoma cell lines
10557309	igfbp5
10557309	igf2
10557309	six1
10557309	cdna microarrays detect activation
10557309	pax3
10557309	slug
10557309	study utilizes cdna microarrays
10557309	oncogenic transcription factor
10557309	gene expression
10557309	gene possesses
10557309	resultant gene expression changes
10557309	profound myogenic properties
10557309	relevance
10557309	murine cdna microarray
10557309	growth factor gene
10557309	chimeric oncogene
10557309	hsix1
10557309	limb myogenesis
10557309	transcription factors
10557309	forkhead family
10557309	fkhr
10557309	myod
10557309	muscle function
10557309	fusion oncogene
10557309	myogenic transcription program
10557309	nih
3032521	observation raises doubts
3032521	quantitative
3032521	situ hybridization
3032521	normal homolog
3032521	retinoblastoma locus
3032521	human chromosomes
3032521	re-evaluation
3032521	rb1
3032521	situ hybridization studies
3032521	esd
10612394	hypomorphic mutations
10612394	jun
10612394	hmre11/hrad50/nbs1 protein
10612394	mutant hmre11 proteins
10612394	repair gene hmre11
10612394	atld
10612394	hmre11 mutations
10612394	a-t
10612394	certain individuals
10612394	hmre11 mutant cells
10612394	atm
10612394	link hmre11
10612394	damage response pathway
10612394	atm-dependent
10612394	gamma irradiation
10612394	nbs
10612394	nbs1
10612394	complex act
10612394	complex pathology
10612394	dna
10612394	ataxia-telangiectasia-like disorder
2450401	myogenic cell cultures
2450401	normal human muscle
2450401	muscle fibers
2450401	human muscle
2450401	normal fetal muscle
2450401	expression
2450401	skeletal muscle
2450401	dmd
2450401	muscular dystrophy
2450401	duchenne
2450401	rna
2450401	muscular dystrophy gene expression
2450401	myoblast fusion
6086495	short arm
6086495	rflps
6086495	dna
6086495	linkage analysis
6086495	linkage study
6086495	muscular dystrophy gene
6086495	localisation
6086495	centromeric region
6086495	p21 region
6086495	becker
6086495	bmd
6086495	duchenne
6086495	restriction fragment length polymorphisms
6086495	muscular dystrophy
6086495	practical use
10830915	negative selection
10830915	at-risk alleles
10830915	triplet repeat expansion mutation
10830915	% confidence interval
10830915	+/-203 generations
10830915	age
10830915	vast majority
10830915	large expansion
10830915	linkage disequilibrium analysis
10830915	mutational event
10830915	europe
10830915	friedreich
10830915	frda
10830915	gaa
10830915	haplotype data
10830915	polymorphic markers
10830915	ancient spread
10830915	frataxin gene
10556298	transcripts encode putative proteins
10556298	pws
10556298	critical region
10556298	prader-willi
10556298	mouse homologue
10556298	specific expression
10556298	human candidate
10556298	complex neurogenetic disorder
10556298	mouse model
10556298	mouse homologues
10556298	molecular basis
10556298	magel2/magel2
10556298	mage
10556298	northern blot analysis
10556298	direct repeat sequences
10556298	paternal allele
10556298	cpg
10556298	ndn/ndn
10556298	adult brain
10556298	mouse models
10556298	human 15q11-q13 region
10556298	ndn
10556298	human 15q11-q13
10556298	rt-pcr
10556298	mouse 7c regions
10556298	new genes
10556298	potential role
10556298	magel2
10556298	contiguous gene syndrome
1361100	potential roles
1361100	pku
1361100	present distribution
1361100	chromosomal haplotypes
1361100	comprehensive european sample population
1361100	genetic mechanisms
1361100	rflps
1361100	r158q
1361100	pah
1361100	r408w
1361100	ethnic groups
1361100	phenylketonuria
1361100	distinct origins
1361100	amino acid metabolism prevalent
1361100	together
1361100	relative frequencies
1361100	multiple
1361100	ivs12n1
1361100	europe
1361100	significant differences
1361100	r261q
1361100	hepatic enzyme phenylalanine hydroxylase
1361100	time periods
1361100	haplotype associations
1361100	specific ethnic subgroups
1361100	caucasians
1361100	ivs10nt546
1361100	molecular lesions
1361100	european population
1361100	heterogeneous disorder
10724160	binding
10724160	actin regulatory machinery
10724160	wasp
10724160	distinct structural
10724160	domain occlude residues
10724160	functional states
10724160	c-terminal
10724160	activation
10724160	organic co-solvents
10724160	intramolecular interactions
10724160	domain causes
10724160	autoinhibition
10724160	rho-family gtpase
10724160	cdc42
10724160	autoinhibitory contact
10724160	family members
10724160	arp2/3
10724160	carboxy-terminal region
10724160	gtpase-binding
10724160	actin cytoskeleton
10724160	dramatic conformational
10724160	syndrome protein
10724160	wiskott-aldrich
10724160	data show
10724160	c terminus
10724160	hydrophobic core
10724160	activation mechanisms
1733838	dxs426
1733838	xp
1733838	norrie
1733838	4-xp11 4-xp11
1733838	informative crossover localize
1733838	xp11
1733838	informative microsatellite marker
1733838	gene proximal
1733838	localisation
1733838	maps proximal
1733838	dxs7
1733838	dsx426
1733838	ndp
7479827	human mitochondrial very-long-chain acyl-coa dehydrogenase deficiency
7479827	missense mutation
7479827	c1837
7479827	] catalyzes
7479827	polymerase
7479827	molecular defects
7479827	base deletion
7479827	complete nucleotide sequences
7479827	defects
7479827	liver failure
7479827	initial delineation
7479827	very-long-chain
7479827	ec
7479827	molecular
7479827	vlcad
7479827	acute hepatic encephalopathy
7479827	homozygous mutation
7479827	acyl-coa dehydrogenase [
7479827	consensus dinucleotide
7479827	skeletal myopathy
7479827	major source
7479827	donor splice site
7479827	compound heterozygote
7479827	energy production
7479827	sudden death
7479827	long-chain fatty acids
7479827	beta-oxidation pathway
7479827	genomic exons
7479827	cardiac arrest
7479827	deficiency reduces myocardial fatty acid beta-oxidation
7479827	g +
7479827	chain reaction amplification
7479827	human mutations
1577476	consensus splice site
1577476	dystrophin mrna processing
1577476	x-linked
1577476	animal homologue
1577476	processing error
1577476	fatal disease
1577476	dmd
1577476	muscular dystrophy
1577476	duchenne
1577476	dystrophin deficiency
1577476	dystrophin reading frame
1577476	detectable deletions
1577476	two-thirds
1577476	detectable loss
1577476	grmd
1577476	analysis
1577476	n-terminal
1577476	splice-site mutation
1577476	canine dystrophin gene
1577476	golden retriever
1577476	rna
1577476	dystrophin gene
1981994	jews
1981994	mef
1981994	mef-associated
1981994	family studies
1981994	serum
1981994	candidate gene approach
1981994	tight linkage
1981994	protein genes
1981994	mediterranean
1981994	saa
1981994	recent studies
1981994	apcs
1981994	armenians
1981994	allele frequency
1981994	healthy parents
1981994	serum amyloid
1981994	lod score =
1981994	mef-amyloidosis
1981994	informative families
1201235	genoa
1201235	italian
1201235	italian ancestry
1201235	enzyme deficiency
1201235	sicily
1201235	sardinia
1201235	calabria
1201235	gddcbrousse-like
1201235	italy
1201235	screening
1201235	a-
1201235	mediterranean
1201235	newborn babies
1201235	g6pd
1201235	maternity
1201235	cord blood
1201235	dehydrogenase variants
1201235	different variants
1201235	non-immunological origin
1201235	galliera
1201235	peripheral blood
1201235	sardinian
1201235	glucose-6-phosphate
1201235	severe neonatal jaundice
1201235	abnormal enzymes
1201235	present work
1201235	gdagrigento
1201235	gdgallura
1351034	adrenocorotical carcinoma
1351034	loss
1351034	loh
1351034	normal allele
1351034	familial adenomatous polyposis
1351034	apc
1351034	endocrine
1351034	functional loss
1351034	desmoid tumor
1351034	benign tumors
1351034	present results
1351034	various parts
1351034	adrenocortical carcinoma
1351034	family history
1351034	adenomatous polyposis coli
1351034	adrenocortical tumors
1351034	heterozygous mutant/wild-type condition
1351034	fap
1351034	previous data
7191069	myasthenia gravis
7191069	c2
7191069	hla
7191069	complement
7191069	mg
7191069	deficiency states
7191069	heterozygous c2-deficiency
7191069	immediate family
7191069	19-year-old woman
10472529	diagnostic mutation analysis
10472529	mutant alleles
10472529	clinical severity
10472529	pah
10472529	recessive disorders relies
10472529	phenylalanine hydroxylase
10472529	large deletion
10472529	e390g
10472529	pcr
10472529	homozygous missense mutation
10472529	presence
10472529	comprehensive examination
10472529	diagnostic dna
10472529	clinical use
10472529	paternal allele
10472529	heterozygous deletion
10472529	polymorphic markers
10472529	molecular analyses
10472529	standard methods
10472529	carrier status
10472529	dna
10472529	unusual pattern
10472529	whole relevant gene
10472529	exact characterization
10472529	phenylalanine hydroxylase gene
10472529	large
2912069	milder form
2912069	biochemical studies
2912069	g6pd seattle-like
2912069	mediterranean
2912069	independent mutational events
2912069	g6pd
2912069	different geographical areas
2912069	glucose 6-phosphate dehydrogenase
2912069	sardinia
2912069	careful clinical
2912069	point mutations
2912069	x-linked
6902670	c2
6902670	dw2
6902670	discoid lupus erythematosus
6902670	hla-acb/dbf
6902670	bf
6902670	family members
6902670	hla-dw2
6902670	hla-b
6902670	chronic discoid lupus erythematosus
6902670	linkage
6902670	factor b
6902670	b18
6902670	deficiency gene
6902670	slow allotype
6902670	histocompatibility markers
6902670	familial
6902670	hla-b18
6902670	bfs
6902670	close linkage
6902670	hla-d
7545954	amino acids
7545954	ovarian cancer susceptibility
7545954	amino-terminal region
7545954	strong candidate
7545954	numerous tissues
7545954	missense substitution
7545954	influences susceptibility
7545954	brca1
7545954	identification
7545954	ovarian cancer susceptibility gene
7545954	ovarian cancer
7545954	11-base pair deletion
7545954	susceptibility alleles
7545954	1-base pair insertion
7545954	zinc finger domain
7545954	regulatory mutation
7545954	stop codon
7545954	breast cancer biology
7545954	protein contains
8198128	kb centromeric
8198128	probable historic recombination
8198128	island patients
8198128	d9s15
8198128	ataxia locus
8198128	descent localize
8198128	order cen-frda-d9s5-d9s15-qter
8198128	yac
8198128	markers proximal
8198128	distal recombination
8198128	candidate genes
8198128	taken
8198128	severe neurodegenerative disease
8198128	frda
8198128	rare recombination events
8198128	reunion
8198128	genetic information
8198128	individuals homozygous
8198128	friedreich
8198128	direct search
8198128	450-kb interval
8198128	cosmid contig
8198128	founder haplotypes
8198128	results place
8198128	rare cutter restriction map
8198128	phase-known recombination
8198128	new microsatellite markers
8198128	centromeric side
8198128	d9s5
8198128	1-cm confidence interval
8198128	recombinations
2220826	likely order
2220826	d11s144
2220826	genetic markers
2220826	recent refinements
2220826	at
2220826	ataxia-telangiectasia group
2220826	thy1
2220826	present paper
2220826	contiguous segments telomeric
2220826	11q22-23 region
2220826	physical maps
2220826	s144
2220826	ataxia-telangiectasia locus
2220826	] segment
2220826	linkage analysis
2220826	ata
2220826	location
2220826	stmy-s144
2220826	contiguous subsegments
2220826	s144-thy1
2220826	chromosome 11q22-23
2220826	centromeric [
1311721	normal lymphocytes
1311721	hl-60
1311721	proliferation-related
1311721	large tumor mass
1311721	leukemia cell line
1311721	variable expression
1311721	normal human
1311721	inhibits proliferation
1311721	cell proliferation
1311721	high level expression
1311721	mitotic stimulation
1311721	p19/nm23 nucleoside diphosphate kinase
1311721	nucleoside diphosphate kinase
1311721	stage tumors
1311721	p19/nm23 levels
1311721	two-dimensional electrophoretic gels
1311721	different subtypes
1311721	cell proliferative activity
1311721	induces terminal differentiation
1311721	nm23-h1 expression
1311721	nm23-h1 gene
1311721	dna
1311721	protein product
1311721	different tumors
1311721	n-myc
1311721	acute leukemia
1311721	pbls
1311721	leukemia cells
1311721	stage disease
116187	pyruvate
116187	detect carriers
116187	skin fibroblasts
116187	pepck
116187	pyruvate carboxylase deficiency
116187	carrier
116187	peripheral lymphocytes
116187	e. c.
116187	renal cortical
116187	fibroblast pyruvate carboxylase deficiency
116187	fibroblasts
116187	autosomal recessive manner
116187	patients mother
116187	pc portland
116187	lymphocyte
116187	pyruvate carboxylase
2852474	genomic sequences
2852474	japanese patients
2852474	j-bir
2852474	ert87-1
2852474	deletion suggests
2852474	b24
2852474	clinical manifestations
2852474	restriction endonucleases
2852474	c7
2852474	otc-1
2852474	gonadotropin deficiency
2852474	mental retardation
2852474	certain gene
2852474	ornithine transcarbamylase
2852474	ahc
2852474	high-resolution gtg-banded
2852474	glycerol kinase deficiency
2852474	ert87-8
2852474	cgkd
2852474	d2
2852474	otc
2852474	dmd
2852474	muscular dystrophy
2852474	duchenne
2852474	xp21
2852474	glycerol kinase
2852474	complex
2852474	southern hybridizations
2852474	congenital adrenal hypoplasia
2852474	previous studies
2852474	clinical studies
2852474	p20
2852474	ert87-30
2852474	complex glycerol kinase deficiency
2852474	dnas
2852474	xj-1
2852474	l1-4
2852474	gk
2852474	j66-hi
2852474	ert87-15
2852474	putative genes
2852474	dna
2852474	gtd
2852474	male japanese patients
2852474	muscle weakness
2852474	present study
7726234	strong history
7726234	ambulatory post age
7726234	histopathological levels
7726234	dystrophin revertant fibers
7726234	myotonic
7726234	myotonic dystrophy
7726234	clinical severity
7726234	pathophysiological interactions
7726234	dmd
7726234	intrafamilial pathological expansion
7726234	muscular dystrophy
7726234	ctg
7726234	dystrophin deficiency
7726234	duchenne
7726234	muscle biopsy
7726234	somatic mosaic
8500791	mature vwf subunit
8500791	close molecular relationship
8500791	cos-1
8500791	polymerase
8500791	point mutation
8500791	autosomal hemophilia.
8500791	hemophilia phenotype
8500791	heterozygous family members
8500791	vwf mutation
8500791	putative factor
8500791	x-linked
8500791	differential diagnosis
8500791	describe demonstrates
8500791	recessive inheritance
8500791	pcr
8500791	chain reaction
8500791	recombinant
8500791	recessive transmission
8500791	defective factor
8500791	amino acid substitution
8500791	willebrand
8500791	met
8500791	amino acid position
8500791	autosomal
8500791	coagulation factor
8500791	female patient
8500791	viii
8500791	autosomal inheritance
8500791	low levels
8500791	wild-type vwf
8500791	dna
8500791	factor mutation
8500791	phenotypic expression
8500791	mutant vwf
8500791	inheritance pattern
8500791	thr
8500791	bind factor
10737980	very-long-chain fatty acids
10737980	sscp
10737980	skin fibroblasts
10737980	sequence-determination reactions
10737980	vlcfas
10737980	nervous system
10737980	adrenal cortex
10737980	distinct clinical phenotypes
10737980	x-linked
10737980	x-linked adrenoleukodystrophy
10737980	x-ald
10737980	pcr
10737980	effective
10737980	vlcfa
10737980	white matter
10737980	c22
10737980	normal results
10737980	particular concern
10737980	mutation detection
10737980	frequent peroxisomal disease
10737980	genetic status
10737980	obligate female carriers
10737980	principal biochemical abnormality
10737980	female members
10737980	diagnosis
10737980	carrier status
10737980	determination
10737980	fast method
10737980	c26
10737980	adrenoleukodystrophy mutations
7894491	final cysteine
7894491	clinical application
7894491	early-onset breast
7894491	germline mutations
7894491	mutations
7894491	sscp
7894491	missense mutations
7894491	large size
7894491	tumour suppressor model
7894491	candidate gene
7894491	dna
7894491	brca1
7894491	zinc finger motif
7894491	pcr-amplified
7894491	family history
7894491	ovarian cancer
7894491	single-strand conformation polymorphism
7894491	breast and/or ovarian cancer
7894491	nonsense mutations
2355960	insertion mutation
2355960	mutant allele
2355960	mutant alleles
2355960	dna-based
2355960	background and methods
2355960	adult-onset disease
2355960	diagnostic tests
2355960	gm2
2355960	ashkenazi jews
2355960	severe exon
2355960	screening
2355960	conclusions
2355960	tay-sachs
2355960	useful adjunct
2355960	enzyme tests
2355960	hexa
2355960	ashkenazi
2355960	i. e e.
2355960	splice-junction mutation
2355960	enzyme test
2355960	false negative enzyme-test result
2355960	mutation sites
2355960	specific mutations
2355960	results
2355960	high frequency
2355960	autosomal recessive disorder
2355960	polymerase chain reaction
2355960	dna
2355960	predictive value
2355960	obligate carriers
2355960	adult-onset form
8002973	gene encodes
8002973	c-terminal
8002973	northern blot analysis
8002973	control fibroblasts
8002973	punctate pattern
8002973	ald
8002973	adrenoleukodystrophy
8002973	293t cells
8002973	kda protein
8002973	expression vector
8002973	western blot
8002973	normal fibroblasts
8002973	kda band protein
8002973	kda membrane protein
8002973	immunocytological study
8002973	x-linked
2568588	normal retinoblastoma gene
2568588	genetic markers
2568588	point mutation
2568588	bilateral patients
2568588	preferential
2568588	maternal allele
2568588	allele suffers
2568588	germ line
2568588	somatic retinal cell
2568588	new germline mutations
2568588	paternal allele
2568588	early embryo affects chromosomal susceptibility
2568588	retinoblastoma tumours
2568588	non-familial cases
2568588	early embryo
2568588	unilateral tumours
2568588	rb1
2568588	family history
2568588	germline mutation
2568588	rb1-linked
2568588	mutational event
2568588	malignant proliferation
2568588	parental origin
2568588	new germline
2568588	unilateral patients
10817650	missense mutation
10817650	amino acid composition
10817650	mutation
10817650	common mutation types
10817650	ischemic heart disease
10817650	splice junctions
10817650	a-t
10817650	pcr
10817650	unique mutations
10817650	splice site
10817650	patients
10817650	nonsense mutations
10817650	mutations
10817650	height distribution
10817650	early mortality
10817650	ataxia-telangiectasia locus
10817650	different ways
10817650	specific mutations
10817650	distinctive autosomal recessive syndrome
10817650	in-frame deletion
10817650	n-terminal
10817650	gene product
10817650	clinical phenotype
10817650	clinical phenotypes
10817650	dna
10817650	shorter survival
10817650	heteroduplex
10817650	chromosome band
10817650	predispose heterozygotes
10817650	alterations
7815415	full mutation
7815415	relentless process
7815415	different branches
7815415	subsequent generations
7815415	adult type
7815415	anticipation
7815415	risk family members
7815415	ancestral generations
7815415	myotonic dystrophy gene
7815415	clinical
7815415	gene
7815415	female transmission bias
7815415	mild disease
7815415	asymptomatic cases
7815415	gene carriers
7815415	congenital disease
7815415	risk subjects
7815415	long term
7815415	high population frequency
7815415	patient group
7815415	asymptomatic/mild phenotype
7815415	gene loss
7815415	male patients
7815415	adult onset disease
7815415	myotonic dystrophy
7815415	protomutation carriers
7815415	stable transmission
7815415	unequal number
7815415	dm
7815415	male parent
10571943	fs
10571943	defective alternative
10571943	new mutations
10571943	molecular biological point
10571943	exon
10571943	splice isoforms
10571943	syndromes originate
10571943	atypical form
10571943	wt1
10571943	gene abnormality
10571943	kts
10571943	denys-drash
10571943	dds
10571943	frasier
10500204	yfh1
10500204	vivo mitochondrial
10500204	autosomal recessive degenerative disorder
10500204	gaa
10500204	mitochondrial disorder
10500204	triplet expansion
10500204	vibration sense
10500204	yeast frataxin homologue gene
10500204	vivo evidence
10500204	maximum rate
10500204	frda
10500204	limb ataxia
10500204	normal range
10500204	severe defect
10500204	gene encodes
10500204	atp
10500204	mitochondrial respiration
10500204	oxidative phosphorylation
10500204	friedreich
10500204	strong negative correlation
10500204	skeletal muscle
10500204	frataxin
10500204	mitochondrial function
10500204	deep tendon reflexes
10500204	210-aa protein
10500204	muscle mitochondrial
10500204	magnetic resonance spectroscopy
10500204	deficit
10500204	extensor plantar responses
10500204	progressive gait
2912886	heat
2912886	normal apparent affinity
2912886	g6pd duarte
2912886	severe erythrocytic
2912886	normal electrophoretic mobility
2912886	biphasic ph curve
2912886	molecular characteristics
2912886	substrate analogues
2912886	chronic
2912886	abnormal utilization
2912886	enzyme activity
2912886	2-deoxyglucose-6-phosphate utilization
2912886	chronic nonspherocytic hemolytic anemia
2912886	molecular
2912886	nadp
2912886	g6pd
2912886	molecular study
2912886	g6pd bangkok
2912886	oxidant drugs
2912886	new variant
2912886	acidic ph optimum
2912886	particular characteristic
2912886	present variant
2912886	normal activity
2912886	new glucose-6-phosphate dehydrogenase
2912886	g6pd clinic
2912886	fap
2912886	familial amyloidotic polyneuropathy
2912886	km
2912886	standard methods
2912886	phosphate dehydrogenase
2912886	residual activity
2912886	g6p
2912886	faba beans
2912886	residual
2912886	low ph
2912886	nonspherocytic hemolytic anemia
2912886	unusual ph curve
2912886	young patient
2912886	degrees c
2912886	unique ph optimum
2912886	cnsha
3422216	interstitial deletion
3422216	regional localization
3422216	dxys12/dxs3
3422216	tcd
3422216	dna
3422216	choroideremia locus
3422216	dxys2-
3422216	xqter
3422216	southern blot analysis
3422216	dxs17/dxs101
3422216	different polymorphic
3422216	1-q21 1-q21
3422216	2-q21 2-q21
3422216	deletion chromosomes
3422216	dxys1/dxys23/dxys5
3422216	long arm
2016095	hybridisation
2016095	cmw1
2016095	prader willi
2016095	allele loss
2016095	xy
2016095	pws
2016095	pwcr
2016095	dna
2016095	critical region
2016095	interstitial
2016095	molecular
2016095	prader-willi
2016095	cytogenetic deletions
2016095	reciprocal translocation
2016095	+ der
2016095	chromosome 15q11-13
10807385	median time
10807385	germline mutations
10807385	hereditary cases
10807385	clinical significance
10807385	age
10807385	hereditary group
10807385	ethnic group
10807385	ovarian cancers
10807385	clinical trials
10807385	brca1-
10807385	brca2
10807385	disease-free interval
10807385	survival analysis
10807385	brca2-linked
10807385	brca-associated
10807385	conclusions
10807385	sporadic cases
10807385	cytoreductive surgery
10807385	histology
10807385	brca-linked
10807385	brca
10807385	surgical outcome
10807385	brca1
10807385	clinicopathologic
10807385	ovarian cancer
10807385	cohort study
10807385	mutation status
10807385	consecutive series
10807385	patients
10807385	nonhereditary group
10807385	additional groups
10807385	ii
10807385	advanced-stage hereditary cancer patients
10807385	group protocols
10807385	surgical stage
10807385	national cancer institute
10807385	12-year period
10807385	distinct clinical
10807385	august
10807385	sporadic cancers
10807385	main outcome measures age
10807385	comprehensive cancer center
10807385	pathological characteristics
10807385	objective
10807385	results hereditary
10807385	brca1-linked
10807385	gynecologic oncology
10807385	sporadic ovarian cancer
10807385	primary chemotherapy
10807385	december
10807385	germline founder mutation
10807385	design and setting retrospective
10807385	hereditary ovarian cancers
10807385	iii
10807385	jewish origin
10807385	hereditary cancers
10807385	context
10807385	histologic cell type
10807385	nonhereditary cancer patients
10807385	independent prognostic
10807385	iv
10807385	attempts
1302008	splice donor sites
1302008	germline
1302008	genetic evidence
1302008	zinc finger domains
1302008	germline point mutations
1302008	tumour gene
1302008	wilms
1302008	tumour suppressor gene
1302008	renal failure
1302008	exonic mutations
1302008	rare human developmental disorder
1302008	wt1
1302008	urogenital system
1302008	intersex disorders
1302008	functional roles
1302008	urogenital development
1302008	denys-drash
3014348	analysis
3014348	recently
3014348	large population
3014348	detect structural alterations
3014348	dna
3014348	x-chromosome dna
3014348	biochemical defect
3014348	independent sites
3014348	genetic locus
3014348	dmd
3014348	dxs164
3014348	muscular dystrophy
3014348	becker
3014348	bmd
3014348	recessive genetic disorder
3014348	duchenne
3014348	dmd x
3014348	x-linked
3014348	research laboratories
7802009	partial mirror inactivation
7802009	female monozygotic twins discordant
7802009	methylation pattern
7802009	heterozygous carriers
7802009	skin fibroblast cell lines
7802009	molecular studies
7802009	situ hybridization
7802009	review shows
7802009	clinical manifestations
7802009	x-linked
7802009	x-chromosome
7802009	dmd
7802009	mz
7802009	female monozygotic
7802009	clinical discordance
7802009	additional
7802009	duchenne
7802009	twinning
7802009	female twins discordant
7802009	muscular dystrophy
1127526	small-for-gestational-age infant
1127526	serum globulins
1127526	analbuminemia
1127526	plasma amino acids
1127526	serum albumin
1127526	apparent
1127526	chloride diuresis
1127526	arterial hypotension
1127526	neonatal period
1127526	patients
1127526	albumin synthesis
1127526	serum protein
1127526	beta lipoprotein
1127526	compensatory mechanisms
1127526	examination
1127526	small volume changes
1127526	minimal ankle edema
1127526	world literature
1127526	rapid sodium
1127526	capillary hydrostatic pressure
1127526	low plasma tryptophan level
7857677	gd ii
7857677	early neonatal lethal disease
7857677	severe type
7857677	gba
7857677	v460v
7857677	direct sequence analysis
7857677	t6433c
7857677	complex allele
7857677	fusion gene
7857677	d409h
7857677	structural gene
7857677	mice homozygous
7857677	ii gd
7857677	null allele
7857677	nucleotide substitutions
7857677	subacute neuronopathic
7857677	cns
7857677	ec
7857677	pcr
7857677	knock-out mouse model
7857677	gd
7857677	ii gaucher
7857677	ii
7857677	normal and/or fusion gene
7857677	g6482c
7857677	iii gd
7857677	homozygous form
7857677	acute neuronopathic
7857677	severe clinical phenotype
7857677	l444p
7857677	abstract truncated at
7857677	involvement occurs
7857677	specific mutations
7857677	specific amplification
7857677	a456p
7857677	words
7857677	g6468c
7857677	complex alleles
7857677	macedonian/ashkenazi
7857677	homozygous
7857677	previous conceptus
7857677	neonates
7857677	gaucher
7857677	g5957c
7857677	disease fetus
7857677	base-pair mutation
7857677	gene symbol
10403837	dopa-responsive dystonia
10403837	gtp
10403837	novel mutations
10403837	hpd/drd
10403837	diurnal fluctuation
10403837	drd
10403837	inactive state
10403837	splice junctions
10403837	japanese family
10403837	hereditary
10403837	hpd
10403837	mrna level
10403837	progressive dystonia
10403837	gene expression
10403837	mononuclear blood cells
10403837	decrease
10403837	gch1
10403837	genetic defect
10403837	normal level
10403837	hereditary progressive dystonia
10403837	unknown region
10403837	pha
10447259	missense mutation
10447259	such case
10447259	syndrome protein gene
10447259	studies
10447259	functional domains
10447259	protein level
10447259	wasp
10447259	reduced
10447259	milder phenotype
10447259	x-linked
10447259	heteroduplex analysis
10447259	xlt
10447259	pcr
10447259	western blot analyses
10447259	recurrent infections
10447259	mutations
10447259	novel
10447259	recessive immunodeficiency
10447259	splice site mutations
10447259	missense mutations
10447259	clinical phenotypes
10447259	rt-pcr
10447259	dna
10447259	actin cytoskeleton
10447259	was
10447259	splice sites
10447259	wiskott-aldrich
10447259	ssca
10447259	clinical course
10447259	obligate carriers
10447259	mutation analysis
10447259	gene mutations
511159	normal utilizations
511159	g6pd kamiube
511159	beutlers
511159	normal electrophoretic mobility
511159	incidence
511159	g6pd-deficient
511159	g6pd ube
511159	tris-edta-borate
511159	yamaguchi
511159	kamiube
511159	ph 8..
511159	g6pd
511159	fast electrophoretic mobility
511159	normal heat stability
511159	normal ph curve
511159	kiwa
511159	starch gel electrophoresis
511159	km g6p
511159	buffer system
511159	electrophoretic mobility
511159	glucose-6-phosphate dehydrogenase
511159	clinical signs
511159	normal levels
511159	japan
511159	ki nadph
511159	nakashima
511159	spot test
511159	g6pd konan
511159	glucose-6-phosphate dehydrogenase variants
511159	korea
511159	g6pd kiwa
511159	new variants
511159	km nadp
511159	phosphate buffer system
511159	tris-hydrochloride
8266996	chromosome region 15q11-13
8266996	methylation patterns
8266996	genetic information
8266996	abnormalities
8266996	difference
8266996	pws
8266996	as
8266996	differences
8266996	dna
8266996	d15s9
8266996	dn34
8266996	normal individuals
8266996	prader-willi
8266996	angelman
8266996	familial paracentric inversion
8266996	chromosome 15q11-13
1307245	exon-intron structure
1307245	recently
1307245	norrie
1307245	mutations
1307245	strand conformation polymorphism
1307245	sscp
1307245	relevant base changes
1307245	nd
1307245	carrier detection
1307245	candidate gene
1307245	pcr
1307245	significant structural changes
1307245	reliable diagnosis
1307245	eleven
1307245	causal role
1307245	different mutations
1307245	promoter region
1307245	point mutations
7874117	recently
7874117	sscp
7874117	amino acid substitutions
7874117	g103d
7874117	short trunk
7874117	kniest
7874117	point mutations
7874117	abnormal allele
7874117	mid-face hypoplasia
7874117	dysplasia phenotype
7874117	triple helical domain
7874117	amino acid substitution
7874117	ii
7874117	collagen triple helix
7874117	col2a1
7874117	protein
7874117	cleft palate
7874117	sequence analysis
7874117	retinal detachment
7874117	severe chondrodysplasia phenotype
7874117	characteristics
7874117	collagen protein
7874117	dna
7874117	hearing loss
10434119	mucous cysts
10434119	hopital trousseau
10434119	rare autosomal dominant
10434119	lip and/or palate
10434119	genetic map
10434119	disease trait
10434119	theta =
10434119	d1s245
10434119	syndrome kindreds
10434119	d1s205
10434119	vws gene
10434119	results support linkage
10434119	novel van der
10434119	lod
10434119	maxillofacial surgery
10434119	paris
10434119	novel vws families
10434119	linkage analysis
10434119	mim
10434119	cleft lip and/or palate repair
10434119	d1s491
10434119	d1s425
10434119	favour locus heterogeneity
10434119	woude
10434119	1q32-q41 markers
10434119	vws region
10434119	supports locus homogeneity
10434119	microsatellite markers
10434119	lower-lip pits
10434119	d1s414
10434119	linkage
10434119	van der
10434119	d1s249
3578281	urine cysteinyldopa excretion
3578281	lightest skin type
3578281	hairbulb
3578281	cutaneous
3578281	criteria
3578281	pws
3578281	globe transillumination
3578281	ocular pigmentation
3578281	small interstitial deletion
3578281	hypopigmentation
3578281	prader-willi
3578281	glutathione content
3578281	iris translucency
3578281	tyrosinase activity
3578281	long arm
3578281	full criteria
3578281	significant proportion
3578281	ii
495634	major histocompatibility
495634	chemotactic responsiveness
495634	heritable deficiency
495634	chemotactic activity
495634	sensitive bactericidal assay
495634	human subjects
495634	bacteriolytic activity
495634	c5
495634	b loci
495634	c5-deficient
495634	clinical
495634	new clinical
495634	alternative pathways
495634	gonococcal infectio
495634	hemolytic
495634	probands twin
495634	autosomal codominant mode
495634	immunologic studies
495634	good health
495634	immunologic data
495634	chemotactic factors
495634	family members
495634	whole hemolytic complement levels
495634	gonococcal infection
495634	twenty-two
495634	low levels
495634	polymorphonuclear leukocytes
495634	patients polymorphonuclear leukocytes
495634	deficiency
8533762	far
8533762	genetic basis
8533762	phe
8533762	ala
8533762	deficiency varies
8533762	ser
8533762	gly
8533762	major polymorphic variant
8533762	mediterranean
8533762	g6pd
8533762	g6pd mediterranean
8533762	new glucose-6-phosphate dehydrogenase variant
8533762	such information
8533762	remarkably
8533762	india
8533762	glucose-6-phosphate dehydrogenase
8533762	urban populations
8533762	high frequencies
8533762	indian populations
8533762	kmnadp
8533762	africa
8533762	different tribal
8533762	molecular analysis
8533762	different indian populations
8533762	tribal populations
8533762	urban groups
8533762	deficient alleles
8533762	normal enzyme
8533762	g6pd orissa
8533762	deficient variant
8533762	alanine residue
8533762	deficiency
1655284	germline mutations
1655284	juvenile granulosa cell tumor
1655284	direct role
1655284	independent cases
1655284	tumor suppressor gene
1655284	gene copy
1655284	point mutations
1655284	abnormal urogenital development
1655284	urogenital system development
1655284	rare human condition
1655284	renal failure
1655284	zinc finger
1655284	ii
1655284	sequence recognition
1655284	zinc finger domains
1655284	wt1
1655284	possible role
1655284	severe urogenital aberrations result
1655284	denys-drash
1655284	iii
1655284	germline
1655284	wilms
1655284	dna
10366443	reverse transcription
10366443	cat testis
10366443	missense mutation
10366443	retroviral gene
10366443	normal
10366443	cat fibroblasts
10366443	e351k
10366443	beta-glucuronidase mrna
10366443	enzymes conformation
10366443	expression studies
10366443	feline beta-glucuronidase deficiency
10366443	biochemical abnormalities consistent
10366443	cat cdna
10366443	molecular
10366443	mps vii
10366443	g-to-a
10366443	polymerase chain reaction products
10366443	multiple
10366443	northern blot analysis
10366443	feline beta-glucuronidase cdna
10366443	autosomal recessive lysosomal storage disorder
10366443	beta-glucuronidase deficiency
10366443	half-normal beta-glucuronidase activity
10366443	animal model
10366443	carriers
10366443	domestic cats
10366443	gusb
10366443	vii
10366443	rat beta-glucuronidase cdna
10366443	polymerase chain reaction
10366443	dna
10366443	beta-glucuronidase activity
10366443	species comparison
10366443	crystal structure
10366443	bsssi
10366443	e351
10366443	prospective breedings
10366443	enzymatic activity
10366443	human beta-glucuronidase
10581027	pls
10581027	functional assay
10581027	late onset
10581027	keratosis
10581027	loss-of-function
10581027	candidate region
10581027	patients display
10581027	d11s4082
10581027	palmoplantar
10581027	overt hyperkeratosis
10581027	lysosomal protease cathepsin c
10581027	2-cm interval
10581027	mild psoriasiform
10581027	genomic structure
10581027	ctsc
10581027	periodontal disease
10581027	rare individuals
10581027	chromosome 11q14-q21
10581027	severe periodontitis
10581027	premature tooth loss
10581027	palmoplantar keratosis
10581027	mim
10581027	afflicts patients
10581027	cathepsin c gene result
10581027	papillon-lefevre
10581027	small consanguineous families
10581027	autosomal recessive disorder
10581027	total loss
10581027	d11s931
10581027	cathepsin c activity
10581027	obligate carriers
10581027	keratosis palmoplantaris
10581027	dipeptidyl aminopeptidase
10581027	permanent dentitions
8563759	tumour suppressor
8563759	mutant allele
8563759	spina bifida
8563759	zinc-finger protein
8563759	potential model
8563759	mice homozygous
8563759	rapid proliferation
8563759	allele suggests
8563759	mammary epithelial cells
8563759	brca1
8563759	mouse line
8563759	ovarian cancer
8563759	e10-e13
8563759	sporadic ovarian cancers
8563759	normal development
8563759	normal tissue growth
8563759	mutations
8563759	early embryonic lethality
8563759	abnormalities
8563759	neural tube
8563759	analysis
8563759	neuroepithelial abnormalities
8563759	deficiency results
8563759	excessive cell death
8563759	cancer susceptibility
8563759	brca1-deficient
8563759	unknown function
8563759	ovarian cancer susceptibility gene
8301658	significant immune deficiencies
8301658	early childhood
8301658	laboratory evidence
8301658	saudi arab
8301658	similar findings
8301658	platelet volume
8301658	significant immunological abnormalities
8301658	dna
8301658	was
8301658	wiskott-aldrich
8301658	mild phenotypic variant
8301658	relevant gene
8301658	recessive thrombocytopenic disorder
8301658	hypermegakaryocytic bone marrow
8301658	m27
8301658	various features
8301658	small platelets
8301658	recessive thrombocytopenia
7315872	autosomal recessive trait
7315872	sephardim
7315872	moroccan
7315872	ctx
7315872	small number
7315872	ethnic subgroup
7315872	sephardic jews
7315872	genetics
7315872	tendinous xanthomas
7315872	early adolescence
7315872	high gene frequency
7315872	cholestanol study
7315872	cerebrotendinous xanthomatosis
7315872	gene frequency
7315872	possible treatment
8408659	missense mutation
8408659	active molecular species
8408659	plasma hdl
8408659	cetp
8408659	wild type
8408659	d g
8408659	hdl
8408659	mutant cdna results
8408659	subjects
8408659	cellular expression
8408659	transfers cholesteryl ester
8408659	cholesteryl ester
8408659	plasma high density lipoproteins
8408659	negative risk factor
8408659	heterozygous state
8408659	possible dominant
8408659	wild type secretion
8408659	amino acids
8408659	protein gene
8408659	mutant cdnas
8408659	mild increases
8408659	cholesteryl
8408659	threefold increases
8408659	cellular
2571579	caucasian
2571579	small families
2571579	% confidence interval
2571579	rare locus
2571579	black
2571579	theta =
2571579	maximum lod score
2571579	hd
2571579	maximum likelihood estimate
2571579	negative lod scores
2571579	huntington
2571579	positive lod scores
2571579	fifty-seven
2571579	locus heterogeneity
2571579	d4s10
2571579	maximum frequency
2571579	g8
3258663	tissue stores
3258663	dosage analysis
3258663	alloantibodies
3258663	genetic abnormalities
3258663	quantitative slot blots
3258663	central region
3258663	homozygous deletions
3258663	complete heterozygous deletion
3258663	southern blots
3258663	trace quantities
3258663	gene
3258663	vwf expression
3258663	genetic abnormality
3258663	heterozygous deletions
3258663	willebrand
3258663	complete homozygous deletions
3258663	vwf cdna
3258663	asymptomatic parents
3258663	gene deletions
3258663	asymptomatic siblings
3258663	factor gene
3258663	different type
3258663	severe von
3258663	vwf gene
3258663	severe
3258663	dna
3258663	asymptomatic parent
3258663	homozygous
3258663	restriction endonuclease digests
3258663	gene dosage analysis measurements
7795591	spectrum
7795591	mutation survey
7795591	gene confer hereditary predisposition
7795591	germline mutations
7795591	germline
7795591	gene sequence
7795591	non hereditary retinoblastoma
7795591	molecular mechanisms
7795591	clinical management
7795591	rb1
7795591	point mutations
2773936	neurologic disorders
2773936	classical type
2773936	molecular genetic analysis
2773936	oligonucleotide primers
2773936	plp
2773936	neurologic disorder
2773936	carrier mother
2773936	serine substitution
2773936	molecular classification
2773936	x-linked
2773936	proteolipid protein
2773936	novel mutation
2773936	possible molecular pathology
2773936	pcr
2773936	base difference
2773936	myelin metabolism
2773936	glial cells
2773936	structural protein
2773936	patients
2773936	ii
2773936	classical form
2773936	pelizaeus-merzbacher
2773936	myelin sheath
2773936	historically
2773936	typical clinical progression
2773936	results delineate
2773936	structural myelin proteins
2773936	inborn errors
2773936	central nervous system
2773936	connatal variant
2773936	display mutation
2773936	iii-vi
2773936	pathologic loss
2773936	carboxy end
2773936	enwraps axons
7874163	southern blot analyses
7874163	mjd
7874163	similar abnormalities
7874163	chromosome 14q32.1
7874163	machado-joseph
7874163	gene contains
7874163	pathological diagnosis
7874163	normal individuals
7874163	cag
7874163	genetic locus
7874163	show expansion
7874163	novel gene
3659917	nucleic acid
3659917	tissue distribution
3659917	amino acid sequence
3659917	mouse adult heart
3659917	protein product
3659917	structural role
3659917	gene transcript
3659917	muscular dystrophy gene
3659917	dmd
3659917	amino acid sequences
3659917	muscular dystrophy
3659917	human fetal skeletal muscle
3659917	duchenne
3659917	rna
3659917	percent homologous
2303408	identical 2-base pair deletion
2303408	pvuii
2303408	base-pair deletion
2303408	b10
2303408	sufficient mouse
2303408	molecular mechanism
2303408	c5
2303408	a/hej
2303408	hindiii
2303408	swr/j
2303408	uga
2303408	c5-deficient
2303408	causes murine
2303408	deficient mouse
2303408	genomic
2303408	c5d
2303408	base pairs
2303408	congenic strains
2303408	2-base pair gene deletion
2303408	protein deficiency
2303408	restriction fragment length polymorphisms
2303408	ta
2303408	akr/j
2303408	mouse strains
2303408	base pair substitutions
2303408	c5-sufficient
2303408	nzb/b1nj
2303408	c57bl/6j
2303408	deficient cdnas
2303408	mouse liver
2303408	2-base pair deletion
2303408	deletion shifts
2303408	d2/osnj
2303408	termination codon
2303408	complement component
2303408	cdna libraries
2303408	dna
2303408	sequence
2303408	reading frame
2303408	d2/nsnj
2303408	genomic dna
2303408	dba/2j
2303408	balb/cj
2303408	dba/1j
2303408	deficiency
2241452	white man
2241452	index patient
2241452	complement
2241452	c9
2241452	recurrent meningitis
2241452	risk factor
2241452	complete deficiency
2241452	complement defect
2241452	purulent meningitis
2241452	individual component levels
2241452	swiss family
2241452	family study
2241452	white patient
2241452	recurrent
2241452	europe
2241452	bacterial meningitis
2241452	hemolytic activity
2241452	congenital deficiency
2241452	deficiency suggests
2241452	ch50
2241452	acute meningococcal meningitis
2241452	immunoglobulin deficiency
2241452	patients healthy brother
2241452	cellular immunity
6387532	neurologic deterioration
6387532	progressive reduction
6387532	white blood cell
6387532	hla
6387532	ald
6387532	enzyme activity
6387532	high plasma levels
6387532	complete hematologic recovery
6387532	marrow transplant
6387532	13-year-old boy
6387532	bmt
6387532	ten
6387532	vlcfa
6387532	bone
6387532	chain fatty acids
6387532	progressive adrenoleukodystrophy
6387532	engraftment
6387532	allogeneic bone marrow transplant
6387532	adenovirus infection
7458742	male subjects deficient
7458742	rbc
7458742	glucose-6-phosphate dehydrogenase
7458742	rbcs
7458742	presenile cataracts
7458742	increased
7458742	galactosemic states
7458742	control subjects
7458742	g6pd
7458742	sardinian
7458742	sensitive indicator
7458742	male cataractous patients
7458742	metabolic abnormalities
7458742	g6pd-deficient
7458742	glucose-6-phosphate
7458742	riboflavin deficiency
2894613	autosomal dominant disorder
2894613	raf1
2894613	vhl
2894613	oncogene activation
2894613	sporadic
2894613	vhl-associated
2894613	renal cell carcinoma
2894613	human homologoue
2894613	multifocal tumours
2894613	crossovers
2894613	tumour suppressor gene
2894613	chromosome 3p
2894613	renal cell carcinomas
2894613	tumour formation
2894613	non-familial cases
2894613	cell carcinomas constitute
2894613	putative tumour suppressor
2894613	tumour type
2894613	various forms
2894613	central nervous system
2894613	von hippel-lindau
2894613	pancreatic malignancies
2894613	sporadic forms
2894613	disease maps
2894613	renal
2895982	xq25-qter
2895982	35-kb sequence
2895982	defective renal tubular function
2895982	specific method
2895982	somatic cell hybrids
2895982	mental retardation
2895982	theta =
2895982	oculocerebrorenal syndrome
2895982	congenital cataract
2895982	z =
2895982	tight linkage
2895982	additional families
2895982	carrier determination
2895982	carrier assessment
2895982	dxs10
2895982	xq25
2895982	dxs42
2895982	linkage analysis
2895982	derivative chromosome
2895982	original polymorphism
2895982	tightly
2895982	evidence
2895982	female patient
2895982	xq26
2895982	ocrl
2895982	lowe
2895982	xpterq25
2895982	carrier status
2895982	normal counterpart
2895982	additional polymorphisms
2895982	map assignment
2895982	linkage
2895982	xq24-q26
2895982	slit-lamp exam
2895982	ophthalmologic examination
10716718	cd4
10716718	immune deficiencies
10716718	abnormal development
10716718	thymic lymphoma
10716718	abnormal
10716718	a-t
10716718	cerebellar dysfunction
10716718	motor incoordination
10716718	atm
10716718	lymphocytes contributes
10716718	gross cerebellar degeneration
10716718	purkinje
10716718	neuropathological abnormalities
10716718	hereditary disease ataxia-telangiectasia
10716718	motor learning indicative
10716718	mutant mice
10716718	mice exhibit deficits
10716718	mice show
1303173	drastic effect
1303173	bacterial expression system
1303173	non-deficient polymorphic variant
1303173	gln
1303173	asn
1303173	enzyme deficiency
1303173	glu
1303173	a-
1303173	biochemical properties
1303173	b background
1303173	g6pd a-
1303173	nadp
1303173	g6pd
1303173	glucose 6-phosphate dehydrogenase
1303173	enzyme yield
1303173	met
1303173	enzyme variant
1303173	val
1303173	synergistic effect
1303173	africa
1303173	asp
1303173	high prevalence
1303173	specific activity
1303173	comparable results
1303173	thermal stability
1303173	amino acid replacements
1303173	african populations
1303173	deficient phenotype
1303173	additive effect
2253937	hot spot
2253937	prenatal diagnosis
2253937	pcr-based
2253937	describe oligonucleotide primer sequences
2253937	furthermore
2253937	multiplex reactions detect
2253937	dmd/bmd
2253937	muscle promoter
2253937	pcr
2253937	dmd
2253937	muscular dystrophy
2253937	duchenne
2253937	becker
2253937	bmd
2253937	primers amplify
2253937	detection
2253937	gene deletions
2253937	translational reading frame
2253937	multiplex polymerase chain reaction
2253937	deletion endpoints
2253937	deletion detection
2253937	polymerase chain reaction
2253937	southern blot analysis
2253937	dystrophin gene
2591962	s9
2591962	ldlr
2591962	recombination
2591962	s19
2591962	myotonic dystrophy distal
2591962	bcl3
2591962	s22
2591962	additional
2591962	ckmm
2591962	distal probes
2591962	haplotyping
2591962	insr
2591962	linkage group
2591962	marker recombinations
2591962	antenatal diagnosis
2591962	d19s19
2591962	+ + +
2591962	prkcg
2591962	future research
2591962	apoc2
2591962	myotonic dystrophy
2591962	dm
10425038	hot spot
10425038	sscp
10425038	new intragenic polymorphisms
10425038	herein
10425038	single-strand conformation polymorphism
10425038	a-t
10425038	pcr
10425038	protein truncation
10425038	polymorphic sites
10425038	atm
10425038	defining
10425038	comprehensive compilation
10425038	new mutations
10425038	entire gene
10425038	mutations
10425038	intragenic polymorphisms
10425038	unknown mutations
10425038	rare variants
10425038	great importance
10425038	polymerase chain reaction
10425038	dna
10425038	rna
10417280	end-repeat
10417280	germline tissues
10417280	proximal breakpoint clusters
10417280	herc2
10417280	pws
10417280	15q11-q13 mediate homologous recombination
10417280	analyses
10417280	prader-willi
10417280	furthermore
10417280	yac
10417280	angelman
10417280	female germ cells
10417280	novel gene
10417280	yacs
10417280	chromosome
10417280	novo frequency
10417280	4-mb deletion
10417280	distinct neurobehavioral disorders
10417280	maternal gametogenesis
10417280	pws/as
10417280	chromosome 15q11-q13
10417280	fish
10417280	syndromes involves recombination
10417280	end
10417280	distal breakpoints
10417280	distal cluster
10417280	human genome
10417280	novel dna
10417280	deletion event
10417280	active transcription
10417280	as
10417280	large genomic duplications
10417280	homologous recombination process
10417280	common structural chromosome
10417280	rodent-human somatic-cell hybrids
8530105	ext1
8530105	lgs
8530105	langer-giedion
8530105	syndrome region
8530105	trichorhinophalangeal syndrome
8530105	deletion region
8530105	yac
8530105	functional copies
8530105	somatic cell hybrids
8530105	trps1
8530105	trps
8530105	distal end
8530105	minimal region
8530105	mb
8530105	minimal deletion region
8530105	human chromosome 8q24.1
8530105	human chromosome
8530105	chromosomal region
8530105	syndrome deletions
8530105	multiple exostoses
8530105	multiple exostoses genes
8530105	physical map
8530105	proximal end
8401501	hereditary breast-ovarian cancer
8401501	d17s78
8401501	candidate gene
8401501	chromosome 17q12-21
8401501	breast-ovarian cancer families
8401501	breast cancer trait excludes
8401501	small interval
8401501	sequence variation
8401501	breast-ovarian cancer syndrome
8401501	encodes estradiol
8401501	candidate genes
8401501	susceptibility gene
8401501	pcr
8401501	brca1
8401501	rara
8401501	cm interval
8401501	ii
8401501	mutations
8401501	single
8401501	candidate
8401501	linkage analysis
8401501	meiotic crossovers
8401501	d17s579
8401501	chromosome 17q12-21 region
8401501	genetic
8401501	retinoic acid receptor alpha
8401501	edh17b2
8401501	beta-hydroxysteroid dehydrogenase
8401501	thra1
8401501	hereditary breast-ovarian cancer syndrome
313733	c2
313733	dw2
313733	antibody responses
313733	antilymphocytic autoantibodies
313733	chromosomal abnormalities
313733	variable immunodeficiency
313733	serum
313733	normal limits
313733	19-year-old boy
313733	t-cell
313733	hereditary c2
313733	b lymphocytes
313733	patients lymphocytes
313733	common variable immunodeficiency
313733	hla-d
313733	homozygous c2
313733	immunoglobulin levels
3012567	pws
3012567	db1257
3012567	lambda phage
3012567	prader-willi
3012567	hindiii
3012567	stem-loop structures
3012567	flow
3012567	molecular basis
3012567	proximal 15q
3012567	isolation
3012567	human chromosomes
3012567	long arm
3012567	physical instability
3012567	human chromosome
3012567	chromosomal region
3012567	molecular probes
3012567	analysis
3012567	distinct chromosome 15-specific probes
3012567	molecular analysis
3012567	le392
3012567	chromosomal abnormalities
3012567	dna
3012567	charon
3012567	heteroduplex
3012567	total-digest libraries
7543316	molecular mechanisms
7543316	multisystemic disease
7543316	expansion mutation
7543316	possible dominant-negative
7543316	rnas
7543316	repeat causes
7543316	muscle biopsies
7543316	small decreases
7543316	kinase genes
7543316	dramatic decreases
7543316	dominant effect
7543316	analysis
7543316	patient muscle
7543316	dominant inheritance
7543316	protein kinase gene
7543316	trans suggests
7543316	myotonic
7543316	myotonic dystrophy
7543316	dominant-negative mutation
7543316	novel molecular pathogenetic mechanism
7543316	classical adult-onset myotonic dystrophy patients
7543316	trinucleotide expansion mutation
7543316	rna
7543316	dm
7543316	gene elements
8004674	hematopoietic systems
8004674	mcleod
8004674	novel membrane transport protein
8004674	point mutations
8004674	x-linked
8004674	transcription units
8004674	isolation
8004674	acceptor sites
8004674	kb deletion
8004674	direct evidence
8004674	whole cosmids
8004674	splice donor
8004674	xk
8004674	gene locus
8004674	sequence analysis
8004674	novel protein
8004674	multisystem disorder
8004674	eukaryotic membrane transport proteins
8004674	cosmid contig
8004674	dna
8004674	nucleotide
8004674	mrna expression pattern
8004674	structural characteristics
10790204	739a > c transversion
10790204	bases upstream
10790204	novel mutations
10790204	drastic effect
10790204	patient
10790204	transient expression analysis
10790204	israeli
10790204	k247q
10790204	early onset
10790204	enzyme activity
10790204	mitochondrial fatty acid beta-oxidation
10790204	molecular
10790204	complex mutant allele
10790204	vlcad
10790204	mutation locates
10790204	nonsense mutation 65c >
10790204	amino acid
10790204	chain acyl-coa dehydrogenase
10790204	immunoblot
10790204	p65l
10790204	splice donor site
10790204	chain acyl-coa dehydrogenase deficiency
10790204	aberrant form
10790204	null mutations
10790204	frameshift mutation
10790204	high mortality
10790204	s22x
10790204	194c >
10790204	exonic mutation
10790204	severe childhood form
10790204	mutant cdnas
10790204	whereas normal-size
10932179	amino-terminal region
10932179	hd
10932179	mutant mice
10932179	axonal terminals
10932179	mutant huntingtin induces selective neuronal loss
10932179	huntington
10932179	amino-terminal
10932179	synaptic vesicles
10932179	synaptic toxicity
10932179	selective neuropathology
10932179	neuronal processes
10932179	huntingtin fragments
10932179	mutant huntingtin
10932179	glutamate uptake
10932179	neuritic degeneration
10932179	toxic fragments
10932179	glutamine repeat
10932179	widespread expression
10932179	striatal neurons
10932179	n-terminal
10932179	mutant huntingtin form aggregates
10932179	hd-affected
10932179	mutant huntingtin show selective accumulation
10932179	specific processing
8240110	pattern dystrophy
8240110	fluorescein
8240110	setting
8240110	retinitis pigmentosa
8240110	peripheral visual field
8240110	peripherin/rds gene
8240110	retinitis punctata albescens
8240110	multiple phenotypes
8240110	separate phenotypes
8240110	autosomal dominant retinitis pigmentosa
8240110	abnormal electroretinogram
8240110	medical centers
8240110	conclusions
8240110	kinetic perimetry
8240110	molecular genetics
8240110	3-base pair deletion
8240110	pericentral
8240110	fluorescein angiography
8240110	pattern macular dystrophy
8240110	disparate phenotypes
8240110	clinical disease
8240110	phenotypic
8240110	patients
8240110	background and objectives mutations
8240110	49-year-old son
8240110	75-year-old woman
8240110	fundus flavimaculatus
8240110	macular degeneration
8240110	peripherin/rds mutations
8240110	results
8240110	adult-onset retinitis pigmentosa
8240110	punctate pigment epithelial transmission defects
8240110	design case
8240110	report herein
8240110	erg
8240110	electrophysiological studies
8240110	clinical picture
8240110	novel 3-base pair deletion
10441571	eye anomalies
10441571	transcriptional regulator
10441571	alternative splice isoforms
10441571	20th nucleotide position
10441571	exon 5a results
10441571	gac
10441571	pax6
10441571	novel missense mutation
10441571	peters
10441571	c-terminal
10441571	transactivation activity
10441571	cts
10441571	congenital cataract
10441571	specifies target genes
10441571	respective consensus
10441571	target genes
10441571	additional amino acids
10441571	ocular morphogenesis
10441571	v54d
10441571	axenfeldt
10441571	gene encodes
10441571	exon 5a
10441571	7th codon
10441571	molecular switch
10441571	exon 5a abolishes
10441571	val
10441571	distinct structure
10441571	missense
10441571	corneal dystrophy
10441571	various types
10441571	n-terminal
10441571	and/or foveal hypoplasia
10441571	asp
10441571	nts
10441571	dna-binding
10441571	ocular anomalies
10441571	gtc
10441571	dna
10441571	splice-variant region
10441571	foveal hypoplasia
10441571	alternative splice region
10441571	functional
1673289	genotypic data
1673289	computational methodologies
1673289	anonymous sequences
1673289	telomeric region
1673289	reference panel
1673289	linkage maps
1673289	rflps
1673289	hd
1673289	continuous linkage group
1673289	genetic locations
1673289	markers form
1673289	huntington
1673289	continuous map
1673289	stepwise algorithm
1673289	utilizing
1673289	10-point map
1673289	human chromosome
1673289	high-resolution genetic map
1673289	ceph
1673289	linkage heterogeneity
1673289	position-specific recombination rates
1673289	multipoint map
1673289	map integrates
1673289	likely
1673289	linkage
1673289	position-specific recombination frequencies
1673289	crimap
1673289	20-locus multipoint genetic map
8566965	% amino acid identity
8566965	chromosome 11d
8566965	mouse model
8566965	human breast
8566965	situ hybridization
8566965	genomic clones maps
8566965	mouse clones
8566965	brca1
8566965	mouse genomic library
8566965	two-color fluorescence
8566965	human exon
8566965	human chromosome
8566965	murine genomic clones
8566965	murine homolog
8566965	nf1-gene
8566965	human gene
8566965	sequence
8566965	% nucleic acid identity
8566965	comparative study confirms
8566965	relative location
8566965	mouse chromosome 11d
8566965	ovarian cancer susceptibility gene
8101038	new mutant alleles
8101038	gly309
8101038	high residual arylsulfatase
8101038	patient show
8101038	mutant enzyme
8101038	residual arylsulfatase
8101038	ser
8101038	late-infantile type
8101038	mld
8101038	significant sulfatide degradation activity
8101038	ser309-arsa
8101038	amino acid position
8101038	particular features
8101038	previous results
8101038	complete absence
8101038	analysis
8101038	arsa
8101038	% enzyme activity
8101038	fibroblasts
8101038	late-infantile metachromatic leukodystrophy
8101038	transient
10802660	postzygotic maintenance
10802660	snrpn
10802660	pws
10802660	pws ic
10802660	ic
10802660	gonadal hypoplasia
10802660	paternal genetic information
10802660	prader-willi
10802660	ipw
10802660	independent embryonic stem
10802660	region involves
10802660	deletion
10802660	mkrn3
10802660	male germ line
10802660	novo deletions
10802660	maternal methylation imprint
10802660	par-1
10802660	early human
10802660	genes map
10802660	deletion chromosome
10802660	es
10802660	identical findings
10802660	ndnl1
10802660	maternal imprint switch
10802660	de
10802660	par-5
10802660	mouse embryos result
10802660	profound obesity
10802660	similar deletion
10802660	cell lines
10802660	paternal chromosome
10802660	infantile hypotonia
10802660	chimaeric mice
10802660	ndn
10802660	paternal imprint
10802660	obsessive behaviour
10802660	neurogenetic disease
10802660	somatic cells
10802660	imprinting
1897530	molecular level
1897530	missense mutation
1897530	escherichia
1897530	mutation results
1897530	saccharomyces
1897530	enzyme galactose-1-phosphate uridyl transferase
1897530	variable clinical outcome
1897530	molecular basis
1897530	galactosemia mutations
1897530	molecular
1897530	amino acid residues
1897530	human galactose metabolism
1897530	active site histidine-proline-histidine triad
1897530	galactosemia alleles
1897530	normal enzymatic activity
1897530	galactose-1-phosphate uridyl transferase
1897530	common galactosemia mutation
1897530	missense mutations
1897530	substitutes glutamine
1897530	autosomal recessive disorder
1897530	e.
1897530	galactosemia
1897530	galt
1897530	homologous enzymes
1897530	undetectable enzymatic activity
1897530	severe mutation
10078732	effective treatments
10078732	ald
10078732	unchanged clinical
10078732	mep
10078732	oil dietary therapy
10078732	mri
10078732	oil therapy
10078732	lorenzos
10078732	meps
10078732	sep
10078732	neurophysiologic
10078732	background seps
10078732	long-term dietary treatment
10078732	dietary treatment
10078732	methods
10078732	severe neurologic symptoms
10078732	inflammatory brain lesions
10078732	adult-onset adrenoleukodystrophy
10078732	conclusions lorenzos
10078732	experimental treatments
10078732	negative brain
10078732	central dying-back axonopathy
10078732	abnormal brain
10078732	pure spinal
10078732	clear signs
10078732	natural course
10078732	objective
10078732	inflammatory damage
10078732	results
10078732	seps
10078732	early stages
10078732	pure spinal abnormalities
10078732	underwent clinical examination
10078732	cerebral somatosensory tracts
10577908	amino acid substitutions
10577908	fatty aldehyde dehydrogenase
10577908	dna-based
10577908	molecular defects
10577908	genetic basis
10577908	nineteen
10577908	snps
10577908	mental retardation
10577908	diagnostic tests
10577908	> c [
10577908	+ 1delg
10577908	molecular basis
10577908	single-nucleotide polymorphisms
10577908	splice-site defects
10577908	intragenic recombination
10577908	faldh
10577908	thirty-seven
10577908	mammalian cells
10577908	sjogren-larsson
10577908	nonsense mutations
10577908	common mutations
10577908	fatty aldehyde dehydrogenase gene
10577908	deficient activity
10577908	cryptic acceptor-splice sites
10577908	complex mutations-were
10577908	enzyme catalytic activity
10577908	mrna stability
10577908	missense mutations
10577908	heterogeneous group
10577908	splice-site mutations
10577908	autosomal recessive disorder
10577908	severe reduction
10577908	k266n
10577908	snp
10577908	mutation analysis
10577908	sls
10577908	middle eastern descent
7055648	possible mechanisms
7055648	who
7055648	molecular characteristics
7055648	substrate analogues
7055648	mutant enzyme
7055648	leukocyte alkaline phosphatase
7055648	red cells
7055648	functional studies
7055648	congenital nonspherocytic hemolytic anemia
7055648	severe deficiency
7055648	molecular
7055648	g6pd
7055648	fast electrophoretic mobility
7055648	chronic hemolytic anemia
7055648	heat stability
7055648	patients granulocytes
7055648	new molecular variant
7055648	optimum ph
7055648	present variant
7055648	apparent affinity
7055648	granulocyte dysfunction
7055648	nitroblue tetrazolium
7055648	severe-glucose-6-phosphate
7055648	standard methods
7055648	specific activity
7055648	random migration
7055648	chemotaxis
7055648	degrees c
7055648	cnsha
7055648	engulf latex particles
7055648	lap
7055648	normal properties
7055648	g6pd barcelona
8162071	pax-6
8162071	gene underlies
8162071	mutations
8162071	sey/+ smalleye
8162071	anterior segment malformations
8162071	mutation
8162071	anterior segment anomalies
8162071	pax6
8162071	nonsense mutation
8162071	peters
8162071	heterogeneous anterior segment malformations
8162071	r26g
8162071	ocular phenotype
10364525	1q24-25 region
10364525	heterogeneity tests
10364525	cancer clusters
10364525	hpc1
10364525	smith
10364525	npl
10364525	hpc
10364525	d1s202
10364525	d1s422
10364525	complete set
10364525	prostate cancer
10364525	prostate
10364525	early-onset prostate cancer
10364525	present report
10364525	maximum two-point
10364525	chromosome 1q24-25
10364525	lod
10364525	straight theta =
10364525	early age
10364525	25-cm interval
10364525	prostate cancer-susceptibility genes
10364525	sweden
10364525	hereditary prostate cancer
10364525	swedish
10364525	d1s413
10364525	nonparametric linkage
10364525	multiple cases
10364525	npl z
10364525	recombination fraction [ theta ]
10364525	early-onset families
10364525	age <
2037285	ckm
2037285	proximal markers
2037285	c-ii
2037285	new markers
2037285	localisation
2037285	centre
2037285	polymorphisme humain
2037285	genetic map
2037285	somatic cell hybrids
2037285	base pairs
2037285	creatine kinase
2037285	ten
2037285	polymorphic loci
2037285	long arm
2037285	reference families
2037285	apoc2-ckm-dm
2037285	human chromosome
2037285	paris
2037285	prkcg
2037285	polymorphic markers
2037285	myotonic dystrophy locus
2037285	ceph
2037285	apoc2/ckm
2037285	apoc2
2037285	myotonic dystrophy
2037285	dna
2037285	linkage relationship
2037285	directional chromosome
2037285	d19s22
2037285	dm
10712225	female germline
10712225	negative selection
10712225	recurrent expansion
10712225	gonadal mosaicism
10712225	maternal allele
10712225	male germline
10712225	large expansion
10712225	trinucleotide repeat
10712225	huntington
10712225	large expansions
10712225	large
10712225	different instability behavior
10712225	cag
10712225	female germlines
10712225	long repeats
10712225	intergenerational repeat expansions
10712225	hd
10072428	sscp
10072428	germline mutations
10072428	non-maori populations
10072428	cdh1
10072428	e-cadherin
10072428	early onset colorectal cancer
10072428	familial gastric cancer kindreds
10072428	signal peptide domain
10072428	germline e-cadherin
10072428	mutations predispose
10072428	colorectal cancer
10072428	splice site
10072428	inherited
10072428	gastric cancer
10072428	familial gastric cancers
10072428	loss
10072428	degree relatives
10072428	novel
10072428	irish origin
10072428	mutation carrier
10072428	maori
10072428	sporadic colorectal
10072428	gastric cancer susceptibility
10072428	colorectal cancers
10072428	familial gastric cancer
10072428	familial
3346017	distinct types
3346017	common female ancestor
3346017	meiotic segregation products
3346017	molecular deletion
3346017	postzygotic deletion
3346017	common ancestor
3346017	dmd
3346017	marker restriction fragment length polymorphisms
3346017	rflps
3346017	duchenne
3346017	germinal
3346017	muscular dystrophy
3347839	mdx mutations
3347839	different strains
3347839	expression
3347839	dystrophic mdx mice
3347839	allelic variants
3347839	normal levels
3347839	muscular dystrophy gene
3347839	cardiac muscle
3347839	rna
3347839	brain raises
3347839	dmd
3347839	muscular dystrophy
3347839	duchenne
3347839	gene expression
3347839	gene mutations
3347839	mental retardation
3347839	complementary dna
7790377	part
7790377	pas8-pts1r
7790377	protein-import defect
7790377	skin fibroblasts
7790377	complementation group
7790377	peroxisome matrix
7790377	human peroxisomal disorders
7790377	zellweger
7790377	cells
7790377	cell biol
7790377	molecular basis
7790377	peroxisomal disorder genes
7790377	fatal peroxisomal disorders
7790377	mccollum
7790377	pts1-containing
7790377	human cdna homologue
7790377	genetic complementation groups
7790377	human tissues
7790377	fusion protein complements
7790377	pts2
7790377	human peroxisomal
7790377	pts1
7790377	signal-1 receptor restores peroxisomal protein import
7790377	pastoris pas8 mutant
7790377	inhibit peroxisomal protein-import
7790377	pichia
7790377	human patients
7790377	neonatal adrenoleukodystrophy
7790377	protein-import deficiency
7790377	d.
7790377	peroxisomal membrane
7790377	s. subramani
7790377	cell system
7790377	pas8
7790377	hamster cells
7790377	peroxisomal deficiency disorders fall
7790377	e. monosov
7790377	antibodies
7790377	pts1r
7790377	chromosomal location
7790377	cho
7790377	p.
8012387	his139tyr
8012387	exon 3b
8012387	plp
8012387	point mutation
8012387	allelic disorders
8012387	x-linked
8012387	xq21-q22
8012387	genetic interval
8012387	disease locus
8012387	proteolipid protein gene
8012387	theta =
8012387	spg
8012387	myelin proteins
8012387	spg2
8012387	spastic paraplegia
8012387	proteolipid protein locus
8012387	zmax
8012387	xq28
8012387	pelizaeus-merzbacher
8012387	xq22
8012387	large pedigree
8012387	distinct forms map
8012387	central nervous system
8012387	dm20
8012387	allelic disorder
8012387	possible candidate gene
8012387	pmd
9949209	bedlington
9949209	wd
9949209	wilson
9949209	atp7b
9949209	dog chromosome
9949209	region devoid
9949209	situ hybridization
9949209	candidate genes
9949209	ctr1
9949209	common autosomal recessive copper toxicosis
9949209	ctr2
9949209	fish
9949209	mutations
9949209	rarer human copper overload disease non-indian childhood cirrhosis
9949209	hepatic copper accumulation
9949209	ct
9949209	new locus
9949209	chromosomal co-localization
9949209	c04107
9949209	canine chromosome regions
9949209	copper transport genes
9949209	canine chromosome region
9949209	cfa10q26
9949209	cfa11q22
9949209	cfa22q11
9949209	genetic
9949209	human chromosome 2p13-p16
9949209	c04107-containing bac
9949209	abnormal
9949209	bac
9949209	positional candidate genes
9949209	genetic heterogeneity
9949209	anonymous microsatellite marker
9949209	progressive liver disease
9949209	region syntenic
9949209	copper toxicosis locus
9949209	human chromosome region 2p13-p16
9950360	variable range
9950360	amino
9950360	direct mutation analysis
9950360	certain extracolonic manifestations
9950360	gradient gel electrophoresis
9950360	amino acid changes
9950360	non-fap colorectal cancer
9950360	results chain
9950360	protein truncation test
9950360	background/aims
9950360	genotype-phenotype correlations
9950360	apc
9950360	colorectal cancer predisposition
9950360	colorectal cancer
9950360	methods
9950360	molecular
9950360	extracolonic manifestations
9950360	mutation subgroups
9950360	prophylactic treatment regimens
9950360	conclusions extended
9950360	genotype-phenotype
9950360	non-fap group
9950360	significant differences
9950360	appropriate surveillance
9950360	fap
9950360	dominant inheritance
9950360	familial adenomatous polyposis
9950360	pathological nature
9950360	adenomatous polyposis coli
9950360	non-fap colorectal cancer patients
9950360	gene mutations
9950360	acid changes
9950360	colorectal cancer patients
9634518	mhp
9634518	pku
9634518	considerable proportion
9634518	metabolic phenotype
9634518	simple model
9634518	phenotypic characteristics
9634518	pah
9634518	causative mutations
9634518	allelic disorders
9634518	phenylalanine hydroxylase
9634518	genotype-phenotype inconsistencies
9634518	phenotype classification
9634518	pah-mutation
9634518	european centers
9634518	previous
9634518	phenylketonuria
9634518	biochemical phenotype
9634518	main determinant
9634518	general system
9634518	phenotypic outcome
9634518	mild hyperphenylalaninemia
9634518	deficiency correlate
9634518	mutation detection
9634518	european multicenter study
9634518	arbitrary phenotype categories
9634518	variable metabolic phenotypes
9634518	hemizygous patients
9634518	phenylalanine hydroxylase deficiency
9634518	present study
9563950	nuclear ribonucleoprotein
9563950	pathogenesis suggests
9563950	myotonic
9563950	myotonic dystrophy
9563950	gain-of-function mutation
9563950	cardiac troponin
9563950	cug-binding
9563950	cug-bp
9563950	cug
9563950	trans-dominant effect
9563950	altered
9563950	splicing
9563950	data
9563950	ctg
9563950	disruption
9563950	rnas
9563950	rna
9563950	dm
9563950	normal cells
9674903	paternal der
9674903	b. maternal
9674903	snrpn
9674903	pws
9674903	true gamete complementation
9674903	polymerase chain reaction analysis
9674903	critical region
9674903	prader-willi
9674903	furthermore
9674903	pattern characteristic
9674903	simultaneous maternal meiotic nondisjunction
9674903	paternal t
9674903	syndrome consistent
9674903	patients father
9674903	adjacent-1 segregation
9674903	situ hybridization analysis
9674903	uniparental disomy
9674903	exon alpha
9674903	long arm
9674903	fluorescent
9674903	pw
9674903	microsatellite repeats
9674903	maternal chromosome
9674903	uniparental
9674903	derivative chromosome
9674903	distal chromosome arm 3p
9674903	gamma-aminobutyric acid receptor beta3 subunit
9674903	gamete complementation
9674903	gabrb3
9674903	phenotype consistent
9674903	unusual case
9674903	familial translocation
9674903	upd
9674903	b. methylation
9674903	maternal
9674903	maternal disomy
9674903	normal pair
9674903	short arm
9674903	non-robertsonian translocations
9863607	autosomal dominant disease
9863607	segregation distortion
9863607	generation anticipation cascade
9863607	ireland
9863607	cdm
9863607	meiotic drive
9863607	myotonic
9863607	myotonic dystrophy
9863607	studies
9863607	preferential transmission
9863607	non-dm heterozygotes
9863607	sibships
9863607	typical pedigree
9863607	congenital myotonic dystrophy
9863607	expansion tends
9863607	ctgn
9863607	dm
9863607	segregation
9443866	mutant alleles
9443866	italian
9443866	ataxia-telangiectasia
9443866	additional
9443866	genomic mutations
9443866	english
9443866	a-t
9443866	founder-effect mutations
9443866	assays
9443866	breast cancer
9443866	atm
9443866	costa rican
9443866	common mutations
9443866	polish
9443866	identical mutations
9443866	ethnic populations
9443866	common ancestry
9443866	utah mormon
9443866	african
9443866	minimal amounts
9443866	common ethnic mutations
9443866	american patients
9443866	dna
9443866	norwegian
9443866	protein-truncation
9443866	rapid assays
9443866	amish/mennonite
9311732	sscp
9311732	multifocal tumors
9311732	loh
9311732	constitutional rb1-gene
9311732	rb1-gene
9311732	bilateral retinoblastoma
9311732	constitutional deletions
9311732	small mutations
9311732	detectable mutation
9311732	somatic inactivation
9311732	constitutional mutation
9311732	early age
9311732	uninformative patients
9311732	identify mutations
9311732	informative patients
9311732	mutations
9311732	somatic mosaicism
9311732	peripheral blood
9311732	intragenic loci
9311732	corresponding peripheral blood
9311732	rb1
9311732	hetero-duplex analysis
9311732	thirty-nine
9311732	tumor development
9311732	transmit retinoblastoma predisposition
9311732	molecular analysis
9311732	dna
9311732	unilateral retinoblastoma
9311732	southern blot analysis
9311732	large structural alterations
9311732	constitutional heterozygosity
9311732	tumor tissue
9311732	rna
9931324	congenital absence
9931324	extraordinary conservation
9931324	aniridia patients
9931324	congenital nystagmus
9931324	pathological missense mutations
9931324	pax6
9931324	ancient residues
9931324	amino acid level amongst vertebrates predicts
9931324	underlie phenotypes distinct
9931324	strikingly
9931324	premature truncation
9931324	recognizable aniridia phenotypes
9931324	amino acid
9931324	substantial burden
9931324	rare dominant malformation
9931324	gene underlie aniridia
9931324	human congenital eye malformations
9931324	mutations
9931324	ascertainment bias
9931324	domain underlie
9931324	missense
9931324	heavy ascertainment bias
9931324	results support
9931324	textbook aniridia
9931324	missense mutations
9931324	amino acids
9931324	mutation analysis
9931324	domain proteins
9931324	atypical phenotypes ectopia pupillae
9668171	human genetic diseases
9668171	transcriptional levels
9668171	major instability
9668171	clinical severity
9668171	instability mechanisms
9668171	furthermore
9668171	good correlation
9668171	different tissues
9668171	relative inter-tissue difference
9668171	somatic
9668171	pcr
9668171	transgenic mice
9668171	mice transgenic
9668171	somatic mutation rates
9668171	proliferative capacities
9668171	tissue proliferation capacity
9668171	utr
9668171	dmahp
9668171	somatic mosaicism
9668171	high levels
9668171	trinucleotide repeat instability mechanisms
9668171	chromatin environment
9668171	dmpk
9668171	relative intertissue transcription levels
9668171	somatic mutation rate
9668171	myotonic dystrophy region
9668171	protein kinase gene
9668171	somatic instability
9668171	myotonic dystrophy
9668171	large expansions
9668171	repeat size
9668171	various tissues
9668171	ctg
9668171	repeat length
9668171	dm
9463314	missense mutations
9463314	a-t
9463314	in-frame deletions
9463314	families native
9463314	wide variety
9463314	hodgkin
9463314	t-cell
9463314	founder mutations
9463314	milder clinical phenotype
9463314	cerebellar degeneration
9463314	breast cancer
9463314	ataxia-telangiectasia families
9463314	atm
9463314	mutation types
9463314	relative risk
9391879	missense mutation
9391879	germline mutations
9391879	novel splice site mutation
9391879	breast cancer families
9391879	general population
9391879	susceptibility gene
9391879	low
9391879	average age
9391879	brca1
9391879	small fraction
9391879	german breast/ovarian cancer families
9391879	nonsense mutation
9391879	frameshift mutation
9391879	breast/ovarian cancer families
9391879	causative mutations
9391879	disease onset
9391879	breast-ovarian cancer family
9700175	pathogenic mutations
9700175	oral
9700175	percent confidence interval
9700175	lifetime
9700175	brca2
9700175	clinical
9700175	conclusions oral-contraceptive
9700175	pathogenic mutation
9700175	methods
9700175	control women
9700175	brca1
9700175	ovarian cancer
9700175	case-control study
9700175	past use
9700175	hereditary forms
9700175	odds ratio
9700175	oral-contraceptive
9700175	results
9700175	oral-contraceptive use
9700175	hereditary ovarian
9700175	hereditary ovarian cancer
9700175	background
9700175	high lifetime risk
9700175	oral contraceptives
9700175	percent reduction
9792861	similar haplotypes
9792861	french
9792861	brca1 c4446t
9792861	mutant alleles
9792861	different families
9792861	canadian breast cancer
9792861	breast/ovarian cancer families
9792861	brca2
9792861	breast cancer-susceptibility genes
9792861	ovarian cancer families
9792861	brca1
9792861	ovarian cancer
9792861	8765delag mutation
9792861	breast cancer
9792861	founder population
9792861	together
9792861	interestingly
9792861	mutations
9792861	french canadian cancer families
9792861	facilitate carrier detection
9792861	canadian breast
9792861	breast cancer case <
9792861	common mutation
9792861	carriers
9792861	founder brca1
9792861	quebec
9792861	identify founder
9705283	pst
9705283	heterozygous
9705283	mutant proteins
9705283	kinetic
9705283	pax6
9705283	peters
9705283	genetic haploinsufficiency
9705283	c-terminal
9705283	aniridia
9705283	inactive protein
9705283	transactivation region
9705283	truncation
9705283	dominant-negative mutants
9705283	regulates eye development
9705283	transient transfection assays
9705283	new insight
9705283	transactivation domain
9705283	familial foveal dysplasia
9705283	various phenotypes
9705283	-rich transactivation domain
9705283	various truncation mutants
9705283	transcription factor
9705283	loss-of-function mutants
9705283	such mutants
9705283	dna-binding
9705283	dna
9705283	gene result
9705283	contrary
9705283	autosomal dominant keratitis
9705283	drosophila
9705283	truncation mutations
9546397	tfr hfe
9546397	basic ph
9546397	cell surface
9546397	intracellular vesicles
9546397	hemochromatosis mutations
9546397	hemochromatosis protein
9546397	mhc-related
9546397	iron-overload disease hereditary hemochromatosis
9546397	transferrin stoichiometry
9546397	different mode
9546397	tfr
9546397	crystal structure
9546397	hfe
9546397	acidic ph
9546397	transferrin receptor
9546397	ph-dependent interactions
9774970	repair and/or homologous recombination
9774970	encode products
9774970	early onset breast and/or ovarian cancer
9774970	+ replication sites
9774970	pcna
9774970	meiotic cells
9774970	general phenomenon
9774970	s phase cells
9774970	synaptonemal complexes
9774970	brca2
9774970	rad51
9774970	brca1
9774970	tumor suppressor genes
9774970	uv
9774970	somatic cells
9774970	stable interaction
9774970	axial elements
9774970	hereditary breast and/or ovarian cancer
9774970	dysfunction
9774970	subnuclear foci
9790667	penultimate nucleotide
9790667	quantitative
9790667	cgt
9790667	cos-1
9790667	mutant minigene
9790667	sterol 27-hydroxylase gene
9790667	cerebrotendinous xanthomatosis
9790667	novel c
9790667	enzyme activity
9790667	exon 6-intron
9790667	splice site
9790667	cyp27
9790667	transfection
9790667	adrenodoxin cofactor
9790667	mutant cdna
9790667	bp upstream
9790667	normal level
9790667	residue 362arg
9790667	gene products
9790667	ctx
9790667	agt
9790667	gene mrna
9790667	alternative pre-mrna
9790667	mrna species
9790667	sterol 27-hydroxylase activity
9790667	arg362ser
9702690	oxygen metabolism
9702690	cerebello-brain stem forms
9702690	ald
9702690	massive demyelination
9702690	brain stem
9702690	alzheimers
9702690	mri
9702690	adult cerebral
9702690	ad
9702690	lorenzos
9702690	autopsy findings
9702690	cerebrospinal fluid
9702690	white matter
9702690	tau reflects
9702690	ct
9702690	insidious lesion
9702690	oleic
9702690	phenotypic variations
9702690	erucic acids
9702690	magnetic resonance image
9702690	bilateral cerebellar hemispheres
9702690	u-fibers
9702690	cerebral blood flow
9702690	sufficient effectiveness
9702690	adolescent form
9702690	csf
9702690	rare intermediate type
9702690	base pair deletion
9702690	early stage
9702690	positron emission tomography
9702690	genetic report
9702690	pet
9702690	tau level
9702690	neuronal degeneration
9618166	missense mutation
9618166	putative sulfate transporter
9618166	additional non-consanguineous families
9618166	disease gene
9618166	base deletions
9618166	l236p
9618166	chromosome 7q22-q31
9618166	early childhood deafness
9618166	pds
9618166	consanguineous families
9618166	t416p
9618166	frequent missense mutations
9618166	non-consanguineous families
9618166	pendred
9618166	compound heterozygotes
9618166	heterozygous state
9618166	homozygous state
9618166	splice site mutation
9618166	missense mutations
9618166	autosomal recessive disorder
9618166	vaughan pendred
9618166	molecular diagnosis
9618166	mutation analysis
9427148	autosomal recessive trait
9427148	finland
9427148	glycoprotein metabolism
9427148	patients excrete
9427148	agu
9427148	large amounts
9427148	aga
9427148	founder effect
9427148	non-finnish origin
9427148	urine chromatography
9427148	lysosomal enzyme aspartylglucosaminidase
9427148	clinical diagnosis
9427148	aspartylglucosaminuria
9427148	jerusalem
9427148	palestinian arabs
9427148	rare disorder
9427148	high frequency
9467011	broad role
9467011	hot spot
9467011	major organ systems
9467011	genotype-phenotype analysis inthe group
9467011	mutation
9467011	nonsense point mutations
9467011	germline pten
9467011	cowden
9467011	amino acid dual specificity phosphatase
9467011	malignant breast disease
9467011	possible associations worthy
9467011	specifically
9467011	ruvalcaba-riley-smith
9467011	versus benign versus malignant
9467011	core motif
9467011	human malignancy
9467011	cd mutations
9467011	ptpase
9467011	entire length
9467011	susceptibility gene
9467011	tumour suppressor gene
9467011	pten
9467011	thyroid tumours
9467011	malignant melanoma
9467011	hamartoma syndromes
9467011	endometrial carcinomas
9467011	constitutive dna
9467011	interestingly
9467011	r233x
9467011	sporadic breast
9467011	somatic pten
9467011	bannayan-zonana
9467011	breast disease
9467011	genotype-phenotype
9467011	bzs
9467011	functional significance
9467011	breast involvement
9467011	mim
9467011	kidney cancer cell lines
9467011	mutations upstream
9467011	splice site mutations
9467011	small group
9467011	missense mutations
9467011	central nervous system
9467011	gastrointestinal tract
9467011	primary tumours
9467011	dna
9467011	independent analyses
9467011	secondly
9467011	protein tyrosine phosphatase
9467011	nonsense point mutation
9467011	interdependent association
9467011	genotype-phenotype analyses
9467011	cd families
9831355	jewish origins
9831355	non-jewish family
9831355	colorectal cancer
9831355	i1307k
9831355	hmlh1 mutations
9831355	i1307k apc
9831355	ashkenazi
9831355	french canadian hereditary non-polyposis colorectal cancer
9831355	hereditary non-polyposis colorectal cancer
9831355	hnpcc
9831355	interestingly
9590178	candidate dosage-sensitive sex-reversal gene
9590178	nuclear receptor
9590178	products
9590178	sexual differentiation
9590178	testis development
9590178	mammalian gonadogenesis
9590178	direct interaction
9590178	x-linked
9590178	polypeptide hormone
9590178	mullerian
9590178	-kts isoforms
9590178	dax-1
9590178	sf-1
9590178	wt1
9590178	mis
9590178	denys-drash
9590178	male pseudohermaphroditism
9590178	missense mutations
9590178	sf-1-mediated
9590178	steroidogenic factor
9590178	wilms
9590178	antagonizes synergy
9590178	sex-specific gene expression
9590178	sexual development
9590178	additionally
9358014	restriction site
9358014	recent
9358014	hla-a
9358014	population
9358014	finns
9358014	allele frequency
9358014	prevalence estimates
9358014	rflp
9358014	new approach
9358014	hfe tyr
9358014	different disorders
9358014	hh
9358014	rsal
9358014	mb
9358014	comparisons
9358014	cys282tyr
9358014	hereditary hemochromatosis
9358014	allele frequencies
9358014	mordvinians
9358014	mutation creates
9358014	saamis
9358014	different ethnic groups
9358014	asiatic
9358014	swedes
9358014	tyr
9358014	cys/tyr
9358014	hfe
9358014	previous observations
9358014	ethnic
9382108	linkage approaches
9382108	knowledge
9382108	risk
9382108	hd
9382108	limits
9382108	direct tests
9382108	risk reversal
9382108	dna
9382108	huntington
9382108	potential reasons
9382108	pedigree structure
9382108	test individuals
9382108	significant disparity
9382108	such individuals
9382108	family members
9382108	risk reversals
9554743	p-type atpase
9554743	korean patients
9554743	cdna nucleotide
9554743	novel mutations
9554743	high frequency
9554743	gene rearrangements
9554743	korean
9554743	l1083f
9554743	a874v
9554743	identification
9554743	r778l
9554743	arg778leu
9554743	allele frequency
9554743	wilson
9554743	atp7b
9554743	novel single nucleotide deletion
9554743	asian populations
9792860	comprehensive gene screen
9792860	collagen chains
9792860	col4a3
9792860	novel mutations
9792860	collagenous domain
9792860	glycine substitution
9792860	genomic structure information
9792860	furthermore
9792860	homozygous individuals
9792860	alpha4 type
9792860	subsequent detection
9792860	col4a4
9792860	complete characterization
9792860	autosomal recessive
9792860	genomic structure
9792860	autosomal
9792860	progressive hematuric glomerulonephritis
9792860	individual homozygous
9792860	glomerular basement membrane abnormalities
9792860	heterozygous carriers
9792860	alanine substitution
9792860	obvious phenotype
9792860	determination
9792860	control individuals
9792860	alport
9792860	iv
9771706	disease phenotype
9771706	diabetes mellitus
9771706	mutations
9771706	meiotic recombinants
9771706	wolfram
9771706	optic atrophy
9771706	wfs1
9771706	omim
9771706	islet beta-cells
9771706	linkage
9771706	putative transmembrane protein
9771706	wfs
9771706	young-onset non-immune insulin-dependent diabetes mellitus
9771706	chromosome 4p
9771706	autosomal recessive neurodegenerative disorder
9771706	bac/p1
9771706	transmembrane protein
9771706	novel gene
9771706	progressive optic atrophy
9472666	heterozygous mother
9472666	meningococcal meningitis
9472666	complement
9472666	c6
9472666	allele-specific pcr
9472666	neisserial infection
9472666	null alleles
9472666	novel mutation
9472666	patients father
9472666	gene mutations
9472666	pcr
9472666	human complement component
9472666	exon-specific polymerase chain reaction
9472666	molecular
9472666	/single-strand conformation polymorphism
9472666	mutations result
9472666	1195delc mutation
9472666	1936delg mutation
9472666	compound heterozygote
9472666	premature termination codons
9472666	african-american
9472666	homozygous father
9472666	c6d
9472666	target exons
9733027	triplet repeats
9733027	trinucleotide repeats
9733027	repeat sizes
9733027	normal allele
9733027	sperm dna
9733027	notable exception
9733027	expansion size decreases
9733027	dna
9733027	mitotic expansion
9733027	friedreich
9733027	trinucleotide repeat
9733027	expansion occurs
9733027	frda
9733027	ataxia premutation carrier suggests
9733027	gaa
9733027	premutation carrier
9733027	mans leucocyte
9733027	informative carrier father
9733027	child transmissions
9733027	tight range
9506545	eye
9506545	movement abnormalities correlate
9506545	spinocerebellar ataxias
9506545	horizontal eye movements
9506545	autosomal dominant cerebellar ataxia type
9506545	mjd
9506545	sca2
9506545	sca1
9506545	control subjects
9506545	n =
9506545	smooth pursuit gain
9506545	trinucleotide repeats
9506545	patient group
9506545	sca3/machado-joseph
9506545	disease onset
9506545	orient diagnoses
9506545	saccade amplitude
9506545	correct assignment
9506545	smooth pursuit
9506545	major criteria
9506545	sca3
9506545	early clinical stages
9506545	saccade velocity
9506545	saccade hypometria
9506545	autosomal dominant cerebellar ataxias type
9288106	t-pll
9288106	b-cell
9288106	tumour suppressor
9288106	tumours establishes somatic inactivation
9288106	atm-related
9288106	chromosomal instability
9288106	ataxia-telangiectasia
9288106	recessive multi-system disorder
9288106	lymphoid neoplasias
9288106	non-hodgkins lymphomas
9288106	normal copy
9288106	prolymphocytic leukaemia
9288106	a-t
9288106	t-cell
9288106	loss-of-function mutations
9288106	atm
9288106	amino-acid substitutions
9288106	significant proportion
9288106	atp
9288106	kinase domain
9288106	cell line
9288106	substrate recognition
9288106	putative hereditary predisposition
9288106	complete absence
9288106	high frequency
9288106	clustering
9288106	p53 gene
9288106	missense mutations
9288106	frequent nucleotide changes
9288106	b-nhl
9288106	ataxia-telangiectasia gene
9288106	dna
9288106	mutation pattern
9288106	rare clonal malignancy
9288106	drosophila
9288106	occasional
9580132	signal peptidases
9580132	missense mutation
9580132	antidiuretic hormone arginine vasopressin
9580132	neurohypophyseal diabetes insipidus
9580132	ala
9580132	spanish kindreds
9580132	avp-neurophysin ii
9580132	premature termination
9580132	c-terminal
9580132	glu
9580132	g279a
9580132	solid phase
9580132	novel nonsense mutation
9580132	avp
9580132	ii
9580132	autosomal dominant disease
9580132	signal peptide
9580132	npii
9580132	identification
9580132	cysteine residue
9580132	familial neurohypophyseal diabetes insipidus
9580132	stop signal
9580132	familial
9580132	dna
9580132	pcr-amplified avp-npii dna
9580132	avp-npii
9580132	fndi
9580132	missense substitution
9580132	thr
9714764	spacer domains
9714764	ldlr
9714764	insulin-dependent diabetes mellitus
9714764	new category
9714764	evolutionary conservation
9714764	cytoplasmic domain
9714764	novel member
9714764	putative signal peptide
9714764	receptor family
9714764	chromosomal position
9714764	ldl
9714764	low-density lipoprotein
9714764	cloning
9714764	lrp5
9714764	low-density lipoprotein receptor
9714764	low-density lipoprotein receptor family
9714764	egf
9714764	sequence analysis
9714764	epidermal growth factor
9714764	high degree
9714764	ldl-receptor
9714764	iddm4
9714764	iddm
9714764	amino acids
9714764	novel transmembrane protein
9714764	dna
9714764	mature proteins
9714764	unique organization
9714764	based
9792409	germline mutations
9792409	classical ataxia-telangiectasia patients
9792409	relative high percentage
9792409	7-kb genomic deletion
9792409	ethnic origin
9792409	significant founder effect
9792409	point mutations
9792409	dutch
9792409	protein truncation test
9792409	detection efficiency
9792409	a-t
9792409	small ethnic population groups
9792409	such communities
9792409	atm
9792409	mutation spectrum
9792409	line
9792409	mutations
9792409	ptt
9792409	europe
9792409	small deletions
9792409	cellular radioresistant
9792409	immigrant populations
9792409	compound heterozygote
9792409	autosomal recessive disorder ataxia-telangiectasia
9792409	germline
9792409	splice-site mutations
9792409	splice sites
9792409	founder mutation
9792409	genetic heterogeneity
9792409	dna
9792409	high carrier frequency
9792409	restriction endonuclease
9792409	ref
9867744	currently
9867744	diagnosis
9867744	serious illness
9867744	useful role
9867744	serum ferritin level
9867744	diagnose hemochromatosis
9867744	hepatic cirrhosis
9867744	dna-based
9867744	liver biopsy specimens
9867744	phlebotomy therapy
9867744	serious chronic disease
9867744	assess patients
9867744	normal life expectancy
9867744	case detection
9867744	early death
9867744	liver
9867744	hfe
9867744	serum ferritin levels
9867744	family members
9867744	serum transferrin saturation
9482572	congenital cataracts
9482572	twenty-eight
9482572	nonsense codons
9482572	mutations
9482572	missense mutations
9482572	mutant allele
9482572	increased
9482572	c-t
9482572	exonic substitutions result
9482572	high sequence conservation
9482572	insertion events
9482572	cpg
9482572	foveal hypoplasia
9482572	pax6
9482572	peters
9482572	autosomal dominant keratitis
9482572	human aniridia
9674906	radiographic findings
9674906	lethal form
9674906	recent
9674906	possible nosologic identity
9674906	rare condition
9674906	molecular methods
9674906	syndrome type
9674906	follow-up observation
9674906	patients
9674906	comprises campomelia
9674906	sws
9674906	unique pattern
9674906	schwartz-jampel
9674906	stuve-wiedemann
9674906	frequent death
9674906	skeletal dysplasia
9674906	sjs
9674906	prenatal-onset neuromuscular disorder
9674906	congenital joint contractures
9674906	distinct campomelic-metaphyseal skeletal dysplasia
9674906	early death
9674906	progressive bone dysplasia
9536083	jews
9536083	iraqi jews
9536083	general population
9536083	jewish 185delag mutation carriers
9536083	iranian jews
9536083	founder effect notion
9536083	allelic pattern
9536083	moroccan
9536083	ashkenazi jews
9536083	jewish mutation carriers
9536083	non-ashkenazi subsets
9536083	mutation carriers
9536083	mutation occurs
9536083	brca1
9536083	ovarian cancer
9536083	ashkenazi
9536083	n =
9536083	ashkenazim
9536083	familial breast
9536083	similar allelic pattern
9536083	non-ashkenazi populations
9536083	mutations origin
9536083	previous study
9536083	additional non-ashkenazi 185delag mutation carriers
9536083	common allelic pattern
9536083	allelic patterns
9536083	dna
9536083	185delag mutation
9536083	different allelic pattern
9536083	heteroduplex
9536083	iranians
9536083	yemenites
9536083	breast/ovarian cancer
9536083	non-ashkenazi individuals
9400934	gene mutation
9400934	retinal tumours
9400934	pocket region
9400934	pineal tumours
9400934	ectopic intracranial retinoblastoma
9400934	dna
9400934	constitutional cells
9400934	rb1
9400934	nonsense mutation
9400934	germline origin
9400934	initial mutation
9729124	putative promoter region sequence shows
9729124	intestinal anion transporter
9729124	gt/ag
9729124	genomic
9729124	tata
9729124	complete genomic organization
9729124	congenital
9729124	facilitate mutation
9729124	h_rg364p16
9729124	similar genomic structure
9729124	pds
9729124	human congenital chloride diarrhea
9729124	genomic structure
9729124	homologous gene
9729124	multiple transcription factor
9729124	exon-specific
9729124	multiple large-insert libaries
9729124	cld
9729124	pendred
9729124	finnish cld
9729124	chloride diarrhea
9729124	bac
9729124	dna
9729124	exon/intron boundaries conform
9729124	syndrome gene
9585605	missense mutation
9585605	sscp
9585605	mutation
9585605	ube3a
9585605	angelman
9585605	sporadic case
9585605	sporadic cases
9585605	coding-region mutations
9585605	unique mutations
9585605	stop codon
9585605	syndrome patients
9585605	e2
9585605	small deletions
9585605	maternal origin
9585605	novo 5-bp duplications
9585605	familial cases
9585605	upd
9585605	ubiquitin-protein ligase
9585605	hect domain
9585605	maternal grandfather
9585605	as
9585605	paternal uniparental disomy
9585605	chromosome 15q11-q13 deletions
9585605	shows brain-specific
9360520	missense mutation
9360520	progressive degeneration
9360520	diabetes insipidus
9360520	t1-weighted
9360520	affected
9360520	adndi
9360520	novel missense mutation
9360520	avp-neurophysin ii
9360520	fathers pituitary gland demonstrates
9360520	dominant neurohypophyseal diabetes insipidus
9360520	bright spot
9360520	posterior pituitary
9360520	hormone arginine vasopressin
9360520	avp
9360520	amino acid substitution
9360520	ii
9360520	early age
9360520	signal peptide
9360520	symptoms suggests
9360520	val
9360520	autosomal
9360520	npii
9360520	gly23
9360520	restriction endonuclease analysis
9360520	prepro-avp-npii precursor
9360520	magnocellular neuron
9360520	g1758
9360520	magnetic resonance
9360520	genetic locus
9360520	magnocellular neurons
9709714	f458l
9709714	5-year-old girl
9709714	missense mutation
9709714	dehydrogenase deficiency
9709714	very-long-chain acyl-coenzyme
9709714	excellent neuropsychologic outcome
9709714	reversal
9709714	intravenous glucose
9709714	t1372c
9709714	fatty acid beta oxidation
9709714	clinical
9709714	severe hypertrophic cardiomyopathy
9709714	ventricular hypertrophy
9709714	inactive enzyme
9709714	very-long-chain
9709714	vlcad
9709714	molecular
9709714	treatable causes
9709714	biochemical
9709714	low-fat diet
9709714	high rates
9709714	superior range
9709714	initial treatment
9709714	genetic analysis
9709714	splice site mutation
9709714	acag
9709714	medium-chain triglyceride oil
9600235	premature protein truncation
9600235	mutant alleles
9600235	different families
9600235	a-t
9600235	founder mutations
9600235	different mutations
9600235	atm
9600235	human recessive disease ataxia-telangiectasia
9600235	mutations
9600235	human chromosome
9600235	possible mutational hotspots
9600235	splice donor site
9600235	mutations 4612del165
9600235	microsatellite
9600235	possible preponderance
9600235	exon exon
9600235	founder mutations 4612del165
9600235	4612del165 mutations
9600235	restriction endonuclease
9600235	minute deletions
9600235	japanese ataxia-telangiectasia patients
9600235	rna
9600235	common haplotype
9770531	vhl
9770531	renal cell carcinoma cell lines
9770531	one-pass transmembrane
9770531	similar results
9770531	additional
9770531	chromosome bands
9770531	parental renal cell carcinoma cell lines
9770531	down-regulation
9770531	human cancers
9770531	wild-type von
9770531	ca
9770531	vhl-expressing
9770531	ca ix
9770531	extracellular microenvironment
9770531	differential display technology
9770531	intact catalytic domain
9770531	large-scale rna
9770531	cell lines
9770531	ca xii
9770531	potential impact
9770531	hippel-lindau
9770531	protein contribute
9770531	reintroduced
9770531	ca9
9770531	ca12
9770531	cancer cell growth
9770531	alpha carbonic anhydrase gene
9770531	protein sequence
9770531	transmembrane carbonic anhydrases
9385378	s162f
9385378	racial origin
9385378	colombian mps iva
9385378	mucopolysaccharidosis iva
9385378	genetic backgrounds
9385378	colombian
9385378	various ethnic groups
9385378	novel common missense mutation
9385378	american descen
9385378	genetic background
9385378	iva
9385378	common mutations
9385378	haplotype analysis
9385378	genetic defect
9385378	novel missense mutations
9385378	sulfatase gene
9385378	autosomal recessive lysosomal storage disorder
9385378	previous studies
9385378	n-acetylgalactosamine-6-sulfate
9385378	mtdna lineages
9385378	common ancestor
9385378	caucasians
9385378	g301c
9385378	f69v
9385378	mutational spectrum
9385378	galns
9385378	dna
9385378	mps iva
9385378	restriction fragment length polymorphisms
9603435	base substitution
9603435	less
9603435	clinical manifestations
9603435	tsd
9603435	furthermore
9603435	enzyme deficiency
9603435	tatc
9603435	subacute variant
9603435	early processing
9603435	alpha-subunit precursor
9603435	m2
9603435	enzyme activity
9603435	tay-sachs
9603435	fatal infantile form
9603435	mature alpha-subunit
9603435	hexa
9603435	4-bp insertion
9603435	precursor level
9603435	w474c
9603435	amino acid
9603435	w474c-containing
9603435	mutations
9603435	type
9603435	broad spectrum
9603435	alpha-subunit processing
9603435	proband fibroblasts
9603435	hex
9603435	non-jewish proband
9603435	cos-7
9603435	amino acid substitution affects
9603435	pulse-chase
9603435	> c
9603435	residual levels
9603435	> c mutation
9603435	mature lysosomal alpha-subunit
9603435	normal alpha-subunit precursor levels
9603435	normal alpha-subunit transfections
9294109	normal biological role
9294109	involves changes
9294109	muscular disorder
9294109	dm
9294109	atpase
9294109	[ -/- ] myotubes exhibit
9294109	atp-driven
9294109	voltage-dependent l-type
9294109	dystrophy protein kinase
9294109	n-repeat expansion
9294109	+ channels
9294109	high external
9294109	sarcoplasmic reticulum
9294109	mutant myotubes exhibit
9294109	ca2
9294109	+ channel
9294109	+ transients
9294109	ca2+
9294109	initial events
9294109	ion pumps
9294109	wild-type myotubes
9294109	dmpk
9294109	+/k +
9294109	skeletal muscle
9294109	ion homeostasis
9294109	[ -/- ] knockout mice
9294109	+ ] i
9294109	myotonic
9294109	protein kinase
9294109	cellular ion homeostasis
9294109	skeletal muscle cells
9294109	+ -atpase
9294109	na
9294109	ctg
9294109	open probability
9294109	+ responses
9618170	japanese patients
9618170	unique site
9618170	muscle exon
9618170	insertional
9618170	x-linked
9618170	japanese families
9618170	pathogenic correlation
9618170	l1
9618170	transposable element
9618170	gene results
9618170	cardiospecific mutations
9618170	dmd
9618170	duchenne
9618170	skeletal myopathy
9618170	preferential myocardial involvement
9618170	cell form
9618170	purkinje
9618170	muscle form
9618170	dystrophin transcripts
9618170	clinical phenotype
9618170	xldcm
9618170	muscular dystrophy gene
9618170	overt clinical signs
9585583	interfamilial phenotypic variability
9585583	limb development
9585583	fgfrs
9585583	low frontal hairline
9585583	significant
9585583	coronal synostosis
9585583	pfeiffer
9585583	fgfr
9585583	fgfr2
9585583	craniosynostotic condition-such
9585583	fgfr2 vv269-270
9585583	limb anomalies
9585583	molecular pathway
9585583	thirty-two
9585583	fgfr3 p250r
9585583	saethre-chotzen
9585583	common autosomal dominant condition
9585583	syndrome patients
9585583	facial asymmetry
9585583	fgfr3
9585583	crouzon
9585583	genetic
9585583	broad great toes
9585583	common phenotypic
9585583	twist
9585583	detection rate
9371490	allelotype studies
9371490	major genetic events
9371490	common male cancer
9371490	sporadic
9371490	frequent loss
9371490	sporadic prostate cancer
9371490	deletion
9371490	primary prostate cancer
9371490	new tumor suppressor gene
9371490	frequent
9371490	pten/mmac1
9371490	homozygous deletion
9371490	western world
9371490	prostate cancer cell lines
9371490	fatal cancer
9371490	numerous
9371490	prostate tumors
9371490	sequence analysis
9371490	tumors establishes
9371490	new intragenic markers
9371490	chromosomal arm 10q
9371490	minimal area
9371490	mutational event
9371490	microsatellite analysis
9371490	main inactivation target
9371490	prostate carcinoma
9371490	10q loss
9521421	mild phenotype
9521421	novel mutations
9521421	milder patients
9521421	mucopolysaccharidosis iva
9521421	various clinical phenotypes
9521421	mutant cells
9521421	rflps
9521421	novel mutation
9521421	extensive allelic heterogeneity
9521421	common single mutation
9521421	high residual
9521421	t312s
9521421	molecular
9521421	severe phenotype
9521421	previous
9521421	additional data
9521421	iva
9521421	relative frequencies
9521421	common mutations
9521421	genetic defect
9521421	ireland
9521421	autosomal recessive lysosomal storage disorder
9521421	haplotype
9521421	severe clinical phenotype
9521421	n-acetylgalactosamine-6-sulfate
9521421	british-irish
9521421	common ancestor
9521421	mutant cdna
9521421	irish migrants
9521421	i113f
9521421	common allele
9521421	galns
9521421	mps iva
9521421	australia
9852676	major ancient mutation
9852676	n repeat mutation
9852676	mutation exists
9852676	copy number
9852676	expansion mutation
9852676	founder chromosome
9852676	caucasian
9852676	triplet repeat expansion
9852676	common ancestral mutations
9852676	previous
9852676	n =
9852676	different haplotypes
9852676	n repeat
9852676	ancestral n =
9852676	normal chromosomes
9852676	molecular events
9852676	polymorphic markers
9852676	linkage disequilibrium studies
9852676	japanese populations
9852676	n repeat region
9852676	myotonic dystrophy
9852676	data support multistep models
9852676	ctg
9852676	friedreichs
9852676	dm
9425228	germline mutations
9425228	melanoma pedigrees
9425228	cdk4
9425228	arg24his
9425228	gene worldwide
9425228	familial melanoma
9425228	p16 gene mutation
9425228	p16 gene
9425228	major criteria families
9425228	n =
9425228	frequent involvement
9425228	france
9425228	different p16 germline mutations
9425228	sixteen
9425228	melanoma-prone families
9425228	germline mutation
9425228	additional minor criterion
9425228	germline
9425228	such germline mutations
9425228	french melanoma-prone families
9425228	prevalence
9888388	respective expression
9888388	dgge
9888388	hereditary coproporphyria
9888388	new different mutations
9888388	infectious diseases
9888388	mutation update
9888388	novel mutations
9888388	bp deletion polymorphism
9888388	prokaryotic system
9888388	autosomal dominant inheritance
9888388	hc
9888388	gradient gel electrophoresis
9888388	point mutations
9888388	cyclical hormonal changes
9888388	q385x
9888388	w427r
9888388	clinical
9888388	coproporphyrinogen oxidase gene defects
9888388	pathological significance
9888388	> g
9888388	hereditary
9888388	neurological dysfunction
9888388	france
9888388	czech
9888388	exon/intron boundaries
9888388	skin
9888388	normal termination codon
9888388	cpo
9888388	small deletions
9888388	acute hepatic porphyria
9888388	deficient activity
9888388	intragenic dimorphisms
9888388	gene defects
9888388	new polymorphisms
9888388	g197w
9888388	ivs1-15c
9888388	bp upstream
9888388	transcriptional initiation site
9888388	c/g
9888388	high degree
9888388	iii
9888388	in-frame deletion
9888388	new acceptor splice site
9888388	promotor region
9888388	acute attacks
9888388	allelic heterogeneity
9888388	holland
9888388	q306x
9888388	systematic
9463309	hp2/hpdel
9463309	allelic deletion
9463309	gene-dosage effect
9463309	hpr
9463309	low level
9463309	hp1
9463309	alpha chain
9463309	anomalous inheritance
9463309	gene cluster
9463309	pcr
9463309	n =
9463309	hp2
9463309	promoter region
9463309	hp2-1
9463309	hp
9463309	hp1/hp2
9463309	gene deletion
9463309	beta chain
9463309	+/-sd =
9463309	healthy volunteers
9463309	haptoglobin gene
9463309	control sera
9463309	hp1/hpdel
9463309	dna
9463309	hpdel
9463309	haptoglobin-gene deletion
9463309	southern blot
9463309	present study
9585611	colonic adenomas
9585611	different regions
9585611	tumor suppressor
9585611	desmoid tumors
9585611	distal end
9585611	rectal polyp
9585611	germ-line
9585611	apc
9585611	colorectal adenomas
9585611	colorectal cancer
9585611	aapc
9585611	clinical-management protocols
9585611	specific phenotypic expression
9585611	upper-gastrointestinal manifestations
9585611	mutations
9585611	genotype-phenotype
9585611	ptt
9585611	assess genotype-phenotype correlations
9585611	variability
9585611	novel germ-line
9585611	fap
9585611	protein-truncation test
9585611	familial adenomatous polyposis
9585611	age >
9585611	average number
9585611	phenotypic differences
9585611	adenomatous polyposis coli
9724771	recently
9724771	multiple colorectal adenomas
9724771	general population
9724771	germ-line variants
9724771	e1317q
9724771	germ-line mutations
9724771	apc
9724771	metaplastic polyps
9724771	classical
9724771	colorectal adenomas
9724771	multiple colorectal adenomas and/or carcinoma
9724771	multiple adenomas
9724771	florid phenotype
9724771	ashkenazi
9724771	ashkenazim
9724771	large number
9724771	missense variant
9724771	colorectal tumors
9724771	i1307k
9724771	high-penetrance autosomal dominant disease
9724771	family history
9724771	exon 15g
9724771	fap
9724771	adenomatous polyposis coli patients
9724771	familial adenomatous polyposis
9724771	colorectal cancer risk
9724771	adenomatous polyposis coli
9724771	attenuated
9585606	australian aboriginal
9585606	> =
9585606	hla-typed
9585606	allele frequency
9585606	chinese samples
9585606	northern european origin
9585606	caucasian
9585606	amino acid substitutions-cdna nucleotides
9585606	recent admixture
9585606	islanders
9585606	non-caucasian populations
9585606	pcr
9585606	restriction-enzyme digestion
9585606	wide variety
9585606	premature death
9585606	caucasians
9585606	c282y
9585606	hla
9585606	h63d
9585606	hfe
9585606	hemochromatosis gene
9585606	hemochromatosis
9585606	present study
9703501	repair protein
9703501	dna
9703501	hydrogen peroxide
9703501	zinc finger protein
9703501	brca1
9703501	rad51
9703501	cellular localization
9703501	dna-damaging
9703501	mouse embryonic stem cells deficient
9703501	unknown function
9703501	ovarian cancer susceptibility gene
9689113	willebrand
9689113	endothelial cells
9689113	vwf-deficient mice
9689113	defective
9689113	ferric chloride
9689113	vivo model
9689113	homozygous mutant mice
9689113	normal physiology
9689113	intravital microscopy
9689113	vwf propolypeptide
9689113	severe human von
9689113	mouse model
9689113	human disease
9689113	disease models
9689113	severe von
9689113	mutant mice
9689113	viii
9689113	ii
9689113	vascular injury
9689113	deficiency causes
9448273	vhl-negative
9448273	vhl
9448273	tumor suppressor
9448273	sporadic renal cell carcinomas
9448273	tumor suppressor gene
9448273	growth rate
9448273	tumor suppressor gene predisposes
9448273	cyclin-dependent kinase inhibitor
9448273	cells exit
9448273	cell cycle profile
9448273	low serum
9448273	nude mice
9448273	cancer cells
9448273	gene results
9448273	serum withdrawal
9448273	rcc
9448273	gatekeeper function
9448273	remarkably
9448273	serum-dependent growth control
9448273	vhl-positive
9448273	cell line
9448273	hippel-lindau
9448273	cancer syndrome
9448273	cell cycle
9448273	initiate tumor formation
9448273	g0/quiescence
9448273	vhl-negative rcc
9448273	contact inhibition
9448273	brain hemangioblastomas
9448273	gene restores
9448273	specific cellular defect
9448273	cell cycle exit
9703418	cga
9703418	japanese complement
9703418	molecular basis
9703418	meningococcal meningitis
9703418	deficiency
9703418	mutant alleles
9703418	dna
9703418	common complement deficiency
9703418	nonsense substitution
9703418	japan
9703418	c9
9703418	c9-deficient
9703418	direct
9703418	common mutation
9703418	nonsense
9703418	human complement
9703418	allele-specific polymerase chain reaction system
9703418	tga
9848786	acute renal disease
9848786	large deletion
9848786	complement deficiency
9848786	hemolytic uremic syndrome
9848786	pcr
9848786	fhr
9848786	fh
9848786	hus
9848786	factor h
9848786	factor h-like
9848786	study reports
9848786	150-kd form
9848786	heterozygous deficiency
9848786	fh-related
9848786	idiopathic hemolytic uremic syndrome
9848786	fhl-1
9848786	human complement regulatory protein
9848786	human complement factor
9848786	homozygous deficiency
9848786	dna
9848786	southern blot
9342365	nuclear dots.
9342365	tumor suppressor
9342365	discrete subnuclear foci
9342365	brca1-mediated
9342365	cell cycle-dependent colocalization
9342365	gene predispose women
9342365	tumor suppression
9342365	subcellular localization
9342365	genes presumptive function
9342365	early-onset breast
9342365	germ-line
9342365	cell cycle progression
9342365	biochemical properties
9342365	nuclear fractions
9342365	brca1
9342365	ovarian cancer
9342365	expression pattern
9342365	nuclear dots
9342365	nuclear domains
9342365	cell-cycle regulation
9342365	bard1
9342365	s-phase
9342365	steady-state levels
9342365	g1
9342365	cell
9342365	cycle-dependent colocalization
9342365	s phase
9342365	cell cycle
9342365	g1-
9342365	s phase cells
9521325	missense mutation
9521325	sodium channels
9521325	small size
9521325	molecular mechanism
9521325	sudden deaths
9521325	frameshift mutation causes
9521325	usa
9521325	fibrillation causes
9521325	scn5a
9521325	ion channels
9521325	ivf
9521325	idiopathic ventricular fibrillation
9521325	cardiac rhythm disturbance
9521325	characteristic electrocardiographic pattern
9521325	molecular genetic studies
9521325	ventricular
9521325	genetic
9521325	frameshift mutation
9521325	high incidence
9521325	distinct group
9521325	sudden death
9521325	cardiac sodium channel gene
9521325	sodium channel
9521325	cardiac ion-channel genes contribute
9521325	splice-donor mutation
9521325	non-cardiac causes
9869602	colorectal
9869602	jews
9869602	non-european origin
9869602	colorectal cancer incidence
9869602	israelis
9869602	ethnic origin
9869602	israeli jews
9869602	i. e.
9869602	ethnic group
9869602	i1307k apc
9869602	aims israeli jews
9869602	israeli
9869602	ashkenazi jews
9869602	methods dna
9869602	conclusions
9869602	european birth
9869602	susceptibility gene
9869602	colorectal cancer
9869602	cancer risk
9869602	ashkenazim
9869602	ashkenazi i1307k
9869602	average risk
9869602	familial cancer
9869602	familial colorectal cancer cases
9869602	i1307k
9869602	noncolonic neoplasia
9869602	family history
9869602	results
9869602	gene variant
9869602	background
9869602	personal and/or family history
9869602	aso
9869602	allele-specific oligonucleotide
9869602	ashkenazi israelis
9869602	prevalence
9336417	mx
9336417	conclusion susceptibility
9336417	disease severity scores
9336417	b27
9336417	susceptibility
9336417	radiographic examinations
9336417	dr1
9336417	environmental factors
9336417	environmental trigger
9336417	twin pairs
9336417	sequence-specific primers
9336417	clinical
9336417	relative effects
9336417	hla-b60
9336417	nonsignificant
9336417	methods
9336417	objective
9336417	previous studies
9336417	overall genetic susceptibility
9336417	twin pairs overall
9336417	b27-positive
9336417	genetic
9336417	mz
9336417	results
9336417	disease concordant
9336417	disease onset
9336417	population variance
9336417	environmental variance components
9336417	royal national hospital
9336417	hla-b27
9336417	microsatellite markers
9336417	hla
9336417	as
9336417	hla-dr1
9336417	polymerase chain reaction
9336417	dz
9336417	b60
9336417	additive
9336417	rheumatic diseases
9336417	disease concordance
9336417	disease severity
9731533	homopolymer tract
9731533	apc i1307k
9731533	first-degree relatives
9731533	apci1307k
9731533	ashkenazi jews
9731533	apc
9731533	somatic loss occurs
9731533	penetrant autosomal dominant disorder
9731533	crc
9731533	colorectal cancer
9731533	cancer risk
9731533	wild-type sequence
9731533	ashkenazi
9731533	ashkenazim
9731533	multiple intestinal polyps
9731533	mutations
9731533	i1307k
9731533	personal histories
9731533	somatic mutation
9731533	community survey
9731533	fap
9731533	tumour-suppressor gene
9731533	familial adenomatous polyposis
9731533	risk
9731533	t-to-a
9731533	a8
9731533	allele converts
9731533	surgical intervention
9465039	major histocompatibility
9465039	patients heterozygous
9465039	scatchard
9465039	beta2m association
9465039	candidate gene
9465039	studies
9465039	stable complexes
9465039	protein decreases
9465039	furthermore
9465039	patient chromosomes
9465039	addition
9465039	soluble wild-type
9465039	hfe/beta2m
9465039	cys-282
9465039	hela
9465039	regulatory mechanism
9465039	complex class
9465039	h63d hfe
9465039	tfr
9465039	direct evidence
9465039	proteins form
9465039	hereditary hemochromatosis
9465039	key protein
9465039	apparent affinity
9465039	i-like
9465039	prevents cell-surface expression
9465039	molecular link
9465039	c282y
9465039	gene product
9465039	tyr
9465039	h63d
9465039	degrees c
9465039	hfe
9465039	functional consequence
9465039	hemochromatosis gene product complexes
9465039	steady-state conditions
9465039	concentration-dependent manner
9465039	transferrin receptor
9457913	abnormal processing
9457913	aberrant transcripts
9457913	mrna splice variants
9457913	bases upstream
9457913	splice variants
9457913	mrna decay
9457913	new methodology
9457913	cycloheximide
9457913	cycloheximide treatment
9457913	atrophic benign epidermolysis bullosa
9457913	g-to-t
9457913	cryptic splice site
9457913	patients
9457913	premature termination codon
9457913	acceptor splice-site mutation
9457913	novel splice-site mutation
9457913	reverse transcriptase polymerase chain reaction
9457913	frameshift mutation
9457913	splice-site mutations
9457913	report documents
9457913	transmembrane hemidesmosomal protein
9457913	premature termination codons
9457913	microg cycloheximide
9457913	splice-site mutation
9457913	col17a1
9457913	keratinocytes homozygous
9457913	mutational
9457913	based
9457913	undetectable levels
9457913	rna
9457913	xvii
9463318	methylation pattern
9463318	sacii
9463318	hpaii
9463318	preliminary
9463318	complete methylation
9463318	methylation-sensitive restriction enzymes
9463318	restriction sites
9463318	gene segment
9463318	protein-dna contact
9463318	normal genes
9463318	repetitive sequence
9463318	myotonic dystrophy patients
9463318	significant reduction
9463318	normal individuals
9463318	site upstream
9463318	dmpk
9463318	saci-hindiii
9463318	constitutive methylation
9463318	hhai
9463318	bp upstream
9463318	myotonic dystrophy
9463318	sp1
9463318	ctg
9425239	allele length
9425239	genetic basis
9425239	clinical severity
9425239	high level
9425239	progression
9425239	size heterogeneity
9425239	allele size
9425239	different tissues
9425239	dm
9425239	progressive nature
9425239	repeat somatic instability
9425239	blood cells
9425239	direct progression
9425239	repeat length changes
9425239	myotonic dystrophy patients
9425239	utr
9425239	somatic mosaicism
9425239	time interval
9425239	repeat length heterogeneity
9425239	high degree
9425239	protein kinase gene
9425239	somatic instability
9425239	myotonic dystrophy
9425239	accurate predictor
9425239	repeat size
9425239	ctg
9425239	dm ctg
9425239	attempts
9425239	individual specific genetic and/or environmental factors
9425239	time intervals
9973276	recently
9973276	familial adenomatous polyposis syndrome
9973276	apc i1307k
9973276	initiate colorectal tumor formation
9973276	furthermore
9973276	long-term-outcome studies
9973276	jewish population
9973276	separate population control groups
9973276	colorectal cancer prevention
9973276	allelic variant
9973276	germ-line
9973276	apc
9973276	compared
9973276	colorectal cancer
9973276	large cohort
9973276	cancer risk
9973276	inherited
9973276	jewish subjects
9973276	ashkenazi
9973276	relative risk
9973276	i1307k
9973276	adenoma formation
9973276	specific clinical
9973276	sporadic colorectal carcinogenesis
9973276	colorectal polyposis
9973276	> lysine polymorphism
9973276	colorectal carcinogenesis
9973276	adenomatous polyps
9973276	colorectal cancers
9973276	jewish colorectal cancer
9973276	colorectal neoplasia
9927033	hereditary nonpolyposis colorectal cancer family
9927033	heterozygous
9927033	neurofibromatosis type
9927033	homozygous germ-line
9927033	leukemia and/or lymphoma
9927033	mutator phenotype
9927033	germ-line mutations
9927033	deficiency predisposes
9927033	arg226stop
9927033	mismatch repair genes lead
9927033	hematological malignancy
9927033	mlh1
9927033	consequent mismatch repair deficiency results
9927033	sequence analysis
9927033	disease susceptibility
9927033	nf1
9927033	dna
9927033	allele-specific amplification
9927033	c676t
9927033	hereditary nonpolyposis colorectal cancer
9927033	wild-type alleles
9800909	molecular explanation
9800909	dp140 dna
9800909	comparison
9800909	molecular
9800909	qualitative
9800909	dmd
9800909	severe cerebral dysfunction
9800909	muscular dystrophy
9800909	duchenne
9800909	dp140
9800909	visuospatial intelligence
9800909	cognitive impairment
9800909	complete
9800909	brain dystrophin isoforms
9800909	neuropsychological analysis
9800909	dp71
9800909	verbal memory
9800909	distal part
9800909	psychometric findings
9800909	neuropsychological
9800909	reading skills
9800909	dystrophin gene
9861003	bipolar affective disorder
9861003	psychiatric disorder
9861003	genome-wide linkage scan
9861003	clinical manifestations
9861003	large multigeneration
9861003	old order
9861003	high risk
9861003	identify chromosomal loci
9861003	chromosome 4p
9861003	certain alleles
9861003	mental health wellness
9861003	compelling
9861003	protective alleles
9861003	suggestive evidence
9861003	chromosomal loci
9861003	significant genetic component
9861003	strong evidence
9861003	d4s2949
9861003	evidence supports
9861003	bpad
9861003	genetic disorders
9861003	value <
9861003	amish
9861003	genehunter-plus
9861003	d4s397
9861003	high incidence
9861003	affective disorders
9861003	manic-depressive illness
9861003	genome-wide search
9861003	nonparametric linkage score =
9861003	chromosome 4q
9861003	linkage studies
9861003	sibpal pempirical
9861003	mania and/or hypomania
9861003	affective disorder
9861003	bipolar
932197	hemolytic assay
932197	black female
932197	family studies
932197	autosomal codominant inheritance
932197	biologic functions
932197	c4
932197	alternate-day corticosteroid therapy
932197	c5
932197	serum hemolytic complement activity
932197	inhibitory effect
932197	normal
932197	c5-deficient
932197	c5d
932197	clinical
932197	normal concentrations
932197	low dilutions
932197	systemic lupus erythematosus
932197	hereditary
932197	complement components
932197	pyogenic infection
932197	linear dose-response plots
932197	hemolytic assays
932197	bacterial infections
932197	c1
932197	c3
932197	family members
932197	membranous glomerulonephritis
932197	c2
932197	hemolytic titers
932197	neutrophilic leukocytosis
932197	remarkable propensity
932197	hereditary deficiency
932197	normal coagulation function
932197	clinical interest
932197	normal serum
9439660	strong pre-disposition
9439660	chromatid damage
9439660	phase chromosomal radiosensitivity
9439660	vitro radiosensitivity
9439660	tumor risk
9439660	a-t
9439660	manifests extreme radiosensitivity
9439660	x-irradiation
9439660	atm
9439660	peripheral blood lymphocytes
9439660	detection
9439660	sporadic cancers
9439660	gy
9439660	molecular genetic analyses
9439660	moderate increase
9439660	g2
9439660	clinical expression
9439660	normal controls
9439660	heterozygous carriers
9439660	blind chromosomal analysis
9439660	potential involvement
9439660	g2-phase
9439660	cytogenetic method
9439660	heterozygotes
9439660	chromosomal radiosensitivity assay
9439660	autosomal recessive syndrome
9856498	small variations
9856498	molecular defects
9856498	c6
9856498	meningococcal
9856498	molecular basis
9856498	netherlands
9856498	c6/c7
9856498	recurrent disease
9856498	1195delc defects
9856498	1936delg defect
9856498	african-americans
9856498	879delg defect
9856498	common defect
9856498	total deficiency 879delg
9856498	dutch c6-deficient
9856498	africa
9856498	western cape
9856498	dna
9856498	c6q0
9856498	marker haplotypes
9856498	human complement
9856498	deficiency
9744473	arsa
9744473	recently
9744473	metachromatic leukodystrophy
9744473	draghia
9744473	ml
9744473	f =
9744473	enzyme activity
9744473	american population
9744473	african
9744473	mld
9744473	n =
9744473	r496h
9744473	enzyme activity causes metachromatic leukodystrophy
9744473	gene mutations
9744473	high frequency
9744473	deficiency
9450866	kit
9450866	gene mutation
9450866	various forms
9450866	xhosa
9450866	profound congenital sensorineural deafness
9450866	sensorineural deafness
9450866	waardenburg
9450866	intracellular kinase domain
9450866	severe piebaldism
9450866	clinical similarity
9450866	r796g
9450866	african
9450866	auditory anomalies
9450866	phenotypic range
9450866	human piebaldism
9450866	piebaldism
9450866	novel missense substitution
9450866	molecular evidence
9497246	penetrance analysis
9497246	carriers <
9497246	mutation data
9497246	penetrance model
9497246	breast
9497246	female breast cancer
9497246	breast-ovarian cancer families
9497246	ci
9497246	predisposition genes
9497246	conversely
9497246	brca2
9497246	brca1
9497246	overall
9497246	brca2-mutation
9497246	breast cancer
9497246	lod
9497246	possible penetrance functions
9497246	% confidence interval [
9497246	genetic
9497246	breast cancer families
9497246	linkage consortium
9497246	lifetime risk
9497246	corresponding ovarian cancer risks
9497246	families
9497246	splice sites
9497246	mutation analysis
9497246	cumulative risk
9620771	brain melanocortin-4-receptor
9620771	recent
9620771	patient
9620771	new monogenic endocrine disorder
9620771	msh
9620771	c3804a
9620771	precursor protein pre-pro-opiomelanocortin
9620771	adrenal insufficiency
9620771	hair pigmentation predicts
9620771	human obesity
9620771	central role
9620771	red hair pigmentation
9620771	appropriate synthesis
9620771	melanocortin peptides adrenocorticotrophin
9620771	food intake
9620771	mc4-r
9620771	dual role
9620771	pomc
9620771	genetic defect
9620771	g7013t
9620771	omim
9620771	compound heterozygote
9620771	opioid-receptor ligand beta-endorphin
9620771	severe
9620771	early-onset obesity
9620771	acth
9620771	sequential
9620771	c7133delta
9620771	animal models
9420335	pancreatic cancers
9420335	growth retardation
9420335	key signal transducer
9420335	show abnormal visceral endoderm development
9420335	tumor suppressor gene
9420335	embryos results
9420335	homozygous smad4
9420335	non-cell autonomous
9420335	mutant mice
9420335	cell proliferation
9420335	tgfbeta-related
9420335	visceral endoderm
9420335	smad4 es
9420335	gastrulation defect
9420335	smad4
9420335	rescued
9420335	anterior development
9420335	mutations
9420335	wild-type tetraploid morulae rescues
9420335	severe anterior truncations
9420335	aggregation
9420335	mouse embryo
9420335	smad4/dpc4
9420335	mutant
9420335	mesodermal marker
9420335	smad4-deficient
9420335	important role
9888390	a464v
9888390	+ 1g >
9888390	mutation
9888390	late infantile patient
9888390	values need
9888390	coincidence
9888390	prognostic implications
9888390	gs
9888390	thymidine transition
9888390	novel cytosine
9888390	metachromatic leukodystrophy
9888390	molecular basis
9888390	0-type mutations
9888390	clinical manifestation
9888390	clinical disease
9888390	clinical outbreak
9888390	mld
9888390	fathers genotype
9888390	maternal mutation
9888390	certain genetic conditions
9888390	paternal allele
9888390	phenotypic heterogeneity
9888390	pseudodeficiency allele
9888390	sequence analysis
9888390	classical late infantile metachromatic leukodystrophy
9888390	basepair microdeletion
9888390	mld-like arsa
9888390	mutation a464v
9888390	arsa
9888390	frequent 0-type mutation
9888390	intrafamilial phenotypic heterogeneity
9888390	novel arylsulfatase
9888390	deficient arylsulfatase
9888390	mutation 459+1g >
9888390	serious diagnostic
941901	melanoma tissue
941901	skin fibroblasts
941901	family studies
941901	low
941901	tsd
941901	direct visualization
941901	incomplete hex
941901	rare mutant
941901	appreciable beta hexosaminidase
941901	healthy individuals
941901	tay-sachs
941901	total beta hexosaminidase activity
941901	deae-cellulose
941901	previous
941901	beta hexosaminidase
941901	radial immunodiffusion
941901	common mutant
941901	identification
941901	compound heterozygotes
941901	rate mutant gene
941901	false-positive prenatal diagnosis
941901	apparent deficiency
941901	ion-exchange chromatography
941901	mutant gene
941901	cellulose acetate gel electrophoresis
941901	a. heterozygotes
941901	low amounts
9590284	snrpn
9590284	pws-ic
9590284	molecular mechanisms
9590284	pws
9590284	intragenic deletion
9590284	ic
9590284	prader-willi
9590284	ipw
9590284	mouse homologue
9590284	15q11-q13 region involves
9590284	mouse model
9590284	deletion
9590284	lack expression
9590284	znf127
9590284	gene expression
9590284	syndrome imprinting-centre mutations
9590284	suitable model system
9590284	ndn
9590284	deletion mutations
9590284	zfp127
9590284	mice
9590284	imprinting
9457914	hot spot
9457914	recently
9457914	nail dystrophy
9457914	affected
9457914	junctional epidermolysis bullosa
9457914	patchy alopecia
9457914	atrophic benign epidermolysis bullosa
9457914	eco0109
9457914	patients
9457914	nonlethal form
9457914	4003deltc occurs
9457914	deletion mutation
9457914	austrian
9457914	skin
9457914	families signifies propagation
9457914	intragenic polymorphisms
9457914	polymorphic markers
9457914	compound heterozygotes
9457914	4003deltc alleles
9457914	microsatellite polymorphisms
9457914	dental abnormalities
9457914	ancestral allele
9457914	regions consistent
9457914	cross-over events
9457914	col17a1
9457914	xvii
9457914	high heterozygosity
9457914	new restriction site
9843038	tic
9843038	polymerase
9843038	chain reaction-single strand conformational polymorphism
9843038	tic-2
9843038	tic-1
9843038	novel mutation
9843038	hereditary coproporphyria family
9843038	maei
9843038	hereditary
9843038	autosomal dominant disease
9843038	amino acid position
9843038	cpo
9843038	identification
9843038	alternative translation initiation codon
9843038	nucleotide position
9843038	mutation changes
9843038	hcp
9843038	termination codon
9843038	c-t
9843038	restriction analysis
9843038	direct sequence analyses
9843038	coproporphyrinogen oxidase
9843038	putative presequence
993342	major histocompatibility
993342	informative matings
993342	hla-a
993342	hla-b
993342	recombinant fraction
993342	deficiency gene
993342	informative meioses
993342	b gene
993342	connective tissue disorders
993342	chromosomal order
993342	maximum likelihood value
993342	b allotype
993342	patients
993342	genes lie
993342	matings informative
993342	properdin factor b
993342	lod score
993342	c2
993342	hla
993342	deficiency gene suggests
993342	apparent lack
993342	b allotypes
993342	factor
993342	hla-d
9671401	missense mutation
9671401	retinoblastoma pedigree
9671401	sscp
9671401	restriction enzyme site
9671401	novel missense mutation
9671401	unilateral tumors
9671401	mild expression
9671401	mutation carriers
9671401	strand conformation polymorphism analysis
9671401	linkage analysis
9671401	tumor phenotype
9671401	rb1
9671401	only modify
9671401	family members
9671401	nucleotide position
9671401	analysis
9671401	> arg
9671401	retinoblastoma phenotype
9671401	distinctive phenotypes
9671401	ndei
9671401	important questions
9856499	c6/c7
9856499	splice sites
9856499	molecular defects
9856499	single-nucleotide events
9856499	compound heterozygous individuals
9856499	c7
9856499	new molecular defects
9856499	complement c7
9856499	marker haplotypes
9856499	molecular bases
9856499	others codons
9529364	hot spot
9529364	r394w
9529364	sexual ambiguity
9529364	idms
9529364	significant evidence
9529364	diffuse mesangial sclerosis
9529364	zinc-finger transcription factor
9529364	germ-line mutations
9529364	mutation database
9529364	constitutional
9529364	genotype/phenotype correlations
9529364	zinc finger
9529364	female phenotype
9529364	xy
9529364	identification
9529364	dms
9529364	wt1
9529364	pseudohermaphroditism and/or
9529364	urogenital abnormalities and/or
9529364	male phenotype
9529364	denys-drash
9529364	patients lie
9529364	amino acids
9529364	gonadal development
9529364	normal puberty
9529364	wt
9529364	wilms
9529364	genetic heterogeneity
9529364	different symptoms
9529364	heterozygous mutations
9529364	mutations underwent
9529364	different functions
9529364	dds
9391889	late father
9391889	adult onset
9391889	paternal
9391889	severe muscular weakness
9391889	rare case
9391889	childhood onset
9391889	male transmission contribute
9391889	sibs suffer
9391889	adult type
9391889	paternal transmission
9391889	decreased
9391889	absent occurrence
9391889	repeat lengths
9391889	severe clinical symptoms
9391889	ctg
9391889	congenital myotonic dystrophy
9391889	dm
9465301	gene encodes
9465301	syndrome patients
9465301	ube3ap2
9465301	utr
9465301	ubiquitin-protein ligase
9465301	cdna analysis
9465301	genomic organization
9465301	paternal uniparental disomy
9465301	lack 15q11-q13 deletions
9465301	additional cdna clones
9465301	mrna sizes
9465301	ube3a
9465301	ube3a/e6-ap
9465301	northern analysis
9465301	e6-ap
9465301	angelman
9465301	genomic
9465301	previous ube3a
9465301	ube3ap1
9949197	non-myocyte cells
9949197	autosomal form
9949197	monoclonal antibodies
9949197	candidate gene
9949197	western blot
9949197	lamin b1
9949197	emerin
9949197	edmd
9949197	lap1
9949197	distribution
9949197	lap2
9949197	lamin b receptor
9949197	polyclonal rabbit antiserum
9949197	alternative explanation
9949197	muscular dystrophy
9949197	affinity purification
9949197	specific sites
9949197	emery-dreifuss
9949197	intranuclear spots
9949197	lbr
9949197	nuclear membrane
9949197	nuclear lamina
9949197	skeletal muscle nuclei
9949197	localize emerin
9949197	nuclear membrane protein
9949197	b1
9949197	rabbit heart
9949197	lack emerin
9949197	additional absence
9949197	different emerin epitopes
9949197	cardiac defects
9949197	cardiomyocyte nuclei
9949197	emerin molecule
9949197	pure-emerin band
9949197	emerin gene
9949197	peptide libraries
9988281	non-familial cancers
9988281	breast carcinomas
9988281	epigenetic
9988281	localization
9988281	breast malignancies
9988281	conversely
9988281	ovarian cancers
9988281	subcellular localization
9988281	anti-brca1 antibodies
9988281	sporadic breast cancers
9988281	220-kd protein
9988281	cytoplasmic invaginations
9988281	general acceptance
9988281	epithelial cell lines
9988281	low-grade ductal carcinomas
9988281	benign breast
9988281	brca1
9988281	immunohistochemical
9988281	ovarian cancer
9988281	human breast specimens
9988281	sporadic cancers
9988281	incorrect subcellular localization
9988281	nuclear foci
9988281	reagents detect
9988281	ductal carcinomas
9988281	er/golgi
9988281	non-familial breast
9988281	invasive lobular cancers
9988281	significant percentage
9988281	tumour-suppressor gene
9988281	hereditary breast